A study of biochemical and morphological aspects of macrophage function in experimental murine Nocardia asteroides and Nocardia brasiliensis infections by Stephens, Janet
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
A STUDY OF BIOCHEMICAL AND MORPHOLOGICAL ASPECTS OF MACROPHAGE 
FUNCTION IN EXPERIMENTAL MURINE NOCARDIA ASTEROIDES AND NOCARDIA 
BRASILIENSIS INFECTIONS 
by 
JANET STEPHENS 
B. Pharm (Rhodes) 
Thesis submitted in fulfilment of the requirements of the degree 
of Doctor of Philosophy. 
University of Cape Town 
1987 
i 
  
 
 
 
 
 
 
 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 
of the non-exclusive license granted to UCT by the author. 
 
Un
ive
rsi
ty 
f C
ap
e T
ow
n
DEDICATION 
For Bruce 
ii 
ACKNOWLEDGEMENTS 
I wish to express my sincere appreciation to my husband, Bruce, 
for his encouragement and enduring patience throughout my 
studies, and without whose support I could never have progressed 
this far. 
I would also like to thank Professor Peter Folb for giving me the 
opportunity of working in his laboratory, for his supervision of 
the project and for his ready advice and encouragement. 
I am indebted to Professors Eugene Dowdle and Lyn Wilson and to 
the Department of Clinical Science who taught me the techniques 
of tissue culture, the plasminogen activator assay and allowed me 
to work in their laboratory. 
I am also grateful to Dr Mustapha Keraan for his supervision of 
the thesis, for the use of his laboratory, for his assistance in 
the initial research and for his guidance. 
I would also like to thank: 
My sister, Alison Standish for preparing the graphs and for her 
continual encouragement. 
Dr Stephen Cridland and Dr Rauf Sayed for their advice and 
assistance with the statistics used. 
iii 
Mr Scammel and the staff of the animal house for assistance with 
the research and care of the experimental animals. 
The Department of Clinical Microbiology for the use of their 
laboratory, for their advice and technical assistance. 
Ms Sylvia Pienaar for typing the manuscript and for enduring so 
cheerfully the many changes that needed to be made. 
Mr Andrew Clarke and Mr Rodney Mountain for willing technical 
assistance. 
Ms Susan Abraham for advice and assistance with the graphic work. 
Mr Dane Gernicke for his assistance with the electron microscopy. 
Dr Gregory Filice for useful discussions on several aspects of my 
work. 
Samantha and Carmen for the constant attentiveness. 
Susan Coates for her support and companionship during the writing 
of this thesis. 
I am grateful to the University of Cape Town, the Medical 
Research Council, the Loewenstein Trust, Lilly Laboratories (SA) 
(Pty) Ltd and the Harry Crossley Foundation for financial 
support. 
iv 
Finally, I would like to thank my parents, family and friends for 
their encouragement, help and patience which has meant so much to 
me. 
V 
CONFERENCE PRESENTATIONS 
Part of the work reported in this thesis has been presented at 
the following scientific meetings: 
J Vickerman, M Keraan, PI Folb, EB Dowdle. 
Plasminogen activator release by macrophages as an index of 
stimulation by antigens of Nocardia asteroides and Nocardia 
brasiliensis. 
Johannesburg, SA; 1978 SA Pharmacolog ica 1 Society Congress, SA 
Journal of Science, 1979;75(7):322. 
J Vickerman, M Keraan, PI Folb, EB Dowdle. 
Plasminogen activator release by macrophages as an index of 
stimulation by antigens of Nocardia asteroides and Nocardia 
brasiliensis. 
Cape Town, SA: 1979 Annual Pathology Congress. 
J Vickerman, PI Folb, M Keraan, EB Dowdle. 
Macrophage responses in vitro to Nocardia antigens. 
Cape Town, SA; October 1979. SA Pharmacological Society 
Congress. SA Journal of Science, 1980;76(11):521. 
J Vickerman, PI Folb, M Keraan. 
Macrophage function in opportunistic Nocardia infections 
complicating immunosuppressive drug therapy. 
Brighton, UK; July First International Conference on 
Immunopharmacology Int. J. Immunopharmacology 1980;2(3):220. 
vi 
J Vickerman, PI Folb, M Keraan, EB Dowdle. 
An experimental model of opportunistic Nocardia infections. 
Oaxtepec, Morelos, Mexico, August 1982. 
Symposium on Actinomycetes Biology. 
J Vickerman, PI Folb. 
Fifth International 
Macrophage plasminogen activator release in experimental 
nocardiosis. 
Durban, SA: October 1983. SA Pharmacological Society Congress. 
vii 
CONTENTS 
DEDICATION 
ACKNOWLEDGEMENTS 
CONFERENCE PRESENTATIONS 
CONTENTS 
SUMMARY 
LIST OF FIGURES 
LIST OF TABLES 
GLOSSARY OF ABBREVIATIONS USED 
FIGURE KEY 
TABLE KEY 
SECTION I 
INTRODUCTION 
LITERATURE REVIEW, METHODS AND GENERAL PRINCIPLES 
ii 
iii 
vi 
viii 
xi 
xvi 
xxvii 
xxxxi 
xxxxii 
xxxxiii 
CHAPTER 1 : A review of naturally acquired Nocardia 2 
infections in man and experimental 
Nocardia infections in animals. 
CHAPTER 2 An experimental model of Nocardia 
infections. 
viii 
81 
SECTION II 
IN VITRO SECRETION OF LYTIC ENZYMES BY PERITONEAL 
MACROPHAGES FROM MICE PREVIOUSLY INOCULATED WITH PATHOGENIC 
NOCARDIAE 
CHAPTER 3 
CHAPTER 4 
Nocardia asteroides and Nocardia 
brasiliensis infection in the mouse : 
Induction of plasminogen activator 
secretion by macrophages. 
Lysozyme release from mouse peritoneal 
macrophages Influence of in vivo 
infection with Nocardia asteroides and 
Nocardia brasiliensis. 
SECTION III 
A PHASE CONTRAST AND SCANNING ELECTRON MICROSCOPY STUDY : 
INFLUENCE OF PREVIOUS INOCULATION WITH NOCARDIA ASTEROIDES 
OR NOCARDIA BRASILIENSIS ON MURINE MACROPHAGE MORPHOLOGY 
CHAPTER 5 
PART I 
PART II 
Morphological characteristics of 
macrophages from mice previously 
infected with Nocardia asteroides or 
-------------
Nocar di a brasiliensis A study using 
the phase-contrast inverted microscope. 
A scanning electron microscopy study of 
ix 
145 
296 
441 
455 
CONCLUSIONS 
CHAPTER 6 
the surface characteristic of 
macrophages from mice previously 
inoculated with Nocardia asteroides or 
Nocardia brasiliensis. 
SECTION IV 
Developments in understanding the 
pathogenesis of Nocardia asteroides and 
Nocardia brasiliensis infections. 
X 
499 
SUMMARY 
A STUDY OF BIOCHEMICAL AND MORPHOLOGICAL ASPECTS OF MACROPHAGE 
FUNCTION IN EXPERIMENTAL MURINE NOCARDIA ASTEROIDES AND NOCARDIA 
BRASILIENSIS INFECTIONS. 
Pathogenic Nocardia are facultative intracellular pathogens which 
are capable of growing within macrophages. Host resistance is 
believed to depend on interaction between activated macrophages 
and specifically sensitized T-lymphocytes. 
The macrophage occupies a central position in the control of 
intracellular parasites by cellular immunity, and it has been 
established that initial interactions between Nocardia and 
macrophages are important in limiting the extent of infection 
that might develop. 
Both specifically and non-specifically activated macrophages are 
important in the normal host defence against Nocardia. Although 
most studies suggest that macrophages are activated in 
N.asteroides and N.brasiliensis infections, it may be that an 
alteration in macrophage function occurs in association with the 
disease or as a result of corticosteroid treatment of the host. 
With these considerations in mind this study of macrophage 
function in experimental N.asteroides and N.brasiliensis 
infections was undertaken. 
It had previously been noted that macrophage function in 
xi 
N.asteroides and N.brasiliensis infections may be different. It 
was found that N. brasiliensis infection causes a depression in 
cellular immunity that affects the local host response.This study 
examines the possibility that macrophage responses in 
N.asteroides and N.brasiliensis infections respectively may be 
different by comparing biochemical and morphologica 1 aspects of 
macrophage function. 
Murine macrophage function was determined at 2, 7, 13 and 21 days 
post-inoculation with live organisms of N.asteroides or 
N.brasiliensis and with normal saline. The macrophage function 
was assessed according to the release of pla smi no gen ac ti va tor 
and lysozyme; and by morphology and ul trastructural study. The 
responses of macrophages to in vitro exposure to homologous 
culture filtrate antigens of Nocardia were determined. 
The work has shown that there is early biochemical, morphological 
and ultrastructural change of peritoneal macrophages to 
inoculation with both N.asteroides and N.brasiliensis and that 
these responses do not differ in any major way in the two types 
of infection, although minor differences in enzyme release were 
shown at certain times post-inoculation. 
It was found that plasminogen activator release by macrophages 
from mice previously inoculated with N.asteroides or 
N.brasiliensis was significantly greater at each time interval 
that was studied post-inoculation. Exposure to antigen in vitro 
did not significantly modify release of the enzyme. Macrophage 
xii 
responses in N.asteroides and N.brasiliensis infections appear to 
be comparable with regard to the release of the enzyme, which was 
increased in both infections, al though the degree of response 
differed at the different time intervals post-inoculation. 
Lysozyme release, another index of macrophage activation, was 
examined in N.asteroides and N.brasiliensis infections. This was 
found to be less in macrophages from both N.asteroides and 
N.brasiliensis-inoculated mice harvested 7 days post-inoculation, 
and in macrophages harvested 13 days post-inoculation with 
N.brasiliensis and macrophages harvested 21 days post-inoculation 
with N.asteroides. Diminished secretion of lysozyme was 
associated with reduced intracellular levels, suggesting that 
reduced de novo synthesis rather than inhibition of enzyme 
secretion cause the reduced lysozyme levels in the extracellular 
medium. This aspect of macrophage response to the two Nocardia 
infections was different at 13 and 21 days post-inoculation. 
Macrophages from N.asteroides- and N.brasiliensis-inoculated 
mice, and from controls were examined by phase-contrast and 
scanning electron microscopy. Macrophages from Nocardia 
-inoculated mice exhibited greater spreading, ruffled membranes, 
numbers of lysozomes, and pinocytic activity, which is 
characteristic of activated macrophages. 
Macrophage responses to N.asteroides and N.brasiliensis 
infections were found to be comparable in respect of the 
parameters studied with the exception of lysozyme release at 13 
xiii 
and 21 days post-inoculation. In both infections macrophages are 
activated at each time in terva 1 post-inoculation studied with 
regard to release of plasminogen activator and morphology but not 
with regard to lysozyme release. This finding reinforces the 
idea that different conclusions regarding occurrence of 
activation of macrophages may be drawn depending on the criteria 
selected to assess this phenomenon. The finding that macrophages 
are activated in Nocardia 
parameters of macrophage 
findings of others. 
infections with respect to certain 
activation is in keeping with the 
It is submitted in this thesis that the degree of activation or 
inhibition of macrophage function may differ in N.asteroides and 
N.brasiliensis infections with respect to release of plasminogen 
activator and of lysozyme The pattern of secretion of 
plasminogen activator and lysozyme in N.asteroides infections 
appears to differ in N.brasiliensis infection; and there is 
possibly a difference in the amount of lysozyme released by 2 day 
N.asteroides-activated macrophages and 2 day N.brasiliensis 
-activated macrophages. Strains of Nocardia organism did not 
influence macrophage morphology or ultrastructure. 
The study also shows the biochemical characteristics of 
plasminogen activator and lysozyme release, but not macrophage 
morphology and ultrastructure, are modified in the first 21 days 
of experimental Nocardia infections. 
There are three apparent mechanisms by which virulent strains of 
xiv 
N.asteroides manage to survive within macrophages: (i) an ability 
to inhibit phagosome-lysozome fusion: (ii) alteration in the 
intraphagosomal pH: and (iii) alteration in the activity of the 
lysozomal enzyme acid- phosphatase. This study attempted to 
elucidate further the mechanisms enabling Nocardia organisms to 
persist and grow within macrophages. Reduced lysozyme release 
reflects diminished functional status of the macrophages of mice 
inoculated with N.asteroides or N.brasiliensis at certain times 
during infection. Reduced intracellular lysozyme levels have 
been linked with defects in bactericidal function. Such a 
reduction in intracellular and consequently extracellular levels 
of lysozyme might explain the capacity of Nocardia to survive 
intracellularly and to proliferate in the macrophage host. 
xv 
LIST OF FIGURES 
1. Linear regression for recovery of x from y. 
2. Influence of duration of N.asteroides infection on number of 
peritoneal cells harvested per mouse 
their 95% confidence limits. 
median values and 
3. Influence of duration of N.brasiliensis infection on number 
of peritoneal cells harvested per mouse : median values and 
their 95% confidence limits. 
4. Enzymatic cleavage reactions involved in fibrinolysis. 
5. Molecular weight of plasminogen activators : calibration 
curve of log molecular weight vs refractive index. 
6. Fibrinolysis produced by macrophages from mice inoculated 2 
days previously with N.asteroides or with saline only 
Direct assay. 
7. Plasminogen activator secreted by macrophages from mice 
inoculated 2 days previously with N.asteroides or saline 
only: Indirect assay. 
8. Fibrinolysis produced by macrophages from mlce inoculated 2 
days previously with N.brasiliensis or with saline only 
Direct assay. 
xvi 
9. Plasminogen activator secreted by macrophages from mice 
inoculated 2 days previously with N. brasiliensis or saline 
only : Indirect assay. 
10. Fibrinolysis produced by macrophages from mice inoculated 7 
days previously with N.asteroides or with saline only 
Direct assay. 
11. Fibrinolysis produced by macrophages from mice inoculated 7 
days previously with N.asteroides or with saline only 
Indirect assay. 
12. Fibrinolysis produced by macrophages from mice inoculated 7 
days previous! y with N. brasi 1 iensi s or with sa 1 ine only 
Direct assay. 
13. Fibrinolysis produced by macrophages from mice inoculated 7 
days previously with N.brasiliensis or with saline only 
Indirect assay. 
14. Fibrinolysis produced by macrophages from mice inoculated 13 
days previously with N.asteroides or with saline only 
Direct assay. 
15. Fibrinolysis produced by macrophages from mice inoculated 13 
days previously with N.asteroides or with saline only 
Indirect assay. 
xvii 
16. Fibrinolysis produced by macrophages from mice inoculated 13 
days previously with N. brasi 1 iensi s or with sa 1 ine only 
Direct assay. 
17. Fibrinolysis produced by macrophages from mice inoculated 13 
days previously with N.brasiliensis or with saline only 
Indirect assay. 
18. Fibrinolysis produced by macrophages from mice inoculated 21 
days previously with N.asteroides or with saline only 
Direct assay. 
19. Fibrinolysis produced by macrophages from mice inoculated 21 
days previously with N.asteroides or with saline only : 
Indirect assay. 
20. Fibrinolysis produced by macrophages from mice inoculated 21 
days previously with N.brasiliensis or with saline only 
Direct assay. 
21. Fibrinolysis produced by macrophages from mice inoculated 21 
days previously with N.brasiliensis or with saline only : 
Indirect assay. 
22. Pattern of plasminogen activator secretion over the 21 day 
period of infection with N.asteroides and N.brasiliensis. 
xviii 
23. 
24. 
Log-log linear regression standard curve of rate of 
decrease in turbidity of substrate suspension vs lysozyme 
concentration. 
Exponential least squares regression standard curve of 
rate of decrease in turbidity of substrate suspension vs 
lysozyme concentration. 
25. Optimum incubation time. 
26. Cumulative lysozyme release by macrophages from mice 
inoculated 2 days previously with N.asteroides. 
27. Cumulative lysozyme release by macrophages from mice 
inoculated 2 days previously with N.brasiliensis. 
28. Cumulative lysozyme release by macrophages from mice 
inoculated 7 days previously with N.asteroides. 
29. Cumulative lysozyme release by macrophages from mice 
inoculated 7 days previously with N.brasiliensis. 
30. Cumulative lysozyme release by macrophages from mice 
inoculated 13 days previously with N.asteroides. 
31. Cumulative lysozyme release by macrophages from mice 
inoculated 13 days previously with N.brasiliensis. 
xix 
32. Cumulative lysozyme release by macrophages from mice 
inoculated 21 days previously with N.asteroides. 
33. Cumulative lysozyme release by macrophages from mice 
inoculated 21 days previously with N.brasiliensis. 
34. Rate of lysozyme release by macrophages from mice inoculated 
2 days previously with N.asteroides. 
35. Rate of lysozyme release by macrophages from mice inoculated 
2 days previously with N.brasiliensis. 
36. Rate of lysozyme release by macrophages from mice inoculated 
7 days previously with N.asteroides. 
37. Rate of lysozyme release by macrophages from mice inoculated 
7 days previously with N.brasiliensis. 
38. Rate of lysozyme release by macrophages from mice inoculated 
13 days previously with N.asteroides. 
39. Rate of lysozyme release by macrophages from mice inoculated 
13 days previously with N.brasiliensis. 
40. Rate of lysozyme release by macrophages from mice inoculated 
21 days previously with N.asteroides. 
41. Rate of lysozyme release by macrophages from mice inoculated 
xx 
41. Rate of lysozyme release by macrophages from mice inoculated 
21 days previously with N.brasiliensis. 
42. Modulation of 1 ysozyme release over the 21 day period of 
infection. 
43. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 2 days previously with N.asteroides. Cells 
were incubated for 13.5 hours (magnification x 320). 
44. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 2 days previously with saline only. Cells 
were incubated for 13.5 hours (magnification x 320). 
45. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 2 days previously with N.brasiliensis. Cells 
were incubated for 13.5 hours (magnification x 320). 
46. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 7 days previously with N.asteroides. Cells 
were incubated for 46 hours (magnification x 200). 
47. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 7 days previously with saline only. Cells 
were incubated for 72 hours (magnification x 200). 
xxi 
48. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 7 days previously with N.brasiliensis. 
Cells were incubated for 72 hours (magnification x 200). 
49. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 13 days previously with saline only. Cells 
were incubated for 42 hours (magnification x 200). 
50. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 13 days previously with N.asteroides. Cells 
were incubated for 42 hours (magnification x 200). 
51. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 13 days previously with saline only. 
were incubated for 2.5 hours (magnification x 200). 
Cells 
52. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 13 days previous 1 y with N. brasi 1 iens is. 
Cells were incubated for 2.5 hours (magnification x 200). 
53. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 21 days previously with saline only. Cells 
were incubated for 24 hours (magnification x 200). 
54. Phase-contrast photomicrograph of living macrophages from 
mice inoculated 21 days previously with N.asteroides. Cells 
were incubated for 24 hours (magnification x 200). 
xxii 
55. Scanning electron micrograph of macrophages from mice 
inoculated 21 days previously with saline only 
(magnification x 310). 
56. Scanning electron micrograph of macrophages from mice 
inoculated 13 days previously with N.asteroides (magnifi-
cation x 350). 
57. Scanning electron micrograph of macrophages from mice 
inoculated 7 days previously with N.brasiliensis (magnifi-
cation x 305). 
58. Scanning electron micrograph of macrophages from mice 
inoculated 21 days previously with saline only 
(magnification x 1150). 
59. Scanning electron micrograph of macrophages from mice 
inoculated 21 days previously with saline only 
(magnification x 1540). 
60. Scanning electron micrograph of a spherical cell with 
extensive filopodia and microvilli. Mice were inoculated 21 
days previously with saline only (magnification x 7700). 
61. Scanning electron micrograph of a highly microvillous 
triangular-shaped macrophage harvested from mice inoculated 
13 days previously with saline only (magnification x 3500). 
xxiii 
62. Scanning electron micrograph of a triangular-shaped 
macrophage with ruffled and ridged membranes. Mice were 
inoculated 7 days previously with saline only (magnification 
X 1710). 
63. Scanning electron micrograph of an elongated macrophage with 
long pseudopodia and raised ruffled nuclear area: between 
two flattened, well-spread eel ls. Mice were inoculated 13 
days previously with saline only (magnification x 3070). 
64. Scanning electron micrograph of a spherical macrophage with 
surface ruffles and ridges. Mice were inoculated 7 days 
previously with N.asteroides (magnification x 6600). 
65. Scanning electron micrograph of a spreading spherical 
macrophage showing microvilli and blebs as well as radiating 
peripheral filopodia. Mice were inoculated 13 days 
previously with N.asteroides (magnification x 5100). 
66. Scanning electron micrograph of an elongated macrophage 
with long pseudopodia terminating in broad ruffled 
cytoplasmic veils. Mice were inoculated 2 days previously 
with N.asteroides (magnification x 2410). 
67. Scanning electron micrograph of a triangular-shaped 
macrophage with pseudopodia terminating in numerous 
radiating slender filopodia (13 day N.asteroides infection: 
magnification x 2000). 
xxiv 
68. 
69. 
Scanning electron 
macrophage with 
micrograph of 
fairly smooth 
a triangular-shaped 
membranes and broad 
lamellipodia (2 day N.asteroides infection; magnification x 
3140). 
Scanning electron micrograph of a spherical macrophage 
showing prominent membrane ruffles and flap-like protrusions 
(7 day N.asteroides infection; magnification x 6800). 
70. Scanning electron micrograph of a spherical macrophage 
showing ruffled membranes. Mice were inoculated 2 days 
previously with saline only (magnification x 7500). 
71. Scanning electron micrograph of a spreading cell showing 
filopodia and membrane ruffles (7 day N.asteroides 
infection; magnification x 4100). 
72. Scanning electron micrograph of macrophages harvested from 
mice incubated 7 days previously with N.brasiliensis. 
Micrograph shows variation in shape of cells (magnification 
X 910). 
73. Scanning electron micrograph of a spherical macrophage 
showing prominent surface ruffles (2 day N.brasiliensis 
infection; magnification x 7500). 
XXV 
74. Scanning electron micrograph of a flattened macrophage 
showing raised ruffled nuclear pole and smooth cytoplasmic 
veils. Mice were inoculated 7 days previously with 
N.brasiliensis (magnification x 3500). 
75. Scanning electron micrograph of a well-spread, irregularly 
shaped macrophage which is markedly flattened. 21 day 
N.brasiliensis infection: magnification x 1960). 
76. Scanning electron micrograph of a markedly flattened 
macrophage showing smooth 
subplasmalemmal sphericals 
cytoplasmic veils 
and ruffled area over 
with 
the 
nuclear pole (7 day N.brasiliensis infection: magnification 
X 28 20). 
77. Scanning electron micrograph of a triangular-shaped 
macrophage showing extensive pseudopodia and filopodia ( 2 
day N.brasiliensis infection: magnification x 4100). 
78. Scanning electron micrograph of an elongated, irregularly 
shaped macrophage with extensive lamellipodia and 
pseudopodia (7 day N.brasiliensis infection; magnification x 
7 500) • 
79. Scanning electron micrograph of 3 control macrophages 
showing ruffled membranes and extensive filopodia. Mice 
were inoculated 2 days previously with saline only 
(magnification x 1740). 
xxvi 
LIST OF TABLES 
la,b Summary of post mortem findings. 
2. Influence of time course of infection on total number of 
cells and on number of peritoneal macrophages harvested per 
mouse : Median values and their 95% confidence limits. 
3. 
4. 
5. 
2 day N.asteroides infection 
incubation on cell number. 
2 day N.brasiliensis infection 
incubation on cell number. 
7 day N.asteroides infection 
incubation on cell number. 
Influence of duration of 
Influence of duration of 
Influence of duration of 
6. 7 day N.brasiliensis infection : Influence of duration of 
incubation on cell number. 
7. 13 day N.asteroides infection : Influence of duration of 
incubation on cell number. 
8. 
9. 
13 day N.brasiliensis infection 
incubation on cell number. 
21 day N.asteroides infection 
incubation on cell number. 
xxvii 
Influence of duration of 
Influence of duration of 
10. 21 day N.brasiliensis infection 
incubation on cell number. 
Influence of duration of 
11. Some characteristics of activated macrophages. 
12. Fibrinolysis produced by unstimulated peritoneal macrophages 
exposed in vitro to Con A. 
13. Optimization of number of macrophages distributed into each 
well : Thioglycolate-elicited macrophages. 
14. Optimization of number of macrophages distributed into each 
well mice inoculated 7 days previously with 
N.brasiliensis. 
15a,b Optimization of number of macrophages distributed into 
each well mice inoculated 7 days previously with 
N.asteroides or N.brasiliensis. 
16a,b,c Optimization of volume of conditional medium (CM) to be 
added to each well and period of culture in serum-free 
17a,b 
medium 21 day N.asteroides and 2 day N.brasiliensis 
infections. 
Comparison of macrophage fibrinolysis in dog serum and 
fetal calf serum. 
xxviii 
18. Fibrinolysis by control macrophages from individual mice in 
different batches of ATDS. 
19. Plasminogen dependence of macrophage fibrinolysis in ATDS. 
20. Fibrinolysis produced by macrophages from individual control 
mice in HIATFCS and ATDS. 
21. Effect of removal of lymphocytes on macrophage fibrinolysis 
in ATDS. 
22. Comparison of macrophage fibrinolysis in the presence of 
purified plasminogen (PLG) or ATDS and confirmation of 
plasminogen dependence of fibrinolysis. 
23a,b 
24a,b 
Comparison of macrophage fibrinolytic activity when 
measured by the direct and indirect assay. 
Effects of Con A exposure in vitro on fibrinolysis by 
thioglycolate-elicited peritoneal macrophages; and selection 
of appropriate mouse strain. 
25. Fibrinolysis by macrophages over the 48 hour incubation 
period prior to assay for fibrinolysis. 
26. Macrophage counts in washes after 48 hour incubation period. 
27. Cell counts after fibrinolysis assay. 
xxix 
28. Dose response and time response data : 7 day N.asteroides 
infection. 
29. 
30. 
Dose response and time response data 
infection. 
Dose response and time response data 
infection. 
7 day N.brasiliensis 
13 day N.brasiliensis 
31. Fibrinolysis produced by macrophages from mice inoculated 2 
days previously with N.asteroides or with saline only 
direct assay. 
32. 2 day N.asteroides infection : Median % fibrinolysis values 
and their 95% confidence limits. 
33. Data for indirect assay for macrophages from mice inoculated 
2 days previously with N.asteroides 
34. 2 day N.asteroides infection : Median values and their 95% 
confidence limits for indirect assay. 
35. Significance level (Mann Whitney U Test, 2 tailed) achieved 
on comparison of different experimental data groups : 2 day 
N.asteroides infection. 
36. Fibrinolysis produced my macrophage from mice inoculated 2 
days previously with N.brasiliensis. 
XXX 
37. 2 day N.brasiliensis infection Median % fibrinolysis 
values and their 95% confidence limits. 
38. Indirect assay data for macrophages from mice inoculated 2 
days previously with N.brasiliensis or normal saline only. 
39. 2 day N.brasiliensis infection : Median values and their 95% 
confidence limits for indirect assay. 
40. Significance level ( Mann Whitney U Test, 2 tailed) achieved 
on comparison of different experimental data groups : 2 day 
N.brasiliensis infection. 
41. Fibrinolysis produced by macrophages from mice inoculated 7 
days previously with N.asteroides or saline only : direct 
assay. 
42. 7 day N.asteroides infection : Median% fibrinolysis values 
and their 95% confidence limits. 
43. Indirect assay data for macrophages from mice inoculated 7 
days previously with N.asteroides or normal saline only. 
44. 7 day N.asteroides infection Median values and their 95% 
confidence limits for indirect assay. 
45. Significance level ( Mann Whitney U Test, 2 tailed) achieved 
on comparison of different experimental data groups : 7 day 
xxxi 
N.asteroides infection. 
46. Fibrinolysis produced by macrophages from mice inoculated 7 
days previously with N.brasiliensis or saline only : direct 
assay. 
47. 7 day N.brasiliensis infection : Median % fibrinolysis 
values and their 95% confidence limits. 
48. Indirect assay data for macrophage plasminogen activator 
from mice inoculated 7 days previously with N.brasiliensis. 
49. 7 day N.brasiliensis infection : Median values and their 95% 
confidence limits for indirect assay. 
50. Significance level (Mann Whitney U Test, 2 tailed) achieved 
on comparison of different experimental data groups : 7 day 
N.brasiliensis infection. 
51. Fibrinolysis produced by macrophages from mice inoculated 13 
days previously with N.asteroides or saline only direct 
assay. 
52. 13 day N.asteroides infection : Median% fibrinolysis values 
and their 95% confidence limits. 
53. Indirect assay data for macrophage plasminogen activator 
from mice inoculated 13 days previously with N.asteroides. 
xxxii 
54. 13 day N.asteroides infection : Median values and their 95% 
confidence limits for indirect assay. 
55. Significance level (Mann Whitney U Test, 2 tailed) achieved 
on comparison of different experimental data groups : 13 day 
N.asteroides infection. 
56. Fibrinolysis produced by macrophages from mice inoculated 13 
days previously with N.brasiliensis or saline only : direct 
assay. 
57. 13 day N.brasiliensis infection 
their 95% confidence limits. 
Median % fibrinolysis and 
58. Indirect assay data for macrophage plasminogen activator 
from mice inoculated 13 days previously with N.brasiliensis. 
59. 13 day N.brasiliensis infection Median values and their 
95% confidence limits for indirect assay. 
60. Significance level (Mann Whitney U Test, 2 tailed) achieved 
on comparison of different experimental data groups : 13 day 
N.brasiliensis infection. 
61. Fibrinolysis produced by macrophages from mice inoculated 21 
days previously with N.asteroides or saline only direct 
assay. 
xxxiii 
62. 21 day N.asteroides infection : Median% fibrinolysis values 
and their 95% confidence limits. 
63. Indirect assay data for macrophage plasminogen activator 
from mice inoculated 21 days previously with N.asteroides or 
saline only. 
64. 21 day N.asteroides infection : Median values and their 95% 
confidence limits for indirect assay. 
6 5. Significance leve 1 ( Mann Whitney U Test, 2 tailed) achieved 
on comparison of different experimental data groups : 21 day 
N.asteroides infection. 
66. Fibrinolysis produced by macrophages from mice inoculated 21 
days previously with N.brasiliensis or saline only : direct 
assay. 
67. 21 day N.brasiliensis infection 
their 95% confidence limits. 
Median% fibrinolysis and 
68. Indirect assay data for macrophage plasminogen activator 
from mice inoculated 21 days previously with N.brasiliensis 
or saline only. 
69. 21 day N.brasiliensis infection Median values and their 
95% confidence limits for indirect assay. 
xxxiv 
70. Significance leve 1 ( Mann Whitney U Test, 2 tailed) achieved 
on comparison of different experimental data groups : 21 day 
N.brasiliensis infection. 
71. Median percentage f ibr incl ysis va 1 ues for N. as teroides and 
N.brasiliensis over the 21 day infection period. 
72. Direct plasminogen activator assay: median percentage 
fibrinolysis values for N.asteroides and N.brasiliensis 
expressed as percentage of their own controls. 
73. Lysozyme release by 1 x 10 6 macrophages. 
74. Lysozyme release by 1 x 103 macrophages. 
75. Optimum time of incubation. 
76. Optimum time of incubation. 
77. 2 day N.asteroides infection 
conditioned medium. 
accumulation of lysozyme in 
78. 2 day N.asteroides infection : specific activity of 
cumulative lysozyme released. 
79. 2 day N.asteroides infection 
macrophages over 3 days in culture. 
XXXV 
lysozyme production by 
80. 2 day N.asteroides : specific activity of lysozyme produced 
by macrophages over three days in culture. 
81. 
82. 
83. 
84. 
85. 
2 day N.brasiliensis infection 
conditioned medium. 
accumulation of lysozyme in 
2 day N.brasiliensis infection 
cumulative lysozyme released. 
2 day N.brasiliensis infection 
macrophages over 3 days in culture. 
2 day N.brasiliensis infection 
specific activity of 
lysozyme production by 
specific activity of 
lysozyme produced by macrophages over three days in culture. 
7 day N.asteroides infection 
conditioned medium. 
accumulation of lysozyme in 
86. 7 day N.asteroides infection 
cumulative lysozyme released. 
specific activity of 
87. 7 day N.asteroides infection 
macrophages over 3 days in culture. 
lysozyme production by 
88. 7 day N.asteroides infection : specific activity of lysozyme 
produced by macrophages over three days in culture. 
89. 7 day N.brasiliensis infection accumulation of lysozyme in 
xxxvi 
conditioned medium. 
90. 7 day N.brasiliensis infection : specific activity of 
cumulative lysozyme released. 
91. 7 day N.brasiliensis infection : lysozyme production by 
macrophages over 3 days in culture. 
92. 7 day N.brasiliensis infection : specific activity of 
lysozyme produced by macrophages over three days in culture. 
93. 
94. 
13 day N.asteroides infection 
conditioned medium. 
13 day N.asteroides infection 
cumulative lysozyme released. 
accumulation of lysozyme in 
specific activity of 
95. 13 day N.asteroides infection : lysozyme production by 
macrophages over 3 days in culture. 
96. 
97. 
98. 
13 day N.asteroides infection specific activity of 
lysozyme produced by macrophages over three days in culture. 
13 day N.brasiliensis infection 
in conditioned medium. 
13 day N.brasiliensis infection 
cumulative lysozyme released. 
xxxvii 
accumulation of lysozyme 
specific activity of 
99. 13 day N.brasiliensis infection : lysozyme production by 
macrophages over 3 days in culture. 
100. 13 day N.brasiliensis infection specific activity of 
lysozyme produced by macrophages over three days in culture. 
101. 21 day N.asteroides infection 
conditioned medium. 
accumulation of lysozyme in 
102. 21 day N.asteroides infection : specific activity of 
cumulative lysozyme released. 
103. 21 day N.asteroides infection 
macrophages over 3 days in culture. 
104. 21 day N.asteroides infection 
lysozyme production by 
specific activity of 
lysozyme produced by macrophages over three days in culture. 
105. 21 day N.brasiliensis infection 
in conditioned medium. 
106. 21 day N.brasiliensis infection 
cumulative lysozyme released. 
107. 21 day N.brasiliensis infection 
macrophages over 3 days in culture. 
xxxviii 
accumulation of lysozyme 
specific activity of 
lysozyme production by 
108. 21 day N.brasiliensis infection : specific activity of 
lysozyme produced by macrophages over three days in culture. 
109. 2 day N. as teroides infection : Median 1 ysozyme va 1 ues and 
their 95% confidence limits for N.asteroides-activated 
macrophages at each sampling interval. Medians expressed as 
percentages of their own controls. 
110. 2 day N.brasiliensis infection 
expressed as percentage controls. 
111. 7 day N.asteroides infection 
expressed as percentage controls. 
112. 7 day N.brasiliensis infection 
expressed as percentage controls. 
113. 13 day N.asteroides infection 
expressed as percentage controls. 
Median lysozyme values 
Median lysozyme values 
Median lysozyme values 
Median lysozyme values 
114. 13 day N.brasiliensis infection : Median lysozyme values 
expressed as percentage controls. 
115. 21 day N.asteroides infection 
expressed as percentage controls. 
116. 21 day N.brasiliensis infection 
expressed as percentage controls. 
xxxix 
Median lysozyme values 
Median lysozyme values 
117. Protein content as an expression of cell size. 
118. Nornencla ture of macrophage surface projections observed by 
SEM. 
119. Macrophage size from SEM rnicrographs. 
xxxx 
DB 
TD 
TRIS 
UK 
BSA 
FCS 
HIFCS 
ATFCS 
ATDS 
P+S 
M 
PMN 
M0 
CM 
PBS 
SGOT 
GLOSSARY OF ABBREVIATIONS USED 
Dulbeccos Modified Eagle Medium 
Tris Dulbecco's saline 
0.14M NaCl: SmM KCl: 
HCl3: PH 7.4 
Tris (hydroxymethyl)-aminomethane 
Urokinase 
Bovine Serum Albumin 
Fetal Calf Serum 
Heat-inactivated Fetal Calf Serum 
Acid-treated Fetal Calf Serum 
Acid-treated Dog Serum 
Penicillin and Streptomycin 
Mycostatin 
Polymorphonuclear leukocyte 
Macrophage 
Conditioned Medium 
Phosphate Buffered Saline 
Serum glutamic oxaloacetic transaminase 
xxxxi 
24. 8mM Tris 
C 
NA 
NB 
= 
= 
= 
NA+ 0.002% AG= 
NB+ 0.002% AG= 
C* 
NA* 
NA** 
NB* 
NB** 
p 
M0 
T 
s 
mu UK 
= 
= 
= 
= 
= 
= 
= 
= 
= 
FIGURE KEY 
Control macrophages 
N.asteroides-activated macrophages 
N.brasiliensis-activated macrophages 
N.asteroides-activated macrophages exposed in 
vitro to 0.002% antigen 
N.brasiliensis-activated macrophages exposed 
in vitro to 0.002% antigen 
Control macrophages exposed in vitro to 0.02% 
antigen 
N.asteroides-activated macrophages exposed in 
vitro to 0.02% antigen 
N.asteroides-activated macrophages exposed in 
vitro to 0.002% antigen 
N.brasiliensis-activated macrophages exposed 
in vitro to 0.02% antigen 
N.brasiliensis-activated macrophages exposed 
in vitro to 0.002% antigen 
Level of significance, Mann Whitney U Test 
Macrophage 
Timepoint (e.g. Tl, T2, T3) 
Sample (e.g. Sl, S2, S3) 
Milliunits of Urokinase 
xxxxii 
Ag = 
C = 
N = 
Na = 
Nb = 
n = 
cone = 
M = 
M0 = 
LL = 
UL = 
T = 
s = 
d = 
p = 
MWU = 
Sal = 
PA = 
PLG = 
Con A = 
Fib = 
L = 
Thio = 
Inoc = 
Incu = 
DA = 
IA = 
Spleno = 
Hepa to = 
ATDS = 
FCS = 
H IA'l' = 
E = 
%C = 
N.ast infect = 
N.bras infect = 
CM = 
ATFCS-P = 
ATDS-P = 
2d Na = 
2d Nb = 
7d Na = 
7d Nb = 
13d Na = 
13d Nb = 
21d Na = 
21d Nb = 
TABLE KEY 
Antigen 
Control macrophages 
Nocardia-activated macrophages 
N.asteroides-activated macrophages 
N.brasiliensis-activated macrophages 
No. of replicates 
Concentration 
Median 
Macrophages 
95% confidence limit : Lower limit 
95% confidence limit : Upper limit 
Timepoint (eg Tl, T2, T3) 
Sample (eg Sl, S2, S3) 
Days 
Significance level using Mann Whitney U Test 
Mann-Whitney U-Test 
Saline 
Plasminogen Activator 
Purified plasminogen 
Concanavalin A 
Fibrinolysis 
Lymphocytes (eg L+ = present, L- = absent) 
Thioglycolate-elicited macrophages 
Inoculation 
Incubation 
Direct Assay 
Indirect Assay 
Splenomegaly 
Hepa tomegaly 
Acid-treated dog serum 
Fetal calf serum 
Heat inactivated acid treated 
Experiment number 
Median enzyme va 1 ue expressed as percentage 
control value 
N.asteroides infection 
N.brasiliensis infection 
Conditioned medium 
Plasminogen-depleted 
Plasminogen-depleted 
Mice inoculated 2 
N.asteroides 
Mice inoculated 2 
N.brasiliensis 
Mice inoculated 7 
N.asteroides 
Mice inocula tea 7 
N.brasiliensis 
Mice inoculated 13 
N.asteroides 
Mice inoculated 13 
N.brasiliensis 
Mice inoculated 21 
N.asteroides 
Mice inoculated 21 
N.brasiliensis 
xxxxiii 
fetal calf serum 
dog serum 
days previously with 
days previously with 
days previously with 
days previously with 
days previously with 
days previously with 
days previously with 
days previously with 
SECTION l 
INTRODUCTION: LITERATURE REVIEW, METHODS AND GENERAL PRINCIPLES 
1 
CHAPTER l 
A REVIEW OF NATURALLY ACQUIRED NOCARDIA INFECTIONS IN MAN AND 
EXPERIMENTAL NOCARDIA INFECTIONS IN ANIMALS 
1.1 
1.2 
1.3 
1. 3 .1 
1. 3. 2 
1.3.2.l 
1.3.2.2 
1.3.2.3 
1.3.2.4 
1.3.2.5 
1.4 
1. 4.1 
1. 4. 2 
1. 4. 3 
1. 4. 4 
1. 4. 5 
1.5 
1.6 
INTRODUCTION 
MICROBIOLOGY 
EPIDEMIOLOGY 
HABITAT AND DISTRIBUTION OF THE NOCARDIAE 
FACTORS INFLUENCING DISEASES IN MAN 
INCIDENCE OF DISEASE 
PREDISPOSING FACTORS 
SEX PREDILECTION 
AGE PREDILECTION 
ROUTE OF INFECTION 
CLINICAL MANIFESTATIONS 
NOCARDIOSIS 
CHARACTERISTICS OF GROWTH OF NOCARDIA ORGANISMS IN 
TISSUES 
MYCETOMA 
PRIMARY CUTANEOUS NOCARDIOSIS 
PROGNOSIS 
DIAGNOSIS 
TREATMENT 
2 
1.7 
l. 7 .1 
l. 7. 2 
1.7.2.1 
1.7.2.2 
1.7.2.3 
l. 7. 3 
1.7.3.1 
ANIMAL MODELS OF NOCARDIAL PATHOGENESIS 
INTRODUCTION 
ANIMAL MODELS OF NOCARDIA INFECTIONS 
NOCARDIOSIS 
MYCETOMA 
CONTRADICTORY INTERPRETATIONS OF ANIMAL MODEL DATA 
EXPERIMENTAL NOCARDIA INFECTIONS IN ANIMALS 
IMMUNODEFICIENT MURINE MODELS 
1.7.3.1.1 Congenitally Athymic (Nude) mice 
1.7.3.1.2 Hereditarily Asplenic (Dh/+) mice 
1.7.3.1.3 B-lymphocyte Deficient Mice 
1.7.3.1.4 Germfree Mice 
1.7.3.1.5 T-cell depleted mice (B mice) 
1.7.3.1.6 Immunocompromised Host Models 
1.7.3.2 
1.7.3.3 
1.7.3.4 
l. 7. 4 
1.7.4.1 
1.7.4.2 
1.7.4.3 
l. 7. 5 
1.7.5.1 
STUDIES IN GUINEA PIGS 
ANTIBIOTIC TESTING IN MURINE MODELS OF NOCARDIOSIS 
INDUCED BY N.ASTEROIDES 
AMYLOIDOSIS IN EXPERIMENTAL NOCARDIA INFECTIONS 
IN VITRO STUDIES 
INTERACTIONS OF N.ASTEROIDES WITH MACROPHAGES IN VITRO 
IN VITRO STUDIES ON N. BRASILIENSIS AND MURI NE 
MACROPHAGES 
INTERACTION OF N.ASTEROIDES WITH NEUTROPHILS AND 
MONOCYTES IN VITRO 
OTHER FACTORS INFLUENCING HOST-PARASITE RELATIONSHIPS 
AND PATHOGENESIS 
VIRULENCE 
3 
1.7.5.2 
1.7.5.3 
1.7.5.4 
1.7.6 
1.8 
1.9 
1.10 
ROUTE OF INFECTION 
L-FORMS AND NOCARDIAL PATHOGENESIS 
ROLE OF THE CELL WALL-ASSOCIATED LIPIDS IN THE 
PATHOGENESIS OF THE LESION 
ROLE OF THE HUMORAL IMMUNE RESPONSE 
CONCLUSIONS 
OBJECTIVES OF THIS STUDY 
REFERENCES 
4 
Chapter 1 
1.1 INTRODUCTION 
Almost 100 years ago, Nocard first described "bovine farcy" - a 
granulomatous disease of cattle characterized by abscesses, sinus 
tracts, pulmonary disease and eventual death - after isolating an 
agent from lesions in cattle in Guadeloupe (Nocard, 1888). 
Trevisan created the genus Nocardia in 1889 and Nocard's isolate 
became the type species, Nocardia farcinica (Stanford, 1983). 
Considerable taxonomic confusion over the identity of the 
original isolate has reigned since the 1970's and it has recently 
been accepted that N.farcinica be replaced by N.asteroides as 
the type species. It has also recently been requested that 
N.farcinica be rejected on the basis that the only existing 
sample of Nocard's original isolate is N.asteroides (Stanford, 
1983). 
Two years after Nocard first recognized N.asteroides as a 
pathogen, the first human disease due to this organism was 
reported by Eppinger (1890): and the first human infection caused 
by N.brasiliensis was reported by Lindenberg in 1909. Human 
disease ascribed to Nocardia was reported infrequently during the 
next 50 years (Sen and Louria, 1980:336) and was considered rare 
in comparison to other infectious diseases - an impression which 
was probably erroneous. Over the past 25 years there has been a 
striking increase in the frequency of reports of infections due 
to Nocard ia species ( Cox and Hughes, 197 5: Krick, Stinson and 
Remington, 1975: Falb et al, 1976: Simpson et al, 1981: Law and 
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Marks, 1982). There is no readily available reason for the 
increase in the incidence of the disease but factors responsible 
include greater awareness, more aggressive diagnostic approaches 
and improved med ica 1 surve i I lance, better laboratory isolation 
techniques, increased survival of compromised individuals and the 
increasing use of agents that promote development of 
opportunistic infections (Sen and Louria, 1980 : 336; Beaman and 
Sugar, 1983; Smego et al, 1983). 
1. 2 MICROBIOLOGY 
Nocardia organisms were formerly considered to be fungi but are 
currently classified as bacteria belonging to the order 
Actinomycetales within the family Nocardiaceae Castellani and 
Chalmers (Buchanan and Gibbons, 1974: 726). Organisms belonging 
to the genus Nocardia are Gram positive and either partially· or 
completely acid-fast ( Z iehl-Neelsen stain) , aerobic, non-spore 
forming and grow as a mycelium of branching filamentous rods, 
most nocardiae producing aerial hyphae which fragment into short 
rods (Curry 1980; 
Stanford, 1983). 
De Villiers 1978; Sen and Louria 1980: 336; 
Other families of the Order Actinomycetales 
include Actinomycetaceae, Mycobacteriaceae and Streptomycetaceae 
(Buchanan and Gibbons, 1974 : 657). 
Currently, there are about 20 species of nocardiae on the list of 
approved bacterial names (Skerman, McGowan and Sneath, 1980) and 
four species a re genera 11 y recogni sea as pot en tia 11 y pathogenic 
to humans. N.asteroides, N.brasiliensis, N.caviae and N.madurae 
(Smego and Gallis, 1984). The major pathogenic species in man 
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are N.asteroides, N.brasiliensis and N.caviae, in that order 
(Smego, Moeller and Gallis, 1983). 
1. 3 EPIDEMIOLOGY 
1. 3.1 HABITAT AND DISTRIBUTION OF THE NOCARDIAE 
The nocardiae seem to live as saprophytes on grains, grasses and 
in water. They are indigenous inhabitants of the soil, where 
they play an important part in the biological change taking 
place; and of decaying vegetable matter. The organisms are 
worldwide in distribution (Wilson and Miles, 1964 : 500; Sen and 
Louria, 1980 : 336; Beaman, 1976). They are not part of normal 
human flora (Stevens et al, 1981) but may rarely be a saprophyte 
in the upper respiratory tract or the skin (Stevens, 1983). 
N.asteroides, 
soils of most 
N.brasiliensis and N.caviae seem to live in the 
countries, however, N.asteroides occurs more 
often in temperate 
subtropical areas. 
specific geographic 
and Gallis, 1984). 
climates and N.brasiliensis in tropical and 
N.caviae has not been shown to have a 
distribution (Beaman and Sugar, 1983; Smego 
1. 3. 2 FACTORS INFLUENCING DISEASE IN MAN 
1.3.2.1 INCIDENCE OF DISEASE 
An epidemiologic study between 1972 - 1974 in the USA revealed 
that 83.3% of Nocardia sp. infections were caused by 
N.asteroides, 6.9% by N.brasiliensis and 2.9% by N.caviae, the 
other 6.3% were indentified only as Nocardia species. In 
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contrast, N.brasiliensis is isolated from more than 90% of 
patients with mycetoma in Central and South America (Srrego, 
1984). The "Beaman" study indicated that about 500 - 1000 cases 
of nocardial infections may be seen each year (Beaman et al, 
1976), al though 
higher (Curry, 
diseases such as 
others suggest that the incidence of disease is 
1980), since Nocardia masquerades as other 
tuberculosis, systemic mycosis, carcinoma and 
pyogenic infections and may therefore go unrecognized (Smego and 
Ga 11 i s , 198 4 ) • The study revealed no geographic predominance for 
nocardial infections in the USA. 
The pathogenic nocardiae are capable of causing overwhelming 
disease with a high mortality rate - a survey of 147 case reports 
( Presan t, Wiernik and Serpi ck, 197 3) showed a 38% mor ta 1 i ty in 
localized infections and 81% mortality in disseminated 
I infections. 85% of the cases in Beamans epidemiological study 
were severe pulmonary-systemic or "primary" central nervous 
system infections (Beaman et al, 1976) - other sites besides the 
lung serve as primary infection sites, especially in the 
compromised host. The brain and central nervous system are the 
most frequent sites of disseminated nocardial infection (Beaman 
and Sugar, 1983). In accord with the figures of Beaman et al 
(1976), 85% of cases 
and/or systemic, with 
in Europe and North America are pulmonary 
estimates that 45% will have systemic 
dissemination and 75-79% pulmonary involvement. 81-91% of human 
infections are due to N.asteroides (Stevens, 1983). Although 
Nocardia incections can be serious and life-threatening cure is 
often achieved with early diagnosis and treatment (Curry, 1980). 
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The idea that Nocardia organisms are pathogenic only for 
immunologically incompetent individuals is incorrect (Curry, 
1980). Nocardia infections are associated with immunocompromised 
hosts and an underlying defect is present in 50-80% of cases 
(Law and .Marks, 1982; Stevens, 1983) • Instances of nocardial 
infections have been reported in individuals in whom no 
underlying disease or immunosuppressive therapy can be 
identified. 15% of cases reported by Beaman et al (1976) 
occurred in apparently heal thy people. In the same series, 
Nocardia was considered to be an opportunist in 53% of the 
cases. This figure is similar to that of Williams, Krick and 
Remington (1976). N.asteroides is 
an opportunistic pathogen whereas 
recognized most commonly as 
N.brasiliensis produces 
disease most frequently in healthy people (Smego and Gallis, 
1984). In their study, 28% of N.brasiliensis- associated disease 
occurred in compromised hosts. 
1.3.2.2 PREDISPOSING FACTORS 
Numerous predisposing factors have been associated with 
N.asteroides and N.brasiliensis infections. In the report by 
Beaman et al ( 1976), immunosuppressan ts, neoplasia and organ 
transplants were the commonest under 1 ying factors. Localised 
lung disease such as tuberculosis and pulmonary alveolar 
proteinosis contribute to opportunistic nocardial infection 
(Beaman et al, 1976). Other underlying diseases include 
diabetes mellitus, systemic lupus erythematosis (Law and Marks, 
1982); chronic granulomatous disease of childhood (CGD) and pre-
existing pulmonary disease such as obstructive lung disease 
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(Stevens, 1983); mycosis fungoides (Smego and Gallis, 1984); 
hypogammaglobulinemia (Dolan, McCullough and Gibson, 1960) and 
malnutrition (Ballenger and Goldring, 1957). 
In various series, a large number of individuals infected with 
noca rdiae have been associated with diseases characterized by 
defects in cell-mediated immunity, such as Hodgkins disease (Sen 
and Louria, 1980 337) and CGD. Immunosuppression with 
corticosteroids is a common predisposing factor (Rosett and 
Hodges, 1978) and about 20% of nocardial infections have occurred 
in these patients (Sen and Louria, 1980 : 337). 
Simpson et al ( 1981) studied nocardial infections in the 
immunocompromised host and several factors predisposing the 
transplant patient to Nocardia infections were identified by 
reviewing the literature. These include the intensification of 
immunosuppressive therapy during rejection episodes, multiple 
rejection episodes, qua 1 i ty of donor organ his tocompa ti bi 1 i ty, 
granulocytopenia, hyperglycaemia, renal failure, hypogamma-
globulinemia and schedule for administration of 
corticosteroids. 
maintenance 
Systemic nocardial infections are often associated with impaired 
immunity (Hay, 1983). Individuals infected with N.brasiliensis 
with apparently normal immune defences most frequently had 
infections confined to skin and soft tissues whereas those with 
impaired host defences were predisposed to developing systemic 
rather than cutaneous disease (Smego and Gallis, 1984). The same 
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appears to be true for N .asteroides. Most cases of nocardiosis 
due to N.asteroides in healthy individuals have presented as 
localized pulmonary infection (Freese et al, 1963). 
1.3.2.3 SEX PREDILECTION 
In all series reviewed for this dissertation there was a marked 
preponderance of males infected with nocardiae. 
al's series (1976) men outnumbered woman about 3 
In Beaman et 
l; according 
to Senn and Louria (1980 : 337) the male female ratio is 2 : 
l; in the study by Presant, Wiernik and Serpick(l973) 69% of the 
patients were male. Other studies showed a male preponderance 
(Law and Marks, 1982; Smego and Gallis, 1984) and it seems that 
overall, infections in males predominates over females 2-3:l 
(Stevens, 1983). Although the sex predilection remains 
unexplained ( Sen and Louria, 1980 337) suggestions have been 
that rather than an increased susceptibility in males, 
differences in occupation or environment may lead to greater 
exposure to these soil-dwelling 
1984). 
1.3.2.4 AGE PREDILECTION 
organisms (Smego and Gallis, 
Nocardia infections most frequently occur midlife (Sen and 
Louria, 1980 : 337). In the study by Beaman et al (1976), most 
patients were between 21 and 50 years old al though ages ranged 
from 3 to 83 years. Other series have quoted mean patient ages 
as 42 years (Smego and Gallis 1984) and 41.7 years (Presant, 
Wiernik and Serpick, 1973). However, nocardial infections appear 
to occur at any age and the midlife predisposition may be related 
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to age when diseases treated by transplantation or characterized 
by defects in CMI such as Hodgkins disease are contracted (Sen 
and Louria, 1980 : 337). 
1.3.2.5 ROUTE OF INFECTION 
Nocardia organisms gain access to and cause disease in the human 
body by two main routes - the skin or lung (Law and Marks, 
1982; Hay, 1983). It has been suggested that entry may be 
gained via the gas troi n tes ti na 1 tract eg via contaminated food, 
but evidence for this route is inconclusive (Hay, 1983). 
Organisms, probably originating in the soil, enter most commonly 
via an airborne route or by traumatic inoculation (Stevens, 1983; 
Sen and 
primary 
Louria, 1980 
infection site 
336), the lung being the commonest 
and accounting for 60-80% of cases of 
systemic nocardiosis (Smego, Moeller and Gallis, 1983). In the 
series described by Presan t, Wiernik and Serpick ( 197 3), the 
port of entry was the lung in 65% of cases, the skin in 25% and 
the intestine in 4%. Although most nocardial infections are 
ca used by inhalation of contaminated dust, some 1 ung infections 
result from invasion of the lung by aspirated organisms or from 
bloodstream infections (Beaman, Goldstein et al, 1978). It is 
not certain whether there is widespread exposure to Nocardia, or 
whether sub-clinical sensitization occurs commonly as a 
consequence. If widespread exposure, eg via inhalation, does in 
fact occur, development of disease or clearance of the organisms 
may depend on the immunolog i ca 1 competence of the host, as wel 1 
as on other factors (Hay, 1983). There is a possibility of 
direct or indirect patient-to-patient or fomite transmission 
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occurring occasionally ( Sen and Louria, 1980 336: Stevens, 
1983). There have been reports of clustering in paediatric 
cases ( Cox and Hug hes, 197 5), in groups of compromised hos ts 
(Palmer, Harvey and Wheeler, 1974: Stevens et al, 1981) and of 
nosocomial cases (Rosett and Hodges, 1978). 
1. 4 CLINICAL MANIFESTATIONS 
N.asteroides, N.brasiliensis and N.caviae, the three commonly 
recognized pathogenic nocardiae, are capable of producing three 
distinct types of infection : pulmonary or systemic nocardiosis, 
actinomycotic mycetoma, or localized extrapulmonary suppurative 
infections which are generally confined to the skin and adjacent 
tissues (Beaman et al, 1976). Originally it was believed that 
N.asteroides was the only species that produced pulmonary-
systemic nocardiosis and N.brasiliensis and N.caviae the sole 
agents of actinomycetoma (Hay, 1983). However it is now clear 
that N.asteroides can produce actinomycetoma and N.brasiliensis 
and N.caviae pulmonary or systemic nocardiosis (Beaman et al, 
1976: Hay, 1983). 
1. 4.1 NOCARDIOSIS 
Nocardiosis is described as "usually a pulmonary, less often a 
cutaneous, illness that can become a multisystem illness" (Curry, 
1980). Invasive pulmonary infection is the most frequently 
encountered form of systemic nocardiosis and the main route of 
infection is via the respiratory tract (Hay, 1983). Nocardiosis 
may be an acute, subacute or chronic suppurative infection 
( Smego and Ga 11 is, 1984), - the spectrum of noca rdiosi s ranges 
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from mild localized bronchopulmonary disease 
lung infections that 
central nervous sys tern, 
to extremely 
disseminate 
skin and less 
aggressive primary 
haema togenously to the 
frequently to practically 
1976: Smego, Moeller and 
any organ in the body (Beaman et al, 
Gallis, 1983: Law and Marks, 1982). 
Therefore nocardiosis has a highly variable clinical 
presentation, in addition it mimics a variety of other pulmonary 
infections ( Beaman and Sugar, 1983). The conunonest aetiological 
agent of nocardiosis is N.asteroicas (Hay, 1983). Symptoms of 
nocardiosis vary widely, from none at all to malaise, cough, 
fever and 
Remington, 
occasionally pleuritic pain (Williams, Krick and 
typical of the disease 1976). Abscess formation is 
and frequently cases present with chronic suppura ti ve pneumonia 
and bronchi tis ( s_tevens, l 98~). The cl inica 1 man i fes ta tion is 
generally a suppurative lesion (usually non-caseating granuloma) 
(Stevens, 1983). It has also been described as a "focal 
pneumonitis with little inflammatory response, 
abscess formation often occurs with progressive 
though frank 
involvement II 
(Curry, 1980). Chest roentrographs are highly variable and non-
specific - features inc 1 ude small and large cavities, sma 11 and 
single and multiple nodules, segmental large abscesses, 
infiltrates, lobar infiltrates, necrotizing bronchopneumonia or 
lobar 
with 
pneumonia, lobar pneumonia with bulging fissures, masses 
central cavitation, pleural effusions, empyema and 
occasionally miliary patterns have been observed. Haemoptysis 
may occur. Extension of the pulmonary infection to the chest 
wall may lead to formation of sinus tracts. Leukocytosis and 
mild anaemia have been associated with the disease (Curry, 1980: 
14 
Sen and Louria, 1980 : 338). After pulmonary infection, central 
nervous system infection, manifested by non-capsula ted abscess, 
is the next most common presentation in Europe and North America 
(Stevens, 1983; Sen and Louria, 1980 : 338). 
l. 4. 2 CHARACTERISTICS OF GROWTH OF NOCARDIA ORGANISMS IN 
TISSUES 
Growth characteristics of Nocardia organisms in systemic 
nocardiosis differ from their growth characteristics in mycetoma 
- organisms grow as slender branching filaments in nocardiosis, 
whereas in actinomycetoma the organisms are grouped into tight 
aggregates of filaments called grains, although the tissue 
reaction is similar (Hay, 1983). 
l. 4. 3 MYCETOMA 
Mycetomas are chronic, indurated, granulomatous masses localized 
to skin and underlying bone, that steadily become more severe 
over several months or years. Early in infection, the maii sign 
is the formation of a firm subcutaneous swelling but development 
is slow and insidious and later multiple draining nodules and 
sinus tracts develop 
serosanguinous fluid 
which discharge 
onto the surface 
sulphur 
of the 
granules and 
skin. These 
granules are characteristic of the causative agent of the 
mycetoma. The abscesses become indurated and are surrounded by 
granulomatous inflammation. Spread of infection is usually by 
direct extension through the tissues and invasion of underlying 
muscle, bone and connective tissue occurs. Myce tomas have been 
described as a "fistulous tumour" (Conde et al, 1982). Although 
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swelling, suppuration and healing occur in a cyclic pattern, 
progressive development of the disease process occurs ( Conde et 
al, 1982). 
Myce toma s a re thought to occur after wound contamination by 
Nocardia-containing soil and most frequently develop on the 
lower extreme ties, usually the foot or leg, however they may 
develop in any region of the body (Beaman and Scates, 1981). In 
Mexico, mycetomas are found on the backs of farm labourers, who 
tend to carry loads of soil on their shoulders. Secondary 
invasion of the lung may occur by direct extension from these 
Curry, mycetomas (Beaman, 1976 387; Law and Marks, 1982; 
1980; Hay, 1983; Smego and Gallis, 1984; Zlotnick and 
Buckley, 1980; Beaman and Scates, 1981; Gonzalez-Ochoa, 1962). 
N.brasiliensis is the most important etiologic agent of mycetoma 
in the Americas and it is also a causative agent in Africa, India 
and other tropical and subtropical regions (Smego and Gallis, 
1984). 
l. 4. 4 PRIMARY CUTANEOUS NOCARDIOSIS 
The third form of Nocardia infection, primary cutaneous 
nocardiosis, follows a more acute course. Route of en try is 
thought to be by traumatic inoculation and in this disease the 
organisms grow in the branching filamentous form. Presenting 
signs include ce 11 ul i tis, pyoderma or subcu ta nous abscesses, it 
may also present as a lymphocutaneous or sporotrichoid syndrome 
in which the initial infection site is acutely inflamed with 
cutaneous nodules, and secondary lesions are produced along the 
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course of the lymphatics. It is not certain whether N.caviae can 
cause primary cutaneous nocardiosis by inoculation, however, 
this form of infection caused by N.asteroides and N.brasiliensis 
is seen more and more frequently in the United States ( Law and 
Marks, 1982: Hay, 1983). 
1. 4. 5 PROGNOSIS 
Factors affecting prognosis of nocardial infections were 
identified by Presant, Wiernik and Serpick (1973). High 
mortality was associated with three patient groups. (1) Poorest 
prognosis was associated with disseminated disease (80% 
mortality). ( 2) Pulmonary nocardiosis with underlying disease 
and concommi tan t immunosuppresi ve therapy or Cushing' s disease 
( 80-100% mortality, whereas in patients with underlying disease 
not receiving corticosteroid or antineoplastic therapy, mortality 
was 20%) • ( 3) Acute disease with symptoms of less than three 
weeks duration. These authors also found that primary central 
nervous system (CNS) disease which disseminated was associated 
with 90% mortality rate. Other factors associa tea with poor 
prognosis include prior use of steroids, CNS involvement and 
inappropriate antibiotic therapy (Rosett and Hodges, 1978). 
1. 5 DIAGNOSIS 
In order to diagnose Nocardia sp. as the etiologic agent of 
disease, cultural confirmation is necessary since staining 
characteristics and morphology cannot be used to differentiate 
Nocardia sp. from Actinomyces (Sen and Louria, 1980 : 338). 
Serologic and skin tests are becoming useful diagnostic tests but 
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because of antigenic cross-reactivity with organisms such as 
Mycobacteria false positive results may occur. Recently a 
complement -fixation test has been developed (Stevens, 1983). 
Blood and cerebrospi na 1 f 1 uid rare 1 y yield a positive Nocardia 
culture, even when non-capsulated abscesses are present (Sen and 
Louria, 1980 338,339; Smego and Gallis, 1984). Falsely 
negative results may be obtained from sputum specimens and 
aggressive diagnostic procedures are advocated, especially when 
pulmonary infection in the compromised host is being 
investigated. Invasive procedures such as aspiration of 
cutaneous lesions, thoracentesis, transtracheal aspiration, 
bronchial brushing and skin or lung biopsy may be required (Sen 
and Louria, 1980 : 338; Krick, Stinson and Remington, 1975; Smego 
a n a Ga 11 i s , 1 9 8 4 ) • Since Nocardia organisms can take up to four 
weeks to form colonies, organisms may not be isolated and 
identified in the bacteriology laboratory because of the common 
practice of discarding 
consequently appropriate 
taken (Stevens, 1983). 
culture plates after 48 72 hours, 
measures to retain the plates must be 
Diagnosis is aided by a high index of suspicion, particularly in 
the immuncompromised patient who has acute respiratory tract 
infection. 
Presence of cutaneous Nocardia infection indicates the need to 
investigate the patient for other infected foci, especially if 
the patient is immunocompromised (Krick, Stinson and Remington, 
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1975; Rosett and Hodges, 1978). 
1.6 TREATMENT 
The mainstay of treatment of nocardial infections for the last 
forty years has been the sulphonamides and they remain the drugs 
of choice today, according to many 1 i tera ture sources. The 
usual dose required is 10 grams per day in divided doses. 
Although nocardiosis may be treated effectively, mycetoma is 
frequently refractory to treatment, a 1 though dapsone and long-
term sulphonamides may be effective (Sen and Louria, 1980 : 
339); Curry, 1980; Law and Marks, 1982). 
Because of the known efficacy of the sulphonamides in nocardial 
infections and the synergistic action of sulphonamide and 
trimethoprim against various organisms, the combination appeared 
to be a promising one in the treatment of nocardial infections 
(Curry, 1980). Smego, Moeller and Gallis, (1983) assessed the 
efficacy of this combination and from the results of their study 
concluded that 
choice. In 
this combination should be considered the drug of 
this study the commercial fixed dosage tablets 
( 80/ 400 mg tr ime thopr im and sulphame thoxa zole) were given, the 
mean daily dosage being 8.2 tablets per day. However, it seems 
that there is controversy over the optimal trimethoprim-
sulphame thoxa zole combination ratio ( Smego and Ga 11 is, 1984; 
Curry, 1980). Synergistic effect depends on the 
sulphmethoxazole-trimethoprim 
inoculum and length of incubation 
ratio, the specific strain, 
(Bennett and Jennings, 1978) 
and failure of therapy has also been reported (Geiseler et al, 
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1979). From retrospective case evaluations, it appears that the 
drug combination offers advantages over 
patients with severe metastatic nocardial 
Ga 11 i s , l 9 8 4 ) • 
sulphonamides only, in 
infections (Smego and 
Many other antimicrobial agents have been used either alone or in 
combination in the therapy of Nocardia infections. Dapsone is 
reported to be useful in the treatment of infections due to 
N.brasiliensis eg mycetomas (Stevens, 1983). Ampicillin, 
amikacin, clindamycin, cycloserine, minocycline and erythromycin 
have been used successfully, but marked strain-to-strain 
variation in sensitivity makes in vitro sensitivity testing 
imperative (Curry, 
agents, eg the 
1980 ; Smego and Gallis, 1984). Beta-lactam 
cephalosporins, cefamandole, cefotaxime, 
cefuroxime (Stevens, 1983) have shown in vitro activity and 
cefotaxime has been shown to be highly effective in a murine 
model of acute pulmonary nocardiosis (Sugar, Chahal and Stevens, 
1983). 
Duration of treatment has not been clearly defined but relapse 
after inadequate time of therapy is common. Smego and Gallis 
(1984) advise treatment for 3-12 months 
severity of disease, immune status of the 
depending on clinical 
patient and duration 
of time when there is risk of infection. Immunosuppressed 
patients on maintenance corticosteroids may benefit from 
prophylactic low-dose therapy after resolution of the nocardial 
infection. 
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Helpful adjunct therapy includes surgical drainage of abscesses, 
excision of abscess cavities and necrotic tissue and amputation 
(Smego and Gallis, 1984; Sen and Louria, 1980 : 339). 
1. 7 
1. 7 .1 
ANIMAL MODELS OF NOCARDIA INFECTIONS: INVESTIGATION OF 
PATHOGENESIS AND HOST RESPONSE 
INTRODUCTION 
Although a large variety of animals are susceptible to naturally 
acquired Nocardia infections, difficulties were experienced with 
initial attempts to develop a suitable, representative animal 
model of the disease and contradictory or conflicting results 
were obtained (Beaman and Sugar, 1983). Early workers reported 
that nocardiae were not pathogenic for mice or guinea pigs, 
others concluded that adjuvants were required for reliable 
results and enhanced virulence of the organisms, and others 
reported that guinea pigs were susceptible and died following 
infection ( Beaman and Sugar, 1983). Beaman and Sugar have 
published a comprehensive review of naturally acquired and 
ex per imen ta 1 noca rdia 1 infections in animals which inc 1 udes a 
discussion of early experimental infections, and consequently 
this will not be repeated here (Beaman and Sugar, 1983). A 
recently published review of the interactions of N.asteroides in 
BALB/c mice with special reference to modulation of macrophage 
function and induction of specific T-cells (Beaman and Black, 
1985) is also recommended for the interested reader. 
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A variety of animals have been used as models in the 
investigation of mechanisms of nocardial pathogenesis. Recently, 
experimental infections have been produced in guinea pigs 
(Sundararaj and Agarwal, 1978; 1977a; 1977b) and rabbits have 
been used as a source of unelicited and specifically activated 
alveolar macrophages (Beaman, 1977; Beaman and Smathers, 1976; 
Beaman, 1979; Davis-Scibienski and Beaman, 1980) but the vast 
majority of work investigating host resistance and pathogenesis 
of nocardial infections has been done using a mouse model (Folb, 
Jaffe and Altmann, 1976; Beaman et al, 1980; Beaman, Gershwin 
and Maslan, 1978; Beaman and Maslan, 1977; Folb, Timme and 
Horowitz, 1977; Beaman and Maslan, 1978; Beaman et al, 1980; 
Beaman, 1980; Rico et al, 1981; Ximenez et al, 1980; Conde et 
al, 1982). The laboratory mouse is particularly suitable for 
use as a model because there are numerous varieties such as 
immunodeficient strains, which are immunologically well defined 
and facilitate investigation into immune aspects of host 
response to the nocardiae (Beaman and Sugar, 1983). 
1. 7. 2 ANIMAL MODELS OF NOCARDIA INFECTIONS 
1.7.2.l NOCARDIOSIS 
A critical problem in establishing an animal model of 
N.asteroides infections was the requirement for addition of 
specific adjuvants to the inoculum. N.asteroides suspended in 
saline and introduced intraperitoneally frequently induced a 
benign infection, whereas addition of adjuvant increased the 
virulence and produced malignant infection (Uesaka et al, 1971; 
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Krick and Remington, 1975). 
Acute and chronic progressive Nocardia infections were 
established in mice without the use of adjuvant after 
intraperitoneal inoculation by Beaman (1973) and Falb, Jaffe and 
Altmann (1976), and this permitted detailed study of the natural 
history and pathology of the infection. 
Host response to and pathogenesis of pulmonary and systemic 
nocardiosis has been investigated using a murine model by several 
workers. Krick and Remington (1975) developed a mouse model 
using N.asteroides suspended in saline or mucin adjuvant and 
although the resultant intraperitoneal infection did not appear 
to resemble human nocardiosis they came to the very important 
conclusion that N.asteroides infection produces a population of 
activated macrophages and that cell-mediated immunity, 
functioning through these macrophages, plays a significant role 
in host defence against N. as teroi des. This paper paved the way 
for numerous studies attempting to define the mechanisms of host 
response to invasion by N.asteroides. Recently, murine models 
of nocardiosis that have the essential clinical characteristics 
of the disease in humans have been developed using particular 
strains of organisms (Beaman and Sugar, 1983). 
1.7.2.2 MYCETOMA 
Gonzalez-Ochoa (1973), Gonzales-Ochoa and Kumiko-Hojyo (1967) 
developed a murine model of mycetoma with most of the clinical 
features of human disease associated with Nocardia. He produced 
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a typical mycetoma in the foot pad of the mouse after a single 
Folb, Jaffe and inoculation of N.brasiliensis without adjuvant. 
Altmann (1976) also produced a granulomatous lesion with a 
central mass of organisms forming a granule after single foot 
pad inoculation with N.brasiliensis without adjuvant. Beaman and 
Scates (1981) 
adjuvant) and 
inocula tea mice intravenously with N. ca viae ( no 
produced a chronic mycetoma model, al though the 
route of inoculation in this model has been criticized since the 
commonest site of mycetoma development in humans is in the feet 
(Conde et al, 1982). Conde et al ( 1982) induced characteristic 
mycetoma in 
Histological 
an inbred mouse model without use of adjuvant. 
features of the lesions were similar to those 
described by Folb, Jaffe and Altmann (1976); Melendro et al 
( 1978) and Ximenez et al (1980). However, approximately 100-
fold fewer Nocardia organisms were required to produce mycetoma 
in inbred mice in comparison to ou tbred mice ( Folb, Jaffe and 
Altmann, 1976; Conde et al, 1982). 
Several reports describe induction of mycetoma after foot pad 
inoculation with N.brasiliensis organisms in incomplete Freund's 
adjuvant (Melendro et al, 1978; Ximenez et al, 1980; Rico et 
al, 1981; 1982). Zlotnik and Buckley (1980) induced mycetoma in 
mice using N.brasiliensis in saline or in adjuvant and showed 
that development of mycetoma is accelerated by presence of 
adj uvan t. Al though the use of incomplete Freund' s adjuvant 
increases 
undefined 
the 
way, 
susceptibility of the 
the his to logy of the 
host to infection in an 
lesions do not differ from 
that of naturally occurring lesions in humans (Rico et al, 1982). 
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1.7.2.3 CONTRADICTORY INTERPRETATIONS OF ANIMAL MODEL DATA 
Animals models of Nocardia infections described in the literature 
differ and hence conflicting reports have been 
there t1as been considerable controversy regarding 
published, eg 
the relative 
pathogenicity of Nocardia organisms for mice 
1971; Gonzalez-Ochoa, 1973, Folb, Jaffe and 
Beaman, 1973; Beaman, 1976 387). Factors 
(Uesaka et al, 
Altmann, 1976; 
contributing to 
these contradictory reports include difficulties in working with 
pathogenic nocardiae; lack of standardization of culture 
conditions in inocul um pre para ti on; use of adj uvan t in the 
i nocul um; use of an ima 1 s of different gene tic backgrounds and 
consequently different susceptibilities to the organism; lack of 
standardization of parameters of virulence, eg some workers have 
used lethality as a parameter (Krick and Remington, 1975; Folb, 
Jaffe and Altmann, 1976; Beaman and Maslan, 1978); organ 
tropism, and different routes of inoculation. It is important, 
therefore, to be ca re ful when comparing results from different 
animal models ( Beaman and Maslan, 1977; Conde et al, 1982; 
Beaman and Sugar, 1983). 
l. 7. 3 
1.7.3.1 
EXPERIMENTAL NOCARDIA INFECTIONS IN ANIMALS 
IMMUNODEFICIENT MURINE MODELS 
Several genetically immunodeficient strains of mice have been 
used to investigate in vivo mechanisms of host response to 
pathogenic nocardiae. Immunooeficient mice have also been 
produced by manipulation, such as thymectomy, lethal irradiation 
and immunosuppressive therapy. 
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1.7.3.1.1 Congenitally Athymic (nude mice) 
In a histopathological study of lesions produced by N.asteroides 
and N.brasiliensis, Folb, Jaffe and Altmann (1976) noted 
microscopical features of special interest in the N.brasiliensis 
lesion : foamy macrophages and the presence of organisms within 
the cell cytoplasm. These features are suggestive both of the 
features noted in leproma tous leprosy in man and of systemic 
Mycobacterium bovis (BCG strain) infection in the immune-
suppressed mouse. This finding lead to the suggestion that the 
pathological effects of N.brasiliensis could be related to 
inactivation of normal T-lymphocyte function by this organism 
( Folb, Jaffe and Altmann, 1976). The idea that disorders of 
cell-mediated immunity may be particularly important in the 
pathogenesis of Nocardia infections (Folb, Jaffe and Altmann, 
1976) led to the initial attempt to define the role of the T-
lymphocyte in normal immunity to nocardial infections and the 
results suggested that the T- lymphocyte is an essential 
component in normal host resistance to N.asteroides and 
N.brasiliensis infection (Folb, Timme and Horowitz, 1977). 
The a thymic nude (nu/nu) mouse functions as an excellent model 
for defining the roles of T-lymphocytes in host resistance to 
Nocardia since these mice are totally deficient in T-cell 
function (Beaman and Sugar, 1983). Several detailed studies 
investigating nude mouse responses to N.asteroides, 
N.brasiliensis and N.caviae infections (Folb, Timme and Horowitz, 
1977: Beaman, Gershwin and Maslan, 1978: Beaman, Goldstein et 
al, 1978: Beaman and Sea tes, 1981: Deem, Beaman and Gershwin, 
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1982) have established that T-cells are critical in host 
resistance to systemic and chronic nocardial infections (Beaman 
and Sugar, 1983). Nude mice were initially more resistant to the 
acute phase of infection than their immunologically intact 
littermates, but after about 72 hours the nude mice showed 
increased susceptibility and at about 2 weeks post-infection were 
significantly more susceptible than their normal littermates 
(Beaman, Gershwin and Maslan, 1978; Beaman, Goldstein et al, 
1978; Beaman and Scates, 1981; Beaman and Sugar, 1983). Nude 
mice were more susceptible to intravenous (Beaman, Gershwin, and 
Maslan, 1978) and intranasal challenge (Beaman, Goldstein et al, 
1978) than their normal heterozygous littermates. Studies with a 
virulent strain of N.asteroides showed that T-cells were 
essen tia 1 for ef fee ti ve host reponse against systemic inf ec ti on 
(Beaman, Gershwin and Maslan, 1978) and that T-cells are 
important in pulmonary clearance and prevention of dissemination 
from the lung since nude mice cannot eliminate the intranasally 
administered bacteria (Beaman, Goldstein et al, 1978). 
Nude mice did not generally develop the granuloma tous lesion 
characteristic of murine mycetoma that is induced in 
immunologically intact mice by N.brasiliensis (Folb, Jaffe and 
Altmann, 1976; Folb, Timme and Horowitz, 1977; Ximenez et al, 
1980) and it was suggested that T-lymphocytes have a central role 
in granuloma development (Folb, Timme and Horowitz, 1977). 
Others 
typical 
have shown that a thymi c mice were not able to deve 1 op 
mycetomatous lesions after infection with either 
N.brasiliensis or N.caviae. Rather, the nude mouse developed 
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purulent abscesses and aggressive systemic disease which 
resulted in mortality of the mice much earlier than the 
immunologically intact animals. 
N. asteroides, nude mice became 
soon after infection, whereas 
acute footpad inflammatory 
After foot pad inoculation with 
systemically infected and died 
littermate controls developed an 
response (Beaman, Gershwin and 
Maslan, 1978; 
1983). 
Beaman and Scates, 1981; Beaman and Sugar, 
In an attempt to further elucidate the inter-relationship between 
T-lymphocytes and the state of macrophage activation, a thymic 
nude and control littermate BALB/c mice were pretreated with 
either Corynebacterium parvum (Propronibacterium acnes) to non-
specifically activate macrophage function, or dextran sulphate 
500 to suppress macrophage function (Beaman and Black, 1985). 
Sublethal doses of N.asteroides were administered intra-nasally 
and pulmonary clearance determined in pretreated and 
unmanipulated control mice. Dextran sulphate inhibited organism 
clearance from the lungs of heterozygous (nu/+) mice whereas 
pulmonary clearance of nude (nu/nu) mice did not appear to be 
affected. The authors suggested that alveolar macrophage 
activity in nude mice is either already maximally suppressed 
against Nocardia or that a functional T-cell population is 
required for the systemic effect of dextran sulphate. In 
contrast, non-specific macrophage activation by C.parvum markedly 
enhanced pulmonary clearance of Nocardia in both athymic and 
heterozygous lit terma te mice. These data suggest that T-cel ls 
are not required for the non-specific stimulation of anti-
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nocardial lung clearance mechanisms; 
activation of macrophages may occur 
function (Beaman and Black, 1985). 
and that non-specific 
independent of T-cell 
Conclusive evidence that T-cells are vital for adequate host-
resistance to nocardial infection was supplied by Deem, Beaman 
and Gershwin (1982). These workers adoptively transferred 
specifically primed purified T-cells to nude mice and 
demonstrated increased resistance to a virulent strain of 
N.asteroides in these animals. 
1.7.3.1.2 Hereditarily Asplenic (Dh/+) Mice 
Hereditarily asplenic mice show a major age-dependent deficiency 
in T-cell function with the development of decreased immuno-
globulin production 
and Sugar, 1983). 
(Beaman, Gershwin and Maslan, 1978; Beaman 
Young asplenic mice which have a decreased T-
cell function are most susceptible to acute, systemic nocardial 
infections (Beaman, Gershwin and Maslan, 1978; Beaman and 
Sea tes, 1981). Further, those animals that survived the acute 
phase of infection .showed a marked inability to clear Nocardia 
organisms from the body. Asplenic mice appeared to remain 
uninfected or always died before progressive mycetomas developed 
in response to N.brasiliensis and N.caviae (Beaman, Gershwin and 
Maslan, 1978; Beaman and Scates, 1981; Beaman and Sugar, 1983). 
1.7.3.l.3 B-Lymphocyte Deficient Mice 
CBA/N mice have an X-linked deficiency in B-lymphocyte function 
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and therefore have a poor antibody response to T-dependent and T-
independent antigens, resulting in production of abnormally low 
levels of immunoglobulin M ( Ig M) and IgG 3 antibody. They seem 
to have a functional T-cell population. The ma ting of CBA/N 
females with DBA/2 males results in CBD2/Fl males which are B-
cell deficient, whereas the female littermates are 
immunologically intact (Beaman, Gershwin et al, 1982: Beaman 
and Sugar, 1983). 
deficient mice and 
Use of these genetica 11 y control led B-ce 11 
their normal littermates as an animal model 
of Nocardia infections permits evaluation of the role of B-cells 
in the immune response. (Beaman, Gershwin et al, 1982). The B-
cell deficient male mice were no more susceptible to 
N.asteroides infection than were the normal female control mice. 
Interestingly, the immunologically intact female mice were 
markedly more susceptible than their male littermates to 
intravenous challenge with a lethal dose of N.asteroides. 
Preimmunized deficient and normal mice were similar in their 
ability to resist challenge with a lethal dose of N.asteroides: 
and both the groups of preimmunized mice seemed to have the same 
ability to develop a cell-mediated immune response to Nocardia. 
High antibody titres were measured in female mice but not in the 
B- cell deficient males. The increased susceptibility of normal 
female mice suggested that presence of antibodies against 
Nocardia are detrimental to the host and enhance the development 
of the disease (Beaman, Gershwin et al, 1982: Beaman and Sugar, 
1983). 
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Rico et al (1982) investigated the effect of specific deletion of 
B-lymphocytes bearing receptors for Nocardia on the pathogenesis 
of nocardial infection. Lethally irradiated mice were 
reconstituted with spleen cells previously depleted of 
lymphocytes bearing specific receptors for a Nocardia extract 
(NE), ie these animals would not be able to produce antibody 
against NE but would produce all other immunoglobulins normally. 
Specific B-lymphocyte-depleted mice had less swelling of the 
inoculated foot and mycetomas healed whereas control mice 
reconstituted with 
some spontaneously 
whole spleen cells 
lost their limbs. 
developed 
The sera 
mycetomas and 
of specific B-
lymphocyte depleted mice did not contain haemagglutinating 
antibodies to Nocardia whereas control mice sera contained these 
antibodies. Production of delayed-type hypersensitivity (DTH) 
reaction was positive in specific B-lymphocyte depleted mice 
indicating that induction of cell-mediated immunity to Nocardia 
was not affected. 
1.7.3.1.4 Germfree Mice 
These mice have been maintained in a germfree environment which 
isolates the host from the influences of exogenous microbial 
interactions and from interactions with its own normal 
microflora. Also, germfree mice are ideal for study of immune 
reactions against a single, specific external factor (Beaman, 
Gershwin et al, 1980). 
The response of germfree mice to N.asteroides administered 
intranasally or intravenously was very different from that of 
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conventionally grown 
more susceptible to 
mice. The germ free 
infection with 
mice were very 
N.asteroides 
germfree mice frequently died. 
much 
than 
The conventionally grown mice; 
germfree mice did not appear able to inhibit rapid growing of 
the organism in brain, kidney, adrenals or lungs. Treatment of 
germfree animals with lipopolysaccharide (LPS) prior to 
infection abrogated this increased susceptibility and rendered 
these animals equally or 
grown animals. Therefore 
more resistant than conventionally 
resident microflora and exposure of 
the host to exogenous micro - organisms are important in 
increasing host resistance to Nocardia. The suggested mechanism 
of the enhanced host resistance is that resident microflora non-
specifically and continuously activate the host defence system. 
The study further suggests that the state of macrophage 
activation and the development of cell mediated immunity are 
vital in host protection against systemic nocardial infections 
(Beaman, Gershwin et al, 1980; Beaman and Sugar, 1983). 
1.7.3.1.5 T-cell depleted mice (B mice) 
T-cell depletion of mice was accomplished by thymectomy at or 
before 4 weeks of age, followed by lethal irradiation (900R) and 
reconstitution with B cells by bone marrow transfer. B mice did 
not form antibodies after immunization with a T-dependent 
antigen, (Burro eythrocytes) and did not produce 
haemagglutinating antibodies to Nocardia. (Rico et al, 1981; 
1982). These mice can be used to determine the role of B-cells 
and antibody in 
were induced in 
resistance 
B mice 
to nocardial infections. Mycetomas 
after footpad inoculation with 
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N.brasiliensis in adjuvant. T-cell depleted mice were far more 
susceptible to severe disease after nocardial infection than 
immunologically intact animals, and 
response was less intense than in 
although the inflammatory 
intact animals, the lesions 
were more destructive and spontaneous loss of infected legs 
occurred (Rico et al, 1981; 1982). These results confirmed the 
important role of T-cells in the immune response to Nocardia but 
did not elucidate whether the lack of T- cells or T-cell 
dependent antibody contributed to severe disease. 
A previous study indicated that passive transfer of specific 
antibody, in the absence of cell-mediated immunity, did not 
modify the course of noca rd ia 1 infection, in fact, the an ti body 
seems to facilitate the growth of the micro-organisms and the 
progression of disease (Rico et al, 1981). These findings were 
confirmed in the 1982 study (Rico et al, 1982) in that specific 
antibody either passively administered to the host or the 
inoculation of antibody-coated Nocardia organisms favoured 
progression of the infection. Administration of antibody, 
whether by passive transfer or by coating of organisms, enhanced 
progression of disease in both normal and T-cell depleted mice. 
These experiments ruled out any role for antibody in protection 
against Nocardia. Direct T-cell participation in resistance was 
demonstrated in the ex per imen ts detailed under 1.7.3.1.3 (Rico 
et al, 1982). Elimination of the specific humoral response to 
Nocardia was accomplished by removal of specific B-cells. These 
animals mounted effective DTH reactions and completely 
controlled their nocardial infection, further supporting the 
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concept that antibody to Nocardia facilitate 
disease and further establishing the critical 
mediated immunity in protection against Nocardia 
1982). 
1.7.3.1.6 Immunocompromised Host Models 
progression of 
role of eel 1-
( Rico et al, 
Nocardiosis is a serious clinical problem in the immuno-
suppressed patient ( Section 1. 3. 2; Beaman and Sugar, 1983). 
Animal models of nocardiosis in the immunocompromised host have 
been developed. Murine susceptibility to infection with 
N.asteroides, N.brasiliensis and N.caviae is enhanced by 
administration of cortisone, which caused more extensive 
lesions and higher mortality (Mishra et al, 1973). 
Cyclophosphamide treatment of 
susceptibility to N.asteroides. 
grow in its target organ was 
Nocardia from the organs was 
mice markedly increased their 
The ability of the organism to 
enhanced and elimination of 
impaired. Cyclophosphamide 
modified host resistance to 
cortisone, prednisolone or 
N.asteroides more effectively than 
azothiaprine (Beaman and Maslan, 
1977; Beaman and Sugar, 1983). 
1.7.3.2 STUDIES IN GUINEA PIGS 
Guinea pigs were inoculated with N.asteroides emulsified in 
incomplete Freund adjuvant (Sundararaj and Agarwal 1977a) or 
immunized with its ribonucleic acid protein (P-RNA) (Sundararaj 
and Agarwal, 1977b). Cell-mediated immunity (CMI) was shown to 
develop both during experimental infections and after 
immunization. Adoptive transfer of immune spleen cells from 
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infected or immunized donor guinea pigs improved guinea pig 
survival and decreased Nocardia organism counts in the tissues, 
indicating that CMI is important in protection against 
N.asteroides (Sundararaj and Agarwal, 1978). The use of outbred 
animals for adoptive transfer experiments has been criticized 
(Beaman, Gershwin and Maslan, 1978; Deem, Beaman and Gershwin, 
1982). 
A further study investigating mechanisms of protection of CMI 
showed that there was a marked decrease in the number of viable 
intracellular organisms in immune macrophages, indicating that 
CMI is mediated in part by activated macrophages. The protective 
role of macrophages in N.asteroides infection was further 
demonstrated by the adverse effects on survival and clearance of 
organisms from the tissues produced by administration of anti-
macrophage sera (AMS) to guinea pigs. Adoptive transfer of 
immune spleen cells to normal guinea pigs increased the 
intracellular decrease in number of viable organisms, indicating 
that humeral immunity has little or no role in protection 
against N.asteroides (Sundararaj and Agarwal, 1978). 
1.7.3.3 ANTIBIOTIC TESTING IN MURINE MODELS OF NOCARDIOSIS 
INDUCED BY N.ASTEROIDES 
The efficacy of amikacin was evaluated in an acute lethality 
model and a chronic infection model and compared with the effect 
of sulphonamides. Amikacin significantly increased survival rate 
in the acute lethality model whereas sulphonamides did not; and 
amikacin and sulphonamide therapy significantly increased the 
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rate of resolution of abscesses 1n the chronic infection model. 
Overall, amikacin appeared to be more effective than sulphonamide 
under the experimental conditions employed (Wallace et al, 1979). 
A study by Sugar, Chahal and Stevens ( 1983) demonstrated the 
efficacy of parenteral cefotaxime in the treatment of acute 
pulmonary nocardiosis in the mouse. The broad spectrum 
therapeutic activity of cefotaxime makes it an attractive agent 
as initial and long-term therapy in febrile immune-impaired hosts 
and it would provide coverage for possible nocardial infection in 
cases where the etiologic agent of disease may not initially be 
apparent (Sugar, Chahal and Stevens, 1983). 
1.7.3.4 AMYLOIDOSIS IN EXPERIMENTAL NOCARDIA INFECTION 
Repeated inoculation of mice with either N.asteroides or 
N.brasiliensis; or chronic progressive disease may lead to the 
development of secondary amyloidosis (Folb, Horowitz and 
Greenwald, 1977). 
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1.7.4. IN VITRO STUDIES 
In vitro studies performed with the aim of elucidating the 
mechanisms of host resistance and pathogenesis of nocardial 
i nfec ti ons have concentrated on ce 11 ula r a spec ts of the immune 
response, in particular Nocardia-macrophage interactions have 
been investigated (Bourgeois and Beaman, 1974; Beaman and 
Smathers, 1976; Beaman, 1977; Filice, Beaman and Remington, 
1980; Davis-Scibienski and Beaman, 1980a, b, c; Beaman, 1979; 
Black et al, 1983; Black et al, 1985). 
The association of defects in cell-mediated immunity and 
increased susceptibility to nocardiosis lead to studies on 
interactions of Nocardia with activated macrophages (Filice, 
Beaman and Remington, 1980). 
1.7.4.1 INTERACTIONS OF N.ASTEROIDES WITH MACROPHAGES IN VITRO 
The first reported studies of the interaction of N.asteroides 
with cultured macrophages established that the Nocardia are able 
to persist and grow intracellularly both in peritoneal 
macrophages ( Bourgeois and Beaman, 1974) and in alveolar 
macrophages ( Beaman and Smathers, 1976) and should therefore be 
considered facultative intracellular parasites (Beaman, 1976 
389). The macrophage response towards Nocardia depended on the 
strain of Nocardia with which they came in contact (Beaman and 
Smathers, 1976; Beaman, 1977). 
Normal rabbit alveolar and mouse peritoneal macrophages failed 
to kill virulent strains of N.asteroides over a three hour 
period of incubation. Upon prolonged incubation the organisms 
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grew within the macrophages and eventually destroyed them 
(Bourgeois and Beaman, 1974; Beaman and Smathers, 1976; Beaman, 
1977; Beaman, 1979; Filice, Beaman and Remington, 1980). In 
contrast, specifically activated alveolar macrophages 
temporarily retarded growth of N.asteroides (Beaman, 1979). 
Non-specifically activated mouse peritoneal macrophages were 
able to kill quite substantial numbers of virulent N.asteroides 
organisms within 6 hours of incubation and to inhibit the 
intracellular growth of the remaining organisms (Filice, Beaman 
and Remington, 1980). Activated macrophages appear, therefore, to 
be important in host defence against Noc a rdia in fee tion ( Krick 
and Remington, 1975; 
Remington, 1980). From 
Beaman, 1979; 
these results, 
Filice, 
peritoneal 
Beaman and 
macrophages 
seem to be more proficient in killing Nocardia than alveolar 
macrophages, a finding confirmed by Black et al ( 1985) 
Killing of N.asteroides by alveolar 
enhanced by a combination of host 
macrophages was markedly 
factors from preimmunized 
animals. Maximal killing of organisms 
specifically activated macrophages combined 
from specifically primed lymph nodes, immune 
was achieved using 
with lymphocytes 
serum and alveolar 
lining material. Killing of Nocardia was negligible and similar 
to that of control macrophages when specifically primed 
lymphocytes were not included and decreased killing resulted 
when other components were omitted, indicating 
macrophages alone are not adequate to kill 
N.asteroides and that specifically primed 
that activated 
phagocytosed 
lymphocytes are 
important in that host defence (Davis-Scibienski and Beaman, 
1980c). 
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Since the initial interaction of Nocardia with macrophages 
determines the extent of the resulting infection (Beaman and 
Smathers, 1976; Black et al, 1983) macrophage responses to 
Scibienski and Beaman (1980a), using rabbit alveolar macrophages, 
showed a correlation be tween 
N.asteroides and their 
relative virulence of strains of 
resistance to phagocytosis and 
intracellular killing. This correlation was also shown by Black 
et al (1983, 1985),in mouse peritoneal and alveolar macrophages. 
In the same study, there was a direct correlation between 
organism virulence, lack of macrophage-induced ul trastructural 
damage and inhibition of phagosome-lysozome fusion (Davis-
Scibienski and Beaman, 1980a). A further study on the same 
strain of N.asteroides at different stages of growth established 
a correlation between the relative virulence of the phase of 
growth of the organism and the degree of inhibition of phagosome-
lysozome fusion (Davis-Scibienski and Beaman, 1980b). Inhibition 
of phagosome-lysozome fusion was studied in alveolar, peritoneal, 
splenic and Kupffer cells from non-immune BALB/c mice. 
Effectiveness of inhibition of fusion was determined using 
virulent and less virulent strains of N.asteroides and the non-
pathogenic yeast Candida krusei was used as a control. Both 
strains of N.asteroides differed significantly from Candida and 
inhibited phagosome-lysozome fusion to a greater extent than 
C.krusei. 
with the 
addition, 
The virulent strain of N.asteroides was associated 
lowest degree 
the different 
of phagosome-lysozome fusion. In 
strains of organisms induced different 
degrees of inhibition of fusion in the different macrophage 
populations (See Beaman and Black, 1985, for details). The 
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inhibition of phagosome-lysozome fusion may therefore be one of 
the mechanisms of nocardial pathogenesis (Davis-Scibienski and 
Beaman, 1980b). 
Further studies attempting to elucidate the mechanism or 
intracellular events enabling virulent Nocardia organisms to 
persist and grow within macrophages showed that, in normal 
murine macrophages, relative virulence and resistance to killing 
by macrophages correlated with resistance to phagocytosis, in 
addition the in trace 11 ular level of activity of the 1 ysozomal 
enzyme, acid-phosphatase was decreased by in vitro infection 
with live virulent Nocardia organisms and the greater the level 
of intracellular infection (in terms of number of organisms) the 
more the level of acid-phosphatase activity was reduced. Killed 
bacteria of the virulent strain or live organisms of a less 
virulent strain did not produce this effect. Live cells of the 
virulent strain reduced acid- phosphatase activity levels to a 
greater extent in alveolar macrophages than in peritoneal 
macrophages, which is cons is tent with evidence that peritoneal 
macrophages are more proficient killers of Nocardia than 
alveolar macrophages ( Black et al, 1983). Subsequent work 
revealed that lysozomal acid-phosphatase activity correlated with 
normal and activated macrophage killing efficiency - increasing 
in macrophages that killed intracellular organisms and decreasing 
inversely with numbers of intracellular oganisms in macrophages 
unable to kill or inhibit Nocardia cells - and consequently acid 
phosphatase activity is an effective marker of macrophage ability 
to inhibit growth of or kill N.asteroides. It was also shown 
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that macrophage populations isolated from different anatomical 
sites, eg splen ic, a 1 veola r, per i ton ea 1 and Kupf fer, differ in 
their nocardicidal activity and concommitant resistance to loss 
of acid-phosphatase activity. Also, the ability of different 
macrophage populations to kill or inhibit nocardial growth 
correlated with the organisms ability to inhibit phagosome-
lysozonie fusion (Black et al, 1985; Beaman and Black, 1985). 
The possibility that Noc a rdia might be able to neutralize the 
acidification of the phagosome was investigated in BALB/c mouse 
peritoneal macrophages ( Beaman and Black, 1985). Less virulent 
N.asteroides and the nonpathogenic yeast, Saccharomyces were 
unable to prevent acidification of the phagosome and did not 
effectively inhibit phagosome-lysozome fusion. However, the 
virulent strain of N.asteroides, which grew within macrophages, 
inhibited phagosome-lysozome fusion and effectively prevented 
acidification of the phagosome. Two important conclusions were 
drawn from these data Virulent N.asteroides may survive and 
grow within macrophages by modifying phagosomal pH; and 
neutralization of acidification may be fundamental in altering 
the activities of some lysozomal enzymes, since in many cases 
enzyme activity, eg acid-phosphatase, is pH dependent (Beaman and 
Black, 1985). 
These studies reveal that virulent Nocardia organisms are 
complicated series of evasive mechanisms - not protected by a 
only do they 
fusion, but 
resist phagocytosis and inhibit phagosome-lysozome 
they also reduce the efficacy of enzymatic attack 
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when fusion does occur (Black et al, 1983; Black et al, 1985; 
Davis-Scibienski and Beaman, 1980a,b). 
1.7.4.2 IN VITRO STUDIES ON N.BRASILIENSIS AND MURINE 
MACROPHAGES 
Peritoneal cells from normal or N.brasiliensis-infected mice 
were incubated in the presence or absence of N.brasiliensis 
antigen and then infected with Listeria monocytogenes to assess 
the listericidal ability of those macrophages. Exudate cells 
from Nocardia-infected mice have a significantly increased 
capacity to digest Listeria in the presence of specific antigen, 
indicating that macrophages are activated by N.brasiliensis. The 
authors suggested that macrophages are important in host defence 
to N.brasiliensis infection (Melendro et al, 1978). 
1.7.4.3 INTERACTIONS OF N.ASTEROIDES \iITH NEUTROPHILS AND 
MONOCYTES IN VITRO 
Neutrophils (PMN) are prominent in sites of infection with 
Nocardia, which suggests that they may have a significant role 
in defence ( Filice et al, 1980), however neutrophils are not 
sufficient to 
progresses until 
(Filice, 1985). 
destroy the organisms since clinical infection 
effective antibiotic therapy is administered 
Studies of the in vitro interactions of 
Nocardia with human peripheral blood monocytes (MN) showed that 
these cells were unable to kill significant numbers of 
N.asteroides despite phagocytosis of the organism, whereas 
S.aureus and 
MN. These 
L.monocytogenes were consistently killed by PMN and 
cells failed to kill N.asteroides despite the 
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occurrence of an oxidative metabolic burst (Filice et al, 1980). 
Investigation of the apparent resistance of N.asteroides to 
metabolites of the burst such as in vitro generated superoxide 
anion, H2o2 , singlet 
highly resistant and 
oxygen, showed that the organism was indeed 
this resistance is thought to be due 
partially to its relatively high levels of intracytoplasmic 
ca ta lase activity (Filice, 1983). 
the oxidative metabolites of the 
Mechanisms of resistance to 
metabolic burst were further 
el uc ida ted by Beaman et a 1 ( 1983: 1985). For a comprehensive 
review see Beaman and Beaman (1984). Beaman et al (1983) 
isolated and characterised a unique form of superoxide dismutase 
(SOD) produced by a virulent strain of N.asteroides, strain GUH-
2. Non-pathogenic strains of Noc a rdia did not secrete this 
enzyme and the less virulent N.asteroides strain 10905 has less 
SOD and catalase activity than the virulent strain GUH-2 (Beaman 
et al, 1983; 1985). SOD catalyses the dismutation of superoxide 
anion to produce the more toxic 
is strongly microbicidal both 
hydrogen peroxide, H 2o 2 • 
alone or in combination, eg with 
myeloperoxidase . Catalase breaks down H2o 2 (Beaman and Beaman, 
1984). A combination of these enzymes could be expected to be 
highly protective against oxidative killing mechanisms. A 
previous study indicated that log phase cells of N.asteroi<les 
GUH-2 are about 1000 times more virulent than stationary phase 
cells of the same organism (Beaman and Maslan, 1978; Beaman et 
al, 1983). Also, resistance to phagocyte antimicrobial 
activities is altered at different phases of growth (Beaman, 
1979: Beaman et al, 1985). The finding that rate of secretion 
of SOD per cell was much greater in the early phase of the growth 
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cycle than during the stationary phase could provide a partial 
explanation for the increased virulence during log phase. The 
SOD is selectively secreted into the medium and is associated 
with the outer cell wall of the organism and could be highly 
protective against superoxide radical toxicity associated with 
phagocytosing PMN (Beaman et al, 1983). 
A further study investigated the role of this SOD and catalase in 
organism resistance to killing by PMN (Beaman et al, 1985). The 
amount of intracytoplasmic catalase activity present in the 
virulent strain N.asteroides GUH-2 was also found to be growth 
stage dependent, with maximal levels during the early stationary 
phase, ie when SOD levels are decreased. PMN were unable to kill 
N.asteroides GUH-2 at this stage of growth but were able to kill 
log phase organisms. Treatment of early stationary phase cells 
with purified antibody specific for surface-associated SOD 
enabled PMN to kill significant numbers of organisms. This 
killing was abrogated by chlorpromazine which inhibits the 
oxidative metabolic burst of PMN's, indicating that kill was 
achieved by oxidative metabolism. 
Experiments were done in which exogenously added SOD or catalase 
partially protected the less virulent strain of N.asteroides 
10905, which lacks surface-associated SOD and which is killed by 
PMN in vitro. Addition of SOD and catalase completely protected 
this less virulent strain from killing by PMN's. Further 
evidence for the protective nature of these enzymes was shown by 
the inability of PMN's to kill log phase cells of a highly 
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virulent mutant of GUH-2 which contains 7 times more catalase at 
this stage than the parent (PMN can kill log phase GbH-2). This 
study showed that there is a relationship between phase of 
growth, virulence, high levels of catalase, production of SOD and 
resistance of N.asteroides to PMN-mediated killings, and clearly 
demonstrates that SOD and catalase are important factors 
associated with virulence of Nocardia (Beaman et al, 1985). 
In a further attempt to elucidate the role of PMN in host defence 
against Nocardia, Filice (1985) demonstrated that PMN inhibit the 
growth of N.asteroides in vitro. Most organisms were 
phagocytosed by PMN in vitro but most nocardiae did not appear to 
be damaged. Effects of PMN were inhibition of filament formation 
and amino acid uptake, also intracellular Nocardia did not become 
acid-fast. 
inhibition. 
The oxidative metabolic burst was not needed for 
Inhibition of filament formation continued for 7.5 
hours and on further incubation the organisms elongated and 
escaped from inhibition. Addition of fresh neutrophils at 7.5 
hours ex tended inhibition of f i lament formation and amino acid 
uptake. After about 20 hours of incubation nocardiae escaped 
from inhibition. Inhibition of growth may therefore occur in 
vivo mediated by attraction of fresh neutrophils into the 
infection site and consequently maintaining inhibition longer 
than the short-lived individual neutrophil is able. 
Consequently, neutrophils may be important early in infection 
before the development of activated macrophages (Filice, 1985). 
A recent study investigated the hypothesis that synergy between 
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antimicrobials and phagocytes may occur during N.asteroides 
infection. Pre-incubation of nocardiae with various appropriate 
antimicrobials did not alter kill achieved by PMN and monocytes; 
similarly pre-exposure of organisms to PMN did not increase 
nocardial susceptibility to antimicrobials. Thus synergy between 
phagocytes and antimicrobials in host defence against 
N.asteroides was not shown (Filice and Fischer, 1986). 
1.7.4.4 INTERACTION OFT-CELLS WITH N.ASTEROIDES IN VITRO 
Deem, Doughty and Beaman ( 1983) demonstrated that macrophage-
depleted populations of splenic lymphocytes from mice immunized 
with killed N.asteroides were able to kill N.asteroides organisms 
whereas lymphocytes from non-immunized mice did not. T-cells 
from spleens of immunized mice killed 80% of N.asteroides 
organisms within a 12 hour incubation period whereas macrophage-
rich ce 11 pre para tions from the same spleens killed only 40-50% 
of the organisms within the same time period. Preincubation of 
Nocardia-primed lymphocytes with nocardial antigen enhanced 
killing ability. Nocardicidal activity was enhanced in T-cell 
enriched populations and was eliminated by lysing lymphocytes 
with anti-Thy-1. 2 plus complement, indicating that T-cells were 
responsible for the killing of N.asteroides. The microbicidal 
activity of N.asteroides-primed T-cells was immunologically 
specific and the mechanism of killing appeared to involve direct 
T-cell-Nocardia contact. This study underlines the importance of 
T-cells in the host-response to Nocardia and suggests that direct 
T-cell kill may be important in vivo since these organisms are 
frequently able to evade macrophage intracellular killing (Deem, 
46 
Doughty and Beaman, 1983). 
l. 7. 5 OTHER FACTORS INFLUENCING HOST-PARASITE RELATIONSHIPS 
AND PATHOGENESIS 
1.7.5.l VIRULENCE 
Several studies have established that the chemical and structural 
composition of the cell walls of Nocardia undergo significant 
changes during the growth cycle (Beaman, 1975; Beaman, Bourgeois 
and Moring, 1981; Beaman and Shankel, 1969; Beaman, 1973; Beaman 
and Sugar, 1983; Vistica and Beaman, 1983). Modification of the 
cell wall characteristics during the growth cycle has been 
correlated with drama tic changes in virulence of the organism 
and in host- parasite interactions (Beaman and Maslan, 1978; 
Vistica and Beaman, 1983; Beaman, 1979; Beaman, 197 3; Beaman 
and Bourgeois, 1981; Beaman, 1976 388, 405; Davis-Scibienski 
and Beaman, 1980b; Beaman et al, 1985; Beaman, Bourgeois and 
Moring, 1981). An accurate and reproducible method for 
determining relative virulence of different strains of Nocardia 
was developed (Beaman, 1975; Beaman and Maslan, 1977; 1978). It 
was shown that a virulent strain of N.asteroides, GUH-2, was 
about 1400 times more virulent when injected intravenously into 
mice than the same organism injected i.v. in the stationary 
phase ( Beaman and Maslan, 
N.brasiliensis and N.caviae 
1978). All strains of N.asteroides, 
studied by these workers were more 
virulent in the log phase than the stationary phase of the same 
culture when inoculated intravenously into mice, however, degree 
of difference in virulence varied according to the strain being 
studied (Beaman and Sugar, 1983). 
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In contrast, Conde et al (1982) found that the virulence of 
N.brasiliensis 
growth. Beaman 
did not vary during the different phases of 
(Beaman and Sugar, 1983) used a different strain 
of N.brasiliensis and found that its virulence was related to 
phase of growth. These conflicting results· were explained in 
terms of rate of growth of 
Beaman and Sugar (1983) 
relative size of individual 
the strains of N.brasiliensis: and 
concluded that growth rate but not 
cells, phase of growth and route of 
inoculation have a 
In addition, it was 
significant effect on nocardial virulence. 
shown that the type of media used to grow 
the organisms, as well as method of preparation of inoculum, had 
a profound effect on the degree of difference in virulence 
between stationary and log phase cells (Beaman and Maslan, 1978: 
Beaman and sugar, 1983). 
Extensive studies have been conducted in order to determine 
mechanisms of nocardial virulence and the effects of phase of 
growth on host-parasite interactions (Beaman, 1979: Davis-
Scibienski and Beaman, 1980a, 1980b: Black et al, 1983: Beaman et 
al, 1983: Beaman et al, 1985: Beaman, Bourgeois and Moring, 1981: 
Filice, 1983: Vistica and Beaman, 1983). Earlier studies showed 
that normal macrophages were unable to kill virulent strains of 
Noca rdia in vitro ( Beaman and Smathers, 1976: Beaman, 1977). 
Incubation of virulent N.asteroides GUH-2 at different phases of 
growth with alveolar macrophages from normal and specifically 
immunized rabbi ts (Beaman, 1979: Davis-Scibienski, 1980b) 
revealed that nocardial cells from all phases of growth were able 
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to grow in normal alveolar macrophages, whereas activated 
macrophages successfully inhibited growth of stationary phase 
cells for at least 12 hours, but only temporarily slowed down 
growth of log-phase cells, which were significantly more toxic 
and antiphagocytic than stationary phase organisms (Beaman, 
1979). 
Interestingly, activated macrophages killed more log-phase cells 
than stationary phase cells at 3 hours after infection (Beaman, 
1979) although log phase cells are more virulent (Beaman and 
Maslan, 1978). It appears that the filamentous or log form are 
initially more fragile and more easily killed than the coccoid 
form of the same culture although they are more virulent and grow 
more rapidly within macrophages ( Beaman and Sugar, 1983). This 
surprising finding has been explained by Beaman et al (1985) who 
suggest that enhanced initial killing of log-phase cells, despite 
increased inhibition of phagosome-lysozome fusion (Davis-
Scibienski and Beaman, 1980b) and reduced levels of lysozomal 
acid-phosphatase (Black et al, 1983), is related to oxygen-
dependent rather than oxygen-independent microbicidal mechanisms. 
Intracytoplasmic levels of catalase are low during log-phase 
whereas SOD levels are high (Beaman et al, 1985) therefore it is 
conceivable that effects of H2o2 may be more lethal to log-phase 
organisms. 
Degree of virulence of strains of N.asteroides as well as cell 
via bi 1 i ty correlated with the abi 1 i ty of phagocytosed Noc a rdia 
organisms to inhibit phagosome-lysozome fusion and to resist 
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intracellular killing (Davis-Scibienski and Beaman, 1980a). 
Investigation of effect of phase growth of the virulent strain 
of N.asteroides GUH-2 established a further correlation between 
relative virulence associated with phase of growth and the 
degree of inhibition of fusion and suggested that this 
inhibition of phagosome-lysozome fusion may be one of the 
mechanisms of nocardial pathogenesis (Davis-Scibienski and 
Beaman, 1980b). 
It appears likely that many aspects of nocardial virulence may be 
attributed to components that are either in the cell wall or on 
the cell surface (Davis-Scibienski and Beaman, 1980a; Vistica 
and Beaman, 1983; Beaman, 1976 407). The composition of the 
nocardial cell wall is structurally and chemically complex, 
consisting of several classes of free and bound lipids, proteins 
or peptides and polysaccharides such as trehalose dimycola tes, 
nocobactins, peptidoglycan, arabinogalactan mycola tes, nocardo-
mycol ic acids etc (Beaman and Beaman, 1984; Beaman, 1975); 
Beaman, 1976 402, 403; Beaman, Bourgeois and Moring, 1981). 
Trehalose dimycolate and sulpholipids are present in the cell 
envelope in mycobacteria and has been linked with pathogenicity 
of these organisms, also trehalose dimycolate is cytotoxic 
(Beaman, 1976 : 403; Vistica and Beaman, 1983). Mycobactins, a 
to nocobatin, are found in the cell chemically similar compound 
wall of mycobacteria and are considered to be a factor of 
mycobacterial virulence (Beaman, 1976 406). Trehalose 
dimycolate, sulpholipids and nocobactin may therefore play a role 
in nocardial virulence and host parasite interaction (Vistica and 
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Beaman, 1983). 
A strain of N.asteroides, 14759, had almost twice the amount of 
muramic acid than glucosamine in its cell walls during the log 
phase compared with the stationary phase of growth (Beaman, 
1975), ie the degree of polyunsa tura tion of muramic acid in both 
the alpha and beta portions of the molecule correlates with 
virulence ( Beaman and Beaman, 1984; Beaman, Bourgeois and 
Moring, 1981). In addition, major changes occur in the size and 
molecular structure of the individual mycolic acids dependent on 
culture age. Stationary phase cells have mycolic acids of 
shorter length than the more virulent log phase of the same 
organism (Beaman, Bourgeois and Moring, 1981). 
Vistica and Beaman (1983) attempted to further define cell wall 
components of nocardial pathogenesis. Com pa r i son of c e 11 s o f 
N.asteroides GUH-2 at different phases of growth showed a 
correlation between fatty acid composition, comparitive degree 
of ce 11 ula r fragmentation from f i la men tous in to coccobaci l la ry 
form, and perhaps intracellular complexity with virulence of the 
organism. 
Relative virulence of Nocardia and resistance to killing has been 
correlated with the ability of the organism to alter the 
intracellular activity of the lysozomal enzyme, acid phosphatase. 
The study showed that acid phosphatase levels increased or 
remained unchanged in macrophages phagocytosing less virulent or 
killed virulent nocardiae, but decreased in cells phagocytosing 
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live virulent organisms. This decrease in lysozomal enzyme level 
has been related to ability of virulent organisms to survive the 
action of the hydrolytic environment within the lysozome and it 
has been suggested that this ability contributes to the 
pathogenesis of Nocardia infection (Black et al, 1983). 
The association of virulence and phase of growth of Nocardia with 
a cell-associated and secreted form of superoxide dismutase (SOD) 
as well as high levels of intracytoplasmic catalase has been 
discussed in section 1.7.4.3. Synthesis of these specific 
enzymes capable of neutralizing the toxic products of oxygen 
metabolism is likely to play a significant role in nocardial 
pathogenesis (Beaman et al, 1983; Beaman and Beaman, 1984; Beaman 
et al, 1985; Beaman and Sugar, 1983). Ability of Nocardia to 
resist oxidative metabolites is probably due to a combined 
interaction between catalase, SOD and the highly unsaturated 
lipids in the cell wall (Beaman and Beaman, 1984). 
Virulence of nocardiae may not be attributed to any single 
specific mechanism but is the result of a complex combination of 
several unique properties ( Beaman and Beaman, 1984). Factors 
associated with virulent strains of noca rd iae include s true ture 
and composition of cell wall components, eg degree of 
polyunsaturation of mycolic acids as well as length of the 
individual mycolic acid chains, which is associated with phase 
of growth of the organisms, presence of SOD and catalase, 
alteration in the activities of the lysozomal enzymes, alteration 
of intraphagosomal pH and ability to inhibit phagosome-lysozome 
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fusion (Beaman, Bourgeois and Moring 1981; Black et al, 1983; 
Beaman et al, 1985; Davis- Scibienski and Beaman, 1980a, 1980b; 
Beaman and Black, 1985). 
1.7.5.2 ROUTE OF INFECTION 
Route of inoculation has a significant effect on the 
susceptibility of the host to Nocardia ( Beaman et al, 1980a; 
Beaman, Maslan et al, 1980a; Beaman, Beaman et al, 1980b; 
Goldstein et al, 1978; 
of N.asteroides and 
Beaman and Sugar 1983). Virulent strains 
N.caviae were grown under identical 
conditions to early stationary phase and then inoculated into 
mice by five different routes. N.caviae 112 was 30 times more 
virulent than N.asteroides GUH-2 when administered intranasally, 
whereas N.asteroides was 10 times more virulent than N.caviae 
when inoculated intravenously, and the organisms were of similar 
pathogenicity when injected intraperitoneally. Host response to 
N.asteroides and N.caviae differed according to route of 
infection, mice being more susceptible to N.asteroides 
administered intravenously and least susceptible to this 
organism inoculated into the footpad or tail. N.caviae was most 
pathogenic via the intranasal route and least pathogenic when 
injected intraperitoneally (Beaman, Maslan et al, 1980a; Beaman 
and Scates, 1981). This study indicated that there is a 
compartmentalization of the host response to Nocardia (Beaman, 
Maslan et al, 1980a). In another study it was shown 
intranasal administration of N.asteroides induces a more 
pulmonary infection than does aerosol administration of 
that 
severe 
similar 
numbers of organisms, indicating that pulmonary defences cope 
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less well with intranasally administered N.asteroides 
Goldstein et al, 1978: Beaman and Sugar, 1983). 
(Beaman, 
1.7.5.3 L-FORMS AND NOCARDIAL PATHOGENESIS 
L-forms or L-phase variants are wall defective microbial variants 
capable of 
rigid cell 
growth 
wall. 
as non-rig id cells due to the absence of a 
They are able to grow continuously in their 
altered form and since these forms are gram-negative and 
pleomorphic they are very difficult to distinguish within lesions 
using conventional light microscopy. There are two types of L-
forms : type A have no apparent cell wall whereas type B have the 
outermost cell wall layers but lack rigidity. Reversion to the 
parental organism may occur in L-phase variants but is not usual 
in true L-forms. (Beaman, 1976 : 398). 
Structural and chemical changes occur in the cell wall during 
growth within the host ( Beaman and Sugar, 1983; Beaman 1976 
3 8 8) • Beaman (1973) found that changes induced in the cell 
envelope of N.asteroides within host tissue were most dramatic in 
the least virulent strains. These observations lead to the 
finding that the nocardiae can live as facultative intracellular 
parasites and that altered forms of the organism ( eg L-forms) 
seem to play a part in nocardial pathogenesis (Beaman, 1976 
407). Bourgeois and Beaman (1974) showed decisively that mouse 
peritoneal macrophages induced altered forms of a strain of 
N.asteroides intracellularly, and these were found to be L-forms 
and transitional phase variants (Beaman, 1976 : 399). 
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Nocardial L-f orms have been induced in vitro by incubating a 
number of strains of Nocardia in medium containing glycine plus 
lysozyme to induce formation of spheroplasts in cultures from 
which L-forms could subsequently be isolated (Bourgeois and 
Beaman, 1976); and by incubating N.asteroides with cultured 
peritoneal macrophages (Bourgeois and Beaman, 1974) and alveolar 
macrophages ( Beaman and Smathers, 1976). In both these latter 
studies, organisms disappeared within in vitro cultured 
macrophages, however some cells were able to avoid being killed 
- since the resulting protoplasts were protected from lysis by 
the macrophages (Beaman, Bourgeois and Moring, 1981) - and 
persisted as wall defective variants which ultimately replicated 
within the macrophages and killed them. During this time typical 
nocardial cells could not be recovered ( Bourgeois and Beaman, 
1974; Beaman and Smathers, 1976; Beaman, 1980). 
There are a number of reports in the literature of initial 
failure to isolate Nocardia or microscopically demonstrate 
organisms in infected tissue, although clinical material obtained 
later or at autopsy was shown to contain organisms. In addition, 
although Nocardia-like organisms could be visualized in the 
tissue, standard culture conditions did not yield positive 
cultures. (Beaman, 1976 
1975; Sen and Louria, 1980 
397; 
338; 
Krick, Stinson and Remington, 
De Villiers 1978; Smego and 
Gallis, 1984). There have been reports of slow progressive 
nocardial infection that developed after a long period of latency 
(Greer, 1974; Beaman, 1976 : 397), as well as reports of relapse 
of nocardial infection after clinical cure has apparently been 
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achieved (Stropes, Bartlett and White, 1980). An early study by 
Uesaka et al 
form 
(1971) suggested 
of Nocardia in 
the presence of an altered gr9m-
organs of mice, since organisms negative 
could be isolated from tissues, whereas no organsism could be 
visualized in tissue sections. Intranasally administered 
N.caviae induced an acute pneumonic reaction and death in mice, 
and al though macroscopic examinia tion of these lungs revealed 
consolidation and abscess formation, few or no bacteria were 
isolated from lung homogenates (Beaman, Maslan et al, 1980a; 
Beaman, 1980). In these reports of human and animal infections 
it is possible that Nocardia organisms were present in the 
tissues in the form of altered variants which were induced in 
vivo (Beaman, 1976 : 397). 
Studies investigating the induction of L-forms and L-phase 
variants in vivo have shown that L-phase variants are induced 
within the lungs of normal mice after intranasal administration 
of N.caviae 112 (Beaman, 1980), and that macrophages are capable 
of removing the cell wall of N.caviae 112 in vivo (Beaman, 1980; 
Beaman and Scates, 1981). It has been suggested that the 
mechanism of induction of L-phase variants and L-forms by 
macrophages in vivo may be similar to the i.v. in vitro induction 
of g 1 ye i ne and 1 ysozyme (Bourgeois and Beaman, 1976; Beaman, 
1980). 
The induct ion of L-f orms and L-f orm variants of N. ca v iae and 
probably other nocardiae appears to play an integral part in 
nocardial pathogenesis (Beaman and Sugar, 1983; Beaman, 1980; 
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Beaman and Scates, 1981). The presence of large numbers of L-
phase variants in infected lung tissue at a time when pulmonary 
consolidation and death are occurring and normal bacteria cannot 
be i sol a tea suggests that these L-phase variants play a major 
role in the infectious process and that these variants should be 
considered an alternate pathogenic form (Beaman, 1980). L-forms 
and L-pha se variants appear to be involved in the latency of 
infection and in bacterial persistence (Beaman, 1980; Beaman and 
Scates, 1981; Beaman and Sugar, 1983). Studies with N.caviae 
showed that a cell wall-deficient form of N.caviae continued to 
exist in host tissues during the latent period between acute and 
chronic infection. The ability of these forms to persist for 
prolonged periods was demonstrated by the discovery that L-forms 
and L-form variants were present in mouse tissues (eg blood, 
liver, lungs and spleen) for more than a year, whereas no normal 
organ isms were isolated from these organs ( Beaman and Sea tes, 
1981). Further, this study revealed that induction of L-forms 
occurs within immunologically competent mice but not in T-cell 
deficient animals, and suggested that L-forms of N.caviae are 
involved in the induction and formation of mycetomatous lesions. 
Mice injected intravenously with N.caviae that survived the acute 
phase of infection developed characteristic mycetomas almost a 
year later. Light microscopy of sections of mycetomatous 
lesions showed that granules contained L-forms of N.caviae. It 
was suggested that replication of these wall-deficient cells to 
form en la rg i ng aggregates would lead to development of a host 
response, reversion of some L-forms to the walled state and 
growth of these revertants at the periphery of the aggregate and 
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development of the 
1981). 
mycetomatous lesion (Beaman and Scates, 
Removal of the nocardial cell wall either in vitro or in vivo can 
result in mutational alterations in the cell wall when it 
redevelops, which lead to altered cellular and colonial 
morphology (Beaman, Bourgeois and Moring, 1981; Beaman and 
Bourgeois, 1981; Beaman and Sugar, 1983). It was found that the 
longer the organisms persisted in a wall-less state, the greater 
the degree of cell wall modification during reversion (Beaman, 
Bourgeois and Moring, 1981). These observations suggest a 
mechanism for taxonomic heterogenecity among strains of Nocardia 
(Beaman and Bourgeois, 1981). 
1.7.5.4 ROLE OF CELL-WALL ASSOCIATED LIPIDS IN THE PATHOGENESIS 
OF THE LESIONS 
A recent study by Miller-Hardy and Reynolds (1984) investigated 
the role played by cell wall-associated lipids of N.asteroides 
and M.fortuitum in the pathogenesis of nocardiosis and 
mycobacteriosis produced by these pathogens respectively. 
Al though these two organisms have similar eel 1 wal 1-assoc ia ted 
lipids they produce a distinctly different tissue response 
ranging from the acute suppurative lesion of nocardiosis to the 
granulomatous disease caused by M.fortuitum. Lipid fractions 
were separated, inoculated into mice and lesion development 
monitored. Wax A from Nocardia produced multiple abscesses 
whereas wax A from Mycobacterium caused a mild, transient 
reaction; Wax D from Mycobacterium caused a marked granulomatous 
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response, whereas Nocardia-derived Wax D produced a minimally 
acute inflammatory response. The authors suggested that the wax 
fractions A and D are responsible for the different tissue 
responses characteristic 
and Reynolds, 1984). 
of these two inf ec ti ons (Miller-Hardy 
1. 7. 6 ROLE OF THE HUMORAL IMMUNE RESPONSE 
Recent studies have revealed that the humeral immune response, 
and B-lymphocytes play little role in host defence against 
nocardial infections (Beaman et al, 1982; Ximenez et al, 1980: 
Rico et al, 1981; Rico et al, 1982; Conde et al, 1983; Beaman 
and Sugar, 1983). Further, it has been demonstrated 
conclusively that the presence of antinocardial antibody produced 
by B-cells can facilitate progression of disease and is 
deleterious to the host (Rico et al, 1981; Rico et al, 1982; 
Beaman et al, 1982; Conde et al, 1983; Beaman and Sugar, 1983). 
Rico et al (1981, 1982) demonstrated that passive administration 
of anti-Nocardia antibody to normal or T-cell depleted mice 
previously infected with Nocardia enhanced the inflammatory 
reaction and increased the tendency to slough off the infected 
leg (the detrimental effect was slower in normal mice than in T-
cell depleted mice). For a more detailed account of the findings 
of these studies see sections 1.7.3.1.3 and 1.7.3.1.5. 
Animals infected with N.brasiliensis showed low antibody titres 
to Nocardia (Ximenez et al, 1980) although N.brasiliensis is a 
potent polyclonal B-cell activator and a mitogen that will 
activate B-cells independently of T-cells (Ortiz-Ortiz et al, 
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1979). To explain this apparent incongruity, Conde et al (1983) 
suggested that antibody may be produced at the site of infection 
but concomitantly absorbed. They showed that anti-N.brasiliensis 
antibody and complement were present in the mycetoma lesion at a 
time when this antibody was absent from the serum, and it 
appeared that the immunoglobulin was produced in part locally and 
was specifically deposited at the site in the form of insoluble 
immune complexes, which could con tribute to the pathogenesis of 
infection by impairing T-cell function and cell-mediated immunity 
(Conde et al, 1983). 
1.8 CONCLUSIONS 
Pathogenicity of Nocardia organisms is determined by a complex 
and multiple series of factors and varying combinations of these 
factors associated with the organisms will give rise to varying 
degrees of virulence and will dramatically influence the ability 
of the organism to establish itself in host tissue ( Beaman et 
al, 1985). Various unique properties such as presence or absence 
of superoxide dismutase, ca ta lase, resistance to phagocytosis, 
ability to inhibit phagosome-lysozome fusion or modulate 
lysozomal enzyme levels, ability to induce alterations in 
intraphagosomal pH, structure and composition of the cell wall, 
phase of growth all contribute to determine the pathogenicity of 
the organism (Beaman et al, 1985: Beaman and Black, 1985: Beaman 
et al, 1983: Beaman and Maslan, 1978: Black et al, 1983: 
Black et al, 1985: Davis-Sci bienski and Beaman, 1980a and b: 
Vistica and 
virulent 
Beaman, 1983: Beaman, 1979). The ability of the 
strains of Nocardia to exist as facultative 
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intracellular 
macrophages, 
parasites (Bourgeois and Beaman, 1974) within 
protected from lysis (Beaman, Bourgeois and Moring, 
1981) probably as L-forms is a 
since any subsequent deficiency 
de v e 1 op men t of a c ti v e i n f e c t i on 
1980; Beaman and Scates, 1981). 
strong 
in host 
(Beaman, 
pathogenic advantage, 
defence will favour 
1976 : 397; Beaman, 
Similarly, host defence consists of a complex combination 
involving both naturally present immune mechanisms and 
specifically induced immunological functions which act in 
concert in response to the infection. Cell-mediated immunity, 
activated macrophages and T-lymphocytes ( involved both in 
activation of macrophages and capable of direct T-lymphocyte-
media ted cytotoxicity to Nocardia) are important in host 
resistance (Beaman and Sugar, 1983; Krick and Remington, 1975; 
Deem et al, 1982; Deem, Doughty and Beaman, 1983; Beaman, 
1977; 1979; Melendro et al, 1978; Ximenez et al, 1980; Folb, 
Timme and Horowitz, 1977; Sundararaj 
Filice, Beaman and Remington, 1980; 
and Agarwal, 1977a; 
Davis- Scibienski and 
Beaman, 1980c; Beaman, Gershwin and Mas la n, 197 8; Beaman, 
Gershwin et al, 1980b; Beaman, Goldstein et al, 1978). In 
addition, the inhibitory effects of PMN may be important 
(Filice, 1985). 
The host-parasite interaction may therefore be compared to a 
delicately - balanced scale - any factor leading to deficiency in 
host immune function or which enhances the pathogenicity of the 
Nocardia organism may tip the scale in favour of progressive 
disease. 
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1. 9 OBJECTIVES OF THIS STUDY 
Pathogenic Nocardia are facultative intracellular pathogens 
(Bourgeois and Beaman, 1974) that reside and grow within 
macrophages (Beaman and Sugar, 1983). Host resistance is 
generally believed to depend upon successful collaboration 
between activated macrophages and specifically sensitized T-
lymphocytes, in addition cell-mediated immunity, the inhibitory 
effects of PMN and direct T-lymphocyte-mediated cytoxicity are 
important (Beaman, Gershwin and Maslan, 197 8; 
et al, 1980; Beaman, Goldstein et al, 1978; 
Beaman, Gershwin 
Beaman and Scates, 
1981; 
1980; 
Krick and Remington, 1975; Filice, Beaman and Remington, 
Beaman and Sugar, 1983; Deem, Beaman and Gershwin, 1982; 
Davis-Scibienski and Beaman, 1980c; Filice, 1985; Deem, Doughty 
and Beaman, 1982). 
The macrophage is a major factor in the control of intracellular 
parasites (Rojas-Espinosa et a 1, 1982). Further, it has been 
established that initial interactions between Nocardia and 
macrophages are important in determining the extent of infection 
that develops (Beaman and Smathers, 1976; Beaman, 1977; Beaman, 
Goldstein et al, 1978; Black et al, 1983, 1985). 
reports have suggested that both non-specifically 
Previous 
activated 
macrophages (Filice, Beaman and Remington, 1980; Krick and 
Remington, 1975) and specifically activated macrophages (Beaman, 
1979) are important in host defence against Nocardia (Davis-
Scibienski and Beaman, 1980c). Although macrophages have been 
shown to be activated in N.asteroides infections (Davis-
Scibienski and Beaman, 1980c; Sundararaj and Agarwal, 1977a, 
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1978; Krick and Remington, 1975; Beaman, 1979) and in 
N.brasiliensis infections (Melendro et al, 1978) it has been 
suggested that a deficiency or alteration in macrophage function 
occurs in association with the disease or as a result of host 
corticosteroid treatment (Beaman, 1976 394). This idea has 
also been expressed by Curry ( 1980) and Rojas-Espinosa et al 
(1982). On the basis of this consideration, a study of macrophage 
function in experimental N.asteroides and N.brasiliensis 
infections was undertaken. The study has attempted to 
determine whether certain biochemical defects or alterations in 
macrophage function occur in association with the disease. The 
concept of macrophage inactivation and thus the persistance of 
Nocardia has been investigated by others (Davis-Scibienski and 
Beaman, 1980a, 1980b; Black et al, 1983, 1985; Beaman and 
Black, 1985) and these workers have el uc ida ted three of the 
mechanisms whereby virulent strains of N.asteroides appear to 
survive within macrophages, these being: the ability of the 
organism to inhibit phagosome-lysozome fusion, to induce 
alterations in intraphagosomal pH and to alter the activities of 
lysozomal enzymes (Beaman et al, 1985). 
This investigation also attempts to directly examine the effects 
of Nocardia infection on macrophage function. Other studies have 
investigated whether macrophages are activated in Nocardia 
infections after inoculation with live organisms (Krick and 
Remington, 1975; Sundararaj and Agarwal, 1977a, 1978; Melendro 
et al, 1978, Filice, Beaman and Remington, 1980) and killed 
organisms (Davis-Scibienski and Beaman, 1980c) and have assessed 
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activation in terms of microbicidal activity macrophage 
Scibienski and Beaman, 1980c; 
1978; 
Sundararaj and Agarwal, 
(Davis-
1977a, 
1978; 
or in 
Melendro et al, 
terms of tumour cell 
Filice, Beaman an Remington, 1980) 
cytoxicity (Krick and Remington, 
1975). Although the parameter of antimicrobial activity is 
accepted as the most definitive measure 
(Karnovsky and Lazdins, 1978; North, 
of macrophage activation 
1978; Cohn, 1978) and 
stimulation of tumoricidal activity is also a lymphokine-mediated 
event (Cohn, 1978), biochemical parameters of macrophage 
activation in Nocardia infections with the exception of the 
recent studies of the lysozomal acid hydrolase, acid-phosphatase 
(Black et al, 1983, 1985) do not appear to have been reported in 
any detail. In addition, the assessment of macrophage 
activation is complicated by the use of sterile irritants 
(Melendro, et al, 1978) or adjuvants 
1977a; Karnovsky and Lazdins, 1978). 
( Sunda ra raj and Agarwal, 
Further, the issue has 
been complicated by the finding the peritoneal macrophages from 
N. as teroides-infec ted mice were not activated, as assessed by 
microbicidal activity, in the study by Filice, Beaman and 
Remington (1980). Some other aspects of macrophage behaviour in 
experimental N.asteroides infection have been studied, eg 
macrophage migration inhibition (Sundararaj and Agarwal, 1977a), 
macrophage aggregation (Sundararaj and Agarwal, 1977a) and 
phagocytes is (Beaman, 1979; Dav is-Sci bienski and Beaman, 1980a 
and c; Black et al, 1983, 1985). 
The study by Folb, Jaffe and Altmann (1976) led to the idea that 
macrophage function in N.asteroides and N.brasiliensis infections 
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may be different. This investigation corroborated the study by 
Uesaka et al, 1971; by showing that inoculation of N.asteroides 
and N.brasiliensis into experimental animals produced two 
different histopathological lesions. Lesions of N.asteroides 
were characterized by an acute, suppurative abscess, whereas in 
N.brasiliensis infections a granuloma was produced in which a 
striking feature was the presence of large numbers of foam-laden 
macrophages with intracellular organisms. The features of the 
'brasiliensis lesion' (Uesaka et al, 1971) were reminiscent of 
the histopathological features of lepromatous leprosy and of 
disseminated Mycobacteri um bovis infection when this occurs in 
the immune-suppressed situation. It was suggested that 
N.brasiliensis infection produces a depression of cellular 
immunity that modifies local host response to the organism (Folb, 
Jaffe and Altmann, 1976). This study investigates the 
possibility that macrophage responses in the two infections may 
be different by comparing biochemical and morphological 
parameters of macrophage function. On the basis of the 
histopathological studies by Folb, Jaffe and Altmann (1976) it is 
suggested that parameters of macrophage function may be depressed 
in N.brasiliensis infection. Alternatively, the degree of 
activation or inhibition of macrophage function may be different 
in N.asteroides and N.brasiliensis infections. 
As already stated, initial interactions between Nocardia and 
macrophages play a significant role in the pathogenesis of 
Nocardia infections. Macrophage function was therefore 
investigated at 2, 7, 13 and 21 days post-inoculation. In 
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addition, such a study would hopefully determine whether 
macrophage responses to the two infections are modulated at these 
specific intervals over the 21 day post-inoculation period. 
This study therefore, at tempts to determine whether macrophage 
function is deficient in N.asteroides or N.brasiliensis 
infections: to directly examine the effects of Nocardia 
infection on macrophage function: to determine whether 
macrophage responses in the two infections are different: to 
assess macrophage responses early in infection and to investigate 
whether macrophage function is modula tea over the 21 day post-
inoculation period. Biochemical parameters of macrophage 
function selected are release of the enzymes plasminogen 
activator and lysozyme, in addition morphologic characteristics 
were investigated. 
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Chapter 2 
AN EXPERIMENTAL MODEL OF NOCARDIA INFECTIONS 
2.1 INTRODUCTION 
This section describes the methods in general use in this study, 
the preparation of reagents, and discusses the Nocardia animal 
model and the culture of mouse per i tonea 1 macrophages. Certain 
terms in general use in this dissertation are defined, or 
abbreviations given, and important concepts are discussed. 
2.2 
2.2.1 
PREPARATION OF REAGENT& 
TISSUE CULTURE MEDIUM 
Dulbecco' s modified eagle medium (DB). Gibco H-18 (Grand Island 
Biological Co., Grand Island, N.Y.) 3.7g sodium bicarbonate 
added per litre. 
Hanks balanced salt solution (HBSS) Gibco Kl2. No sodium 
bicarbonate added. The media were sterilized by filtration 
through Millipore filters (pore diameter 0.4Sum type HAWP, 
Millipore Company, Bedford, Mass. 01730 USA). 
2.2.2 SERUM 
Foetal Calf Serum (FCS) 
Gibco 220-6290 virus and mycoplasma screened. The serum was 
aliquoted aseptically into 10 ml aliquotes and stored at -20°c. 
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Heat Inactivated Fetal Calf Serum (HIFCS) 
Gibco 200-6290. The serum was heated at 56°c in a water bath for 
30 minutes to destroy complement and then aliquoted aseptically 
into 10 ml aliquots and stored at -20°c. 
Acid-Treated Dog Serum 
Gi bco 200-2 500. The serum was adjusted to pH 3. 2 by addition of 
lN hydrochloric acid, incubated at room temperature for two hours 
and then neutralized with lN sodium hydroxide. This acid 
treatment destroys the serum plasmin inhibitors (Unkeless, Gordon 
and Reich, 1974) it destroys alpha 2 macroglobulin, an 
inhibitor of proteinase activity (Gordon, Werb and Cohn, 1976 
344). 
2.2.3 ANTIBIOTICS 
Penicillin and Streptomycin (P+S) 
Novo Strep: lg streptomycin sulphate as base, manufactured by 
Novo Industries, Johannesburg, South Africa. 
saline added. 
5 ml sterile normal 
Crystapen 600 mg, containing 600 mg (lx10 6 u) sodium 
benzylpenicillin. 5 ml sterile normal saline added. 
5 ml penicillin and 5 ml streptomycin combined and diluted 
aseptically to 100 ml with sterile normal saline, and aliquoted 
into 1 ml aliquots and stored at -20°c. Each vial thawed once 
only and discarded. 
85 
Penicillin (100 IU/ml) and streptomycin (0.1 mg/ml) (Schnyder and 
Baggiolini, 1978a) was added to the tissue culture medium 
immediately prior to cell culture. 
Mycostatin (M) 
Squibb Laboratories ( Pty) Ltd, Isando, Transvaal, South Africa. 
Contains Nystatin 100 000 u/ml. 
30 units /ml Mycostatin (Schnyder and Baggiolini, 1978a) was 
added to the culture medium destined for macrophages to be 
assayed for lysozyme release and for indirect plasminogen 
activator (PA) assay. The medium was sterilized by filtration. 
2.2.4 GENERAL REAGENTS 
Phosphate Buffered Saline (PBS) 
PBS 0.154 M pH 7.2 
Recipe : NaCl 40 g 
KCl lg 
Na 2HP0 4 2H 20 7.21 g 
K2HP04 1 g 
H2o distilled to l litre= 5 times concentrated PBS 
The salts were dissolved and the solution made up to volume. 
Tris (hydroxymethyl) aminomethane Merck 8382 (TRIS-HCl) 
0.1 M pH 8.1 
The salt was dissolved in about half the required volume of 
distilled water. The pH was adjusted to 8.1 with 3N HCl and the 
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solution made up to volume and stored at 4°. 
Triton X-100 
Merck Ant 11869 for scintillation grade. sg = 1.05 g 
0.5% V/V required i.e. 0.5 ml/100 ml distilled water 
0.83% ammonium chloride (NH 4CL) Merck pH7.4 
2.3 
2.3.1 
FluramR 
FLUORIMETRIC DETERMINATION OF TOTAL PROTEIN 
PRINCIPLE 
(fluorescamine) [4-phenylspiro 
{furan-2 (3),1 -phthalan} -3,3-dione] reacts with primary amines 
to form intensely fluorescent substances, providing the basis for 
a rapid and sensitive assay of amino acids, peptides, proteins 
and other primary amines (Udenfried et al, 1972). Fluram is non-
fluorescent and any excess reagent is rapidly hydrolysed to form 
water soluble, non-fluorescent products. 
The intensity of fluorescence is proportional to the amine 
concenta tion and the fluorophors are stable over several hours. 
At pH 8 to 9 the reaction occurs with a half-time of 
milliseconds, proceeding to near completion (approximately 80-90% 
of theoretical yield) even when FluramR is not present in large 
excess. 
2. 3. 2 METHOD 
Protein was determined spectrofluorimetrically (Hoal, 1981) using 
bovine serum albumin (BSA) as a standard. (Miles Scientific, Div 
of Miles Labs Inc, Naperville, Illinois 60566, USA). 
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2.3.2.1 REAGENTS 
Borate Buffer (0.2 M pH 9.2) (Merck) 
6.18 g Boric acid was dissolved in 500 ml of triple distilled 
water. The pH was adjusted to 9.2 with 2N sodium hydroxide. 
Fl uramR (Hoffman-La Roche, Bas le, Switzerland) was dissolved in 
acetone to give a final concentration of 0.25 mg/ml. 
Bovine serum albumin (BSA) was dissolved in borate buffer at a 
concentration of 1 mg/ml. 1 ml aliquots were stored at -20°c. 
2.3.2.2 PREPARATION OF THE STANDARD CURVE 
BSA 1 mg/ml in borate buffer was diluted 1:10 in borate buffer (= 
reagent A). The standard curve was prepared over the range 1-15 
fg/ml and 12 standards were prepared 1-10 fg, 12 fg and 15 fg). 
The appropriate volume of reagent A for the required BSA 
concentration was made up to 800/1 with borate buffer. 200 fl 
of FluramR in acetone was added to the borate/BSA while vortexing 
vigorously to ensure complete mixing of the FluramR with the BSA 
solution. 
The blank prepared was 25 fl of 0.5% Triton X-100 0.5% V/V added 
to 775 fl of borate buffer and combined with 200 /1 FluramR. 
Sample volume was adjusted so that fluorimetric values fell well 
within the range of the standard curve. 25 11 sample was found 
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to be a suitable volume, and was added to 775 11 borate buffer 
and combined with 200 )1 Fluram while vortexing very well. 
Cell lysates in 0.5% Triton X-100 were vortexed vigorously to 
obtain a homogeneous suspension. 
Samples, standards and blank were a 11 pre pa red in duplicate in 
Corning light wall rimless pyrex glass tubes. 
Fluorescence of standards, blank and samples was read on a Perkin 
Elmer M PF-44A f 1 uorescence spectrophotometer ( Perkin El mer Ltd, 
Buckinghamshire, England HP9 !QA) with the excitation wavelength 
set at 390 nm (slit width 4 nm) and the emission wavelength set 
at 475 nm (slit width 6 nm). 
2.3.2.3 CALCULATION OF RESULTS 
A linear regression for recovery of x from y was run on the peak 
heights from the standards (Fig 1) and the unknown concentrations 
of the samples were calculated by interpolation. 
2.3.2.4 SIGNIFICANCE OF RESULTS 
Fluorimetric determinations of total protein were done on 
monolayer cultures of macrophages in order to determine specific 
activities of the enzymes studied and to gain an indication of 
cell number. The cells are washed twice with PBS after 
collection of the conditioned medium, as detailed in Chapters 3 
and 4, and 1000ml 0.5% V/V Triton X-100 added to lyse the cells. 
The cell lysate is analyzed as detailed above for protein 
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content. Results obtained in this way permit calculation of 
total protein in the tissue culture dish. Specific activities of 
enzymes within cells and in the cell culture media may be related 
either to actual cell numbers or to the amount of cellular 
protein (Schnyder and Baggiolini, 1978a). Any non-adherent cells 
will be removed in the washing procedure, as will serum or other 
proteins in the culture medium. 
2.4 
2.4.l 
NOCARDIA ORGANISMS 
SOURCE OF NOCARDIA ASTEROIDES AND NOCARDIA BRASILIENSIS 
AND THEIR VERIFICATION 
Nocardia asteroides, strain Dl039 was isolated from a patient, 
and obtained from Dr CN Young, South African Institute of Medical 
Research, Johannesburg, South Africa. 
Nocardia brasiliensis was isolated from a subcutaneous abscess of 
a patient suffering from clinical illness (Folb, Jaffe and 
Altmann, 1976). The N.brasiliensis culture was confirmed by L 
Kaufman, Centre for Disease Control, Atlanta, Ga. 
2.4.2 DETAILS OF CULTURE OF ORGANISMS, CONFIRMATION THAT 
INOCULATION IS A PURE GROWTH, HARVESTING OF ORGANISMS 
Both N.asteroides and N.brasiliensis were cultured for _4 days on 
ISO sensitest agar plates (!ST) OXOID CM471 at.30°c (Oxoid Ltd, 
Basingstoke, Han ts RG24 OPW) • Growth on agar plates gives rise 
to colonies of organisms which are at different stages of growth 
i.e. lag phase at the periphery, progressing through log and 
early stationary phase to stationary phase at the centre of the 
90 
colony. 
Criticism has been levelled at the use of colonies of Nocardia 
grown on media and the inoculation of "crude" suspensions of 
organisms in the investigation of nocardial pathogenesis (Beaman 
and Maslan, 1978; Beaman et al, 1980; Beaman and Sugar 1983), 
since this method contributed to the contradictory reports 
concerning the virulence of Nocardia for mice (Uesaka et al, 
1971; Gonzalez-Ochoa, 1973). The fact that other investigators 
did not standardize their techniques of growing, preparing and 
inoculating the organisms into the host has also been criticized 
(Beaman, Maslan et al, 1980). Consequently it has not generally 
been possible to compare the results of one study with those of 
another (Beaman, Maslan et al, 1980). In this study, virulence of 
Nocardia is not being investigated - virulence of the organisms 
was only a consideration in developing a reproducible non-lethal 
infection of similar degree with both N.asteroides and 
N.brasiliensis. In a previous study, Folb, Jaffe and Altmann 
(1976) found that N.asteroides and N.brasiliensis cause lesions 
in the experimental mouse that are quite different in their 
features (Section 1.7.3.1.1). This finding, which will be 
discussed in more detail at a later stage, gave rise to the idea 
that macrophage function in N.asteroides and N.brasiliensis 
infection in the experimental mouse may be different, and has 
been investigated in this study. The method of preparation of 
the inoculum (Folb, Jaffe and Altmann, 1976) was used since it 
had been employed in the original work leading to this 
investigation. 
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2.4.3 CONFIRMATION THAT INOCULUM IS A PURE GROWTH, AND 
HARVESTING OF ORGANISMS 
The purity of the plates was checked visually with a 10x 
magnifying glass, and the colonies of organisms were harvested 
aseptically from the agar by scraping with a flamed glass slide, 
and placed in a pre-weighed sterile bottle. Great care was taken 
to remove as little agar as possible. Grams stains were done on 
single colonies for each harvest to further ensure purity of the 
culture and to confirm morpholog ica 11 y that the organisms were 
nocardiae. The organisms were suspended in sterile normal saline 
with the aid of a magnetic stirrer at the following 
concentrations: 
N.asteroides 10 mg/ml wet weight 
N.brasiliensis 20 mg/ml wet weight 
The suspension was stirred vigorously for 30 minutes before 
inoculation of animals. Saline has been used as a medium for 
suspension of Nocardia by other workers ( Krick and Remington, 
1975: Uesaka et al, 1971; Beaman, Maslan et al, 1980). 
2.4.4 ROUTE OF INOCULATION 
Folb, Jaffe and Altmann (1976), Folb, Timme and Horowitz (1977), 
inoculated Swiss white mice intraperitoneally (i.p) with a 
suspension of live organisms. The method employed by these 
workers was followed exactly in this study. The mouse abdomen 
was swabbed with an alcohol swab ( The Kendall Company, South 
Africa, isopropyl alcohol 70% V/V). After the animal inoculation 
procedure, an aliquot of the inoculum was cultured on ISO 
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sensitest (IST) agar plates to determine whether any 
contamination of the inoculum had occurred while the animals were 
being injected. Suspensions of the organism were introduced 
through a 26 gauge needle through the lower left abdominal wall. 
The needle was tilted slightly upwards in an attempt to avoid the 
organs of the animal. As the needle was removed the abdomen and 
site of inoculation were swabbed again. 
Animals inoculated intraperitoneally with 0. 5 ml sterile normal 
saline were termed control, uninfected animals. Others have 
inoculated control mice with PBS (Deem, Doughty and Beaman, 
1983). 
Other workers have used the i.p. route for inoculation of animals 
with Nocardia organisms (Krick and Remington, 1975; Sundararaj 
and Agarwal, 1978; Wallace et al, 1979: Beaman, Maslan et al, 
1980; Beaman and Scates, 1981). Infections induced by this 
route were chronic and extensive, characterized by slowly 
progressive multiple lesions throughout the peritoneal cavity 
(Beaman, Maslan et al, 1980). Wallace et al (1979) produced a 
chronic infection model using this route of inoculation in which 
large abscesses developed but only a 5%-10% mortality occurred. 
2.4.5 ESTABLISHMENT OF DOSE REQUIRED FOR SUB-LETHAL INFECTION 
The dose of N.brasiliensis required to produce a sub-lethal 
Nocardia infection in mice was established at 10 mg wet weight 
suspended in 0.5 ml normal saline per animal. Folb, Jaffe and 
Altmann (1976) used 5 mg dry weight per animal. The dose 
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selected produced a sub-lethal general peritonitis which was 
similar to that produced in Swiss white mice by Folb, Jaffe and 
Altmann, (1976). It was therefore felt to be unnecessary to use 
other doses of N.brasiliensis in this study. 
N.asteroides D1039 at a dose of 20 mg/ml wet weight caused a 50% 
inoculated. The dose of inoculum was mortality in the mice 
reduced to 10 mg/ml wet 
inoculated into each mouse. 
weight, i.e. 5 mg wet weight was 
This produced a 5-10% mortality and 
in many mice produced massive peritoneal infection and animals 
appeared very ill. In order to reduce the mortality and develop 
a more s tanda rdi zed peritoneal infection 0. 3 ml of the 10 mg/ml 
wet weight N.asteroides was inoculated i.e. 3 mg wet weight per 
animal. This gave rise to a reproducible sub-lethal general 
peritonitis. There were only occasional fa ta 1 i ties with these 
doses of organisms. 
2.5 
2.5.1 
THE NOCARDIA ANIMAL MODEL 
MOUSE STRAIN 
We have used specific pathogen-free (Ha) ICR/UCT male mice, 
outbred, 25-30 gin weight in this study. In initial experiments 
performed when setting up the experimental system (3.3.1.5.1), 
several inbred strains of mice were used, these being 
BALB/c,/UCT, c 3H/He/UCT and CBA/Ca/UCT, all specific pathogen-
free, male and 25-30 g in weight. (Ha) ICR/UCT mice were 
selected for this study on the basis of the results of these 
initial experiments (3.3.1.5.2) and because Folb, Jaffe and 
Altmann (1976) used outbred Swiss white mice (unobtainable for 
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this study) in the study which led up to this work. Also, cells 
from outbred mice give better cultures than those from highly 
inbred strains (Stuart, Habeshaw and Davidson, 1978: 31.4). 
2.5.2 MAINTENANCE OF ANIMALS 
Mice were house in the Infectious Isolation Unit, Animal House, 
Medical School, University of Cape Town. Animals were kept six 
mice per cage, fed on water and rat cubes ad libitum and control 
mice were kept under the same conditions for the same period of 
time. Mice were monitored daily, and any dead mice removed 
immediately. 
2.5.3 PASSAGING OF NOCARDIA AND FULFILLMENT OF KOCH'S 
POSTULATES 
Nocardia organisms were cul tu red on IST agar plates, harvested 
and inoculated into mice, as detailed previously. Post-mortems 
were performed after peritoneal cell harvest to ensure that 
controls were infection-free and that Nocardia-inoculated animals 
showed evidence of infection. Abscesses in 2 or 3 different 
animals were aseptically incised and pus swabs taken. These pus 
swabs were incubated for one week in Trypticase Soya Broth (TSB) 
and streaked on IST plates. The plates were incubated at 30°c 
for four days and the colonies of organisms harvested and 
inoculated into mice as described previously. At various 
intervals post-inoculation i.e. 2, 7, 13 and 21 days mice were 
sacrificed and post-mortems performed to confirm the presence of 
Nocardia infection. Abscesses were incised, pus swabs taken and 
these were incubated and cultured as described above. Plates 
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were examined visually for pure growth of Nocardia and purity of 
culture was confirmed by Gram's stain of single colonies. 
In an attempt to maintain virulence of the N.asteroides and 
N. bra si 1 iensis, organisms were passaged through mice at regular 
intervals, as described above. 
cultured on agar plates for 
passaged through the animals. 
Nocardia organisms were generally 
two successive passages and then 
2.5.4 AUTOPSY ON MICE : PATHOLOGICAL VERIFICATION OF MODELS 
Post-mortems were performed after peritoneal cell harvest on each 
sacrificed animal. Control animals were examined to ensure that 
they were free of infection and inoculated animals were checked 
for positive signs of Nocardia infection. 
2.5.4.1 METHOD 
Positive signs of infection were taken as splenomegaly with or 
without scattered abscesses in the peritoneal cavity. Presence 
of typical lesions without splenomegaly was also accepted as 
positive. Incision of the lesions in a representative number of 
animals and culture of pure colonies of Nocardia confirmed 
presence of infection. Absence of infection was determined by 
findings of normal spleen size and absence of any lesions. 
After peritoneal cell harvest the abdominal wall of the animal 
was incised and reflected to permit examination of the peritoneal 
cavity. The abdominal viscera were examined carefully and, in 
the case of N.asteroides-inoculated animals, the thoracic viscera 
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were inspected. The viscera were examined in situ initially and 
then were reflected to display the kidneys, spleen, gut 
mesentery, diaphragm, base of the liver, urogenital system, 
inferior vena cava, iliac veins and arteries, etc. In the 
N.asteroides-inoculated mice the heart and lungs were examined. 
2.5.4.2 EXTERNAL APPEARANCE OF ANIMALS 
Inoculated animals were examined and compared to control animals 
immediately prior to sacrifice. 
Mice inoculated 2 days previously with either N.asteroides or 
N.brasiliensis appeared to have lost weight in comparison to 
control animals and appeared unwe 11 and were some times acutely 
ill with attendant symptoms such as sunken eyes, harsh staring 
coats, loss of mobility and seemed dehydrated (determined by 
pinching of skin at the nape of the neck). 
Appearance of animals 7 days post-inoculation with N .asteroides 
or N.brasiliensis was similar to their appearance 2 days post-
inoculation, however condition of the animals appeared to have 
deteriorated as compared to 2 days post inoculation. Apparently 
marked loss of weight was commonly noted and animals generally 
appeared debilitated. 
13 days post-inoculation, animals appeared to have recovered to a 
certain extent in they did not have the debilitated appearance 
seen 7 days post-inoculation. Some loss of weight was noticeable 
but coat appearance had improved and animals seemed mobile 
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(judged from amount of f igh ting in 
evade capture). 
the exception. 
A few animals were 
the cage and by ability to 
seriously ill but this was 
Mice generally seemed well 21 days post-inoculation with 
N.asteroides or N.brasiliensis, with a few exceptions, loss of 
weight was often not noticeable and behaviour was similar to that 
of control animals. 
2.5.4.3 POST-MORTEM FINDINGS 
Post-mortems were conducted on 815 control mice, 446 
N. asteroides-inocula ted and 433 N. brasi l iensi s-inocula ted mice. 
Only visible lesions were documented. 
No abscesses were found in any of the control animals. If 
splenomegaly was suspected, the animals were discarded. Post-
mortem findings were correlated and tabulated for 297 
N. a steroides-inocula ted and 315 N. brasi 1 iensi s-inocula ted mice. 
Abscesses and/or splenomegaly was found in each peritoneal 
cavity. 
Grading of splenomegaly was based on spleen weight. In initial 
experiments, spleens were arbitrarily graded according to the 
size as being normal or enlarged over the range of mild 
splenomegaly (+), moderate (2+), marked (3+) very marked (4+) and 
gross (5+). These spleens were then removed, cleaned of 
mesentary and weighed. The spleen weights and corresponding size 
grading were used to estimate degree of splenomegaly in 
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subsequent experiments. 
mice are as follows : 
Data for spleen weights from control 
median value 0.1274 g, 95% confidence 
limits, lower limit 0.1092 g, upper limit 0.1521 g; data for 
spleen weights from infected mice are shown in Table 1, as well 
as graded estimates of splenomegaly for 612 Nocardia infected 
mice, data for hepa tomega ly and a summary of data on occurrence 
of abscesses. The latter data are presented in more detail in 
section 2.5.4.3.1 - 2.5.4.3.8. 
2.5.4.3.1 Two day N.asteroides infection (31 mice) 
Abscesses and adhesions were present in all the peritoneal 
cavities examined. A characteristic of the abscesses were that 
they were "floating" i.e. were not fixed to the peritoneum. 
Abscesses were genera 11 y sma 11 and paler than noted at longer 
intervals after inoculation. Abscesses occurred most commonly 
under the liver, on the liver, diaphragm and on the stomach. No 
necrotic areas were found. 
2.5.4.3.2 Two day N.brasiliensis infection (46 mice) 
"Floating" abscesses were again noted. Adhesions were present in 
some animals and abscesses were not as prolific as in the 2 day 
N.asteroides animals. Abscesses were most 
the liver, in the gut and gut mesentary, 
commonly found under 
on the diaphragm and 
stomach. The occasional large vascularised abscess was found on 
the bladder, anterior abdominal wall at the site of injection and 
on the stomach (up to 0.6 cm long). 
found. 
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No necrotic areas were 
2.5.4.3.3 Seven day N.asteroides infection (72 mice) 
Marked peritoneal adhesions were generally noted and numerous 
abscesses were present. Gross abscesses were often found medial 
to the spleen and inferior to the stomach, also in the gut. Most 
commonly affected areas were the kidneys, under the liver, 
diaphragm, bladder and spleen. 9 kidneys, 1 liver had an area of 
necrosis, 5 necrotic spleens were found. Occasionally abscesses 
were found on the lungs, upper diaphragm surface and the thoracic 
walls. Intrahepatic, intrasplenic and intrarenal abscesses were 
common. 
2.5.4.3.4 Seven day N.brasiliensis infection (116 mice) 
Marked peritoneal adhesions and multiple abscesses were present. 
Abscesses were found most commonly under the liver, scattered in 
the gut and gut mesentary, diaphragm, spleen ( occasional gross 
abscesses found here), anterior abdominal wall and on the liver. 
No necrotic areas were found. Some large abscesses were 
vascularized. 
frequently. 
Intrasplenic and intrahepatic abscesses occurred 
2.5.4.3.5 Thirteen day N.asteroides infection (103 mice) 
Marked peritoneal adhesions and prolific abscesses were scattered 
in the per i tonea 1 cavity. Gross abscesses were frequently found 
media 1 to the spleen and inf er i or to the stomach. Areas most 
commonly affected were the spleen, anterior abdominal wall, 
kidneys, liver, gut and stomach. Penetration of the thoracic 
cavity and 1 ung s occurred in the most debi 1 i ta ted animals and 
seat tered abscesses were found. Intraperitoneal, intrasplenic 
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and intrahepatic abscesses occurred frequently. 5 necrotic 
kidneys, 5 livers had areas of necrosis and 6 necrotic spleens 
were found. 
2.5.4.3.6 Thirteen day N.brasiliensis infection (103 mice) 
Marked peritoneal adhesions and multiple abscesses were present. 
Abscesses were found predominantly on the gut and in the 
mesentary, on the posterior abdominal wall and sometimes 
extending into the retroperitoneal area, under the liver, 
diaphragm, medial to the spleen and inferior to the stomach, and 
on the spleen. Some large, well vascularized abscesses were 
found, as well as some intrahepatic and intrasplenic abscesses. 
1 necrotic spleen was found. 
2.5.4.3.7 Twenty-one day N.asteroides infection (68 mice) 
Marked peritoneal adhesions and multiple abscesses were found 
scattered in the peritoneal cavity. Abscesses seemed smaller 
than those in the mice inoculated 13 days previously and were 
generally less numerous. Areas most commonly affected were the 
spleen, kidneys, the area medial to the spleen and inferior to 
the stomach and the liver. A few large, well vascularized 
abscesses were found, as well as frequent intrahepatic and some 
intrasplenic and intrarenal abscesses. Penetration of the 
diaphragm occurred in the most debilitated animals and abscesses 
were scattered over the thoracic walls and sometimes the lungs. 
2 necrotic kidneys and 3 necrotic spleens were found. 
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2.5.4.3.8 Twenty-one day N.brasiliensis infection (94 mice) 
Abscesses occurred most frequently under the liver, on the 
diaphragm, on the gut and gut mesentary and on the stomach. 
Adhesions and abscesses were seat tered in the peri ton ea 1 cavity 
but often appeared to be healing. Areas of necrosis were rare, 
as were gross vascularized abscesses. 
2.5.4.3.9 General observations 
Distinct organ tropism was found for N.asteroides and 
N.brasiliensis. N.asteroides infected the kidneys far more 
frequently and more severely than N.brasiliensis. Of 297 mice 
infected with N .asteroides, 170 kidneys or 29% of kidneys had 
abscesses whereas 62 kidneys in 315 N.brasiliensis-inoculated 
mice were affected (10%). N. bras i 1 iensi s seemed to infect the 
gut and the gut mesentary more often than N.asteroides did. 
N.brasiliensis abscesses were generally larger than N.asteroides 
abscesses. The approximate size of abscesses produced in the gut 
by N.asteroides was about 1 mm diameter and by N.brasiliensis 
about 2.5 - 3 mm diameter. Large abscesses scattered through the 
gut appeared to be characteristic of N.brasiliensis. 
N.brasiliensis infected the gut in 185 out of 315 mice (59%) and 
N.asteroides infected the gut in 130 out of 297 mice (44%). The 
liver was more frequently infected in N.asteroides-inoculated 
mice (112/297, 38%) than in N.brasiliensis-inoculated mice 
(98/315, 31%). 
Peritoneal fat was more often infected in N.brasilienis-
inoculated mice (42/315, 13%) than in N.asteroides-inoculated 
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mice (30/297, 10%). Hepatomegaly was more frequent in 
N.asteroides-inoculated mice (181/297, 61%) than in 
N.brasiliensis-inoculated mice (142/315, 45%) 
Some animals infected with N.asteroides and N.brasiliensis 
developed a spinning syndrome. A similar phenomenon was found to 
occur in mice infected with N.caviae (Beaman and Scates, 1981) 
and N.asteroides (Beaman and Sugar, 1983). 
From the appearance of the animals and the post-mortem findings, 
it seems that the acute stage of infection with both N.asteroides 
and N.brasiliensis is 2-7 days post-inoculation with chronic 
infection developing at 7-13 days. Beaman and Scates (1981) have 
described similar findings in that mice inoculated i.v. with 
N.caviae were acutely ill at 48 hours post-infection. 
2.6 NOCARDIA ANTIGENS 
Culture filtrate antigens of Nocardia asteroides (confirmed by 
Ruth Gordon, Rutgers University, New Jersey) and Nocardia 
brasiliensis (confirmed by L Kaufman, Centre for Disease Control, 
Atlanta, Georgia) were kindly given to us by Professor G Baum and 
were prepared in the following way: 
Asparagine broth was prepared by dissolving 7 g of L-asparagine 
in 300 ml of sterile distilled water, and the following reagents 
were dissolved individually in approximately 25 ml of sterile 
distilled water, and each solution was added in sequence to the 
asparagine solution: 
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7.0 g ammonium chloride 
1.5 g magnesium sulphate. 7H 20 
0.9 g sodium citrate 
1.3 g potassium hydrophosphate 
25 g glycerol and 10 g of glucose were added, and the volume was 
brought to 1 litre with distilled water and sterilized by 
autoclaving at 120°c for 20 minutes. 
The Nocardia antigens were prepared by inoculating the asparagine 
broth with large fragments of a colony of N.asteroides and 
N.brasiliensis respectively, grown previously for approximately 
two weeks on Sabouraud dextrose agar slants. The colony 
fragments were floated on the broth surface, the flasks were 
cotton plugged and incubated undisturbed at 23°c. Time of 
incubation for N.asteroides was 7 months, and 10 months for 
N.brasiliensis. After the incubation period the culture fluid 
was decanted and collected. The pooled, unheated culture fluids 
were sterilized by successive passage through 0.45 rm and 0.22 rm 
filters. The sterile filtrate was divided into 500 ml aliquots 
and dialysed at 4°c for 48 hours against distilled water. The 
dialysed material was freeze dried in tared containers and 
reconstituted in pyrogen-free 0. 9% sodium chloride to contain 
10mg (dry weight) of non-dializable solids per ml. The 
concentrated culture filtrate antigen preparation was sterilized 
by filtration, dispensed into sterile vials and stored at -20°c. 
The antigen preparation was thawed, aliquoted into volumes of 35 
11 in sterile plastic vials, 
immediately prior to use. 
104 
stored at -20°c and thawed 
2.7 INTRAPERITONEAL INJECTION OF THIOGLYCOLATE MEDIUM 
Peritoneal macrophages were elicited by intraperitoneal injection 
of 0.75 ml of sterile Brewers thioglycolate medium (Unkeless, 
Gordon and Reich, 1974; Gordon, 1978; 33.6), prepared and stored 
according to manufacturer's instructions. Peritoneal cells were 
harvested by the standard methods described under section 2. 8, 
four days after injection. Macrophages elicited by 
intraperitoneal injection of certain irritants such as 
thioglycolate medium exhibit certain physiological manifestations 
of activation in comparison to cells obtained from the 
unstimulated peritoneal cavity (Bloom et al, 1976 : 20). 
2.8 MACROPHAGES 
Mouse peritoneal cells were harvested according to the methods of 
Cohn and Benson (1964), Stuart, Habeshaw and Davidson (1978: 
31.5) and Edelson and Cohn (1976 : 335). 
2.8.1 TECHNIQUE 
The individual mice were killed in turn immediately prior to cell 
harvest. The animal was anaesthetized with ether, and was killed 
by cervical dislocation. The mouse was then pinned with its 
extremeties extended to a board covered with alcohol-damped paper 
towel, and the fur sprayed well with 70% alcohol. The skin was 
lifted upward and away from the anterior abdominal wall with 
forceps, and an incision of about 3 cm long made through the 
skin. Great care was taken not to penetrate the anterior 
abdominal wall. The skin was cut, reflected away and pinned 
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back. 4 ml Dulbeccos medium (DB) with penicillin, streptomycin 
and heparin ( heparin sodium, 25. 000 IU/ml. Weddel 
Pharmaceuticals Ltd) was injected into the peritoneal cavity. DB 
contained 50IU heparin per ml ( Bray et al, 1983). The injection 
was made along the mid-anterior line, taking care to avoid 
puncture of the gut. If this occurred the mouse was discarded. 
The injected fluid was then circulated by shaking and prodding 
the peritoneal cavity for about two minutes. Care was taken to 
avoid damage to the liver as this results in presence of blood in 
the peritoneal wash. The peritoneal wall was then tented with 
toothed forceps and a tiny incision made with sharp-pointed 
scissors. Care was taken to avoid spillage of the peritoneal 
wash. A preflamed sterile pasteur pipette was used to aspirate 
the injected fluid, and the fluid was placed aseptically in a 
numbered 15 ml conical tube (Falcon) and the tube kept on ice. 
About 3/4 of the fluid was usually recovered. A post-mortem was 
then performed on the animal to ensure absence of infection in 
controls and evidence of infection in Nocardia-inoculated 
animals. The process was repeated with each mouse and the 
a spi rated f 1 uid placed in separate tubes and kept on ice. The 
peritoneal fluid was aspirated within 5 minutes of injection in 
an attempt to avoid contamination with organisms from the gut 
(Stuart, Habeshaw and Davidson, 1978: 31.5). 
If post-mortem examination revealed unusual characteristics, e.g. 
splenomegaly in controls, no evidence of infection in inoculated 
animals, the tube containing the peritoneal fluid from that 
animal was discarded. 
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Contamination of cultures with many red cells usually markedly 
reduces macrophage adherence to glass: of if they do adhere, they 
undergo degeneration (Stuart, Habeshaw and Davidson, 1978 : 
31.9). If any red blood cells were present in the peritoneal 
fluid, the fluid was centrifuged for 5 minutes at a relative 
cen tr i fuga 1 force ( RCF) of 5 7 4 in a Sorva 1 RC 3-B re fr igera ted 
centrifuge (Du Pont Company, Instrument Product, Biomedica 
Division, 
cells were 
Newtown, Conn 064 70) 
then resuspended in 
7.4 (Pantalone and 
placed on ice for 10 minutes. 
to pellet the cells. Pelleted 
3 ml of 0.83% ammonium chloride 
Page, 1977: Filice, 1983), and 
Cells were then pelleted again, 
washed once in DB+ P&S and resuspended in fresh DB+ P&S. 
Peritoneal aspirates from control mice were pooled, as were those 
from Nocardia-inoculated mice. Peritoneal aspirates from batches 
of 4-12 mice were usually pooled. The pooled cells were pelleted 
by centrifugation at a maximum relative centrifugal force (RCF) 
of 574. RCF was determined by the formula: 
N 2 
RCF = 11.17 ( r) 
1000 
where, r = radius of the rotor in cm 
N = revolutions per minute 
The radius at the centre line of the bucket, r CL = 26.2 cm 
Therefore: The maximum RCF at the centre of the bucket at 1400 
rpm = 574. 
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About 2/3 of the supernatant fluid was aspirated and the cell 
pellet was resuspended in the remaining supernatant. The cells 
were mixed by gentle agitation with a sterile pasteur pipette and 
a drop of cell suspension was removed and placed in a counting 
tube (Greiner, Germany). Differential cell counts were performed 
according to the method of Baker, Silverton and Luckock (1966 : 
519) in a haemocytometer chamber ( SpencerR Bright Line Improved 
Neubauer, l/10mm deep), using white cell diluting fluid and a 
white cell pipette at a dilution of 1 in 20 and mixed well by 
shaking for 3-4 minutes. About a quarter of the mixture was then 
discarded and the appropriate volume of cell suspension run into 
the counting chamber. Total and differential cell counts were 
done using a Leitz Laborlux 12 microscope with 16x eyepieces and 
a 32x long working distance objective. 
The number of cells per ml of cell suspension was calculated 
using a standard technique (Baker, Silverton and Luckock, 1966 
520). 
The eel 1 suspensions were di 1 u ted to a ce 11 concentration of 
lxl0 6 or 2xl0 6 macrophages/ml in DB supplemented with the 
appropriate concentrations of serum, 100 IU/ml penicillin and 0.1 
mg/ml streptomycin. l ml of the cell suspension was placed as a 
bubble over the coverslips, which were held in a sterile petri 
dish ( Falcon 3001; Falcon Plastics, Div Becton, Dickinson and 
Co., Cockeysville MD 21030 USA). After attachment (10 min at 
37°c, 5% co 2 ), the petri dish was flooded with medium and 
reincubated in a Forma Scientific co 2 incubator. 
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2.8.2 IDENTIFICATION OF MACROPHAGES 
Differential cell counts were routinely done as wet preparations 
in a haemocytometer (West et al, 1968; Cohn and Benson, 1964; 
Stuart, Habeshaw and Davidson, 1978 : 31.6) as described 
previously. A characteristic of the normal mouse peritoneal 
macrophage is a reniform or horseshoe-shaped nucleus (Fedorko and 
Hirsch, 1970) al though the macrophage nucleus may vary in shape 
from horseshoe-shaped to fusiform (Lessin and Bessis, 1972: 
735). Other morphological criteria used to idE:ntify macrophages 
are their size and the ratio of the nucleus to cytoplasm (Rhodes 
et al, 1979). The nucleus to cytoplasm ratio is < 1 in the 
macrophage (van Furth, Hirsch and Fedorko, 1970) ie it occupies 
less than half of the total cell area (Hirsch and Fedorko, 1970 : 
16). Characteristics of the small lymphocyte are scanty, almost 
empty cytoplasm and the nucleus is rounded or ovoid, generally 
with a little indentation on one of its sides, and is large 
relative to the cytoplasm (Ham 1969 : 273, Feldman, 1972 : 752). 
The nucleus of PMN is lobular and occupies less space than the 
cytoplasm ( Ham 1969 265). Macrophages were distinguished as 
monocyte-like phagocytes with a reniform or horseshoe-shaped 
nucleus ( Cohn and Benson, 1964) which generally occupied less 
than half the total cell area. 
Differential cell counts performed as wet preparations in a 
haemocytometer were initially done by two independent observers. 
Once these two cell counts had become consistently similar, 
counts were done by one observer. 
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Accuracy in di ff eren tia ting 
present in the peritoneal 
macrophages from other cell types 
wash was checked with air dried, 
methanol fixed preparations stained with May-Grunewald-Giemsa 
( Schnyder and Bagg iol ini, 197 Sa; Patterson and Youmans, 1970). 
Peritoneal cells were resuspended at a concentration of lxl0 5 
cells/ml, 0. 3 ml of cell suspension placed in a Shandon Elliot 
cytocentrifuge (Shandon Southern Products Ltd., Cheshire, 
England; Davis-Scibienski and Beaman, 1980c) spun at 800 rpm for 
5 min and stained in a Hemastainer auto slide stainer (Geometric 
Data, Wayne, Penn 19087 USA). Slides were fixed in methanol for 
10 minutes, filtered May-Grunewald 10 minutes, Giemsa stain with 
buffer (pH 6.8, 150 ml of 0.2 M KH 2 Po 4 and 67 ml of 0.2N NaOH -> 
5 1) for 15 mins, distilled water and buffer 20 seconds, finally 
buffer for 4 mins. Slides were examined under oil by light 
microscopy using a 40x objective. 
Phase contrast or light microscopic examination of a stained 
smear is the simplest and usu a 11 y the most re 1 iable method of 
differentiating lymphocytes, macrophages and PMN, although 
sometimes it is impossible to differentiate monocytic cells from 
large lymphocytes (Bloom et al, 1976 : 20). 
Identification of stained cells was based on Diggs, Sturm and 
Bell (1970), and on Sanderson and Phillips (1981). 
2.8.3 VIABILITY OF MACROPHAGES 
Viability of harvested macrophages was determined prior to 
culture by Trypan blue exclusion (2% Trypan blue diluted to 0.2%, 
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mixed with an equal volume of cell suspension and examined 
microscopically). 
Uptake of dye by the cells indicates non-viability. 100 cells 
were counted in each determination. Cell viability should be 
greater than 95% and in most cases it was. Median cell 
viabilities and their 95% confidence limits (Hollander and Wolfe, 
1973) were calculated for control macrophages and Nocardia 
-activated macrophages at each interval post-inoculation studied. 
Median viabilities for control macrophages was greater than 95%; 
for N.asteroides-activated macrophages was equal to 98% in each 
case; and for N.brasiliensis-activated macrophages greater than 
95% (Table 2). 
2.8.4 PREPARATION OF COVERSLIPS 
Glass coverslips (22 x 22 mm, Chance Propper Ltd., Smethwick, 
Warley, England) were boiled in soap solution for two hours, 
rinsed 20 times with triple distilled water, oven dried and 
sterilized by autoclaving (138°C, 15 p.s.i., 30 minutes; 
Einstein, Schneeberger and Col ten, 1976). Coverslips were 
distributed aseptically in tissue culture dishes immediately 
prior to seeding of cells. 
2.9 INFLUENCE OF TIME COURSE OF INFECTION ON TOTAL NUMBER 
OF CELLS AND ON NUMBER OF PERITONEAL MACROPHAGES 
HARVESTED 
The average number of peritoneal cells yielded per mouse was 
calculated in each experiment, as was the average number of 
111 
macrophages yielded per 
from the differential 
mouse. The latter data were calculated 
cell counts. 
interval post-inoculation studied. 
This was done at each 
Median cell numbers, 
macrophage numbers and median viability values and their 95% 
confidence 1 imi ts ( Hollander and Wolfe, 197 3) were calculated 
from these data and are shown in Table 2 and Figs 2 and 3. 
Median total number of cells and number of macrophages harvested 
from control animals remained relatively constant over the 21 day 
period, whereas median cell number in both N.asteroides and 
N.brasiliensis-inoculated animals was increased 2 days post-
inoculation, continued to rise and peaked at 7 days post-
inoculation and thereafter declined towards control levels at 21 
days (Fig 2 and 3). These differences were statistically 
significant at the 0.05 level at 2, 7, 13 and 21 days 
(N.asteroides) and at 2, 7 and 13 days (N.brasiliensis). 
Similarly, median macrophage number peaked at 7 days post-
inoculation and declined towards control levels at 21 days post-
inoculation in both N.asteroides and N.brasiliensis-inoculated 
animals. 
7, 13 
These differences were significant at the 0.05 level at 
and 21 days (N.asteroides) and at 2, 7 and 13 days 
(N.brasiliensis) when compared with control macrophage number. 
Control peritoneal cell yields consisted generally of about 55-
60% macrophages, about 35-40% lymphocytes and 1-5% PMN. 
Peri tonea 1 eel 1 s harvested from mice inoculated previously with 
N.asteroides and N.brasiliensis consisted of about 35% 
macrophages, 15% lymphocytes and 50% PMN, at 2 days post-
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inoculation; 40% macrophages, 20-25% lymphocytes and 35-40% PMN 
at 7 days post-inoculation; 50% macrophages, 20-30% lymphocytes 
and 20-30% PMN at 13 days post-inoculation; and 55% macrophages, 
30-35% lymphocytes and 10-15% PMN at 21 days post-inoculation. 
(These data are approximations, refer to Table 2 for median 
macrophage percentages). The finding that PMN comprised a large 
proportion of the peritoneal exudate early in infection was 
expected, since it is well known that initial infection with 
Nocardia is a pyogenic one with a predominantly polymorphonuclear 
cell infiltrate (Filice et al, 1980; Bradsher, Monson and 
Steele,1982; Rico et al, 1982). Patterson and Youmans (1970) 
immunized mice with M. tuberculosis and different ia 1 counts from 
May-Grunewald-Giemsa stained smears showed 65% macrophages and 
35% lymphocytes and PMN for normal mice and 30% macrophages and 
70% lymphocytes and PMN for immunized mice. 
2.10 STATISTICAL TREATMENT OF DATA 
To examine the significance of each experimental factor discussed 
in this thesis, control, control + antigen, test and test+ 
antigen samples were processed simultaneously, portions being 
withdrawn at three or four time intervals for analysis. For 
log is ti ca 1 reasons, al 1 samples could not be processed at the 
same time and the data bank assembled to describe the behavior of 
each factor consisted of data from several experiments. The 
general format can be described in tabular from as follows 
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Factor (eg. cumulative release of lysozyme into medium) 
sampling time Sl S2 S3 S4 
Expt 1 Control: a b C d 
(performed test: e f g h 
on day A) test + antigen i j k 1 
Expt 2 Control: m n 0 p 
(performed test: q r s t 
on day B) test + antigen u V w X 
etc 
where each letter a I b I C I • • • • I X denotes a block of results 
determined by assay. 
Visual examination of the data showed certain apparent trends: 
1. a tendency towards increase of factor with time eg. a<b<c<d 
(usually); 
2. a tendency for test results to be larger than their 
corresponding controls, eg. e and i>a, f and j>b and so on 
(usually). 
This tendency was noted in the series of experiments measuring 
plasminogen activator release. In the series of experiments 
measuring lysozyme release there was a tendency for test results 
to be smaller than or equal to their corresponding controls, eg. 
e and i<a, f and j<b and so on (usually). 
However, the number of samples possible for each experiment was 
limited so that the number of items in each block (a,b,c,d, 
... ,l,m,n,o, •.•• ,x) were too few for significance of the factor 
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to be established. it was clearly necessary to combine blocks 
from different experiments, thus: 
Factor 
sampling time 
Control 
test 
test+ antigen 
Sl 
A 
E 
I 
S2 
B 
F 
J 
S3 
C 
G 
K 
S4 
D 
H 
L 
where A is collected data from Expt l(a) and Expt 2(m) and Expt 3 
etc. 
The magnitude of corresponding data from different ex per imen ts 
differed markedly {eg. a was appreciably different from m), as 
did the test/control ratios (e/a was appreciably different from 
q/m), so it was clear that the data had perforce to be treated as 
ordinal rather than interval in nature. Random tests also 
indicated that variances were not homogenous nor was the 
distribution of data within each block A,B,C, ••• L normal. The 
decision was therefore taken to use the non-parametric Mann-
Whitney test (Siegel, 1956) to com pa re control and test groups; 
and medians and their 95% confidence limits were calculated by a 
method due to Tukey ( Hollander and Wolfe, 197 3) or due to 
Snedecor and Cochran ( 1980 473, Table A7). Where data was 
insufficient to calculate confidence limits using this method, 
95% confidence limits of the median were calculated using the 
substitute t-test based on the range developed by Lord (1947; 
Snedecor and Cochran, 1980). 
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The following formula was used: 
({HR-LR) * tw)/ 2 = X 
UL = M + X 
LL = M - X 
where: M = Median 
HR = highest reading 
LR = lowest reading 
n = 2 tw = 6.353 
= 3 tw = l. 304 
= 4 tw = 0.717 
= 5 tw = 0.507 
= 6 tw = 0.399 
This test gives significance at the 5% level for a 2-tailed test. 
2.11 INFLUENCE OF DURATION OF INCUBATION ON CELL PROTEIN (AS 
A MEASURE OF CELL NUMBER) 
Schnyder and Baggiolini (1978a) studied macrophages from 
untreated and thioglycolate-treated mice, and found that cell 
numbers decreased with time in culture. Cell number, whether 
expressed as actual number of macrophages or as Jg of cell 
protein dropped sharply in the first 2 days of incubation in the 
untreated cul tu res but cell loss subsided thereafter, whereas 
only slight cell loss was observed in thioglycolate-elicited 
macrophages. When mouse peritoneal macrophages are incubated in 
complete culture medium, a consistent loss of cells is seen with 
time (Lazdins et al, 1978). Patterson and Youmans (1970) found 
100% cell survival over the first 5 days in culture, but 
thereafter cell numbers declined. 
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To determine whether cell number decreased with time in this 
experimental system, total cell protein was measured 
spectrofluorimetrically. The data in Tables 3-10 are the data 
used in Chapter 4 (4.2.4) experimental series "b" to determine 
1 ysozyme specific ac ti vi ties and the ex per imen tal methods used 
are described in this section. 
In both types of culture, cell numbers remain similar or appear 
to decrease slightly with time of incubation, however there does 
not seem to be any clear trend, and in some cases cell protein is 
higher in 
is thought 
final cultures than it was in initial cultures. This 
not to be due to cell division as no dividing cells 
were ever seen in culture, but rather to be due to pipetting 
error when cells were seeded. Cells were, however, resuspended 
immediately prior to being seeded into culture dishes in an 
attempt to avoid such errors. In addition, these data are from 
replicate cultures (see section 4.2.4 for clarification), not 
from a single culture sampled over 4 days. 
In some experiments it appears that cell loss in control cultures 
is higher than that of Nocardia-acti va ted cultures during the 
first two days, in agreement with the literature. 
From the data presented, it seems that decrease in cell number 
with time of incubation is not a significant factor in this 
study. 
117 
2.12 MORPHOLOGICAL EXAMINATION OF CULTURES 
Macrophage cultures were subjected to thorough morphological 
examination immediately prior to washing and addition of fresh 
medium and before each sample was taken, using a Leitz Diavert 
phase-contrast inverted microscope. The criterion of cell 
morphology was used to determine viability of cultured 
macrophages. The morphological appearance of pseudopodia and 
ruffled membranes is indicative of cell viability (Patterson and 
Youmans, 1970), as is adherence of the macrophages to the 
substrate ( Gangadharam and Pratt, 1983). Hea 1 thy culture have 
large, well spread cells firmly adherent to the bottom of the 
dish. Unhealthy cultures contain many refractile rounded cells 
that detach from the dish floor ( Edelson and Cohn, 1976 : 337). 
Any cultures that appeared unhealthy were discarded. 
2.13 THE CONCEPT OF THE ACTIVATED MACROPHAGE 
In his review of the mononuclear phagocytic system, Lasser (1983) 
put forward the following definition: "activated macrophages can 
be defined as the morphologic, biochemical and functional changes 
that these cells undergo in expressing enhanced resistance to 
microorganisms, inf lam ma tion or neopla s ia as com pa red with the 
baseline values of resident and stimulated macrophages". 
Around the turn of the century, Metchnikoff wrote about his idea 
that macrophages needed to undergo functional changes to be able 
to show resistance to infection with certain bacteria (North, 
1978). 
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Lurie' s studies ( 1942) showed that macrophages in tuberculosis 
infection were altered and were able to reduce the growth of 
phagocytosed organisms, in contrast to normal macrophages. 
In the 1960's Mackaness (1962; 1964; 1969) described the 
functional changes that occur in macrophages in animals infected 
with facultative intracellular bacterial parasites, and he 
introduced the term "activated macrophage" to describe the 
enhanced microbicidal activity of these cells. "Activation" has 
a specific immunologic basis, but its expression is non-specific. 
Mackaness showed that macrophages from immune animls had acquired 
the capacity to destroy intracellular bacteria, whereas normal 
macrophages were killed by unrestricted intracellular bacterial 
replication. Mackaness (1969) also elucidated the relationship 
between specific delayed-type hypersensitivity and the 
antimicrobial activity of macrophages. This work led to numerous 
studies into the morphological, biochemical and functional 
differences between these "activated" cells and normal cells. 
Almost 50 functional modifications have been shown to occur in 
activated macrophages (Lasser, 1983; Karnovsky and Lazdins, 
1978; Cohn, 1978; Hopper, Wood and Nelson, 1979; Table 11). 
The finding that macrophages with increased microbicidal activity 
also displayed certain biochemical or functional modifications 
gave rise to the idea that macrophages manifesting altered 
biochemical characteristics, were "activated". Evidence that 
macrophages elicited in the peritoneum by non-specific 
inflammatory a gen ts such as thiog 1 ycola te medium, pep tone and 
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sterile caseinate exhibited biochemical differences also 
manifested by "activated" macrophages led some workers to believe 
that macrophages obtained in this way are "activated". However, 
biochemical modifications produced by non-speci fie inflammatory 
stimuli do not imply that the macrophage has enhanced 
microbicidal activity. Karnovsky and Lazdins (1978) believe that 
the chemical and biochemical evidence available is insufficient 
to define non-immunologically elicited macrophages as 
"activated". 
Cells from animals inoculated with agents such as thioglycolate 
have also been referred to as "stimulated" or "non-specifically 
activated". Other terms which have been used to subdivide 
macrophage activation into categories include "induced", "primed" 
and "armed" ( Morahan, 1980). The lack of uniform terminology 
hampers studies on mononuclear phagocytes, as confusion results 
from terms being used interchangeably. Al though some workers 
(Ogmundsdottir and Weir, 1980) restrict their use of the term to 
macrophage conforming to the original criterion as put forward by 
Mackaness, others such as North (1978), Cohn (1978) and Karnovsky 
and Lazdins (1978) feel that this is a much restricted 
definition. Cohn (1978) suggested that "properties of both 
qualitative and quantitative nature that exceed the baseline 
values exhibited by the resident unstimulated peritoneal 
II 
macrophage should be considered as activated. However, 
differences exist in the state of activation shown by macrophages 
involved in a non-specific inflammatory response and those 
modified by lymphokines. 
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Karnovsky and Lazdins (1978) define "activated macrophages 
strictly as being those macrophages that have been activated by 
immunologic mechanisms in vivo". Listeria and BCG infections are 
given as examples of agents having given rise to activated 
macrophages. North ( 1978) suggests that workers describe 
macrophages as being activated metabolically, bactericidally, 
phagocytically etc. and that the way in which macrophage 
activation was induced be referred to in the same way. 
The definition put forward by Lasser (1983) is a synopsis of the 
ideas of North (1978), Karnovsky and Lazdins (1978) and Cohn 
(1978) on this matter. The Reticuloendothelial Society (Morahan, 
1980) has recommended that a qualified description be given in 
the form "macrophages from ••..•• were obtained by 
for •..••. function". The term "elicited" should be reserved for 
the experimental procedure that results in the accumulation of 
macrophages at a particular anatomical site. These 
recommendations have been followed in this dissertation. 
Accordingly, the sys tern being used in this study is as follows: 
macrophages from mice were obtained by intraperitoneal 
inoculation of live organisms of N.asteroides and N.brasiliensis 
respectively, for secretion of plasminogen activator and lysozyme 
and for studies on morphology. In order to reduce repeated use 
of this definition in this text, this qualified description has 
been shortened to "Nocardia-activated macrophages". 
"Control macrophages" are defined as those resident peritoneal 
macrophages harvested from specific pathogen free mice 2, 7, 13 
and 21 days after inoculation with sterile, pyrogen-free isotonic 
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saline. 
The presence of one manifestation of activation does not 
automatically indicate that others are present. Nogueira, Gordon 
and Cohn ( 1977) demonstrated that al though the T-ce 11 mediated 
increased capacity of mouse macrophages for destroying 
Trypanosoma cruzi may always be associated with increased 
secretion of plasminogen activator, the reverse need not be true. 
Activation is not necessarily an all-or-nothing phenomenon that 
yields a cell with increased ability to deal with all situations. 
It has been suggested by North (1978) and Cohn (1978) that the 
presence of one manifestation of macrophage activation in the 
absence of others may indicate that activation occurs in definite 
steps and that the number of activation steps is regulated by the 
homeostatic functions the macrophage is required to perform. 
Cohn ( 1978) has outlined the stages in the activation of 
mononuclear 
as injection 
phagocytes. Non-specific 
of thioglycolate medium 
inf lam ma tory stimuli sue h 
induces a large number of 
the characteristics of activated macrophages, however a 
lymphokine-mediated event is required to induce microbicidal and 
tumoricidal activty. In this study, the definition of 
"activated" macrophages that is accepted is that of Karnovsky and 
Lazdins (1978) who defined "activated macrophages" as being 
"those macrophages that have been activated by immunologic means 
in vivo". This, in fact, concurs with Cohn's idea of a fully 
activated macrophage, and with Lasser's definition of activated 
macrophages. 
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There are numerous morphologic, biochemical and functional 
changes that are manifested in activated macrophages as compared 
to baseline values exhibited in unstimulated macrophages. The 
absolute relevance of several of the changes to the process of 
activation is debatable ( Karnovsky and La zdins, 1978). However, 
these changes characterise activated macrophages as compared to 
control macrophages. Some of these properties of activated 
macrophages were selected as parameters of macrophage function in 
Nocardia infections in mice. In this study, macrophage function 
was measured in terms of enzyme secretion, ie. plasminogen 
activator and lysozyme production: and morphological changes were 
assessed by phase contrast and scanning electron microscopy. 
123 
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2.16 TABLES 
TABLE la 
Summary of post-mortem findings 
* 
** 
2d Na 
2d Nb 
7d Na 
7d Nb 
13d Na 
13d Nb 
21d Na 
21d Nb 
KEY: No. 
H 
* 
** 
l+ 
2+ 
3+ 
4+ 
5+ 
No. 
None 
42 M 0.1274 
LL 0.1092 
UL 0.1521 
<0.16 
31 5 
46 7 
81 3 
72 
117 2 
103 6 
68 1 
94 13 
No. of mice 
Hepa tomega 1 y 
l+ 
0.1873 
0.1748 
0.204 
0.17-
0.23 
7 
24 
6 
10 
9 
22 
11 
41 
Splenomegaly H 
2+ 3+ 4+ 5+ 
0.2992 0.5151 0.723 1. 014 
0.2413 0.4545 0.6135 0.921 
0.3735 0.5661 0.802 1.165 
0.24- 0.44- 0.59- >0.86 
0.43 0.58 0.85 
16 3 
14 1 
34 24 13 1 
47 12 3 
39 42 24 1 
41 23 10 1 
32 17 7 
28 11 1 
Results from spleen grading experiment (weight in grams) 
Arbitrary spleen weight range in grams 
Mild splenomegaly 
Moderate splenomegaly 
Marked splenomegaly 
Very marked splenomegaly 
Gross splenomegaly 
TABLE lb 
10 
11 
44 
38 
77 
55 
50 
36 
Summary of post-mortem findings 
Presence and site of abscesses 
2d Na 
2d Nb 
7d Na 
7d Nb 
13d Na 
13d Nb 
21d Na 
21d Nb 
Small, pale, "floating" abcesses, most commonly on and under 
liver, diaphragm and stomach. 
Small, 
cavity, 
pale, 
liver, 
"floating" abcesses scattered 
gut, diaphragm and bladder. 
in peritoneal 
Marked peritoneal adhesions and numerous abscesses, 
especially on kidneys, liver, diaphragm and spleen. 
Marked peritoneal adhesions and multiple abscesses, 
especially on gut, diaphragm, liver and spleen. 
Marked peritoneal adhesions and prolific abscesses, 
especially on spleen, kidneys, liver and stomach. 
Marked peritoneal adhesions and multiple abscesses, 
especially on gut, liver, diaphragm and spleen. 
Adhesions and multiple abscesses scattered in peritoneum, 
especially spleen, kidneys and diaphragm. 
Abscesses found most frequently under liver, on diaphragm, 
gut and stomach. 
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TABLE 2 
Influence of time course of infection on total number of cells and on 
number of peritoneal macrophages harvested per mouse Median values 
and their 95% confidence limits. 
CELL TYPE 
a 
2d Na 
2d Nb 
7d l,a 
7a Nb 
13d Na 
13d Nb 
21d Na 
21d Nb 
KEY: a 
b 
C 
d 
e 
f 
b 
6 
10 
15 
14 
14 
21 
11 
15 
CONTROL 
C d e 
M 6.4 56 3.47 
LL 5.7 '.>4 3.01 
UL 7.1 58 3.93 
M 5.21 60 3.1 
LL 4.04 52 2.71 
UL 6.35 69 3.42 
M 5.0 58 2.94 
LL 4.11 55 2.47 
UL 5.93 b0.5 3.48 
M 4.94 55.5 2.71 
LL 3.83 53 2.09 
UL 6.43 58 3.76 
M 5.59 57 2.94 
LL 4.88 55 2.53 
UL 6.55 58 3.37 
M 4.73 57.5 2.64 
LL 4.05 55 2.36 
UL ti. 53 59.5 3.11 
M 5.25 56.75 3.09 
LL 4.54 50.5 2.57 
UL 6.27 59.5 3.63 
M 6.01 59 3.51 
LL 5.46 54 3.19 
UL 6.79 62.5 3.95 
~xperimental type 
Number of observations 
Total cell number x 106 
% Macrophages 
Macrophage number x 106 
% Viability 
NOCARDIA-ACTIVATED 
f C d e f 
97.5 15.03 35.5 5.43 98 
97.3 11. 27 32.71 3.91 97.4 
97.7 18.79 38.29 6.95 98.6 
97.5 16.45 37 6.18 98.5 
96 13.12 35 4.71 98 
99 19.21 40 7.51 99.5 
98 27. 03 43.5 11. 67 98 
97.5 20.3 40.5 8.74 97 
99 34.39 46 14.61 98.5 
%.5 25.04 39.5 9. 96 96. 5 
94.5 20.51 37.5 8.04 ':!3 
98 30.33 42 11. 86 98.5 
98 17.24 49.5 8.9 98 
97.5 14.03 47 7.04 97 
99 21.12 52 10.86 99 
96 13.21 50 b.65 97 
95.5 10.89 48 5.44 96 
97 15.6 52 7.88 97.5 
97.5 10. 58 56.75 5.87 98 
97 7.4 52 4.26 97 
98 17.82 63 10.62 98.5 
96. 75 6.77 53.25 3.64 96 
95 5.79 49 3.08 94.5 
97.5 8. 29 56.5 4.14 98 
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TABLE 3 
2 day N.asteroides infection : Influence of duration of incubation on 
cell number (expressed in terms of protein content). Units = µg of 
cell protein. I 
Control 
Na 
Na + 
0.002% Ag 
Sl 
215.8 
332.24 
462.16 
276.92 
309.6 
247.32 
214.32 
292.29 
200.36 
S2 S3 
313.92 269.16 
179.68 189.12 
355.24 280.28 
335.24 325.24 
238.2 275.2 
243.36 214.08 
254.52 222.68 
277.28 266.28 
232.32 198.36 
197.36 262.28 
316.28 264.28 
TABLE 4 
2 day N.brasiliensis infection: Influence of dur-ation 
on cell number (expr-essed in terms of pr-otein content). 
cell protein. 
Contr-ol 
Nb 
Nb+ 
0.002% Ag 
Sl 
615.04 
271.72 
281.24 
243.44 
434.16 
210.36 
129.12 
219.88 
392.2 
244.08 
163.68 
327.88 
S2 S3 
497.12 450.16 
568.08 402.2 
203.44 163.68 
254.44 156.8 
211. 24 165.44 
369. 24 266.28 
213. 8 192.2 
193.96 285.56 
184.44 176.64 
183.56 
340.24 307.28 
248.40 180.12 
201.72 182.72. 
222.48 180.8 
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S4 
209.8 
255.32 
274.28 
369.84 
455.92 
279. 48 
624.04 
593.08 
218.32 
531.12 
of incubation 
Units = /g of 
S4 
308.28 
289.28 
154.2 
208.64 
179. 24 
262.28 
288.28 
192.97 
130 
216.4 
182. 72 
339.24 
187.88 
151.6 
193.96 
TABLE 5 
2 day N.asteroides infection : Influence of duration of incubation on 
cell number (expressed in terms of protein content). Units 
= /9 of 
cell protein. 
Sl S2 S3 S4 
267.68 261.8 234.84 446.64 
Control 239.32 241.76 75.6 414.28 
491.2 346.04 225.04 237.28 
547.4 320.12 255.28 256.88 
296.12 
146.2 176.52 134.76 153.48 
185.08 179.16 215.04 219.88 
154.28 172.2 225.56 160.76 
Na 318.68 176.16 130.0 232.04 
157.64 167.16 272.6 217.64 
145.56 180.12 186.16 335.36 
153.32 165.44 151.28 379.68 
158.52 180.12 142.08 258.36 
188.32 176.16 228.0 211.8 
265.24 183.44 234.48 255.52 
155.08 229.6 212.2 189.32 
Na + 161.12 193.08 174.92 185.68 
0.002% Ag 139.48 136.92 199.12 195.84 
251.84 165.44 190.48 190.76 
142. 96 156.8 215.56 
TABLE 6 
7 day N.brasiliensis infection : Influence of duration of incubation 
on cell number (expressed in terms of protein content). Units =/g of 
cell protein. 
Sl S2 S3 S4 
236.56 276.6 287.92 262.68 
Control 207.0 281. 8 237.44 213.96 
234.84 
167.84 287.72 155.64 191.32 
Nb 190.44 203.52 257.44 153.04 
178.28 225.24 241.8 174.8 
188.72 170.44 186.12 186.12 
197.4 170.44 203.52 170.44 
Nb+ 184.84 231.36 210.48 220.92 
0. 002% Ag 172. 2 200.04 160.88 188.72 
210. 48 233.36 140.88 
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TABLE 7 
13 day N.asteroides infection : Influence of duration of incubation on 
cell number (expressed in terms of protein content). Units= f9 of 
cell protein. 
Control 
Na 
Na + 
0.002% Ag 
Sl 
187.44 
151.68 
136.24 
173.6 
139.55 
216.68 
S2 
245.92 
183.36 
166.28 
146.8 
197.16 
216.68 
TABLE 8 
S3 S4 
161.4 185.8 
212.6 224.8 
202.84 85.04 
223.16 193.12 
179.28 117. 56 
130.56 
13 day N.brasiliensis infection : Influence of duration of incubation 
on cell number ( expressed in terms of protein content). Uni ts = /9 of 
cell protein. 
Control 
Nb 
Nb+ 
0.002% Ag 
Sl 
416.56 
371.04 
587.2 
385.68 
240.24 
219.92 
198.0 
278.44 
256.48 
S2 
267.88 
342.6 
323.92 
310.6 
214.24 
235.36 
270.32 
296.32 
199.12 
135.12 
130 
S3 S4 
299.44 195.68 
285.64 181.84 
306.36 296.88 
220.76 
200.0 218.16 
195.68 209.52 
161. 96 173.2 
218.16 231.12 
211.88 273.52 
206.92 
TABLE 9 
21 day N.asteroides infection : Influence of duration of incubation on 
cell number (expressed in terms of protein content). Uni ts = fg of 
cell protein. 
Sl S2 S3 S4 
415.36 398.92 209.52 141.2 
Control 436.12 237.2 222.72 233. 96 
317.2 325.92 495.24 242.64 
342.64 400.04 323.0 212.84 
304.94 264.88 
287.36 257.08 226.8 76.32 
318.48 290.8 232.0 174.32 
284.76 262.28 230.72 130.84 
Na 263.44 198.04 362.24 158.16 
270.68 201.68 145.0 159.4 
277.96 242.36 148. 96 
276.52 207.48 
244.12 321.08 172. 32 140.32 
Na + 254.0 197.32 176. 96 124.0 
0.002% Ag 232.92 222.72 111. 56 122.76 
221. 28 190.76 169.36 132.08 
227. 08 201.68 140.0 119. 68 
106.64 
TABLE 10 
21 day N.brasiliensis infection : Influence of duration of incubation 
on cell number (expressed in terms of protein content). Units= rg of 
cell protein. 
Control 
Nb 
Nb+ 
0.002% Ag 
Sl 
296.68 
266.24 
367.28 
435.6 
448.0 
S2 
255.04 
279.92 
393.36 
346.16 
333.36 
430.64 
342.4 
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S3 S4 
169.96 210.96 
253.2 208.48 
215.32 260.64 
502.64 479.04 
378.48 448.0 
325.04 329.92 
374.72 477.6 
405.76. 343.68 
TABLE 11 
SOME CHARACTERISTICS OF ACTIVATED MACROPHAGES 
MORPHOLOGIC Increases in : 
Size (increased protein content) 
Adhesiveness and spreading 
Ruffled membrane activity 
Cytoplasmic granules 
BIOCHEMICAL - Increases in 
A. Metabolic activity 
Glucose oxidation 
Lactic dehydrogenase 
Lactate production 
Oxygen uptake 
Adenyl cyclase 
Cy<;;lic GMP 
Cai+ influx 
ATP level 
02 release 
H202 release 
Glucosamine uptake 
B. Secretions 
C. 
Plasminogen activator 
Lysozyme 
Collagenase 
Elastase 
Prostaglandins 
Interferon 
Enzymes 
Lysozymal hydrolases and their release 
Acid phosphatase 
B-Glucuronidase 
Cathepsin D 
FUNCTIONAL - Increases in 
Pinocytosis 
Phagocytosis (stimulation of E IgM c 3 b ingestion) 
Intracellular microbicidal activity 
Cytotoxic effects on tumour cells 
* 
* Adapted from Lasser, 1983: Cohn, 1978: 
and Hopper, ~ood and Nelson, 1979. 
Karnovsky and Lazdins, 1978 
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SECTION II 
IN VITRO SECRETION OF LYTIC ENZYMES BY PERITONEAL MACROPHAGES 
FROM MICE PREVIOUSLY INOCULATED WITH PATHOGENIC NOCARDIAE 
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LYTIC ENZYMES IN CHRONIC INFLAMMATIO~ 
The secretory enzymes of macrophages are a major factor in many 
pa tholog ica l processes ( Bagg i ol in i and Sc hnyder, 1982). These 
enzymes are able to degrade a great variety of biological 
molecules and this gives rise to two particularly important 
effects: the conditioning of the pericellular environment and 
tissue damage as a result of the breakdown of extracellular 
connective tissue structure. Modulation of rate of secretion of 
lytic enzymes is often used as a parameter of macrophage 
function. They are among the best defined truly secretory 
molecules of the macrophage and are very easy to assay 
(Baggiolini and Schnyder, 1982). 
There are three classes of lytic enzymes secreted by macrophages: 
l ysozyme, l ysozoma l hydro lases and neu tra 1 pro te inases. These 
classes of enzymes are secreted according to different kinetics 
and their responses to agents which modify macrophage function 
are different. Among the three enzyme classes, lysozyme, be ta-
g 1 u cur on id as e and N -ace t y 1-be ta - g l u cos am in id a s s e ( l y so z om a l 
hydrolases), and plasminogen activator (neutral proteinases) have 
been studied most frequently. The studies have shown that for 
all three classes of enzyme, secretion is a long lasting process 
which depends strictly on de novo syn thesis (Gordon, Todd and 
Cohn, 1974); Schnyder and Baggiolini, 1978a and b). 
The lytic enzymes selected in this study were lysozyme and 
plasminogen activator and macrophage function was measured in 
143 
terms of secretion of these enzymes. 
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Chapter 3 
NOCARDIA ASTEROIDES AND NOCARDIA BRASILIENSIS INFECTIONS IN THE 
MOUSE : INDUCTION OF PLASMINOGEN ACTIVATOR SECRETION BY 
MACROPHAGES 
3.1 
3 .1.1 
Following 
LITERATURE REVIEW 
INTRODUCTION 
the lead of Metchnikoff for the last 70 years, 
investigators of mononuclear phagocytes concentrated on studies 
of phagocytosis and intra-cellular digestion of particles 
(Nathan, Murray and Cohn, 1980). Recently, another role of 
mononuclear phagocytes has been recognized their ability to 
synthesize and secrete a variety of biologically active 
products into their extracellular environment • The cells are 
capable of secreting a wide range of materials such as enzymes, 
complement components, enzyme inhibitors, endogenous pyrogen, 
oxygen metabolites, bioactive lipids, tumoricidal agents and 
growth promoting factors (Nathan, Murray and Cohn, 1980; Lasser, 
1983; Hamilton and Moore, 1980). 
Macrophages can secrete a variety of proteases active at neutral 
pH, such as plasminogen ac ti va tor ( Unke less, Gordon and Reich 
1974); collagenase (Wahl et al, 1974) and elastase (Werb and 
Gordon, 1975). A very large number of studies have shown beyond 
doubt that plasminogen activator and the other neutral proteases 
are secreted by macrophages that have been exposed to a 
stimulus and have adopted functionally to it, i.e. neutral 
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protease secretion is dependent on the physiological state of the 
cells and is a characteristic of elicited and activated 
macrophages (Baggiolini and Schnyder, 1982; Cohn, 1978; 
Vassali, 1980). 
Plasminogen activator has been shown to be synthesized by a 
variety of cell types and it is clear that the enzyme is 
associated with many biolog ica 1 even ts in which control led and 
localized proteolysis is involved, such as in embryo 
implantation, (Strickland, Reich and Sherman, 1976), follicle 
rupture at ovulation (Beers, Strickland and Reich, 1975), and 
post-lactational mammary involution (Ossowski, Biegel and Reich, 
1979). Release of the enzyme has been shown to be a property of 
oncogenically transformed fibroblasts (Unkeless et al, 1973), 
activated macrophages (Unkeless, Gordon and Reich, 1974) 
macrophage cell lines (Hamilton and Moore, 1980) and neoplastic 
cells (Wilson et al, 1980). 
3.1. 2 GENERAL PROPERTIES 
Plasminogen activator catalyzes the conversion of the circulating 
zymogen plasminogen to another neutral protease, plasmin, a 
broadly active trypsin-like subunit which activates enzyme 
cascades likely to be important in inflammation. Plasminogen is 
capable of degrading fibrin to give rise to fibrin degradation 
products for which macrophages have receptors; activating 
complement components Cl and C3; generating kinins and cleaving 
activated Hageman factor to subunits that increase the formation 
of of kallikerein from prekallikrein (Goldstein, 1983, Nathan, 
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1980). Plasmin activates collagenase (Werb et al, 1977): 
collagenase and elastase can degrade components of vessel walls, 
perivascular tissue and articular surfaces. 
The major murine plasminogen activator is a diisopropyl phospho-
fluoridate (DFP) - sensitive serine protease, MW 48:000, and is 
very close to the comparable enzymes released by virally 
transformed mouse fibroblasts. Macrophages release a second 
plasminogen activator, MW 28,000 that is also a serine enzyme. 
Studies identified the plasminogen activators as trypsin-like 
enzymes which are stable in culture at 37°c for at least 48 hours 
(Unkeless, Gordon and Reich, 1974). Mechanisms of release of 
plasminogen activator, lysozomal hydrolases and lysozyme are 
independently regulated since the enzymes are secreted according 
to different kinetics and responses to modifications of 
macrophage activity are different (Baggiolini and Schnyder, 
1982). Also, they appear to be confined to different subcellular 
com par tmen ts. 
Plasminogen activator has recently been shown to exist in two 
active forms in inflammatory macrophages: a soluble form 
released probably from secretory vesicles into the 
extracellular medium and a cell-associated form which is 
membrane bound. Release of the membrane bound enzyme is likely 
to occur by a shedding mechanism rather than by exocytosis 
(Solomon et al, 1980: Lemaire, Drapier and Petit, 1983). 
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3 .1. 3 FUNCTION OF PLASMINOGEN ACTIVATOR 
Plasminogen activator has a major role in 
response and, in conjunction with the other 
the inflammatory 
neutral proteases, 
could provide a mechanism for the central role of the macrophage 
in the pathogenesis of chronic inflammatory disease. The 
conversion of plasminogen to plasmin generates fibrinopeptides 
and active complement components capable of increasing vascular 
permeabi 1 i ty and chemotac tic for macrophages and PMN' s. These 
pathways generate peptides that are pharmacologically active. 
Products of collagen degradation elicit macrophages so that it 
appears that plasminogen activator could promote further 
accumulation of macrophages, aid their migration from blood to 
tissues, permit contact with other cells and enhance macrophage 
activity in the site of inflammation (Vassali, 
1980; Baggiolini and Schnyder, 1982; Gordon, 1976). 
1976; Nathan, 
Secretion of proteolytic enzymes will also degrade unwanted 
proteins, permit removal of fibrin debris in wounds by phagocytes 
and contribute to regulating the environment surrounding the 
macrophage in inflammation and tissue repair (Unanue, 1976). 
Two separate stimuli appear to be required to trigger macrophage 
synthesis and secretion of PA (Gordon, Unkeless and Cohn, 1974). 
The first is a preparatory stage that can be achieved by 
inoculation of the animals with small doses of a 
lipopolysaccharide 
little PA, however 
endotoxin. Cells from these animals release 
phagocytosis of 
induces marked enzyme secretion (Cohn, 
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particles such as latex 
1975). It is possible that 
the first stimulus in some way functions to rearrange molecules 
of the plasma membrane so that contact of a second triggering 
stimulus is able to occur (Ogmundsdottir and Weir, 1980). 
Secretion of the enzyme declines after digestion of phagocytosed 
particles. However, persistance of undegraded particles is 
associated with prolonged fibrinolytic activity which could 
generate a chronic granuloma tous response (Gordon, Na than and 
Bloom, 1978). 
Plasminogen activator is able to attack a number of extracellular 
substrates, so extensive control mechanisms are present to 
regulate production and to extend or restrict their range of 
activity (Gordon, 1980). Excessive activity is normally 
prevented by the naturally occurring inhibitors such as 
glucocorticoids and alpha 2 macroglobulin (Vassali, Hamilton and 
Reich, 1976; Nathan, Murray and Cohn, 1980). Secretion of enzyme 
in excess of these inhibitors could give rise to tissue injury 
associated with chronic inflammatory disease. 
In vitro secretion of plasminogen activator by inflammatory 
macrophages can be inhibited by steroids, mitotic inhibitors and 
agents related to cyclic-AMP (C-AMP) and its metabolism. 
Secretion of the enzyme can be induced and stimulated in vitro by 
lectins such as Concanavalin A ( Con A), the tumor promotor and 
potent inflammatory agent phorbol myristate acetate (PMA) and by 
secretion products of activated lymphoid cells (Vassali, Hamilton 
and Reich 1976; Vassali, Hamilton and Reich, 1977; Klimetzek 
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and Sorg,1977 and Vassali and Reich, 1977). By modulating 
stimulatory and inhibitory influences enzyme production can be 
modulated continuously over a 200-f old range ( Vassal i, 1980 
1305). 
3. l. 4 THE CHOICE OF PLASMINOGEN ACTIVATOR RELEASE AS A 
PARAMETER IN THIS STUDY 
Plasminogen activator secretion was selected as a parameter in 
this study because release of tte enzyme is a well established 
marker of macrophage activation (Baggiolini and Schnyder, 1982; 
Gordon, 1980 : 1275; Cohn, 1978). 
Numerous innovative studies have shown that macrophages release 
plasminogLn activator after exposure to various inflammatory, 
immunologic and enciocytic stimuli (Gordon, 1980 : 1275), whereas 
resident peritoneal macrophages show minimal PA activity 
(Unkeless, Gordon and Cohn, 1974; Gordon and Cohn, 1978). 
Unkeless, Gordon and Cohn (1974) were the first workers to show 
that macrophages elicited by an inflammatory stimulus, such as 
intraperitoneal injection of thioglycolate medium, synthesize and 
secrete large amounts of plasminogen activator. A large number 
of studies followed this observation, and showed that plasminogen 
activator is released by macrophages after exposure to asbestos 
(Hamilton et al, 1976); or by microbial infection such as 
Trypanasoma cruzi (Nogueira, Gordon and Cohn, 1977a) or BCG 
( Gordon and Cohn, 197 8) fol lowed by a secondary challenge with 
homologous antigen. PA release can be induced in resident 
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peritoneal macrophages by in vitro exposure to Con A and PMA 
(Vassali, Hamilton and Reich, 1977), by lymphocyte conditioned 
medium (Gordon and Cohn, 1978; Newman et al, 1978; Nogueira, 
Gordon and Cohn, 1977b) and by methylene blue ( Schnyder and 
Baggiolini, 1980). Control of synthesis and secretion is achieved 
by the presence of serum components (Drapier et al, 1979; 
Chapman, Vavrin and Hibbs, 1979). Release is often stimulated 
by phagocytosis (Gordon, Unkeless and Cohn, 1974) or by in vitro 
exposure to Con A or PMA and inhibited by colchicine, 
vinblastine, cholera toxin and glucocorticoids (Vassali, Hamilton 
and Reich, 1976). 
Mackaness' s studies ( 1964, 1967) showed that during infection 
with facultative intracellular bacteria, cell-mediated immunity 
is induced and antimicrobial resistance and delayed type 
hypersensitivty arise simultaneously, and coincide with 
morphological and 
diseased host. 
functional changes in the macrophages of the 
Mackaness (1970) concluded that macrophage 
activation occurs as a result of the infection and leads to the 
destruction and elimination of facultatively intracellular 
bacteria. Chronic microbial infections such as tuberculosis are 
established because of the organisms ability to resist 
destruction within macrophages. Organisms such as M.tuberculosis 
and the nocardiae must be able to neutralize host defence 
mechanisms in order to survive and establish infection. 
Infection of compromised individuals by opportunistic microbes 
such as Nocardia may perhaps be explained by the theory that 
156 
macrophage function is altered or becomes deficient as a result 
of the disease or immunosuppressive treatment of the host 
(Beaman, 1976:394). Plasminogen activator release, an index of 
macrophage function, was selected as a method of determining 
whether macrophage function is enhanced or deficient with respect 
to this index in Nocardia asteroides and/or Nocardia brasiliensis 
infections. 
In most studies, the amount of PA released by the stimulated 
macrophage appears to correlate directly with the degree of 
stimulation (Chapman, Vavrin and Hibbs, 
is a graded response (Gordon, 1980 
1982). Enzyme induction 
1282) and there is a 
correlation between the production of PA and the inflammatory 
response in the peritoneal cavity (Hamilton, 1980). 
.Measurement of macrophage plasminogen activator release would 
therefore give an indication of the inflammatory response to 
Nocardia asteroides and Nocardia brasiliensis infections. 
Nocardia infections are typically chronic and progressive 
(Beaman, 1976:387) and plasminogen activator has been shown to 
play a major role in the inflammatory response. Plasminogen 
activator secretion may be perpetuated by undergradable microbial 
constituents (intracellular parasites are primarily non-
digestible particles [Katoh, 1981]) and lead to chronic 
activation 
which are 
of the coagulation system and 
strongly associated with 
production of kinins 
the development of 
inflammatory lesions and tissue injury (Hamilton, 1980). 
Gordon and Cohn (1978 - see 3.3.1.9 for more detail) showed that 
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stimulation of macrophage plasminogen activator by PPD antigens 
depended on specifically sensitized T-lymphocytes, since it was 
abolished by pre-treatment with anti-thy 1. 2 antiserum and 
complement. The experimental system developed in this study 
provided a simple, sensitive and versatile assay to study the 
role of lymphocytes and specific antigen in macrophage activation 
by BCG (Gordon and Cohn, 1978). Ortiz-Ortiz et al (1979) showed 
that an extract of N.brasiliensis is a B-cell mitogen; PPD is 
also a B-cell mitogen, so we wanted to investigate whether 
extracts such as culture filtrate antigens of N.asteroides and 
N.brasiliensis would modify macrophage responses in vitro. In 
addition, Folb et al (unpublished observations) found that 
exposure of lymphocytes in vitro to culture filtrate antigens of 
N.asteroides and N.brasiliensis significantly inhibited DNA 
synthesis in these cells (see 3.3.1.5.2). Folb, Jaffe and 
Altmann ( 1976) had previously suggested that the pathological 
effects of N.brasiliensis may be related to inactivation of 
normal T-lymphocyte function by the organism. They subsequently 
showed that the T-lymphocyte is an essential component in normal 
host resistance to infection by both N.asteroides and 
N.brasiliensis (Folb, Timme and Horowitz, 1977). Si nee then 
several investigations have established that T-cells are critical 
in host resistance to systemic and chronic nocardial infections 
(Beaman and Sugar, 1983). In order to determine whether 
macrophage responses in vitro might be modulated by secondary 
challenge with specific antigen, a study of macrophage 
plasminogen activator release was undertaken. The investigation 
at tempted to elucidate the role of T-cel ls in the ac ti va tion of 
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macrophages in experimental Nocardia infections. 
The parameter of plasminogen activator release was used to 
determine whether macrophage responses in the two infections are 
different, to assess macrophage responses early in infection and 
to investigate whether macrophage function is modulated over the 
21 day post-inoculation period, as discussed under 1.9. 
3.2 MATERIALS AND METHODS FOR ASSAY OF PLASMINOGEN 
ACTIVATOR 
Levels of plasminogen activator in cultures of unstimulated 
macrophages are barely detectable, however relatively high levels 
of enzyme 
sensitive 
are secreted by inflammatory 
assays are needed to detect 
macrophages. Even 
the enzyme since it 
so, 
is 
released in trace amounts. The methods used were those described 
by Gordon (1978) and Gordon, Werb and Cohn (1976). 
3.2.l PRINCIPLE 
Plasminogen activators catalyze the conversion of plasminogen to 
plasmin, which in turn breaks down fibrin into fibrin degradation 
products. The enzymatic cleavage reactions involved in 
fibrinolysis are shown in Fig 4. 
The plasmin activity generated by activated macrophages is 
regulated by the inhibitors alpha 2 macroglobulin, alpha 1 
anti trypsin antithrombin III and c 1 inactivator, and amplified 
by Hageman factor, kininogen and complement (Gordon, 1978). 
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A simple procedure to assay activity of plasmin from zones of 
lysis in fibrin 
Unkeless et al 
plates was first developed by Astrup (1975). 
(1973) modified this procedure by using 125 I -
labelled fibrin tissue culture dishes and in this way developed 
an assay with increased sensitivity and adaptability. A thin film 
of 125 I -labelled fibrinogen is baked on the bottom of tissue 
culture dishes and the fibrinogen is converted to fibrin by the 
action of thrombin. Plasminogen activator released by intact 
activated macrophages or in cell free fractions generates 
plasmin and this is measured from solubization of the 125 I 
fibrin. 
3.2.2. 
3.2.2.1 
REAGENTS 
PREPARATION OF PURIFIED PLASMINOGEN (PLG) AND 
PLASMINOGEN-FREE SERUM 
Purified plasminogen was prepared according to the method of 
Deutsch and Mertz ( 1970) from human serum and dog serum by 
affinity chromatography on lysine-sepharose. 
3.2.2.1.1 Preparation of lysine sepharose 
Briefly, Sepharose 4B (Pharmacia Fine Chemicals, AB Uppsala, 
Sweden) was suspended in 100 ml distil led water, washed three 
times by settling and decantation to remove azide and then re-
suspended in 100 ml distilled water. Sg of Cyanogen Bromide 
(CNBr) was dissolved in 40 ml of N-methyl-2-pyrrolidone and the 
gel was activated by adding the CNBr using an autoburette with 
the endpoint of the titrator set to pH 11. When the reaction was 
complete the gel was washed with distilled water and then with 
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coupling buffer (0.lM NaH co 3 , pH 9.5). The gel was sucked free 
of excess liquid then suspended in 4°c coupling buffer containing 
20g of ligand (L-lysine monohydrochloride) and tumbled overnight 
at 4°c. The aga rose was then washed with water and unreacted 
imidocarbonate groups on the gel were masked by tumbling with IM 
ethanolamine (pH 9) overnight. The gel was then washed and packed 
loosely into a column. 
3.2.2.l.2 Chromatography 
Filtered serum was run through the affinity column at 4°c and the 
plasminogen-free serum collected, and aliquoted and stored at -
20°c. After washing the column thoroughly with 0 1'.' • - j phosphate 
buffer, pH 7.2 the adsorbed plasminogen was then eluted with a 
solution containing 0.2M Epsilon amino caproic acid (EACA) mixed 
1:1 with 0.lM phosphate buffer pH 7.2. The EACA was removed by 
dialysis against phosphate buffered saline (PBS). The plasminogen 
was then treated with di i sopropy l phosphof l ur ida te ( DFP, Sigma 
Chem i ca l Company , S t Lou i s , MO 6 31 7 8 , US A ) ) i.e. the solution 
was made 10 mM with respect to DFP and incubated at 40°C for 2 
hours to inactivate traces of contaminating plasmin. Unreacted 
DFP was extracted by extensive dialysis against 0.lM Tris-HCl, pH 
8. l. Each batch of plasminogen was assayed against urokinase to 
determine the optimal concentration required for assay. The 
plasminogen was aliquoted and stored at -20°c. 
3.2.2.2 UROKINASE (UK) 
Purified UK was obtained from Leo Pharmaceutical Products 
(Ballerup, Denmark), in the form of a lyophilised powder. The UK 
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was dissolved in 0.lM Tris-HCl, pH 8.1, containing 8 mg/ml bovine 
serum albumin (BSA) to give a stock solution of 2000 Ploug 
uni ts/ml. The solution was acid and DFP treated (as described 
under 3.2.2.3) and stored in 50 microlitre aliquots in microfuge 
tubes at -80°c. Each aliquot was thawed and used once only. Each 
new batch of UK was standardized in the PA assay against the 
previous batch. 
3.2.2.3 BOVINE SERUM ALBUMIN (BSA) 
BSA (Miles Scientific, Division of Miles Laboratories Inc., 
Naperville, Il 60566, USA) was dissolved in water to give a 
solution of 20 mg/ml. Acid-labile protease inhibitors were 
removed by acid treatment : the solution was adjusted to pH 3.0 
with 3N HC1 1 incubated at room temperature for 2 hours and 
neutralized with 2N Sodium hydroxide (NaOH). 
Protease activity was removed by DFP treatment. DFP was added to 
the solution to give a final DFP concentration of 10 mM and then 
incubated at 40°c for 1 hour, then the procedure was repeated. 
Unreacted DFP was removed by extensive dialysis against distilled 
water. BSA was diluted to 8 mg/ml, aliquoted and stored at -20°c. 
3.2.2.4 125 I-FIBRIN PLATES 
3.2.2.4.1 Purification of fibrinogen 
Bovine fibrinogen ( Fraction 1, Sigma Chemical Co.) was purified 
by a modification of Laki's procedure (1951) and by ethanol 
precipitation in the presence of lysine to reduce plasminogen 
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contamination (Mosesson, 1962). 
Briefly, 2g fibrinogen was dissolved in 100 ml 0.lM KP0 4 buffer 
pH 6.4, the volume was made up to 200 ml with distilled water and 
the solution left overnight at 4°C. The solution was centifuged, 
the pellet discarded, and 100ml saturated ammonium sulphate added 
to precipitate the fibrinogen. The mixture was stirred slowly for 
an hour at room temperature, centifuged, the pellet dissolved in 
50ml 0.6M NaCl and the pH adjusted to 7.4 with dilute NH 4oH. The 
solution was dialysed against 0.6M NaCl at room temperature. One 
part fibrinogen solution was diluted with 5 parts 0.12M lysine 
HCl in 0. 005M NaHP0 4 pH 7.0, cooled at 0°c, any precipitate 
that formed was discarded, then the fibrinogen was precipitated 
by adding 8ml of 95% ethanol and dissolved in 30 ml 0.6M NaCl. 
The ethanol precipitation was repeated, the final precipitate 
collected by centrifugation, dissolved in 0. 6M Na Cl and dia 1 ysed 
against PBS. The fibrinogen solution was prefiltered, then 
sterilized by filtration, the 00 280 was read and the fibrinogen 
. 
concentration adjusted to 10 mg/ml. Fibrinogen was aliquoted and 
stored at -20°c. 
3.2.2.4.2 Preparation of 125 1 Fibrinogen plates 
125 1 fibrinogen coated Linbro multiwell plates (Flow Laboratories 
Ltd, Irvine, Scotland, Cat no. FB-16-24-TC) were kindly prepared 
and supplied by the Department of Clinical Science and 
Immunology, Medical School, University of Cape Town. 1 25 1 
fibrinogen coated linbro plates were prepared with purified 
fibrinogen as described by Strickland and Beers (1976). 
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Labelling of the fibrinogen with 125 I was performed by the 
method of Helmkamp et al, 1960, with the modification that each 
well contained 100 000 - 130 000 cpm releasable by trypsin 
(Wilson and Dowdle, 1978). 200 microlitres of a 5 mM NaCl 
solution containing 30 micrograms of 125 I fibrinogen was added to 
each well. The plates were then incubated at 45°c for 48 hours to 
dry the solution and ensure firm attachment of the fibrinogen to 
the well surface. 
3.2.2.4.3 Activation of plates before use 
125I fibrinogen was converted to 12 5I fibrin immediately before 
use by incubating each linbro well with 1ml Dulbecco's medium+ 
5% PCS for 2 hours at 37°c. Wells were then washed twice with 
HBSS ( Direct Assay) or 
pH 8.1 (Indirect Assay) 
twice with PBS and once with Tris-HCl, 
to remove any unbound 125 I fibrinogen, 
which usually amounted to 20-30 000 cpm. 
wells was removed by suction. 
Residual liquid in the 
3.2.2.5 TRYPSIN (DIFCO) 
2.5g of Trypsin (Difeo Laboratories, Detroit, Mi. 48232, USA) was 
dissolved in 500 ml 0.001 N HCl, prefiltered and 1ml 0,5% phenol 
red added. The solution was mi 11 ipored through a 0. 45 micron 
filter and was diluted to 0.25% in sterile TD, double strength, 
pH 7.4 (16.0g NaCl, 0.76g KCl; 0.25g Na 2 HP0 4 . 2H 20; 6.0g Tris 
per litre = double strength TD) with 0.02% EDTA. 
was aliquoted and stored at -20°c. 
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The solution 
3.2.3 CULTURE OF MACROPHAGES 
Peritoneal cells were plated on Falcon petri dishes to assay for 
plasminogen activator secreted into the medium, or on 125 I-
fibrin coated linbro wells for the assay of fibrinolysis by 
intact cells. 
The procedures for culture of macrophages described in Chapter 2 
were followed for the determination of plasminogen activator 
released into conditioned medium. 2 x 10 6 macrophages were 
cultured in sterile petri dishes in 15% ATFBS + M, P+S in DB; 
with or without various concentrations of Nocardia culture 
filtrate antigen. Macrophages from mice inoculated with 
N.asteroides organisms were exposed in vitro to N.asteroides 
antigen and cells from animals inoculated with N.brasiliensis 
were exposed to N.brasiliensis antigen, at concentrations of 
0.02% and 0.002% for 48 hours. 
Standard culture procedures were modified in the assay for 
macrophage f i br inol ys is. 5 x 10 5 macrophages were distributed 
into 125I fibrin-coated linbro wells in DB supplemented with 2% 
FCS and P+S, with or without appropriate antigen, in a total 
volume of 1.5 ml. In cultures of macrophages elicited with 
thioglycolate medium it was necessary to suppress fibrinolysis by 
incubating cells in 60 micrograms /ml soybean trypsin inhibitor 
( STI; Sigma Chemical Co.) in DB supplemented with 5% HIFCS and 
P+S. The plates were washed free of 1 ymphocytes and the cells 
fed fresh medium after 24 or 48 hours incubation. It is 
important to ensure that fibrinolysis is not due to contamination 
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with PMN, which are highly active. PMN die within 6-12 hours in 
culture so the cells were cultured for at least 12 hours before 
fibrinolysis assay (Gordon, 1978:33:10). 
3.2.4 COLLECTION OF CONDITIONED MEDIUM (CM) 
CM was routinely prepared after 48 hours cultivation on regular 
tissue culture dishes. The monolayers were washed twice with 
HBSS ( 37°c) to remove lymphocytes and inhibitors. Macrophages 
were incubated in l ml serum-free DB supplemented with 0.2% 
lactalbumin hydrolysate (LAH, Sigma Chemical Co.) for 24 hours. 
50 microlitres of 8 mg/ml BSA was added to each tube prior to 
collection of CM. The CM was collected, centrifuged at a maximum 
relative centrifugal force of 2633 and the supernatant stored at 
-20°c until assay (Gordon, 1978; 33.6). PA is sticky and is 
easily lost on surfaces especially when handling dilute 
solutions in serum-free medium, so BSA was added to minimize 
enzyme losses. PA activity is stable over several cycles of 
freezing and thawing (Gordon, 1978: 33.6, 33.7). 
3.2.5 CELL LYSATES 
Macrophage monolayers were washed twice with PBS (37°c), lysed in 
1000 microlitres of 0.5% Triton X-100. Tissue culture dishes 
were frozen and thawed once and scraped with a plastic 
policeman. Cell lysa tes were stored in Beckman microfuge tubes 
(Beckman Instruments Inc., Pa lo Al to, Ca 1 i forn ia 94304) at 
-20°c until Fluram assay (described in 2.3). 
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3.2.6 ASSAY OF FIBRINOLYSIS 
In this procedure a solid-phase substrate was provided by radio-
active fibrin coated as a thin layer on the bottom inside surface 
of linbro multiwell plates. Cells or CM to be assayed were added 
to the wells and PA activity was measured as plasminogen-
dependent solubilisation of radioactivity as a function of time. 
The assay was conducted at 37°c in a humid 5% co 2 environment. 
The direct assay of fibrinolysis is done on intact cells plated 
on 1 251 fibrin coated wells. This method measures both secreted 
and cell membrane-associated plasminogen activator (Jones, 
Goldfarb and Holden, 1983). The indirect assay is performed for 
cell-free fractions which have been secreted into the tissue 
culture medium (Hamilton, 1983). 
3.2.6.1 
3.2.6.1.l 
3.2.6.1.1.1 
DIRECT ASSAY : INTACT CELLS 
Methods for calibration and routine experiments 
FCS as a source of plasminogen 
Murine macrophages were elicited by intraperitoneal injection of 
Brewers thioglycolate medium (See Chapter 2.7) and harvested as 
described previously. Resident macrophages were harvested from 
mice inoculated with normal saline only. After 20 hours in 
culture, a 100 microlitre sample was withdrawn from each linbro 
well and the amount of 125 1 fibrin solubilised during incubation 
determined using a Beckman Gamma Counter ( Model 4000, Beckman 
Instruments Inc., Scientific Instruments Division, Irvine Ca, 
92713). Macrophage monolayers were washed twice with TD (37°c) 
and measurement of fibrinolysis was begun by placing cells in DB 
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+ 5% ATHIFCS in the presence or absence of Concanavalin A (Con A, 
British Drug Houses, Poole, England). Fibrinolysis was estimated 
by withdrawing 100 microlitre aliquots at various times and 
assaying them for solubilised radioactivity. 
3.2.6.1.1.2 Dog Serum (DS) as a source of plasminogen 
Monolayers were washed twice with HBSS ( 37°) after the desired 
incubation period and after monitoring degree of f ibr inol ys is 
during incubation. Fibrinolysis was initiated by incubation in 1 
ml of DB+ 5% ATDS + P+S. 100 microlitre aliquots were with 
drawn at intervals (1-6 hours) and assayed for released 
radioactivity. 
3.2.6.1.1.3 Assay using purified plasminogen (PLG) 
This method is identical to that described under 3.2.6.1.1.2 
except that purified PLG (10 micrograms/ml) was substituted for 
ATDS (Gordon, 1978: 33.7). 
3.2.6.1.2 General considerations for the assay of 
fibrinolyis by intact cells 
Fibrinolysis was prevented during the incubation period by the 
use of inhibitors - Soya Bean Trypsin Inhibitor (STI, Sigma 
Chemical Company) was used for thioglycolate-elicited macrophages 
and 2% FCS for unstimulated and Nocardia-activated cells. Media 
were monitored for release of radioactivity before each change of 
medium. 
Cel 1 morphology was monitored at various intervals during the 
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assay by phase-contrast microscopy. Macrophages attach and 
spread well on fibrin (Gordon, 1978; 33.7). Cultures were pre-
incubated to ensure loss of PMN and were washed twice before 
measurement of fibrinolysis to remove inhibitors and most of the 
lymphocytes. 
Appropriate controls were used in a 11 experiments duplicate 
wells without cells were always included and the plasminogen 
dependence of fibrinolysis was tested by the use of plasminogen-
depleted sera. In the experiments using purified plasminogen, 
addition of the zymogen was omitted in appropriate wells. 
Plasminogen dependence of fibrinolysis was confirmed by 
reconstitution with plasminogen. 
Results were expressed as the percentage of total radioactivity 
releasable by trypsin. The percentage trypsin value was obtained 
by determining the cumulative radioactivity released into each 
well over the three separate time points. The percentage radio-
activity released at each separate time point relative to the 
total radioactivity released by trypsin could be calculated from 
this. Background levels of fibrinolysis (no cells plated) were 
usually low. 
In a representative number of experiments, the washes prior to 
initiation of fibrinolysis were collected from individual wells, 
concentrated by centrifugation and an aliquot counted for number 
of macrophages. This was done to determine whether macrophage 
losses at this point were large and whether losses of stimulated 
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and unstimulated macrophages were similar. In a similar number of 
randomly selected experiments the viability of plated 
macrophages was checked by addition of dilute Trypan blue 
(Chapter 2.8.3) to cultures after wells have been washed and 
excess fluid sucked away. 
Several concentrations of macrophages were plated 
fibrin and fibrinolysis assayed to ensure that 
activity was proportional to cell number. Also, 
on the 125 I-
f ibrinolytic 
the optimal 
concentration of AT serum or purified plasminogen was determined. 
Duplicate cultures were assayed in each experiment at least, and 
as many as 8 replicate cultures were assayed where possible 
(depending on the available number of macrophages). 
Fibrinolysis was monitored by measuring the solubilized 
radioactivity in 100 microlitre aliquots at three separate 
timepoints. 
3.2.6.2 INDIRECT ASSAY: SECRETED ENZYME 
The method employed for the determination of secreted PA is that 
de s c r i bed by \H 1 son a n d Dowd 1 e ( 1 9 7 8 ) • Mac r op hag es were 
preincubated in ATFCS as this results in higher levels of 
proteolytic activity in serum-free medium (Gordon, 1978; 
33.8), CM was frozen at -20°c until assay (Gordon, 1978; 1,33.6; 
Hamil ton, 1983). 
CM was thawed and maintained on ice immediately prior to assay. 
In each well, the final reaction volume of 300 microlitres 
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consisi ted of 10 microli tres of 8 mg/ml BSA ( 80 micrograms) 40 
microlitres of 0.1 mg/ml PLG (4 micrograms),200 microlitres 0.lM 
Tris-HCl, pH 8.1 and 50 microlitres of CM added finally to 
initiate the reaction. 
Appropriate controls were included in all assays. The 
plasminogen-independent proteolysis 
the sample in the absence of PLG 
was detected by incubating 
(Tris-HCl substituted), and 
background lysis due to plasmin contamination of the PLG solution 
measured in duplicate wells containing PLG without sample. The 
total radioactivity present in each well was determined by 
incubating 300 microlitres Trypsin solution in duplicate wells. 
Standard wells included in each assay contained UK in 14 doubling 
decrements, usually commencing with 0. 05 Ploug uni ts per well. 
UK was diluted in the same medium used to prepare CM. 
Fifty microlitre aliquots of reaction mixture were removed at 
various time intervals - usually four separate time points were 
taken - and the solubilised radioactivity measured in a gamma 
counter. 
For each time point, the UK standard curve was plotted and sample 
values falling on the linear range of the standard curve were 
determined. Sample values were expressed as percentage of total 
trypsin ac ti vi ty ( see 3. 2. 6 .1.1. 3) in terms of UK uni ts per 
assay well. The average number of UK units was determined from 
the number of UK units calculated at the four separate time 
points. (Only sample values falling on the linear range of the 
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standard curve were used to calculate the average). 
3.2.6.3 FLUORIMETRIC DETERMINATION OF TOTAL CELL PROTEIN 
Total protein present in the petri dish after collection of CM 
was determined as described under 2. 3. PA activity measured in 
the indirect assay was related the total cell protein value and 
results were expressed as milliunits of urokinase/mg of cell 
protein (mu UK/mg cell protein). 
3.2.6.4. MOLECULAR WEIGHT OF PLASMINOGEN ACTIVATOR 
The methods used were those described by Granelli-Piperno and 
Reich (1978) and Wilson et al, 1980. 
Plasminogen activator present in CM was separated by means of 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE). The SDS was removed from the gel after electrophoresis by 
washing with non-ionic detergent (2,5% Triton X-100). The gel was 
then layered onto a second indicator gel consisting of fibrin, 
plasminogen and agar. After incubation at 37°c, zones of fibrin 
degradation, corresponding to the position of proteases in the 
SDS-gel overlay, can be seen as clear areas of lysis under dark 
background illumination. 
3.2.6.4.l Polyacrylamide gel electrophoresis 
The following buffers were used : 
Running gel buffer (RGB) 
Stacking gel buffer (SGB): 
Sample buffer 
0,4% SDS in 1,SM Tris HCl pH 8.8 
0,4% SDS in 0.SM Tris HCl pH 6.8 
1% SDS in 40% sucrose solution 
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Resevoir buffer 0.1% SDS in 0.025M Tris-HCl, 0.192M 
Glycine pH 8.3. 
140mm x 125mm Slab gels contained 12% polyacrylamide in the wick, 
11% polyacrylamide in the running gel and 4% polyacrylamide in 
the stacking gel. The final concentration of SDS in the gel was 
0.1%. Catalysts added were TEMED (0.05% in running and stacking 
gels) and ammonium persulphate NH 4 s 20 3 (0.05% in the running gel 
and 0.1% in the stacking gel). The samples contained a final 
concentration of 1% SDS. 
Electrophoresis was performed at a constant current of 24 mA per 
gel until the dye front reached the bottom of the gel. Following 
electrophoresis, the track containing the molecular weight 
markers was removed and stained. The remainder of the gel was 
washed with gentle shaking for 11 ; 2 hours in 2.5% Triton X-100, 
rinsed three times (10 minutes each time) in distilled water, 
dipped briefly into 0.lM Tris-HCl buffer pH 8.1, 
layered on the fibrin-plasminogen-agar indicator gel. 
3.2.6.4.2 Fibrin-Plasminogen-agar gel 
drained and 
The fibrin-plasminogen-agar gels were cast between two clean 
glass plates, held 0. 8 mm apart by thin wires. The glass and 
wires were clamped together and warmed in a 45°c incubator. The 
gel solution contained 1.25% agar, 5 micrograms/ml of purified 
human plasminogen, 2 mg/ml of purified bovine fibrinogen and 0.06 
units/ml of thrombin (Sigma Chemical Co., Bovine thrombin 
dissolved in 0.5 ml gelatine buffer pH 7.8 [0.05M sodium diethyl 
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barbiturate, 0.lM NaCl and 0.25% w/v gelatine] to give 20 N.I.H 
units/ml. This was stored in 50 microlitre aliquots at -20°c) in 
Tris-HCl pH 8.1. 
The agar was added to distilled water, boiled for 15 minutes, 
then transferred to a 45°c water bath. The solution of 
fibrinogen, plasminogen and thrombin were kept at 37°c, mixed, 
the mixture added rapidly to the agar and immediately pipetted 
between the prewarmed glass plates. The gel was allowed to 
solidify at room temperature then kept at 40c in a humid chamber 
until used. 
The SDS gel was layered onto the indicator gel, incubated at 37°c 
in a humid atmosphere and removed at intervals for viewing and 
photography. Bands of PA activity could be seen as clear zones of 
lysis in the cloudy background provided by the unlysed fibrin. 
Failure of fibrinolysis to occur in control indicator gels 
(plasminogen-free) was used as a criterion to define the enzymes 
as plasminogen activators. 
The indicator gel was preserved by staining in 0.1% amido black 
in 70% methanol, 10% acetic acid for 30 min. The gel was 
destained in 70% methanol+ 10% acetic acid. 
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3.3 
3.3.1 
3.3.l.l 
RESULTS 
CALIBRATION OF THE EXPERIMENTAL SYSTEM 
EFFECT OF INTRAPERITONEAL INJECTION OF 
THIOGLYCOLATE AND IN VITRO EXPOSURE TO 
CONCANAVALIN A ON MACROPHAGE PLASMINOGEN ACTIVATOR 
SECRETION 
Various experiments performed by Vassali, Hamilton and Reich 
( 1977) were repeated to ensure that the assay for PA set up in 
this laboratory could reproduce the results others had achieved. 
The ability to repeat the work of others would indicate correct 
preparation of reagents and setting up of the system. 
3.3.1.1.1 Fibrinolysis by cultured macrophages exposed in 
vitro to Con A 
The fibrinolytic activity of unstimulated macrophages was 
markedly enhanced by exposure to Con A in vitro. Maximal 
stimulation was achieved at a concentration of Con A of 10-7M, 
(Table 12). These results are in accord with Vassali, Hamilton 
and Reich, 1977. 
3.3.1.1.2 Thioglycolate elicted macrophages 
A exposure in vitro 
effect of Con 
Thiogl ycola te-elici ted macrophages showed a high basal level of 
fibrinolytic activity, which was increased only slightly by Con 
A, fibrinolysis being maximal at a concentration of 10-7M Con A, 
(Table 24a and b). These findings are in agreement with those of 
Vassali, Hamilton and Reich, 1977. 
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3.3.1.2 
3.3.1.2.1 
OPTIMISATION OF NUMBER OF MACROPHAGES DISTRIBUTED 
INTO EACH LINERO WELL 
Thioglycolate-elicited macrophages 
Different numbers of thioglycolate-elicited peritoneal 
macrophages were distributed in duplicate linbro wells and 
incubated for 20 hours, media were monitored for breakthrough and 
cells were washed and plated in 5% ATHIFBS. Fibrinolysis was 
monitored at intervals over 48 hours. The range of macrophage • 
numbers distributed in linbro wells was between 1,25 x 10 5 and 2 
x 10 6 macrophages. Results obtained are shown in Table 13. 1 x 
10 6 macrophages appear to produce maximum fibrinolysis under 
these experimental conditions, however distribution of l x 106 
macrophages per well means that substantial numbers of cells are 
required for each experiment which would necessitate impractical 
numbers of mice being sacrificed. Microscopic examination of the 
cultures revealed that in the l x 106 macrophage wells, cells 
were crowded together expecially in the centre and only cells at 
the periphery spread well. In order to optimise experimental 
conditions and to achieve high levels of fibrinolysis, 5 x 10 5 
macrophages were selected as a suitable number of cells to be 
distributed in each well. 
To use this assay quantitively, it is necessary to determine 
conditions such that substrate digestion is proportional to the 
number of cul ti va ted macrophages present, or to the amount of 
PA, i.e. conditioned medium used in the assay (Gordon, 1978 
33.10). In this experiment, fibrinolysis increases with increase 
in cell number, i.e. amount of fibrinolysis is dependent on cell 
number, until a maximum of 1 x 106 macrophages per well. With 
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further increase in cell number, the graph shows a decrease in 
amount of fibrinolysis. This is possibly due to overcrowding of 
the eel ls, and nutrients also may become e xha us ted. A further 
possible explanation for the drop in fibrinolysis is that toxic 
metabolic products are produced which may build up, and although 
cultures may appear heal thy by morphological criteria, normal 
cell function may not occur. 
3.3.1.2.2 Nocardia-activated macrophages 
The experiments with thioglycolate-elicited macrophages were 
repeated using different numbers of Nocardia-activated 
macrophages distributed in duplicate linbro wells. Macrophages 
were incubated in 2% PCS prior to induction of fibrinolysis, as 
described previously. 
3.3.1.2.2.1 Fibrinolysis in the presence of ATDS 
Fibrinolysis was measured using 5% ATDS as a source of 
plasminogen (Gordon and Cohn, 1978). Fibrinolysis was monitored 
over 6 hours. Table 14 shows the relation of fibrinolysis to cell 
number under these experimental conditions. Results are similar 
to those obtained for thioglycolate-elicited macrophages, 
therefore 5 x 10 5 macrophages was selected as a suitable number 
for assay of fibrinolysis in the presence of ATDS. 
3.3.1.2.2.2 Fibrinolysis in the presence of purified 
plasminogen 
Macrophage fibrinolysis was determined in the presence of 10 
micrograms/ml purified plasminogen, which increases the 
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sensitivity of the assay (Gordon, 1978; 33.7). Fibrinolysis was 
monitored over 6 hours. 
Results of a representative experiment using N.asteroides 
-activated macrophages are shown in Table 15a. The range of 
macrophage numbers distributed in linbro wells was between 2.5 x 
105 and 1. 5 x 106 macrophages. Cells were examined at intervals 
during the culture and assay period. It was noted that 
macrophages were well-spaced in the 2. 5 x 105 culture wells; 
numerous cells were plated down in the 5 x 10 5 wells, and normal 
spreading had occurred. In the 7.5 x 10 5 macrophage wells, cells 
were spread and were confluent. Macrophages in the 1 x 106 wells 
were rather rounded, i.e. there was insufficient surface area 
available for spreading. Macrophages in the 1.5 x 106 wells were 
packed solid and were unable to spread on the bottom of the dish. 
The results shown in Table 15a are similar to those presented in 
Table 13. 
Fibrinolysis increases with increase in cell number to a maximum 
with l x 10 6 macrophages per well. Further increase in cell 
number leads to a levelling off of amount of fibrinolysis. 
Similar experiments with N.brasiliensis-activated macrophages 
produced similar results 
presented in Table 15b. 
a representative experiment is 
On the basis of these findings, 5 x 10 5 macrophages was selected 
as the optimum number of cells to be distributed into each linbro 
well. 
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3.3.1.3 OPTIMISATION OF VOLUME OF CONDITIONED MEDIUM (CM) 
ADDED TO EACH LINBRO WELL AND PERIOD OF CULTURE IN 
SERUM-FREE MEDIUM 
Nocardia-activated macrophages were incubated in 0.25% LAH for l 
or 4 days. CM was collected at the end of the culture period and 
aliquots of 20 microlitres, 50 microlitres, 100 microlitres, 200 
microlitres and 250 microlitres were assayed for PA activity. 
(Gordon, 1978; 33.6). Results for N.asteroides-activated 
macrophages are presented in Tables 16a and b. From this data it 
appears that 24 hours of incubation is sufficient - substantial 
fibrinolysis occurs with samples of CM collected after 24 hours 
in culture. In the direct assay, it is important to consider 
possible inactivation of the enzyme in the culture medium. 
Schnyder and Baggiolini (1978a) found that PA was inactivated 
rapidly after release. Unkeless, Gordon and Reich (1974) showed 
that PA in CM was stable at 37°c for at least 48 hours. 24 hours 
was selected in this series of experiments so that losses of PA 
would be minimised. In addition, 50 microlitres of CM 
collected after 4 days in culture rapidly released almost 100% of 
available radioactivity. Excessive solubilisation of the fibrin 
is undesirable since the graph describing fibrinolysis (% 
radioactivity released vs time) starts flat ten ing off at high 
percentages of radioactivity released. Gordon (1978; 33.8) 
states that radioactivity released should be proportional to 
enzyme concentration and time of incubation so long as 
solubilization does not exceed about 30% of the total count 
releasable by trypsin. Use of the urokinase standards allows a 
far greater degree of fibrinolysis to be acceptable. 
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Any enzyme values which fall outside the linear range of the UK 
standard curve are discarded since extrapolation at high and low 
levels of fibrinolysis is very inaccurate. In these experiments 
an upper limit of 80% and a lower limit of 4% was selected, even 
if the sample percentage trypsin lay on the linear part of the UK 
standard curve. However, since enzyme levels secreted by 
unstimulated macrophages are generally very low, enzyme levels 
below 4% trypsin are accepted for control cultures. From Table 
16a it appears that 50 microlitres of CM is a suitable volume for 
assay. Increase in volume of CM assayed does not give rise to a 
proportionally greater degree of fibrinolysis, indeed at very 
high volumes, e.g. 250 microlitres of CM the amount of 
fibrinolysis decreases compared to e.g. 100 microlitres CM. This 
is probably due to the presence of inhibitors of fibrinolysis in 
the tissue culture medium, which in high volumes of CM may 
achieve inhibitory concentrations. 
Experiments done using N.brasiliensis-activated macrophages 
produced similar results - a representative experiment is shown 
in Table 16c. Aliquots of 30 rnicrolitres, 50 microlitres and 100 
rnicrolitres CM were assayed for PA activity. Fifty microlitres 
was selected as being a suitable volume of CM for assay. 
In these experiments, the amount of fibrinolysis increases with 
increase in volume of CM assayed with a maximum at a volume of 
100 microlitres. Fibrinolysis was therefore directly related to 
volume of CM added. 
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3.3.1.4 
3.3.1.4.l 
Macrophage 
CHOICE OF PLASMINOGEN SOURCE IN ASSAYS FOR 
FIBRINOLYSIS 
Comparison of responses in dog serum and in fetal 
calf serum 
fibrinolysis has been determined using AT-fetal calf 
serum (Vassali, Hamilton and Reich, 1977: Unkeless, Gordon and 
Reich, 1974), or AT-dog serum (Gordon and Cohn, 1978; Noguiera, 
Gordon and Cohn, 1977). AT-dog serum is used in the fibrinolytic 
assay for less active cells since FCS retains more antiplasmin 
activity than DS after acid-treatment (Gordon, 1978:33.6,33.7). 
The greater inhibitory effect of HIATFCS compared to ATDS is 
shown in Table 17a, in which fibrinolysis by thioglycolate-
elicited macrophages is compared. Nocardia-activated macrophages 
and unstimulated control macrophages were assayed for 
fibrinolysis in both 5% ATFCS and 5% ATDS. Results are shown in 
Table 1 7b. After 12 hours of assay, 
N.brasiliensis-activated macrophages was 
fibrinolysis by 
negligible in the 
presence of ATFCS and was maximal in the presence of ATDS. ATDS 
was therefore selected as suitable for the fibrinolysis assay. 
Plasminogen-dependence of fibrinolysis was 
in ATFCS-P and ATDS-P 
confirmed by 
incubating macrophages 
- sera were 
depleted of plasminogen by two cycles of chromatography on 
lysine-sepharose (Tables 17b, 19). 
3.3.1.4.2 Assay of fibrinolysis in the presence of acid-
treated dog serum response of unstimulated 
macrophages 
Unstimulated macrophages do not release plasminogen activator 
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( Unkeless, Gordon and Cohn, 1974; 
Nogueira, Gordon and Cohn, ( 1977); 
Gordon and Cohn, 1978). 
and Gordon and Cohn ( 1978) 
investigated macrophage fibrinolysis in the presence of 5% ATDS. 
Unstimula tea macrophages released baseline levels of PA over a 
six hour assay period. Examination of the results in Table 17a 
and in Table 17b reveals that the response of control, 
unstimulated macrophages to exposure to dog serum is different in 
the two experiments. High levels of fibrinolytic activity 
occurred i n the one e x p e r i men t (Tab 1 e 1 7 a) w he re a s b a s e 1 in e 
levels occurred in the other (Table 17b). The fibrinolytic assay 
in the presence of 5% ATDS was repeated many times, and in most 
experiments fibrinolysis produced by control macrophages 
exceeded or was s imi la r to that produced by Noc a rd ia-a c ti va ted 
macrophages; although according to the literature, control 
macrophage fibrinolytic activity may be expected to remain at 
baseline levels over a six-hour assay period ( Gordon and Cohn, 
1978). Occasionally, for no obvious reason, fibrinolytic activity 
of unstimulated macrophages in the presence of ATDS was 
negligible. These inconsistent results lead to an investigation 
into the factors responsible for the occurrence of the 
phenomenon. 
3.3.1.4.2.1 Fibrinolysis in the presence of AT-dog serum from 
different sources 
ATDS used in all previous experiments was compared to a different 
batch of Gi bco dog serum, a 1 so acid treated, and to dog serum 
obtained by bleeding a dog housed in the Animal House, Medical 
School, University of Cape Town. Blood was collected, the serum 
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separated by centrifugation, sterilised by filtration and acid 
treated. 
Macrophages harvested from control mice were not pooled - 5 x 10 5 
macrophages from individual mice were exposed to the three 
different batches of ATDS and fibrinolysis measured. Results are 
shown in Table 18. Plasmin backgrounds, i.e. fibrinolysis in 
wells incubated with serum but without cells, were low. 
Significant fibrinolysis occurred with all three batches of ATDS, 
therefore a particular batch of dog serum was not responsible for 
the phenomenon. 
3.3.1.4.2.2 Plasminogen-dependence of fibrinolysis by 
unstimulated macrophages in the presence of ATDS 
Unstimulated macrophages were assayed for fibrinolysis in the 
presence of ATDS and in ATDS from which the plasminogen had been 
extracted by chromatography on lysine-sepharose. Results are 
shown in Table 19. Fibrinolysis is strictly dependent on the 
presence of plasminogen. 
3.3.1.4.2.3 Fibrinolysis by macrophages from individual mice 
in the presence of AT-dog serum 
Macrophages harvested from mice were not pooled 
macrophages from individual mice were placed in linbro wells and 
fibrinolysis monitored in the presence of 5% ATDS. 
In the experiment shown in Table 20, 20 control mice were used 
and the fibrinolysis produced by the macrophages from the 
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individual mice is presented. Macrophages from individual mice 
were incubated in 5% HIATFCS to compare responses. No detectable 
fibrinolysis occurred in the presence of HIATFCS. However, 
significant fibrinolysis was measured in the presence of ATDS. 
Fibrinolysis by control macrophages occurs with macrophages from 
individual mice as well as with pooled macrophages. Pooling of 
is therefore not responsible for the high levels of macrophages 
fibrinolysis associated with control macrophages. When 
peritoneal washes from outbred strains of mice such as ICR are 
pooled, it is conceivable that each population of lymphocytes may 
react against "foreign" determinants on the surface of the other 
population and lead to a mixed lymphocyte reaction (MLR). This 
could in turn lead to macrophage activation and could, it was 
thought, account for the fibrinolysis produced by pooled control 
macrophages, since lymphocytes and macrophages were co-cultured 
for 48 hours prior to fibrinolysis assay. Serum plasmin 
inhibitors in ATFCS could mask the reaction. 
The experiment presented in Table 20 shows that fibrinolysis 
occurs without pooling the macrophages, therefore a MLR is not 
responsible for the phenomenon. 
3.3.1.4.2.4 Effect of removal of lymphocytes on unstimulated 
macrophage fibrinolysis in AT-dog serum 
To determine whether unstimulated macrophage fibrinolysis in the 
presence of ATDS required the presence of lymphocytes, 
experiments were done in which peritoneal cell cultures were 
184 
washed twice with HBSS after two hours incubation to remove 
most of the lymphocytes. Macrophages were refed 2% 
FCS/DB/P+S and reincubated for 46 hours. Fibrinolysis was 
assayed in the presence of ATDS. 
experiment are shown in Table 21. 
Results of a re pre sen ta ti ve 
Lymphocytes do not appear to 
be required - fibrinolysis by unstimulated macrophages occurs to 
a similar extent irrespective of whether lymphocytes are present 
during the 48 hours in culture or not. Control macrophages 
therefore do not require the presence of lymphocytes to become 
stimulated by contact with dog serum. 
3.3.1.4.2.5 Control macrophages f i br i nol ys is in the presence 
of purified plasminogen 
The possibility that control unstimulated macrophages become 
"activated" in culture was investigated. Schnyder and Baggiolini 
(1978a) found that plasminogen activator was released in very low 
but measurable quantities by unstimulated macrophages after 4 or 
5 days of incubation, and they suggested that non-elicited 
macrophages may become activated in culture, 
first 3 days no enzyme was detectable. 
since during the 
Many workers have implicated serum in the macrophage activation 
process. Drapier et al (1979) showed that in vitro secretion of 
PA by thioglycolate-elicited macrophages does not occur in the 
absence of serum - secretion of soluble activator is blocked and 
cell-associated activator accumulates intracellularly (Lemaire, 
Drapier and Petit, 1983; Drapier, Lemaire and Petit, 1982) -
however a short exposure to serum after 2-3 days of cultivation 
185 
in serum-free medium induced marked enzyme release. Serum 
therefore acts as a stimulus for PA release by thioglycolate-
elicited macrophages. These workers (1982) state that the 
secretion of PA into the extracellular medium is modulated by 
various serum components. 
Lejeune et al (1978) found that the presence of serum in 
macrophage cultures may be responsible for "non-specific" 
activation. They showed that nor ma 1 hea t-inac ti va ted sera from 
various species 
and can amplify 
can render unstimulated macrophages cytostatic, 
the cytostatic properties of macrophages from 
immunised animals. 
1966) established that serum is an Cohn and co-workers (1965, 
essen tia 1 subs ta nee for inducing pinocytosis and production 
et al (1977) 
factor which can 
of lysozomal enzymes by macrophages. Opitz 
demonstrated that fetal calf serum contains a 
support an in vitro primary immune response. Reikvam, 
Gammeltvedt and Hoiby (1975), found that peritoneal macrophages 
can be stimulated in vitro by new born calf serum and show an 
increase in content of lysozomes, lysozomal enzymes and 
phagocytosis. 
Sherman, Lee and Stewart (1981) investigated the hypothesis that 
macrophages could be stimulated to release PA by the speci fie 
substrate, viz fibrin. Unstimulated macrophages were 
incubated in vitro with soluble fibrin/fibrinogen complexes 
for 24, 48 and 72 hours. These eel ls released significant 
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proteolytic activity in 24 hours, and fibrinolysis increased 
with increased time of incubation with soluble substrate. 
In the experimental system described in this chapter, macrophages 
are in contact with fibrin which is gradually solubilising for 48 
hours prior to the assay for fibrinolysis (solubilisation during 
the incubation period is monitored see 3.2.6.1.2 and is 
minimal, however gradual solubilisation of the fibrin does 
occur - Gordon, 1978; 33.7). Release of PA by unstimulated 
macrophages under these conditions is therefore a distinct 
possibility. 
To determine whether serum components or contact with fibrin or 
both were responsible for the marked secretion of PA by 
unstimulated macrophages in the presence of ATDS, 
f ibr i nol ys is was measured using purified pla smi nogen instead of 
ATDS. Addition of purified plasminogen to intact cells has the 
advantage of rendering the assay considerably more sensitive 
(Gordon, 1978:33.7; Gordon, 1980:129). 
Unstimulated and Nocardia-activated macrophages were incubated 
for 48 hours in 2% FCS/DB + P+S and assayed for fibrinolysis in 
the presence of 10 micrograms/ml purified human plasminogen 
(Gordon, 1978; 
concentration was 
33.8) or in 5% ATDS. 
arbitrarily selected from 
by Gordon (1978:33.8). 
The plasminogen 
the data presented 
Substantial fibrinolysis occurred with this concentration of 
187 
plasminogen; in Table 15a and b, plasminogen concentration did 
not appear to be limiting since fibrinolysis was proportional to 
cell number, therefore 10 micrograms/ml plasminogen was 
selected as suitable for the fibrinolysis assay. 
Results of a re pre sen tat i ve expermimen t a re shown in Table 22. 
Plasminogen-dependence of fibrinolysis was confirmed. The 
uns timula tea macrophages give rise to significant f ibrinolytic 
activity - with plasminogen this was expected since Gordon (1978, 
33.8) states that resident macrophages that have been cultivated 
for 24 hours will lyse a substantial amount of the fibrin in the 
presence of plasminogen. However, unstimulated cells lysed far 
less fibrin in the presence of plasminogen than in ATDS. Control 
macrophages generally released higher percentages of available 
radioactivity than Nocardia-activated macrophages in the presence 
of ATDS; in the presence of purified plasminogen this 
relationship is reversed. This reversal of the relationship was 
confirmed in numerous repetitive experiments in the direct assay 
for fibrinolysis, and in the indirect assay for secreted enzyme 
( Section 3. 3. 2). In the assay for secreted enzyme, barely 
detectable levels of fibrinolysis were produced by control 
macrophages. Macrophages from the same pool of cells used in the 
assay for fibrinolysis (Table 23a) were used in the assay for 
enzyme secretion 
in Table 23b. 
(indirect assay, 3.2.6.2) and results are shown 
Significant fibrinolysis occurred with the 
unstimulated macrophages cultured on fibrin but not with CM from 
unstimulated macrophages. Reasons for this are the much greater 
sensitivity of the assay for fibrinolysis, also significant 
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fibrinolytic activity occurs with cells cultivated for 24 hours 
on fibrin and assayed in purified plasminogen, probably due to 
contact with soluble fibrin. 
From this data is appears that the high degree of fibrinolysis 
produced by unstimulated cells may be attributed to a large 
extent to dog serum components, whereas cultivation of cells on 
fibrin contributed to a much lesser extent. 
Purified plasminogen was selected as the most suitable source of 
plasminogen in the assay for fibrinolysis by intact cells. 
SELECTION OF APPROPRIATE MOUSE STRAIN 3.3.1.5 
3.3.1.5.1 Results of thioglycolate and Concanavalin A 
Experiments 
Experiments were done using macrophages from outbred (Ha) 
ICR/UCT mice and the inbred mouse strains 
CBA/Ca/UCT and c 3 H/He/UCT. 
BALB/c/UCT, 
The appropriate mouse strain for use in the assay for 
fibrinolysis was determined by measuring macrophage responses to 
intraperitoneal injection of thioglycolate medium and to 
incubation with Con A in vitro, as described previously. 
Results of a representative experiment are shown in Tables 24a 
and b. Each value shown is the average of duplicate readings. 
Macrophages from CBA/Ca/UCT mice responded poorly to stimulati9n 
with thioglycolate medium and also to in vitro exposure to Con A. 
Macrophages from the other three mouse strains degraded the 
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fibrin to different extents, (Ha)ICR/UCT mouse macrophages 
causing less fibinolysis than c 3 H/He/UCT macrophages and more 
fibrinolysis than BALB/c/UCT macrophages. The CBA/Ca/UCT strain 
was considered unresponsive and therefore unsuitable, and the 
strain producing the intermediate response i.e. (Ha) ICR/UCT was 
selected. 
3.3.1.5.2 Results of histopathological and experimental 
studies of lymphocyte responses 
Folb, Jaffe and Altmann (1976) investigated N.asteroides and 
N.brasiliensis infections in mice and used Swiss white mice in 
their studies. They established a model for N.asterioides and 
N.brasiliensis infections in Swiss white mice and found from 
serial histopathological studies that the lesions produced by the 
two organisms have quite different features (refer to section 
1.7.3.1.1). An acute suppurative abscess characterised the 
lesions of N.asteroides, whereas N.brasiliensis caused a 
granuloma in which a striking feature was the presence of 
numerous "foamy" macrophages. The finding that the local 
pathogenic response to these two species of Nocardia is quite 
different despite relatively similar biochemical and antigenic 
characteristics, lead to the idea that cellular immunity may be 
depressed in N.brasiliensis infection. This possibility has been 
investigated in this study. Folb et al (personal communication) 
studied Swiss white mouse splenic T- and B-lymphocyte responses 
to culture filtrate antigens of N.asteroides and N.brasiliensis. 
Lymphocyte responses to antigen exposure were monitored by 
measurement of uptake of 3H-thymidine. Effect of in vitro 
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homologous antigen exposure on lymphocyte DNA synthesis was 
measured in control mice and in mice previously inoculated 
intraperitoneally with live N.asteroides or N.brasiliensis 
organisms. These workers found that antigens of N.asteroides had 
no significant effect on uptake of 3 H-thymidine by T-lymphocytes 
harvested from control or N.asteroides-inoculated mice, however 
normal B-lymphocyte uptake of 3 H-thymidine was significantly 
depressed by 2% N.asteroides antigen. Depression of B-lymphocyte 
DNA synthesis was also shown with lymphocytes from mice 
previously inoculated with N.asteroides. 
Normal T-lymphocyte responses of Swiss white mice were depressed 
by 2% N.brasiliensis antigens. Prior inoculation to Swiss white 
mice with N.brasiliensis did not modify this finding. Similarly, 
B-lymphocyte reponses were depressed by N.brasiliensis antigens 
in normal and N.brasiliensis-inoculated mice. The authors 
concluded that N.asteroides and N.brasiliensis culture filtrate 
antigens elicited different in vitro T- and B- lymphocyte 
responses in Swiss White mice as a result of antigenic 
differences between the two organisms. They postulated that 
depression of lymphocyte responses may be due to a T-cell-
dependent suppressive influences, resulting in an overall 
hyporesponsiveness to high concentrations of antigens of 
N.brasiliensis. The (Ha)ICR mouse strain is derived from the 
Swiss White mouse, therefore it was appropriate to use that 
particular strain in this study which is a continuation of the 
studies of Folb et al. 
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3.3.1.6 
3.3.1.6.1 
NEGATIVE CONTROL STUDIES 
Plasminogen-Dependence of Fibrinolysis 
Plasminogen-dependence of fibrinolysis was routinely checked in 
both the assay for fibrinolysis and in the assay for secreted PA. 
Intact cells were assayed in the presence of serum depleted of 
plasminogen by two cycles of chromatography on lysine-sepharose 
or puritied plasminogen was replaced with culture medium. 
In the assay for secreted enzyme, plasminogen was replaced by 
Tris. In all experiments, fibrinolysis was strictly dependent on 
the presence of plasminogen and therefore due to macrophage PA. 
3.3.1.6.2 Background fibrinolysis in the absence of cells 
In all assays, duplicate linbro wells were assayed for 
fibrinolysis in the absence of cells. Background levels of 
fibrinolysis were generally low in assays with purified 
plasminogen, after 4 hours (median = 1.955% fibrinolysis, lower 
limit 1.15%, upper limit 2.474%, n = 22) and a median % Trypsin 
value of 6.948% with ATDS, after 4 hours (lower limit 4.499%, 
upper limit 9.718%, n = 22) of assay. Fibrinolysis was 
therefore strictly dependent on the presence of macrophages. 
Significant fibrinolysis in the absence of cells is indicative of 
plasminogen contaminated with plasmin. P la smi n is removed by 
treatment with DFP, as described under 3.2.2.1. Background 
levels of fibrinolysis were subtracted from all sample values, 
before calculation of% Trypsin values. 
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3.3.1.6.3 Evidence that there is minimal spontaneous loss of 
radioactivity during the incubation period 
Media were monitored for "breakthrough" of fibrinolysis before 
each change of medium. An aliquot of medium was removed from 
each linbro well immediately prior to washing, and counted to 
determine released radioactivity. Percentages of fibrinolysis 
that occurred during the 48 hours in culture for a typical 
experiment are shown in Table 25. In general, less than 10% of 
available radioactivity was lysed during the pre-assay culture 
period. 
3.3.1.7 CELL VIABILITY AND INDICATION OF CELL LOSSES 
DURING WASHES 
Equal numbers of control and Nocardia-activated macrophages were 
distributed into linbro wells and incubated for 48 hours. 
Immediately prior to assay for fibrinolysis, cells were monitored 
for "breakthrough" of fibrinolysis and washed twice to remove 
lymphocytes and inhibitors. 
Cell washes for each linbro well were collected, concentrated by 
centrifugation, 
and macrophages 
counts were done 
resuspended in 500 microlitres of 
were counted as described previously. 
medium 
These 
to find out whether cell losses were similar 
in the different ex per 1 men ta 1 groups. Ce 11 loss from the 
groups was minimal and there did not appear to be a group which 
consistently had greater loss of macrophages than another group. 
Results of six representative experiments are shown in Table 26. 
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Viability of macrophages was assessed after the final time point 
by washing cells, wells were sucked dry and dilute Trypan blue 
(0.1%) added. Cells were examined for uptake of dye. 
In the fields of cells examined, occasionally one cell had 
stained blue. This indicates that cell viability was good at the 
end of the culture period. 
3.3.1.8 RELATIVE CELL NUMBER AFTER INCUBATION 
Various methods were employed to assess cell number after the 
culture period. Initially, Versene solution (0.02% w/v EDTA in 
normal saline, Flow Laboratories, Irvine, Scotland # 28-203-49) 
was used to remove adherent cells. After the final timepo1nt, 
media was removed by suction. 1 ml of versene added to the well 
and the dish placed at 4°c for 15 minutes. The well surface was 
scraped with a plastic policeman, the cells were checked 
microscopically and appeared no longer adherent. The medium 
was removed, pelleted and resuspended and an aliquot placed in a 
haemocytometer and examined microscopically. Although several 
wells were treated in this way, 
haemocytometer. 
no cells were seen on the 
An at tempt was then made to count the number of eel 1 s removed 
with 1 ml versene using a coulter counter. 500 microlitres of 
cell suspension in versene was diluted to 10 millilitres in 
isoton (Coulter Electronics, Hialeah, Florida, USA) and 0.5 ml of 
this counted in a coulter counter (model ZBI, Coulter 
Electronics). Results of a representative experiment are shown in 
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Table 27. 
Cell numbers tram control and Nocardia-activated macrophage wells 
were relatively similar, however, cell yields with versene 
treatment was low. In order to increase the number of cells 
recovered, lidocaine, 10.7 mM (Remedia (Pty) Ltd, Johannesburg, 
SA)/EDTA, 3mM (Merck Darmstadt, Germany) was used (van der Meer 
et al, 1978). Cells were treated with 1 ml of lidocaine/EDTA 
for 15 minutes at room temperature, observed microscopically 
and when they appeared to have deta tched were scraped from 
the surface of the well as vigorous rinsing of the surface with 
jets of media from a pasteur pipette did not seem to dislodge 
cells. 500 microlitres of cell suspension were added to 9.5 ml 
of isoton and a 500 microlitre aliquot counted in a coulter 
counter. Although a counting plateau (calibration curve of the 
range of cell sizes in the sample - at high values this curve 
plateaus off) could be established for the control cells, it 
could not be obtained for the Nocardia-activated cells, therefore 
it appeared that lidocaine/EDTA was unsuitable as a cell-
dislodging agent. Nathan and Root ( 1977) found that lidocaine 
was not suitable for the resuspension of adherent ECG-activated 
macrophages because these cells were far more tightly adherent 
than cells from untreated mice and an accurate count could not be 
obtained. 
The next approach was to measure total cell protein at the end of 
the incubation period. Cells were washed twice with PBS and 
lysed with 1000 microl i tres 0. 5% Tri ton X-100 and frozen and 
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thawed (Biggar and Sturgess, 1977). The Lowry method (Lowry et 
al, 1951) was used. However, a yellow precipitate formed 
between the Triton X-100 and the Folin-Ciocalteau's Phenol 
reagent. Total cell protein was then measured using the 
fluorimetric method described in 2.3. This method was selected 
for routine use. The low cell counts recovered with versene and a 
plastic policeman are similar to those described by others. Van 
der Meer et al (1978) state that about 25% of cells are recovered 
using this methoa and about 60% using lidocaine/EDTA. Although 
cell yields were low, cell numbers were similar for control and 
Nocardia-activated macrophages, indicating that the ability of 
both groups of cells to survive in culture was similar, and 
that any differences in enzyme release was probably not related 
to differences in cell number. 
Schnyder and Baggiolini (1978a) say that specific activities in 
the culture media may be related to actual cell numbers or to the 
amount of cellular protein. They prefer to express enzyme 
activities per 10 6 cells, since total cell protein may drop as a 
result of release of enzyme or may markedly increase as the cell 
becomes activated. In the literature both methods are widely 
used (Gordon and Cohn, 1978; 
Vassali, Hamilton and Reich, 
Unkeless, Gordon and Cohn, 1974; 
1977; Nogueira, Gordon and Cohn, 
1977a; Schnyder and Baggiolini, 1978a; Hamilton, 1980; 
Hamilton, 1983). Na than , Karn o vs k y and David ( l 9 7 l ) selected 
cell protein rather than cell number for comparing 
macrophage activities so that differences would not simply 
reflect possible differences in cell size. 
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Activated macrophages are generally increased in size, which is 
expressed in their increased protein content (Cohn, 1978). 
However, studies have shown protein content to remain the same 
(Stubbs et al, 1973) or to be decreased (Kondo and Kanai, 1977). 
From results presented in section 8.3.9 it appears that protein 
content of control cells is similar to that of Nocardia-activated 
cells. 
-activated 
macrophages. 
Calibration experiments indicate that Nocardia 
macrophages release more PA than unstimulated 
Nocardia-activated macrophages appear larger than 
unstimulated macrophages on microscopical examination (Ch 5 and 
9). However this apparent difference is not statistically 
significant except for control and N.brasiliensis-activated 
macrophages in the elongated form (significant at the 0.03 level, 
Mann Whitney U Test. Data from SEM study, section 9.3). Median 
values and their 95% confidence limits for macrophage size are 
shown in Table 117. If Nocardia-activated cells did have 
increased protein content, specific activity of PA expressed as a 
conservative estimate of quantitative enzyme differences in the 
two types of macrophages. Because of the difficulties encountered 
in recovering the cells from the surface into suspension, the 
fluorimetric method for determination of total cell protein was 
selected, 
protein. 
3.3.l.9 
and secreted PA was expressed in terms of total 
ADDITION OF CULTURE FILTRATE ANTIGENS OF 
N.ASTEROIDES AND N.BRASILIENSIS IN VITRO 
Gordon and Cohn (1978) measured fibrinolytic activity of 
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peritoneal macrophages obtained from mice 3 weeks after 
infection with viable BCG organisms and showed only a twofold 
increase in fibrinolytic activity. However, when the 
peritoneal cells from infected animals were incubated in vitro 
with different amounts of either of two soluble antigen 
preparations, 
M.tuberculosis 
purified protein derivative (PPD) 
culture filtrate for l or 2 days, 
antigen and 
a striking 
dose-related enhancement of macrophage fibrinolysis resulted. 
Experiments showed that two different preparations of antigen, 
PPD and M. tuberculosis culture filtrate could both be used for 
challenge in vitro. 
In order to determine whether secondary challenge with specific 
antigen in vitro modulated Nocardia-activated macrophage release 
of PA, unstimulated macrophages and Nocardia-activated 
macrophages were incubated with various concentrations of 
homologous culture filtrate antigen (i.e. macrophages from mice 
previously inoculated with N.asteroides organisms were exposed 
to N.asteroides antigen in vitro and macrophages from mice 
previously inoculated with N.brasiliensis organisms were exposed 
to N.brasiliensis antigen in vitro). 
Cohn (1978) was followed. 
The method of Gordon and 
3.3.1.9.l Noc a rdia as teroides an ti gen 
time response curves 
dose response and 
A number of experiments were performed to determine the optimal 
dose of antigen and time of incubation with antigen. These 
experiments were done with macrophages from mice inoculated 2, 
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7, 13 and 21 days previously with N.asteroides. Representative 
ex per imen ts a re shown in Tables 28 and 29. Macrophages from 
mice inoculated 7 days previously with N.asteroides were 
incubated with various concen tra ti ons of N. as teroi des culture 
filtrate antigen (range 0.2% to 0.00002%) for 24, 48 or 72 hours. 
Time of incubation did not appear to influence macrophage 
responses to antigen. However, macrophages incubated for 48 
hours released a greater percentage of the available 
radioactivity than macrophages incubated for 24 hours ( Table 
28). This observation is in agreement with that of Sherman, Lee 
and Stewart ( 1981). 72 hours of incubation was not selected 
because cells would be maintained on the fibrin for a total of 4 
days. Gordon (1978, 3 3. 7) 
possible to culture cells 
states that it is not usually 
on fior1n for more than 4-5 days 
because of gradual solubilisation of the fibrin; also contact 
of unstimulated cells with fibrin could lead to significant 
fibrinolytic activity, as occurred in the experiment shown in 
Table 29b. From these considerations, 48 hours was selected as 
the most suitable time of incubation with antigen. 
There was no definite effect of the antigen noted in the 
calibration 
concentrations 
experiments. 
were selected as 
0.02% and 0.002% antigen 
being the most suitable dose 
to use in subsequent experiments 
concentration which would be unlikely 
since 0.2% antigen is a 
to occur physiologically 
and 0.0002% and 0.00002% were tnought to be very low 
concentrations. 
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3.3.1.9.2 Nocardia brasiliensis antigen 
time response curves 
dose response and 
The experiments described under 3.3.1.9.l were repeated for 
N.brasiliensis. Macrophages were harvested from mice inoculated 
previously with N.brasiliensis organisms and were exposed 
in vitro to N.brasiliensis culture filtrate antigens. 
Representative experiments are shown in Table 30. Macrophages 
from mice inoculated 13 days previously with N.brasiliensis 
organisms were incubated with N.brasiliensis antigen (range 
0.2% to 0.00002%) for 48 and 72 hours. N.brasiliensis-activated 
macrophages released a higher percentage of available 
radioactivity after 72 hours of incubation. However, 48 hours was 
thought to be more suitable for the reasons given under 
3.3.1.9.1. 
Again there was no consistent antigen effect, so 0.02% and 0.002% 
antigens were arbitrarily selected as the doses to be 
subsequent experiments. 
used in 
3.3.1.10 GELS: MOLECULAR \lEIGHT OF PLASMINOGEN ACTIVATOR 
ASSAYED 
The distances travelled by che molecular weight protein markers 
were measured and a calibration curve of log molecular weight vs 
refractive index plotted (Fig 5); (refractive index, RF 
distance protein has migrated divided by length of gel). 
In this experiment the length of the marker gel and the PA gel 
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was 13,4 cm. Bands of fibrinolysis were measured at 3,6 cm and 
6,6 cm. These values correspond to RF values of 0,269 and 0,493. 
From the calibration curve, log molecular weights of 4,684 and 
4,445 were obtained. The bands correspond to molecular weights of 
48,305 and 27,861. In the literature, the major murine 
plasminogen activator band corresponds to a molecular weight of 
48,000 and the minor band to 28,000 (Unkeless, Gordon ana 
Cohn,1974). The enzyme(s) under study are therefore confirmed to 
be murine plasminogen activators. 
3.3.2 PLASMINOGEN ACTIVATOR RELEASE BY PERITONEAL 
MACROPHAGES HARVESTED FROM MICE PREVIOUSLY 
INOCULATED \ilTH N. ASTEROIDES OR N. BRASILI.ENSIS 
Release of plasminogen activator by macrophages from mice 
inoculated 2, 7, 13 or 21 days previously with N.asteroides or 
N.brasiliensis organisms or normal saline only, was measured 
using the direct assay for fibrinolysis by intact cells and the 
indirect assay for secreted enzyme. 
The Mann Whitney U Test was used to test for statistically 
significant differences between the different experimental 
groups, ie control, control + 0.02% antigen, Nocardia-activated 
macrophages, Nocardia-activated macrophages exposed in vitro to 
0.02% and 0.002% antigen (section 2.9). Each of the different 
groups were compared with at each other for statistically 
significant differences at each of the three time points (Tl, T2 
and T3). For simplicity control macrophages were numbered group 
1, control macrophages exposed to 0.02% antigen group 2, 
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Nocardia-activated macrophages group 3, Nocardia-activated 
macrophages exposed in vitro to 0. 02% antigen group 4 and 
Nocardia-activated macrophages exposed in vitro to 0.002% antigen 
group 5. This coding is used in both the text and in the tables. 
In the figures, C = control; C* = control macrophages exposed in 
vitro to 0.02% antigen; Na= N.asteroides-activated macrophages; 
Na*= N.asteroides-activated macrophages exposed in vitro to 
0.02% antigen; Na**= N.asteroides-activated macrophages exposed 
in vitro to 0.002% antigen. A similar system was used for 
N.brasiliensis. Figures show median enzyme values and their 95% 
confidence limits. In adoition, statistically significant 
differences, determined using the Mann i·Jhitney U Test, between 
control macrophages and Nocardia-activated macrophages are shown 
on the figures. For levels of significance between control cells 
exposed to antigen and Nocardia-activated macrophages, refer to 
the relevant tables. 
3.3.2.1 
3.3.2.l.l 
TWO DAY N.ASTEROIDES INFECTION 
Direct assay for fibrinolysis 
Three replicate experiments were performea, and the data are 
shown in Table 31. 
Median percentage fibrinolysis values and their 95% confidence 
limits are shown in Table 32 and in Fig 6. 
There was no statistically significant difference between the 
amount of fibrinolysis produced by control macrophages and that 
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produced by N.asteroides-activated macrophages at any of the 
three different time points. There was no significant effect of 
antigen exposure in vitro on control macrophages or Nocardia-
activated macrophages, except at T3, where there was 
significantly less fibrinolysis produced by N.asteroides-
activated macrophages compared with N.asteroides-activated 
macrophages exposed in vitro to 0.02% antigen (p < 0.01) and 
0.002% antigen (p < 0.01, Table 35). 
3.3.2.l.2 Indirect assay for secreted plasminogen activator 
Three replicate experiments were performed and the data are shown 
in Table 33. 
Median milliunits of urokinase and specific activities of enzymes 
are shown in Table 34 and Fig 7 (median mu UK/2xl0 6 macrophages 
shown only). The Mann Whitney U Test was used to test for 
statistical difference (Table 35). 
There was a borderline statistically significant difference 
between the number of milliunits of urokinase (mU UK) produced by 
control and N.asteroides-activated macrophages (p = 0.05), 
however there was no significant effect of antigen exposure in 
vitro on control or N.asteroides-activated macrophage enzyme 
secretion. There was a significant difference (p < 0.05) 
between control macrophages and N.asteroides-activated 
macrophages exposed to 0.02% antigen. 
There was a statistically significant difference between the 
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specific activities of control and N.asteroides-activated 
macrophages (p = 0.05); of control and N.asteroides-activated 
exposed to 0.02% antigen (p < 0.05) and of control and 
N.asteroides-activated macrophages exposed to 0.02% and 0.002% 
antigen (p < 0.05 in both cases. 'l'able 35). 
3.3.2.2 
3.3.2.2.1 
TWO DAY N.BRASILIENSIS INFECTION 
Direct assay for fibrinolysis 
Five replicate experiments were performed, the data are shown in 
Table 36. 
Median percentage fibrinolysis values and their 95% confidence 
limits are shown in Table 37 and Fig 8. N.brasiliensis-
activated macrophages produced greatly increased levels of 
fibrinolysis (400% control), as did antigen-exposed 
N.brasiliensis-activated macrophages (0.02% 390% control; 
0.002% 399% control. 
fibrinolysis values). 
Percentages calculated from median 
This finding is in agreement with the 
literature. There was a statistically significant difference 
between fibrinolysis produced by control and N.brasiliensis 
-activated macrophages (p < 0.1) at each time point; between 
control and N.brasiliensis-activated macrophages exposed to 
antigen (see Table 40 for levels of significance); between 
control macrophages exposed to antigen and N.brasiliensis 
-activated cells; and between antigen-exposed controls and 
antigen-exposed activated macrophages (see Table 40). There was 
no signiticant effect of antigen on control macrophages or on 
N.brasiliensis-activated macrophages. 
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3.3.2.2.2 Indirect assay for secreted plasminogen activator 
Five replicate experiments were performed and the results are 
shown in Table 38. 
Median enzyme values expressed as milliuni ts of urokinase and 
specific activities are shown in Table 39 and Fig 9. These 
results confirm the results of the direct assay (3.3.2.2.1) in 
that significantly more enzyme is secreted by N.brasiliensis 
-activated macrophages than by control macrophages. Similarly, 
significantly more enzyme was secreted by antigen-exposed 
N.brasiliensis-activated macrophages than by control cells or 
control cells exposed to antigen. This difference was 
significant whether expressed in terms of milliunits of urokinase 
or as specific activity, and levels of significance were all p < 
0.01 (Table 40). There was no significant effect of antigen on 
control macrophages or on N.brasiliensis-activated macrophages, a 
result which concurs with the results of the direct assay. 
3.3.2.3 
3.3.2.3.l 
SEVEN DAY N.ASTEROIDES INFECTION 
Direct assay for fibrinolysis 
Six replicate experiments were performed and the results are 
shown in table 41. 
Median percentage fibrinolysis values, reflecting plasminogen 
activator levels, and their 95% confidence lir.11ts are shown in 
Table 42 and Fig 10. Fibrinolysis by N.asteroides-activated 
macrophages was significantly greater than that produced by 
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control macrophages and significanlty greater than that produced 
by antigen-exposed control cells (p < 0.001) at each time point. 
Similarly, antigen-exposed N.asteroides-activated macrophages 
released significantly more radioactivity than controls or 
antigen-exposed controls (P < 0.001 in each case, see Table 45). 
There was no significant effect of antigen exposure in vitro on 
control or N.asteroides-activated macrophages. 
3.3.2.3.2 Indirect assay for secreted plasminogen activator 
Seven replicate experiments were performed and the data are shown 
in Table 43. 
Fig 11 and Table 44 show the median values for secreted 
plasminogen activator, expressed in terms of milliunits of 
urokinase and specific activity. The results are in agreement 
with the results obtained using the direct assay and are similar 
to those obtained for 2 day N.brasiliensis-activated macrophages. 
Significantly more plasminogen activator was secreted by 
N.asteroides-activated macrophages than by control cells or 
antigen-exposed control cells (p < 0.001 in each case). 
Similarly, significantly more plasminogen activator was released 
by antigen-exposed N.asteroides-activated macrophages than by 
control macrophages or an ti gen-exposed control macrophages ( for 
levels of significance see Table 45). There was no significant 
effect of antigen exposure on control or N.asteroides-activated 
macrophages. Results are similar whether expressed in terms of 
milliunits of urokinase or specific activity. 
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3.3.2.4 SEVEN DAY N.BRASILIENSIS INFECTION 
3.3.2.4.1 Direct assay for fibrinolysis 
Cell-associated and soluble plasminogen activator release were 
measured in macrophages from mice inoculated seven days 
previously with N.brasiliensis in five replicate experiments. 
The data are shown in Table 46 and median enzyme values and their 
95% confidence limits in Table 47 and Fig 12. Results are 
similar to those obtained with two day N.brasiliensis-activated 
macrophages and seven day N.asteroides-activated macrophages. 
Fibrinolyis was significantly increased in cultures of 
N.brasiliensis-activated macrophages compared to fibrinolysis 
produced by control macrophages and antigen-exposed control 
macrophages (p < 0.001 in each case, Table 50). Antigen-exposed 
N.brasiliensis-activated macrophages released significantly more 
plasminogen activator than control cells or antigen-exposed 
control cells (see Table 50). Antigen-exposure in vitro did not 
modify macrophage plasminogen activator release. 
3.3.2.4.2 Indirect assay for secreted plasminogen activator 
Results from six replicate experiments are shown in Table 48, and 
median plasminogen activator values and their 95% confidence 
limits are presented in Table 49 and Fig 13. The results concur 
with those obtained using the direct assay and are similar 
whether expressed in terms of milliunits of urokinase or specific 
activity. 
Significantly more plasminogen activator was secreted by 
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N.brasiliensis-activated macrophages than by control cells or 
each case). Also, antigen-exposed control cells (p < 0.001 in 
significantly more enzyme was secreted by antigen-exposed 
N.brasiliensis-activated macrophages than control macrophages or 
antigen-exposed control cells (p < 0.001 in each case, Table 50). 
As shown with previous experiments, in vitro exposure to antigen 
did not modify control or N.brasiliensis-activated macrophage 
release of plasminogen activator. Results are similar whether 
expressed in terms of milliunits of urokinase or specific 
activity. 
3.3.2.5 
3.3.2.5.l 
THIRTEEN DAY N.ASTEROIDES INFECTION 
Direct assay for fibrinolysis 
Fibrinolysis by thirteen day N.asteroides-activated macrophages 
was measured in four replicate ex per imen ts. Data from these 
experiments are shown in Table 51 and median enzyme values and 
their 95% confidence limits are shown in Table 52 and Fig 14. 
Significantly more plasminogen activator was released by 
N. as teroides-ac ti va ted macrophages than by control or antigen-
exposed control macrophages (except no significant difference was 
found at T3 for antigen-exposed controls and N.asteroides 
-activated macrophages, Table 55). There was a significant 
difference in the amount of enzyme produced by antigen-exposed 
N.asteroides-activated cells and that produced by control cells 
or antigen-exposed control cells at Tl and T2 (p < 0.05) but not 
at T 3, except for control and 
N.asteroides-activated cells ( p < 
0.002% 
0.01). 
antigen 
In vitro 
exposed 
antigen 
exposure did not modify plasminogen activator production by 
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control or N.asteroides-activated macrophages. Lack of 
significant differences at T3 may be attributed to wide scatter 
of data, in addition, control cells released quite large amounts 
of radioactivity probably as a result of contact with the fibrin. 
3.3.2.5.2 Indirect assay for secreted plasminogen activator 
The data from four replicate ex per imen ts a re shown in Table 53, 
and median plasminogen activator values and their 95% confidence 
limits are given in Table 54 and Fig 15. 
those obtained in the direct assay. 
Results are similar to 
More plasminogen activator was secreted by N.asteroides-activated 
macrophages than by control or antigen-exposed control cells (see 
Table 55). Also, significantly more enzyme was released by 
antigen-exposed N.asteroides-activated macrophages than by 
control macrophages or antigen-exposed control macrophages. 
Antigen exposure had no significant effect on plasminogen 
activator release by control macrophages. Results are similar 
whether expressed in terms of milliunits of urokinase or specific 
activity except in the case of N.asteroides-activated macrophages 
exposed to 0.02% antigen (p < 0.05). 
3.3.2.6 
3.3.2.6.1 
THIRTEEN DAY N.BRASILIENSIS INFECTION 
Direct assay for fibrinolysis 
Five replicate experiments were performed and the data are shown 
in Table 56. 
Median percentage fibrinolysis values and their 95% confidence 
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limits are shown in Table 57 and Fig 16. Results are similar to 
those obtained with two and seven day N. bras i 1 iens is and seven 
day N.asteroides infections (thirteen day N.asteroides infection: 
only some significant differences were found at T3, Table 55). 
Fibrinolysis was significantly increased in cultures of 
N. bras i 1 iens is-activated macrophages com pa red with f i br i nol ysis 
caused by control macrophages and antigen-exposed control 
macrophages (see Table 60 for levels of significance). Antigen-
exposed N.brasiliensis-activated macrophages released 
significantly more plasminogen activator than control macrophages 
(except for 0.02% antigen which showed no significant difference 
at T3, Table 60), or antigen treated control macrophages. Antigen 
exposure in vitro did not modify macrophage plasminogen activator 
release, except at T2 for 0.02% antigen-exposed 
-activated macrophages. 
N.brasiliensis 
3.3.2.6.2 Indirect assay for secreted plasminogen activator 
Results from three replicate experiments are shown in Table 58 
and median plasminogen activator values are shown in Table 59 and 
Fig 17. 
Significantly more plasminogen activator was secreted by 
N.brasiliensis-activated macrophages than control macrophages or 
antigen-exposed control macrophages (p < 0.01,Table 60) when 
results were expressed in terms of urokinase units. \Jhen results 
were expressed in terms of specific activity, a borderline 
significant difference of p = 0.05 was achieved for control and 
N.brasiliensis-activated macrophages. A significant difference 
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was found between antigen-exposed control macrophages and 
N.brasiliensis-activated macrophages. Significantly more 
plasminogen activator was secreted by 0.02% antigen-exposed 
N.brasiliensis-activated macrophages than by control cells or 
antigen-exposed control cells (p < 0.05 in each case) but 
differences in levels of secreted plasminogen activator were not 
significant for 0.002% antigen-exposed N.brasiliensis-activated 
macrophages. Antigen exposure had no significant effect on 
control macrophages or on N.brasiliensis-activated macrophages 
except when plasminogen activator levels for N.brasiliensis 
-activated cells were compared with levels for 0.002% antigen-
exposed N.brasiliensis-activated macrophages. The difference was 
s igni f ican t ( p < 0. 05) when results were expressed in terms of 
urokinase but not when expressed as specific activity. Apart 
from this case, results are similar whether expressed in terms of 
milliunits of urokinase or as specific activity. 
3.3.2.7 
3.3.2.7.1 
TWENTY-ONE DAY N.ASTEROIDES INFECTION 
Direct assay for fibrinolysis 
The data from three replicate experiments 
61. Median percentage fibrinolysis and 
limits are shown in Table 62 and Fig 
are presented in Table 
their 95% confidence 
18. No statistically 
significant differences in enzyme levels were found between any 
of the different groups at T3. Some significant differences were 
found at Tl and T2. Control and N.asteroides-activated 
macrophage enzyme levels were significantly different at Tl (p < 
0.05); control and antigen-exposed N.asteroides-activated cells 
produced significantly different levels of enzyme at Tl and T2 
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(see Table 65 for statistics). Enzyme levels of antigen-exposed 
control cells were significantly different from those of 
N.asteroides-activated cells at T2 (p < 0.05). Antigen-exposed 
N.asteroides-activated macrophages produced significantly 
increased levels of fibrinolysis compared to control cells, 
except at Tl for antigen-exposed controls compared with 0.02% 
antigen-exposed N.asteroides, where no significant differences 
were shown. Antigen exposure in vitro did not modify control or 
N.asteroides-activated macrophage levels of fibrinolysis. 
3.3.2.7.2 Indirect assay for secreted plasminogen activator 
Table 63 shows the results from three replicate experiments and 
the median enzyme values and their 95% confidence limits are 
shown in Table 64 and Fig 19. Significantly more plasminogen 
activator was secreted by N.asteroides-activated macrophages than 
by control macrophages (Table 65) and by antigen-exposed 
N.asteroides-activated macrophages compared to control 
macrophages. These 
whether results were 
specific activity. 
differences were statistically significant 
expressed in terms of urokinase uni ts or 
There was no significant difference in the 
amount of enzyme released by antigen-exposed N.asteroides 
-activated cells compared with the same cells not exposed to 
antigen. There was no significant effect of antigen exposure of 
control macrophages on enzyme release when results were expressed 
in terms of specific activity, but results were significantly 
different when expressed as milliunits of urokinase (p < 0.05). 
Antigen-exposed control cells were not significantly different 
from N.asteroides-activated cells or antigen-exposed 
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N.asteroides-activated macrophages in terms of plasminogen 
activator release except when results for antigen-exposed control 
and N.asteroides-activated cells were expressed in terms of 
specific activity (p < 0.05). 
3.3.2.8 
3.3.2.8.1 
TWENTY ONE DAY N.BRASILIENSIS INFECTION 
Direct assay for fibrinolysis 
Cell-associated and soluble plasminogen activator levels were 
measured in five replicate experiments, data are shown in Table 
66. Table 67 and Fig 20 shows median enzyme levels and their 95% 
confidence limits. At Tl, no statistically significant 
differences were shown between enzyme levels in any of the 
different groups (Table 70). At T2 and T3 there was a 
significant difference between enzyme levels of control cells and 
N.brasiliensis-activated macrophages (p < 0.05) and between 
antigen-exposed control macrophages and N.brasiliensis-activated 
macrophages ( p < 0. 05). At T3, a significant difference (p < 
0.05) was found between enzyme levels of N.brasiliensis-activated 
cells and the same cells exposed in vitro to 0.002% antigen. 
3.3.2.8.2 Indirect assay for secreted plasminogen activator 
Plasminogen activator secretion by 21 day N.brasiliensis 
-activated macrophages was measured in seven replicate 
experiments (Table 68). Median enzyme levels and their 95% 
confidence limits are shown in Table 69 and Fig 21. Results are 
similar to those of two day, seven day, and thirteen day 
N.brasiliensis-activated macrophages, but do not concur with the 
results of the twenty-one day N.brasiliensis direct assay. There 
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was no significant effect of antigen on control or N.brasiliensis 
-activated macrophages. Significantly more plasminogen activator 
was secreted by N.brasiliensis-activated macrophages than control 
(p < 0.001) or antigen-exposed control cells (p < 0.001, Table 
70). Antigen-exposed N.brasiliensis-activated macrophages 
secreted more enzyme than control or antigen-exposed control 
cells. Results were similar whether expressed in terms of 
urokinase units or specific activity. 
3.3.3 DIFFERENCES IN MACROPHAGE FUNCTION IN N.ASTEROIDES 
AND N.BRASILIENSIS INFECTIONS AND MODULATION OF 
PLASMINOGEN ACTIVATOR SECRETION OVER THE 21 DAY 
INFECTION PERIOD 
The idea that plasminogen activator secretion may be different in 
N.asteroides and N.brasiliensis infection and modulated over the 
21 day infection period was investigated by comparing enzyme 
values (expressed as percentage controls, Table 72). By 
inspection of this data, it appears that plasminogen activator 
secretion is maximal at 7 days post-inoculation in N.asteroides 
infection and at 2 days post-inoculation in N.brasiliensis 
infection. The pattern of secretion of plasminogen activator in 
N.asteroides infection appears to be different to that in 
N.brasiliensis infection and to be modulated over the 21 day 
period of infection in that enzyme release expressed as 
percentage control decreases over the 21 day infection period 
from a maximum at 2 days to a minimum at 21 days post-inoculation 
in N.brasiliensis infection; whereas percentage control enzyme 
levels are similar at 2 and 21 days, maximal at 7 days and 
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decreasing at 13 days, with a further decrease at 21 days, in 
N.asteroides infection. These trends are shown in Fig 22 (T2 
only) . 
3.4 DISCUSSION 
The experiments reported in this chapter indicate that 
macrophages from mice inoculated 2-21 days previously with 
N.asteroides or N.brasiliensis are activated with respect to the 
parameter of plasminogen activator release. However, the degree 
of macrophage response to the two infections appears to vary over 
the 21 day infection period. Therefore, macrophage function in 
the pathogenic Nocardia infections studied is not inhibited, it 
is enhanced with respect to plasminogen activator release over 
the 21 day period post-inoculation studied. Enhanced levels of 
plasminogen activator release occurred at 2, 7, 13 and 21 days 
post-inoculation for both N.asteroides and N.brasiliensis 
infections. 
Macrophages from mice inoculated two days previously with 
N.asteroides do not release significantly more plasminogen 
activator than control macrophages when the direct assay method 
is used, however, borderline significant differences were shown 
between levels of enzyme released by the two different cell 
groups with the indirect assay method. In inflammatory 
macrophages, plasminogen activator occurs in two active forms 
(section 3.1.2). Cellular plasminogen activator is firmly 
membrane-bound and the formation of plasmin will be strictly 
dependent on the presence of the cells (Lemaire, Drapier and 
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Petit, 19 8 3) • The direct assay measures cell-bound and soluble 
plasminogen activator released by intact cells and the indirect 
assay measures enzyme secreted into the culture medium. 
Macrophage activation generally results in a much greater 
increase in the amount of released than cell-associated 
plasminogen activator (Unkeless, Gordon and Reich, 1974; Solomon 
et al, 1980). Fibrinolytic proteolysis is most efficiently 
measured by direct attachment of cells to 125 r fibrin plates 
since both secreted and cell-membrane associated plasminogen 
activator is measured (Jones, Goldfarb and Holden, 1983). Under 
the assay conditions, unstimulated macrophages that have been 
cultivated on fibrin for 24 hours will release significant 
amounts of radioactivity (Gordon, 1978;33:7&8). Inspection of 
the data (Table 31) reveals that considerable fibrinolytic 
activity occurred with control macrophages, especially in 
experiment 3. Examination of records of post-mortem details and 
morphological data during culture did not reveal any unusual 
characteristics either for the mice or their macrophages, 
therefore control macrophage f ibr i nol ys is was probably due to 
macrophage exposure to soluble fibrin (3.3.1.4.2.5, Sherman, Lee 
and Stewart, 1981), and the use of purified plasminogen. 
Although the direct assay is more sensitive than the indirect 
assay - in the indirect assay secreted plasminogen activator can 
only be measured under serum-free conditions (Jones, Goldfarb and 
Holden, 1983) - a serious drawback is the lack of standardization 
which makes it difficult to compare results with different 
batches of reagents (Gordon 1978; 33 10). This difficulty is 
overcome in the indirect assay by the use of urokinase reference 
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standards. It is likely that all these factors contributed to 
the different results obtained with the direct and indirect assay 
for 2 day N.asteroides-activated macrophages. 
Macrophages harvested from mice 2 days post-inoculation with 
N.brasiliensis are activated with respect to the parameter of 
plasminogen activator release, compared to unstimulated 
macrophages whether the enzyme is measured by the direct or 
indirect method. Significant differences were shown at each time 
point (direct assay Tl -T3, p < 0.01) and results and statistics 
(p < 0.01) were similar whether indirect assay results were 
expressed in terms of urokinase units or specific activity. 
Seven days post-inoculation with N.asteroides, harvested 
macrophages were activated by the criterion of plasminogen 
activator re 1 ease com pa red to control macrophages whet her the 
enzyme was measured directly or indirectly (direct assay, p < 
0. 001, indirect assay p < 0. 001). Similar results were obtained 
for macrophages from mice inoculated seven days previously with 
N.brasiliensis (direct assay p < 0.001; indirect assay p < 
0.001). Differences were significant at each time point in the 
direct assay and in the indirect assay and results and statistics 
were similar (p < 0.001 in each case) whether data was expressed 
as urokinase units or as specific activity. 
Macrophages harvested from mice inoculated 13 days previously 
with N.asteroides release significantly increased amounts of 
plasminogen activator compared to control macrophages (p < 0.05, 
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direct assay: p < 0.01, indirect assay) and are therefore 
activated by this criterion. Similarly 13 day N.brasiliensis 
-activated macrophages are activated by the criterion of 
increased plasminogen activator release (direct assay, p < 0.01: 
indirect assay p < 0.05). 
Macrophages harvested from mice inoculated 21 days previously 
with N.asteroides are activated with respect to the criterion of 
plasminogen activator release compared to control macrophages 
when enzyme levels are measured using the indirect assay (p < 
0.01), but significant differences in plasminogen activator 
release between control and N.asteroides-activated cells were 
only found at Tl (p < 0.05) using the direct assay. Control 
macrophage percentages of fibrinolysis were fairly high in this 
series of experiments, reasons for this have been discussed 
earlier (discussion of results of 2 day N.asteroides-activated 
macrophages). In the indirect assay, results were similar and 
statistically significant whether expressed as urokinase units or 
specific activity. 
In the series of ex per imen ts using macrophages harvested from 
mice inoculated 21 days previously with N.brasiliensis, 
macrophages were activated by the criterion of plasminogen 
activator release compared to control macrophages when the enzyme 
was measured by the indirect assay (p < 0.001) and by the direct 
method (p < 0.05) although results were not significantly 
different at Tl. Inspection of this data (Table 66) reveals that 
21 day N.brasiliensis-activated macrophages released rather low 
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levels of enzyme compared to macrophages from mice inoculated at 
the different time intervals prior to sacrifice. 
To investigate whether plasminogen activator- secr-etion is 
modulated over the 21 day infection period and whether- degree of 
secr-etion is different in N.asteroides and N.br-asiliensis 
infections, percentage control fibrinolysis values were 
calculated (direct assay). Enzyme secretion appeared to be 
maximal at 7 days post-inoculation in N.asteroides infection and 
at 2 days post-inoculation in N.brasiliensis infection. 
Secretion, in terms of per-centage contr-ols, appeared to be 
successively reduced over the 21 day period of infection with 
N.brasiliensis. In contrast, values for percentage secretion 
were low 2 days post-inoculation with N.asteroides, maximal at 7 
days and thereafter successively reducing at 13 and 21 days to 
levels similar to those obtained at 2 days post-inoculation. 
Comparison of per-centage contr-ol enzyme values for 2 day 
N.asteroides-activated macrophages with per-centage control enzyme 
values obtained at 7, 13 and 21 days reveals that enzyme levels 
appear to be similar at 2 and 21 days and levels at 2 days are 
less than those obtained at 7 and 13 days. 'I'his apparent trend 
must be seen in context within the limitations of this assay 
(direct), since the stimulatory effects of the fibrin and 
purified plasminogen on control macrophages may be responsible 
for the low percentage control values obtained at 2 and 21 days 
post-inoculation, and this may be responsible for the apparent 
trend. 
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Percentage control va 1 ue s were calculated for the direct assay 
but not for the indirect assay since baseline levels of enzyme 
secretion are expected in the indirect assay for control cells, 
(Unkeless, Gordon and Reich, 1974) and this, in general, was 
found in the series of experiments employing the indirect assay. 
In fact, enzyme release from control ce 11 s f requen tl y could not 
be detected. It was therefore felt that calculation of 
percentage controls for this assay was invalid since minor 
fluctuations of the baseline would result in dramatic changes in 
the percentage control value, with consequent modifications of 
the apparent trend of enzyme release. 
There is a correlation between the production of plasminogen 
activator by the stimulated macrophage and the inflammatory 
response in the peritoneal activity (Hamilton, 1981; section 
3.1.4). From percentage control enzyme values it appears that 
the inflammatory response to N.asteroides is greatest at 7 days, 
whereas inflammation is 
N.brasiliensis. Thus, 
greatest at 2 days post-inoculation with 
within the limitations of the assay, it 
appears that degree of macrophage response to N.asteroides and 
N.brasiliensis infection is different and is modulated over the 
21 day infection period. This indicates that the inflammatory 
response in the per i ton ea l cavity is modulated over the period 
under study. 
Macrophage activation by immunologically specific mechanisms 
occurs in the course of infection produced by intracellular 
organisms such as M.tuberculosis (Gordon, Newman and Bloom, 
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1978): and it has been shown in this study that infection with 
the facultative intracellular parasite Nocardia results in 
enhanced secretion of macrophage plasminogen activator. It has 
been stated that chronic inflammatory disease in the lung is 
prominently associated with stimuli that regulate the induction 
of macrophage proteinases in culture (Gordon, 1977), and that the 
ability to induce a sustained release of enzyme depended on the 
per s i s ten c e o f t he p hag o c y t i zed pa r t i c 1 e ( Gordon , Newman and 
Bloom, 1978) the decrease in fibrinolytic activity after 
pa rt ic le di ges ti on should 1 imi t and 1 oca 1 i ze the generation of 
plasmin by macrophages (Gordon, 1978). Persistance of 
intracellular particles (such as intracellular parasites) is 
associated ~ith continued generation of plasmin, collagenase and 
elastase and could serve to perpetuate a chronic granulomatous 
response (Gordon, 1977) such as occurs in Nocardia infection, eg 
in mycetoma. 
Macrophages harvested from control mice or from N.asteroides or 
N.brasiliensis-inoculated mice were exposed to appropriate 
homologous culture filtrate antigens of Nocardia for 48 hours 
prior to the assay for fibrinolysis or incubation in serum-free 
medium. 
Release of plasminogen activator by control macrophages was not 
significantly modified by in vitro exposure to 0.02% culture 
filtrate antigen except in one series of experiments 
plasminogen activator release by 21 day N.asteroides-activated 
macrophages measured by the indirect assay. When data were 
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expressed in terms of urokinase uni ts results were significant 
but not when expressed as specific activity. Inspection of the 
data (Table 63) reveals that antigen-exposed macrophages released 
large amounts of plasminogen activator in one experiment. The 
cell morphology data did not indicate any unusual characteristics 
for these macrophages in culture. Since neither the direct assay 
nor the indirect assay showed significant differences when data 
were expressed as specific activity, these results must be 
artifactual, statistical significance being achieved because of 
the low number of readings. 
Nocardia-activated macrophages were exposed to 0.02% and 0.002% 
of appropriate homologous antigen and plasminogen activator 
release measured. In general, macrophage release of plasminogen 
activator was not significantly modified by exposure to antigen. 
However, significant effects of antigen exposure were found in a 
few instances. Using the direct assay for measurement of 
plasminogen activator, significantly different levels of 
fibrinolysis were found for 2 day N.asteroides-activated 
macrophages compared to the same cells exposed to 0.02% and 
0.002% antigen(p < 0.01) at T3 only. A reduction in percentage 
fibrinolysis occurred in both cases (median fibrinolysis 
percentages, from Table 32: N.asteroides-activated 78.2%, 
N.asteroides-activated + 0.02%, antigen = 63.56%; N.asteroides 
-activated+ 0.002% antigen = 62.67%), i.e. antigen exposure in 
vitro appears to inhibit plasminogen activator release by 2 day 
N.asteroides-activated macrophages. 21 day N.brasiliensis 
-activated macrophages released significantly less plasminogen 
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activator (p < 0.05) when exposed to 0.002% antigen in vitro. 
Thirteen day N.asteroides-activated macrophages released 
significantly less plasminogen activator when exposed to 0.002% 
antigen in vitro when the enzyme was measured by the indirect 
assay and expressed in terms of specific activity. Results were 
not significant when expressed as milliunits of urokinase. 
The apparent but irregular effect of antigen on plasminogen 
activator release led to the idea that antigen exposure in vitro 
did influence macrophage plasminogen activator secretion but that 
the effect was being masked by the pooling of data to test for 
statistically significant differences between groups. It was 
thought that this masking effect could be obviated by performing 
experiments with large numbers of replicate samples and testing 
for significant effects of antigen within a single experiment. 
Experiments were performed using 8 replicate samples in each 
group (i.e. control, Nocardia-activated, etc) in the direct 
assay. Statistically significant effects of antigen exposure 
were shown, however, these significant effects were not 
reproduced when the experiment was repeated, and consequently it 
was decided that antigen effects were erratic and no conclusions 
could be drawn from the results. It could be argued that the 
macrophages were already operating at peak capacity with respect 
to plasminogen activator secretion and could not therefore 
respond to a further stimulus. This was thought to be unlikely 
since comparison of plasminogen activator release by macrophages 
from mice inoculated 2 days previously with N.asteroides with 
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that of macrophages from mice injected 4 days previously with 
thioglycolate medium showed that thioglycolate-elicited 
macrophages lysed vastly greater amounts of the fibrin than 
N.asteroides-activated macrophages over the same time period 
(Table 17a). 
Culture filtrate antigens of N.asteroides and N.brasiliensis were 
shown to be active and antigenic using a modification of the PCA 
skin test and by lymphocyte transformation tests (data not 
shown). One 
generation of 
pathway for activating 
specifically sensitized 
macrophages depends on the 
T-1 ymphocytes ( Gordon and 
Cohn, 1978). It was hoped that the experimental model described 
by these workers would elucidate the role of T-cells in 
macrophage activation in experimental Nocardia infections. 
Experiments with unseparated lymphocytes, culture filtrate 
antigen and control and Nocardia-activated macrophages produced 
inconclusive results, so the attempt to determine the role of T-
cells in macrophage activation was abandoned. It is possible 
that the culture filtrate antigens used in this study were 
inappropriate, and consequently no definite results were 
obtained. The role of T-cells in the activation of macrophages 
in experimental Nocardia infections remains to be determined. 
In the direct assay, the range of pooled data within the groups 
is large (see 95% 
inter-experimental 
confidence 
variation 
limits). In a 
may be expected 
biological system, 
to be large, also 
the direct assay is not standardized, so that it is difficult to 
compare results with different batches of reagents (Gordon, 1978; 
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33 10) • Despite this variation, statistically significant 
difference were shown between data groups. 
Several assays are available for measurement of plasminogen 
activator. However, 
Hibbs, 1979). The 
all present limitations (Drapier, Vavrin and 
125 1-fibrin plate method (Unkeless et al, 
1973) is the most sensitive (Drapier, Vavrin and Hibbs, 1979). 
There are several disadvantages of the 125 I-fibrin plate assay, 
the main drawback being the lack of standardization. Results 
obtained from discontinuous measurements may be obscured by 
plasmin-inacti va tion or by the presence of inhibitors ( Drapier, 
Vavrin and Hibbs, 1979). 
hydrolysis of fibrin 
Several difficulties are caused by the 
fibrinogen adsorbs fibrinolytic and 
thrombolytic factors so in the conversion of fibrinogen to fibrin 
using thrombin, the fibrin will contain adsorbed factors and the 
effect of this on protease systems is unknown. Fibrin-adsorbed 
plasminogen may decrease the sensi ti vi ty of the assay, and the 
insolubility of fibrin retards accomplishment of steady-state 
hydrolysis. These factors result in a logarithmic rather than 
linear assay (Kessner and Troll, 1976). 
However, the 125 1-fibrin plate assay is rapid, sensitive and 
versatile; it can be used to detect plasminogen activator, 
plasminogen or plasmin in minute quantities. The assay can be 
made more or less sensitive by use of acid-treated serum or 
purified plasminogen so it can be tailored to individual 
experimental conditions. The main drawback of lack of 
standardization can be overcome by the use of urokinase reference 
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standards, and percentage fibrinolysis can be expressed in 
arbitrary units. It appears that in most studies of macrophage 
plasminogen activator release, workers have used the 125 1-fibrin 
plate method (Unkeless, Gordon and Reich, 1974; Gordon and Cohn, 
1978; Vassali, Hamilton and Reich, 1977; Sherman, Lee and 
Stewart, 1981; Hamil ton, 1980 and 1983). The vast amount of 
literature published on the subject gives a great deal of 
information on the use of and problems with the assay. Cell 
culture, in conjunction with the 125 1-fibrin plate assay, 
provides a useful closed system to study secretion in vitro, 
since it is feasible to study the effects of addition of antigens 
or mitogens such as Con A in vitro and it is possible to 
determine the intra- and extracellular distribution of 
plasminogen activator during continued cultivation (Gordon, 
1976). The 125 f'b . 'd d I- i rin assay was consi ere to be the most 
suitable method for determination of plasminogen activator in 
this experimental system. 
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3.5 FIGURES 
Fig 4 Enzymatic cleavage reactions involved in fibrinolysis 
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Fig 8: Fibrinolysis produced by macrophages from mice inoculated 2 days 
previously with N.brasiliensis or with saline only : Direct assay 
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Fig 12 
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Fig 16 Fibrinolysis produced by macrophages from mice inoculated 13 days 
previously with N.brasiliensis or with saline only : Direct assay 
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3.6 TABLES 
TABLE 12 
Fibrinolysis produced by unstimulated macrophages exposed in vitro to 
Con A. (Data expressed as percentage fibrinolysis and are means of 
duplicates). 
Mouse Strain (ha) ICR/UCT 
'l'imepoint Tl T1 T3 T4 
(Hours) 16 20 24 42 
Control 0.74 1.17 1. 44 2.4 
Con 5rol + 10- M Con A 1.18 1. 38 1. 68 2.49 
ConGrol + 
10- M Con A 4.74 6.02 6.64 10.26 
Con 7rol + 10- M Con A 5.01 8.23 11. 42 14.57 
KEY: M Molarity 
TABLE 13 
Optimisation of number of macrophages distributed into each well 
thioglycolate-elicited macrophages. (Data expressed as percentage 
fibrinolysis and are means of duplicates. ATHIFCS used as plasminogen 
source) 
Mouse Strain (Ha) ICR/UCT 
ATHIFCS 
Timepoint Tl T2 T3 T4 
(Hours) 5 23 28.25 48 
Control 
Cell no. 5xl05 0.36 1. 4 1. 83 2.97 
1. 25 X 105 U.7 3.92 4.96 6.4 
2.5 X 105 0.81 6.95 8. 77 11. 62 
5 X 105 1. 2 13.28 16.28 20.36 
7.5 X 105 l. 24 15.15 20.82 28.58 
*** 1 X 106 1. 53 19.71 25.4 34.18 
1. 25 X 106 1. 0 15.09 19.65 25.85 
1. 5 X 106 1. 04 17.03 22. 92 3l.5B 
1. 75 X 106 1. 3 21. 45 27.58 28.23 
2 X 106 0.89 15.29 20.39 19.53 
KEY: *** Thioglycolate-elicited macrophages cell number 
TABLE 14 
Optimisation of number of macrophages distributed into each well 
mice inoculated 7 days previously with N.brasliensis (Data expressed 
as percentage fibrinolysis and are means of duplicates. ATDS used as 
plasminogen source) 
ATOS 
Timepoint 
(Hours) 
Control 5 x 105* 
Nb 5 X 10 5 
Nb X 1 X 106 
* macrophage number 
7 
% 
day N.brasiliensis infection 
fibrinolysis 
Tl T2 T3 
2 4 6 
0.05 0.27 ll.43 
1. 41 19.09 33.7 
10.78 54.61 72.88 
TABLE 15a 
Optimization of number of macrophages distributed into each well 
mice inoculated 7 days previously with N.asteroides or N.brasiliensis. 
(Data expressed as percentage fibrinolysis and are means of 
duplicates. Purified plasminogen used as plasminogen source) 
Control 
Cell no. 
Na 
cell no. 
Control 
Cell no. 
Nb 
cell no. 
PLG 
Timepoint 
(Hours) 
5 X 105 
2.5 X 105 
5 X 105 
7.5 X 105 
1 X 106 
1. 5 X 106 
PLG 
Timepoint 
(Hours) 
2.5 X 105 
5 X 10 5 
7.5 X 10 5 
7 day N.asteroides infection 
% fibrinolysis 
Tl T2 
3.25 4.5 
0.22 0.37 
1. 55 8.93 
9.59 22.17 
24.23 31. 28 
29.24 36.26 
22.3 37.44 
TABLE !Sb 
7 day N.brasiliensis infection 
% fibrinolysis 
Tl T2 
2 4.5 
1.15 3.74 
2.55 4.81 
4.41 14.43 
7.61 21.66 
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T3 
6 
0.55 
16.2 
34.42 
45.66 
55.43 
59.28 
T3 
6 
7.1 
10.84 
29.92 
36.72 
TABLE 16a 
Optimisation of volume of conditioned medium (CM) to be added to each 
well and period of culture in serum-free medium : 21 day N.asteroides 
infection, 24 hour incubation. (Data expressed as percentage 
fibrinolysis are means of duplicates) 
24 Hour 21 day N.asteroides infection 
incubation % fibrinolys1s 
Time point Tl T2 T3 
(Hours) 1 4 10 
Volume: 
Volume of CM 20 pl 0.13 0.94 6.75 
from control 50 pl 0.15 1. 45 8.96 
macrophages 100 pl 0.27 2.68 7.48 
200 pl 0.16 3.24 16.4 
250 pl 0.02 0.37 8.43 
Volume of CM 20 pl 0.44 3.99 31.74 
from Na 50 pl 0.71 8.78 50.33 
100 pl 0.53 8.68 62.08 
200 JJl 0.49 8.1 62.48 
250 pl 0.49 8.22 55.52 
TABLE 16b 
Optimisation of period of culture in serum-free medium 21 day 
N.asteroides infection, 4 days incubation. (Data expressed as 
percentage fibrinolysis and are means of duplicates). 
4 day 21 day N.asteroides infection 
incubation % fibrinolysis 
Timepoint Tl T2 T3 
(Hours) 1 4 10 
Volume: 
Control CM 50 }11 0 0 3.14 
Na CM 50 fl 2.12 13.49 96. 84 
TABLE 16c 
Optimisation of volume of CM to be added to each well 
N.brasiliensis infection, 24 hour incubation in serum-free 
{Data expressed as% fibrinolysis and are means of duplicate) 
2 day 
medium. 
24 Hour 21 day N.brasiliensis infection 
incubation % fibrinolysis 
Timepoint Tl T2 T3 
(Hours) 3.5 7.5 18.5 
Volume: 
Volume of CM 20 pl 0.38 1. 21 5.52 
from control 50 pl 0.86 0.51 7.72 
macrophages 100 pl 1. 02 2.35 16.92 
\'olur,e of Ci·i 2l'.· pl 4.36 24.47 63.97 
from Nb SU pl 9.27 62.6 68.91 
100 fl lB.44 81.06 78.47 
') ') 
TABLE 17a 
Comparison of macrophage fibrinolysis in dog serum and in fetal calf 
serum. (Data expressed as% fibrinolysis and are means of duplicates) 
ATHI 
FCS 
ATDS 
Timepoint 
(.Hours) 
Control 
Thio 
Control 
Thio 
2d Na 
Tl 
1. 25 
T2 
3.5 
% Fibrinolysis 
T3 
7.25 
T4 TS 
11. 5 22 
0.65 0.86 
T6 
30.25 
1. 7 
T7 
54.25 
3.84 0.25 
1. 06 
0.28 
1. 34 
0.35 
2.05 4.56 11.37 17.23 28.52 
0.25 6.45 39.86 62.29 
12.82 40.89 61.51 56.2 
0.05 3.26 18.03 30.97 
TABLE 17b 
Comparison of macrophage fibrinolysis in dog serum and in fetal calf 
serum. (Data expressed as% fibrinolysis and are means of duplicates) 
Mice inoculated 7 days previously with N.brasiliensis. 
ATFCS 
ATDS 
ATFCS 
-P 
Timepoint 
(Hours) 
Control 
7d Nb 
Control 
7d Nb 
Control 
7d Nb 
% Fibrinolysis 
Tl 
1. 75 
0.1 
0.1 
0.05 
T2 
4 
0 
0.03 
0. 27 
T3 
6 
0 
0.23 
0.43 
1.41 19.09 33.7 
0 
0 
0 
0 
0 
0 
TABLE 18 
T4 
12.25 
0 
1. 31 
TS 
22.25 
0.1 
3.76 
1.91 10.26 
78.82 86.59 
0 
0 
0 
0 
T6 
30 
0 
4.01 
0 
0 
T7 
51.25 
0 
6.3 
0 
0 
Fibrinolysis by control macrophages from individual mice in different 
batches of ATDS. (Data expressed as % fibrinolysis and are means of 
duplicates) 
Mouse ATDS Control macrophages from individual mice 
No. Batch % fibrinolysis 
Timepoint Tl T2 T3 
(Hours) 2 4.25 6 
1 C 5.31 22.25 38.22 
1 N 9.66 30.87 47.77 
2 N 5.0 42.36 56.95 
3 C 8.27 30.83 43.28 
3 N 10. 56 33.46 57.94 
3 H 10.07 21. 6 44.15 
4 N 5.75 29.33 54.05 
5 N 13.87 50.95 69.01 
6 H 3.21 24.05 48.16 
8 N 4.51 21. 93 39.27 
KEY: C Conventionally used batch of ATDS 
N New batch of ATDS 
H Home prepared ATDS 
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TABLE 19 
Plasminogen-dependence of macrophage fibrinolysis in ATDS. 
Macrophages from mice inoculated 13 days previously with 
N.brasiliensis. (Data expressed as % fibrinolysis and are means of 
duplicates) 
13 day N.brasiliensis infection 
% Fibrinolysis 
Timepoint Tl T2 T3 T4 
(Hours) 2 6 19 25.5 
ATDS l. 27 5.72 48.74 75.18 
Control 
ATDS -P 0 0 0 0 
ATDS 0.16 2.63 26.34 50.5 
Na 
ATDS -P 0 0 0 0 
KEY: ATDS -P Acid-treated dog serum depleted of plasminogen 
TABLE 20 
Fibrinolysis produced by macrophages from individual control mice in 
HIATFCS and ATDS. (Data expressed as % fibrinolysis and are means of 
duplicates) 
Serum Mouse Timepoint 
No. (Hours) 
Tl T2 T3 T4 
2.25 4 6 22 
HIAT 3 0.32 0.35 0.21 0 
FCS 5 0.12 0 0 0 
12 0.18 0.36 0.32 0.51 
l 7.22 16.86 29.63 80.92 
2 4.14 11.48 28.26 87.92 
4 3.46 7.84 17.2 86.32 
6 13.68 18.79 37.36 80.87 
7 3.89 8.11 25 .11 80.99 
8 2.91 6.01 16.14 78.16 
9 4.77 10,23 28.15 84.82 
10 l. 26 5.4 13.59 73.61 
ATDS 12 9.78 23.79 39.51 86.18 
13 2.71 5.76 13.67 63.7 
14 1.18 2.27 5.37 26.64 
15 4.98 8.78 18.81 70.21 
16 3.31 6.53 13. 95 59.68 
18 3. 72 10 .11 20.53 72.95 
19 4.58 13.53 26.12 83.29 
20 2.37 5.27 15.84 67.62 
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TABLE 21 
Effect of removal of lymphocytes on macrophage fibrinolysis in ATDS. 
Macrophages from mice inoculated 7 days previously with N.asteroides. 
(Data expressed as% fibrinolysis and are means of duplicates) 
M0 Presence or Timepoint 
Type absence of (Hours) 
lymphocytes 
Tl T2 T3 T4 
3 5.5 7 11. 5 
Control + L 8.31 47.97 59.61 60.09 
-
L 7. 23 46.58 60.86 73.81 
7d Na + L 11. 41 30.63 47.95 51.61 
- L 8.84 30.66 46.35 49.18 
TABLE 22 
Comparison of macrophage fibrinolysis in the presence of purified 
plasminogen (PLG) or ATDS and confirmation of plasminogen dependence 
of fibrinolysis. Macrophages from mice inoculated 7days previously 
with N.brasiliensis. (Data 'expressed as percentage fibrinolysis and 
are means of duplicates) 
M0 PLG Timepoint 
Type Source (Hours) 
Tl T2 T3 
2.5 4.5 8 
PLG 2.83 10 32.03 
Control ATDS 13.99 44.81 71. 94 
- PLG 0 0 0 
PLG 3.18 19.94 52.88 
7d Nb ATDS 19. 27 33.79 52.33 
- PLG 0 0 0 
KEY: 7d Na Mice inoculated 7 days previously with N.asteroides 
7d Nb Mice inoculated 7 days previously with N.bras1l1ensis 
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TABLE 23a 
Comparison of macrophages fibrinolytic activity when measured by the 
direct and indirect assay. Mice were inoculated 7 days previously 
with N.brasiliensis, and macrophages assayed by the two methods were 
derived from the same cell pool. (Data expressed as median % 
fibrinolysis and 95% confidence limits for n = 8 replicates [direct 
assay) and n = 4 replicates [indirect assay)) 
M0 
Type 
Control 
7d Nb 
Direct 
Assay 
n 
Median 
LL 
UL 
n 
Median 
LL 
UL 
Tl 
2 
8 
1. 72 
1. 51 
1. 99 
8 
3.84 
2.61 
4.71 
Timepoint 
(Hours) 
T2 T3 
4 6 
8 8 
6.45 24.82 
5.05 21.65 
7.87 28.58 
8 8 
14.28 41.34 
9.94 37.04 
19.24 46.57 
TABLE 23b 
Fibrinolysis measured by the indirect assay 
M0 
Type 
Control 
7d Nb 
Indirect 
Assay 
n 
Median 
LL 
UL 
n 
Median 
LL 
UL 
Tl 
6.75 
4 
0 
0 
0 
4 
7.43 
6.14 
9.71 
Timepoint 
(Hours) 
T2 T3 
8. 25 10.75 
4 4 
0 0 
0 0 
0 0 
4 4 
11. 24 26.76 
9.69 23.19 
12.79 30.33 
KEY: 7d Nb mice inoculated 7 days previously with N.brasiliensis 
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TABLE 24a 
Effect of Con A exposure in vitro on 
elicited peritoneal macrophages, and 
strain. (Units=% fibrinolysis data 
fibrinolysis by thioglycolate-
selection of appropriate mouse 
mean of duplicates) 
Mouse (Ha) ICR/UCT c3H/He/UCT Strain 
Timepoint Tl T2 T3 T4 Tl T2 T3 T4 
(Hours) 5.5 21. 5 27.5 42 5.5 21. 5 27.5 42 
Control 1.19 2. 24 2.47 3.83 0.6 1. 32 1. 59 2.19 
Thio 1. 85 8.22 10.08 17.41 1. 63 14.86 20.52 38.2 
Thio (a) 1. 79 7.98 9.85 16.59 1. 43 8.03 10.64 17.67 
Thio (b) 1. 89 9.98 13.04 22.79 1. 87 17.25 23.34 39.27 
Thio ( C) 1. 72 8.65 10.73 17.53 1. 73 15.88 19.4 31. 69 
TABLE 24b 
Mouse Balb/C/UCT CBA/Ca/UCT 
Strain 
Timepoint Tl T2 T3 T4 Tl T2 T3 T4 
(Hours) 5.5 21. 5 27.5 42 5.5 21. 5 27.5 42 
Control 0.16 1. 45 1. 77 2.51 1. 34 5.11 4.92 7.53 
Thio 1. 24 4.11 5.05 7.3 1. 74 5.37 6.05 8.56 
Thio (al 1. 04 4.15 4.1 7.23 1.14 2.58 3.09 4.94 
Thio (b) 1. 96 9.82 12.31 18.66 1. 41 4.93 5.97 9.15 
Thio (Cl 1. 02 5.93 6.96 10.74 1. 34 4.73 5.69 8.65 
KEY: Thio (al Thio, 10-6 M 
10-7 M 
Con A 
Thio (bl Thio, Con A 
Thio (cl Thio, 10-8 M Con A 
TABLE 25 
Fibrinolysis by macrophages over the 48 hour incubation period prior 
to the assay for fibrinolysis. Macrophages are from mice inoculated 7 
days previously with N.brasiliensis. (Data expressed as median % 
fibrinolysis for n = 8 replicates and 95% confidence limits) 
M0 
Type 
Control 
Nb 
Nb + 0.02% 
Nb + 0.002% 
KEY: Control 
Nb 
Nb+ 0.02% 
(0.002%l 
n 
8 
8 
8 
8 
% Fibrinolysis by Macrophages during 
the 48 hour incubation period 
Median 
4.81 
9.54 
10.57 
10. 93 
LL 
4.07 
8.74 
9.36 
10.36 
UL 
5.59 
10.31 
11. 87 
11.46 
Macrophages from saline-inoculated mice 
Macrophages from mice inoculated 7 days previously 
with N.brasiliensis 
Macrophages from mice inoculated 7 days previously 
with N.brasiliensis and exposed in vitro to 0.02% 
(0.002%) N.brasiliensis antigen 
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TABLE 26 
Macrophage counts in washes after 48 hour 
expressed as number of macrophages counted 
linbro wells, using a haemocytometer. N 
Nocardia-activated macrophages exposed in 
homologous antigen) 
incubation period. (Data 
in washes from individual 
+ 0.02% and N + 0.002% = 
vitro to 0. 02% or 0. 002% 
Macrophage counts in washes after 
48 hour incubation 
E C N 
l l l 
Na 2 l 2 
3 2 0 
4 0 1 
Nb 5 l 0 
6 0 2 
KEY: E Experiment 
Control C 
N Nocardia-activated 
Na N.asteroides infection 
Nb N.brasiliensis infection 
TABLE 27 
N+0.02% 
l 
0 
2 
l 
l 
l 
N+0.002% 
2 
1 
l 
0 
l 
0 
Cell counts after fibrinolysis assay. Adherent cells were treated 
with versene solution and cell counts determined using a coulter 
counter. Macrophages were harvested from mice inoculated 21 days 
previously with N.asteroides (Na + 0.02% or 0.002% N.asteroides 
-activated macrophages exposed in vitro to 0.02% or 0.002% 
N.asteroides antigen) 
21d Na Cell counts after assay 
Macrophage type Mean Count Total Cells 
Control 2235 89400 
1961 78440 
Na 2047 81880 
3420 136800 
Na + 0.02% 1666 66640 
Na + 0.002% 2701 108040 
KEY: 21d Na mice inoculated 21 days previously with N.asteroides 
TABLE 28a 
Dose response and time response data 7 day N .asteroides infection. 
Macrophages were incubated with or without various concentrations of 
N.asteroides antigen for 24 or 48 hours and fibrinolysis measured. 
(Data expressed as% fibrinolysis and are means of duplicates) 
M0 24 Hr Timepoint 
Type Incubation (Hours) 
Ag cone Tl T2 T3 
2 4 6 
C 0.44 0.53 0.9 
0.002% 0.46 0.6 0.82 
Na 1. 54 2.7 7.98 
0.2% 1. 31 3.5 11. 9 
0.02% 1. 09 3.0 12.12 
0. 002% 0.98 2.28 6.14 
0.0002% 1. 01 2.13 7. 77 
0.00002% 1. 29 2.71 10.36 
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TABLE 28b 
M0 48 Hr Timepoint 
Type Incubation (Hours) 
Ag cone Tl T2 T3 
2 4 6 
C 0.22 0.37 0.55 
0.002% 0.16 0.41 0.73 
Na 9.59 22.17 34.42 
0.2% 10.38 20.32 35.88 
0.02% 15.7 25.61 41.51 
0.002% 16.57 28.15 44.39 
0.0002% 11.21 21. 64 33.45 
0.00002% 14.16 22.71 37.41 
TABLE 29a 
Dose response and time response data : 7 day N.asteroides infection. 
Macrophages were incubated with or without various concentrations of 
N. asteroides antigen for 48 or 72 hours and fibrinolysis measured. 
(Data expressed as% fibrinolysis and are means of duplicates) 
M0 48 Hr Timepoint 
Type Incubation (Hours) 
Ag cone Tl T2 T3 
2 4 6 
C 1. 89 6.08 11.32 
0.002% 0.65 1. 81 4.1 
Na 4.92 10.68 19.83 
0.2% 1. 52 3.69 7.65 
0.02% 3.15 5.77 11. 77 
0.002% 2.68 9.22 17.04 
0.0002% 3.58 7.97 16.79 
0.00002% 4.65 8.62 17.76 
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M0 
Type 
C 
Na 
72 Hr 
Incubation 
Ag cone 
0.002% 
0.2% 
0.02% 
0.002% 
0.0002% 
0.00002% 
Tl 
2 
0.68 
0.29 
0.5 
0.19 
0.01 
0.48 
0.68 
0.25 
TABLE 29b 
TABLE 30a 
Timepoint 
(Hours) 
T2 
4 
5.54 
2.04 
5.51 
1. 27 
2.21 
3. 72 
3.7 
4.23 
T3 
6 
19.79 
8.69 
14.88 
4.76 
7.14 
11. 56 
13.49 
15.17 
Dose response and time response data 13 day N.brasiliensis 
infection. Macrophages were incubated with or without various 
concentrations of N.brasiliensis antigen for 48 or 72 hours and 
fibrinolysis measured. (Data expressed as % fibrinolysis and are 
means of duplicates) 
M0 48 Hr Timepoint 
Type Incubation (Hours) 
Ag cone Tl T2 T3 
2 4 6 
C 0.86 5.05 9.45 
0.002% 1.19 6.33 10.44 
Nb 2.92 15.33 23.9 
0. 2% 3.65 19.9 30.65 
0.02% 3.73 12.95 25.29 
0.002% 2.58 10.62 20.05 
0.0002% 2.81 16.79 26.29 
0.00002% 1. 7 6.35 12.76 
TABLE 30b 
M0 72 Hr Timepoint 
Type Incubation (Hours) 
Ag cone Tl T2 T3 
2 4 6 
C 0.36 0.62 1. 64 
0.002% 0.39 1. 45 3.0 
Nb 5.03 21.26 49.75 
0.2% 3.71 17.73 46.94 
0.02% 5.8 21. 2 56.55 
0.002% 4.56 19.78 52.89 
0.0002% 3.9 15.63 52.21 
0.00002% 5.1 19.56 52.89 
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TABLE 31 
Fibrinolysis produced by macrophages from mice inoculated 2 days 
previously with N.asteroides or saline only. Direct assay, % 
Fibrinolysis measured at 2 hourly intervals over 6 hours. 
A 
C 
C* 
Na 
E 
1 
2 
3 
1 
2 
3 
1 
2 
3 
Na* 1 
2 
3 
Na** l 
2 
3 
KEY: A 
E 
C 
C* 
Na 
Na* 
Na**= 
Tl 2 Hr T2 4Hr 
% fibrinolysis % fibrinolysis 
0.62 
6.98 
9.7 
18.93 
7.61 
52.22 
36.27 
51. 67 
41. 49 
0.86 
14.11 
12.01 
8.89 
11. 98 
29.64 
29.31 
16.47 
38.22 
2.21 
29.03 
21. 26 
15.34 
18.48 
57. 96 
39.26 
36.88 
49.12 
3.89 
21. 66 
19. 96 
19.59 
16.54 
41.55 
43.25 
48.02 
44.0 
0.3 
18.07 
19.9 
11. 66 
8.14 
40.08 
54.34 
45.05 
41. 69 
0.19 
19.31 
15.51 
12.51 
12.63 
21. 71 
66.79 
42.28 
56.22 
0.76 
18.95 
15.65 
18.78 
12.66 
21.72 
41. 2 
55.87 
31.61 
2.21 
14.17 
17.26 
30.92 
22.02 
43.13 
45.75 
54.15 
43.48 
2.98 
9.94 
9.64 
8.48 
7.34 
43.42 
48.71 
64.07 
50. 77 
0.67 
6.88 
11. 07 
11. 4 
12.29 
29.31 
77.26 
32.19 
47.22 
2.03 
28.73 
27.39 
38.10 
35.91 
80.21 
79.72 
76.08 
72.91 
3.27 
30.73 
27.11 
24.06 
24.71 
64.26 
71. 28 
71.64 
79. 33 
5.98 
55.48 
56.58 
51.57 
54.91 
70.32 
76.41 
77.85 
71. 34 
9.04 
47.53 
55.24 
58.69 
57.75 
74.8 
89.11 
73.81 
79.85 
1. 73 
33.75 
39.35 
28.73 
21. 01 
68.05 
68.62 
71. 67 
64.73 
2d N.asteroides direct assay 
Experiment number 
Control macrophages 
1. 73 
37.05 
35. 71 
32.03 
37.3 
64.31 
83.12 
79.81 
84.52 
3.51 
28.4 
42.28 
40.52 
33.47 
70.14 
74.89 
76.44 
69.87 
5.75 
65.11 
61.51 
55.67 
59.6 
74.51 
82.36 
72.93 
76.73 
7.12 
25.57 
25.17 
24.92 
20.38 
69.57 
72.17 
74.01 
75.82 
2.79 
18.41 
29.42 
25.79 
35.61 
72.62 
78.43 
84.34 
82.9 
T3 6Hr 
% fibrinolysis 
4.79 
60.07 
57.56 
66.59 
66.87 
77.15 
75.62 
75.91 
80.35 
6.14 
54.94 
59.08 
54.82 
57.73 
73.66 
80.76 
70.69 
78.57 
14.71 
82.27 
82. 96 
84.53 
85.18 
71.15 
71.86 
74.55 
78.62 
16.36 
75.2 
74. 77 
79.82 
76.76 
70.41 
71.17 
73.68 
72.57 
3.84 
60.9 
74.11 
57.15 
50.4 
69.04 
70.64 
75.41 
73.86 
2.78 
74.47 
68.86 
71.34 
64.13 
80.94 
83.15 
90.38 
87.8 
6.62 
62.6 
66.7 
75.39 
65.52 
86.39 
78.79 
77.2 
74.77 
10.59 
90.19 
87.17 
79.71 
81.55 
78.64 
77.2 
72.95 
77.08 
14.12 
52 
50.35 
48.49 
46.96 
71.14 
71. 83 
75.49 
77.43 
5.58 
44.68 
47.6 
52.17 
64.61 
76.78 
77.42 
78.88 
76.84 
Control macrophages+ 0.02% Antigen in vitro 
N.asteroides-activated macrophages 
N.astero1des-activated macrophages + 0.02% Antigen in 
vitro 
N.asteroides-activated macrophage + 0.002% Antigen in 
vitro 
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TABLE 32 
Two day N .asteroides infection 
their 95% confidence limits. 
Median % fibrinolysis values and 
2d Na Tl T2 T3 
Direct 
Control M n=l8 25.99 n=l8 53.555 n=l8 71.34 
LL 12.955 34.54 62.08 
UL 36.885 60.61 77. 71 
Control M n=l8 19.595 n=l8 48.49 n=l8 66.93 
+ 0.02% LL 13.815 32.29 56.34 
Ag UL 28.365 58.585 74.53 
Na M n=l8 30.085 n=l8 64.15 n=l8 78.2 
LL 20.735 54.075 72. 41 
UL 39.91 70.83 81. 91 
Na M n=l8 27.33 n=l8 50.37 n=l8 63.56 
+ 0.02% LL 14.765 40.08 49.42 
Ag UL 40.305 68.32 73.97 
Na + M n=l8 24.915 n=l8 47.075 n=l8 62.76 
0.002% LL 12.295 29. 77 48.43 
Ag UL 37.12 59.255 72.23 
TABLE 33 
Indirect assay data for macrophages from mice inoculated 2 days 
previously with N.asteroides or normal saline. Results expressed as 
milliunits of urokinase and as specific activity. 
Indirect 
Assay 
(a) 
(b) 
KEY: E 
C 
C* 
Na 
Na* 
Na** 
(a) 
( b) 
E 
l 
2 
3 
1 
2 
3 
Macrophage 
C C* Na 
6.29 8.43 15.91 
16.47 
16.35 5.3 32.56 
7.57 
7.65 43.38 
30.l 45.62 82.4 
147.54 
68.13 13. 96 153.67 
24.43 
30.55 216.29 
Experiment 
Control macrophages 
type 
Na* 
11. 48 
15.83 
23.18 
44.54 
79.61 
88.76 
65.89 
211.45 
Na** 
25.16 
15.03 
6.42 
25.26 
269.9 
49.93 
32.72 
122.93 
Control macrophages+ 0.02% antigen in vitro 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages+ 0.02% antigen in 
vitro 
~eroides-activated macrophages+ 0.002% antigen in 
vitro 
Total milliunits of urokinase (mu Uk) 
Specific activity (mu Uk/mg protein) 
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TABLE 34 
Two day N.asteroides infection 
confidence limits for indirect assay. 
urokinaae and as specific activity. 
Median values and their 95% 
Data expressed as milliunits of 
Indirect 
Assay 
(a) 
(b) 
KEY: C 
C* 
Na 
Na* 
Na** 
(a) 
(b) 
M 
LL 
UL 
M 
LL 
UL 
Macrophage type 
C C* Na Na* Na** 
n=4 n=2 n=4 n=4 n=4 
7.63 5.3 27.08 21.34 17.97 
4.02 -4.64 17.23 9.49 11. 22 
11. 24 15.24 36.93 33.19 24. 72 
n=4 n=2 n=4 n=4 n=4 
30.44 13.96 149.98 86.47 104.68 
14.77 -86.61 131. 99 34.47 19.65 
46.11 114.53 197.98 138.65 189.7 
Control macrophages 
Control macrophages+ 0.02% antigen in vitro 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages + 0.02% antigen in 
vitro 
1f:asteroides-activated macrophages+ 0.002% antigen in 
vitro 
Total milliuriits of urokinase (mu Uk) 
Specific activity (mu Uk/mgcell protein) 
TABLE 35 
Significance level (Mann Whitney U Test, 2 
comparison of different experimental data groups 
infection. 
tailed) achieved on 
: 2 day N.asteroides 
Data 
groups 
compared 
1, 2 
1, 3 
1,4 
1,5 
2,3 
2,4 
2,5 
3,4 
3,5 
4,5 
KEY: 1 
2 
3 
4 
5 
* 
Direct Assay Indirect Assay 
Tl T2 T3 Milli units 
2Hr 4Hr 6Hr of 
urokinase 
5% 
5% 
1% 
1% 
Control macrophages 
Control macrophages+ 0.02% antigen 
N.asteroides-activated macrophages 
Specific 
Activity 
5% 
5% 
5% 
5% 
N.asteroides-activated macrophages+ 0.02% antigen in vitro 
N.asteroides-activated macrophages+ 0.002% antigen in vitro 
Borderline significance 
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TABLE 36 
Fibrinolysis produced by macrophages from mice inoculated 2 days 
previously with N.brasiliensis or saline only. Direct assay % 
fibrinolysis measured at 2 hourly intervals over 6 hours. 
A 
C 
C* 
Nb 
Nb* 
Nb** 
KEY: 
Tl 2 Hr T2 4Hr T3 6Hr 
% fibrinolysis % fibrinolysis % fibrinolysis 
A 
E 
0.93 
1. 04 
5.82 
0.53 
2.87 
2.75 
3.16 
5.12 
1. 68 
1. 0 
0.37 
2.93 
2.81 
2.3 
3.68 
3.64 
1. 73 
15.67 
1. 48 
11.14 
13.49 
15.24 
16.1 
1. 8 
1. 59 
11.08 
1. 8 
11.06 
24.69 
14.69 
23.12 
2.66 
1. 41 
6.99 
0.83 
16.54 
28.44 
19.97 
16.54 
C 
C* 
Nb 
Nb* 
Nb** 
1.18 
1. 34 
7.04 
1. 28 
2.01 
3.94 
4.6 
2.9 
1. 33 
0.97 
0.52 
2.58 
3.78 
4.55 
4.17 
3.4 
1. 04 
11. 08 
1. 95 
23.52 
30.13 
20.4 
19.57 
4.43 
l. 66 
9.28 
l. 02 
20.44 
18.84 
11. 76 
15.26 
3.05 
0.95 
10. 05 
0.99 
19.12 
21. 32 
15.59 
24.86 
7.36 
4.15 
32.06 
3.85 
5.38 
6.23 
5.95 
13.75 
8.71 
4.02 
2.95 
5.19 
5.75 
6.07 
5.12 
24.08 
3.8 
46.45 
5.69 
29.24 
636.49 
32.53 
19.35 
17.02 
4.13 
41. 65 
6.63 
31.77 
44.61 
30.89 
56.33 
17.09 
3.28 
33.85 
4.77 
34.19 
54.55 
41. 31 
37.41 
9.08 
5.13 
32.15 
4.56 
5.05 
5.65 
8.34 
4.75 
6.3 
3.36 
3.03 
6.9 
8.8 
9.66 
9.18 
19.39 
3.3 
38.34 
7.33 
28.99 
48.56 
43.26 
52.25 
33.63 
5.77 
54.18 
3.52 
39.79 
38.62 
26.42 
30.97 
13.66 
4.1 
42.98 
5.69 
34.38 
33.95 
32.78 
48.78 
2d N.brasiliensis direct assay 
Experiment number 
Control macrophages 
30.1 
12.86 
51. 25 
14.22 
9.38 
11. 93 
10.76 
18.74 
30.5 
11. 68 
11. 58 
10.1 
13.9 
9.23 
8.62 
55.18 
8.91 
60.19 
17.15 
42.34 
45.98 
48.44 
26.62 
40.67 
15.75 
58.97 
22.05 
46.91 
49.55 
46.74 
75.08 
42.67 
9.29 
54.01 
18.76 
50.89 
72.62 
60.09 
55.55 
30.95 
17.54 
51.22 
18.37 
8.62 
9.79 
14.69 
9.45 
22.8 
10.34 
12.21 
11.16 
11. 73 
6.18 
13.77 
48.97 
9.03 
58. 28 
24.15 
46.56 
74.5 
60.15 
69.25 
52.67 
15.95 
57.62 
10. 56 
56.63 
52.37 
38.28 
47.28 
45.75 
10.87 
60.82 
23.14 
51. 77 
49.11 
49.54 
65.65 
Control macrophages+ 0.02% Antigen in vitro 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages+ 0.02% Antigen in 
vitro 
N.brasiliensis-activated macrophages+ 0.002% Antigen in 
vitro 
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TABLE 37 
2 day N.brasiliensis infections 
their 95% confidence limits. 
median% fibrinolysis values and 
2 d Nb Tl T 2 T 3 
Direct 
Control 
Control 
+ 0.02% 
Ag 
Nb 
Nb 
+0.02% 
Ag 
Nb 
+ 0.02% 
Ag 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
n=l6 
n=l4 
n=l6 
n=l6 
n=l6 
2.83 
1. 72 
4.0 
2.33 
1. 41 
3.25 
11. 33 
7.24 
16.89 
11. 03 
6.34 
15.3 
11. 3 
5.52 
17.78 
n=l6 
n=l4 
n=l6 
n=l6 
n=l6 
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6.58 
5.11 
18.0 
6.04 
4.56 
7.51 
27.85 
18.16 
37.72 
30.13 
18.77 
39.21 
27.24 
19.03 
37.85 
n=l6 
n=l4 
n=l6 
n=l6 
n=l6 
16.21 
11. 84 
30.32 
12.12 
10.72 
17.24 
44.92 
32. 11 
55.8 
45.45 
31. 62 
52.86 
48.33 
33.94 
55.93 
TABLE 38 
Indirect assay data for macrophages from mice inoculated 2 days pre-
viously with N.brasiliensis or normal saline. Results expressed as 
milliunits of urokinase and as specific activity. 
Indirect 
Assay 
(a) 
( b) 
KEY: E 
C 
C* 
Nb 
Nb* 
Nb** 
(a) 
(b) 
Macrophage Type 
C C* Nb Nb* 
30.5 60.l 212.05 274.94 
39.95 133.08 90.0 
206.7 22.1 129.9 158.49 
0 16.8 102.67 120.38 
4.81 235.28 
0 2.54 205.79 248.2 
2.42 5.88 213.76 169.26 
1. 98 251. 98 
127.0 151.0 727.0 764.0 
298.7 110. 0 1106.23 590.2 
766.4 116.42 1235.96 1251.9 
0 
37.99 3.67 1296.34 1067.2 
0 9.51 910.97 1103. 6 
3.53 414.1 466.36 
3.12 534.81 329.22 
Experiment 
Control macrophages 
Control macrophages+ 0.02% Ag in vitro 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages 
vitro 
~siliensis-activated macrophages+ 
vitro 
Total milliunits of urokinase (mu UK) 
Specific activity (mU UK/mg protein) 
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Nb** 
264.86 
545.85 
89.57 
202.97 
235.84 
258.88 
1089.0 
3833.2 
715.96 
902.89 
451.7 
548.29 
+ 0.02% Ag in 
0. 002% Ag in 
TABLE 39 
2 day N.brasiliensis infection 
fidence limits for indirect assay. 
urokinase and as specific activity. 
median values and 
Data expressed 
their 95% con-
as milliunits of 
Indirect 
Assay 
n 
(a) 
(b) 
KEY: C 
C* 
Nb 
Nb* 
Nb** 
(a) 
(b) 
n 
M 
LL 
UL 
M 
LL 
UL 
C 
8 
16.35 
0.99 
105.76 
65.16 
1. 56 
402.2 
C* 
5 
13.99 
0.6 
28.58 
62.97 
25.62 
100.32 
Control macrophages 
Macrophage Type 
Nb 
7 
172.99 
116.29 
232.87 
898.18 
474.46 
1266.15 
Nb* 
7 
183.38 
105.19 
261. 57 
787.62 
397.79 
1177.45 
Nb** 
6 
235.84 
144.81 
326.87 
809.43 
134.83 
1484.04 
Control macrophages+ 0.02% Ag in vitro 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages + 0.02% Ag in 
vitro 
~siliensis-activated macrophages+ 0.002% Ag in 
vitro 
Total milliunits of urokinase (mU UK) 
Specific activity (mU UK/mg protein) 
Number of samples 
TABLE 40 
Significance level (Mann-Whitney U-test, 
parison of different experimental 
N.brasiliensis infection. 
2 tailed) achieved 
data groups 
on com-
2 day 
Direct Assay Indirect Assay 
Data Groups 
Compared 
Tl 
2 hr 
T2 
4 hr 
T3 
6 hr 
Milliunits 
of 
Urokinase 
Specific 
Activity 
1, 2 
1,3 
1,4 
1,5 
2,3 
2,4 
2,5 
3,4 
3,5 
4,5 
KEY: l 
2 
3 
4 
5 
1% 1% 1% 1% 1% 
1% 1% 1% 1% 1% 
5% 1% 1% 1% 1% 
1% 1% 0.1% 1% 1% 
1% 1% 0.1% 1% 1% 
5% 1% 0.1% 1% 1% 
Control macrophages 
Control macrophages+ 0.02% Ag in vitro 
N.brasiliensis-activated macrophages 
N.bras1l1ens1s-activated macrophages+ 0.02% Ag in vitro 
N.brasiliensis-activated macrophages+ 0.002% Ag in vitro 
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TABLE 41 
Fibrinolysis produced by macrophages from mice inoculated 7 days pre-
viously with N.asteroides or saline only direct assay. 
%Fibrinolysis measured at 2 hourly intervals over 6 hours. 
A Tl 2 hr T2 4 hr T3 6 hr 
----------------------------------------------------------------------
C 0.48 1. 58 24.2 22.41 32.26 29.9 
2.06 1. 72 7.32 4.83 12.97 9.66 
0.69 0. 71 1. 0 1. 3 2.43 2.64 
0.08 0.36 0.2 0.53 0.66 0.4 
0.59 0.98 10. 5 9.96 17.02 16.34 
0.39 
0.76 10. 42 7.71 13.53 16.85 
1.13 1. 47 3.05 3.19 6.37 7.02 
1. 78 1.4 6.79 3.82 11. 81 7.83 
2.58 2.94 3. 19 5.47 8.26 9.79 
2.24 2.31 4.07 5.47 8.61 9.27 
----------------------------------------------------------------------
C* 1.64 1. 73 17.55 19.96 23.57 23.76 
0.84 0.46 2.59 1. 02 5.48 2.73 
1. 65 1.14 3.52 2.48 6.61 3.67 
0.28 0.04 0.12 0.7 0.86 0.59 
0.69 0.51 4.19 3.01 13.28 8.86 
0.66 0.59 4.46 3.56 11. 52 11. 48 
1. 4 2.0 3.15 3.25 6.26 6.56 
0.81 2.02 2.63 3.32 4.85 6.14 
1. 58 1. 43 2.34 3.25 5.54 7.87 
1. 28 1. 22 2.3 2.75 6.45 7.19 
Na 2.36 1. 9 13.55 11. 95 18 .11 17.63 
4.77 3.62 10.61 10.76 20.31 19.36 
1. 48 1. 36 4.9 4.37 12.9 10.33 
11. 26 7.93 23.09 21. 26 37.0 31.84 
1. 81 0.78 9.01 18.41 26.37 22.98 
1. 35 2.09 20.48 26.83 29.8 28. 72 
10.81 7.66 35.9 21.75 45.71 42.54 
9.03 9.82 27.91 23.51 50.2 44. 27 
8.11 14.09 26.2 39.09 47.9 51. 65 
13.31 10.77 23.61 31.1 45.03 56.91 
----------------------------------------------------------------------
Na* l. 84 2.45 10.23 10. 99 15.65 15.56 
2.36 3.94 4.63 6.9 8.66 14.89 
3.35 3.74 10.06 9.71 20.97 22.47 
15.98 15.41 26.13 25.08 42.05 40.98 
1. 02 1. 47 7.65 13.21 21.57 24.9 
1. 22 1. 65 11.55 11. 58 21.92 23.97 
13.42 12.81 25.42 23.87 51.64 39.94 
11. 76 7.2 25.17 23.84 45.82 39.77 
8.56 9.76 26.68 21.19 41.14 39.36 
11. 71 13.32 26. 27 21.39 41.74 
----------------------------------------------------------------------
Na** 3.34 
2.63 
20.14 
1.16 
10.74 
14.94 
10.69 
5.91 
2.15 
11. 81 
8.75 
l. 99 
KEY: A 
E 
C 
C* 
Na 
Na* 
3.0 18. 72 10.88 
2. 72 9.41 9.04 
13.01 29.16 27.14 
1. 74 13.64 11. 1 
11. 09 19.59 17.15 
9.34 24.49 18.24 
19.55 19.42 6.97 
23.9 18.28 12.78 
2.35 19.8 
1. 39 19.97 
26. 11 
23.78 
6.66 
13.19 
7d N.asteroides direct assay 
Experiment number 
Control macrophages 
22.52 15.15 
16.58 17.5 
47.53 41.24 
30.44 26.8 
36.36 35.78 
39.36 42.39 
34.53 37.62 
33.18 36.15 
38.22 15.94 
36.98 25.89 
14.38 
26.36 
Control macrophages+ 0.02% Antigen in vitro 
N.asteroides-activated macrophages 
N.astero1des-activated macrophages + 0.02% Antigen in 
vitro 
Na** ~eroides-activated macrophages + 0.002% Antigen in 
vitro 
TABLE 42 
7 day N.asteroides infection 
95% confidence limits. 
median % fibrinolysis values and their 
7d N.ast infect 
Direct 
Control 
Control 
+ 0.02% 
Ag 
Na 
Na 
+0.02% 
Ag 
Na 
+0.002% 
Ag 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
Tl 
n=20 
n=20 
n=20 
n=20 
n=22 
1. 29 
0.87 
1. 72 
1.11 
0.81 
1. 42 
6.11 
3.57 
8.47 
7. 23 
3.65 
9.67 
7. 27 
4.96 
11.25 
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T2 
n=20 
n=20 
n=20 
n=20 
n=22 
5.47 
3.51 
8.64 
3.0 
2.41 
3.74 
20.295 
15.55 
24.86 
17.35 
12.1 
22.52 
16.81 
13.83 
19.88 
T3 
n=20 
n=20 
n=20 
n=20 
n=22 
9.83 
7 .1 
14.42 
6.89 
5.2 
9.92 
32.81 
24.98 
40.0 
30.8 
22. 77 
38.27 
30.94 
26.07 
36.15 
TABLE 43 
Indirect assay data for macrophages PA from mice inoculated 7 days 
previously with N.asteroides or normal saline. Results expressed as 
milliunits of urokinase and as specific activity. 
Indirect 
Assay 
(a) 
(b) 
KEY: C 
C* 
Na 
Na* 
Na** 
(a) 
( b) 
Macrophage Type 
C C* Na Na* Na** 
0 0 67.62 5.12 3.96 
7.18 0 4.28 5.14 29.2 
0.065 8.47 7.6 2.54 5.58 
1. 423 3.01 4.52 34.75 24.05 
4.29 0.09 67.62 4.85 38.06 
5.93 0 62.26 73.33 3fl. 23 
8.74 1. 02 31.25 71. 41 18.13 
10. 77 0 22.51 71. 05 14.51 
3.02 1. 26 17.57 13.06 14.97 
1. 25 21. 96 16.53 5.76 
0 14.17 11. 97 13.69 
18.71 14.08 12.27 
12.03 16.53 16.07 
16.83 11. 97 14.37 
5.0 14.08 
52.61 21. 96 
15.75 19.9 
15.47 
0 0 40.48 54.36 32.17 
54.23 0 30.77 22.34 236.4 
0.39 72. 54 73.38 326.25 33.91 
8.57 17.49 495.85 27.5 80.27 
14.24 0.26 24.41 197.13 135.47 
20.61 0 134.48 371.08 104.33 
28.06 3.25 130.39 276.36 91.91 
59.11 0 131.95 23.49 64.33 
8.4 3.5 99.l 75.71 50.57 
3.08 59.36 35.92 16.64 
0 75.0 39.55 67.85 
48.8 48.97 38.95 
88.55 100.28 78.63 
42.26 42.69 42.81 
47.05 
65.7 
Control macrophages 
Control macrophages+ 0.02% Ag in vitro 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages+ 0.02% Ag in vitro 
N.asteroides-activated macrophages+ 0.002% Ag in vitro 
Total m1ll1units of urokinase (mu UK) 
Specific activity (mU UK/mg protein) 
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TABLE 44 
7 day N.asteroides infection 
limits for indirect assay. 
and as specific activity. 
median values and their 95% confidence 
Data expressed as milliunits of urokinase 
(a) 
(b) 
KEY: C 
C* 
Na 
Na* 
Na** 
(a) 
(b) 
n 
M 
LL 
UL 
M 
LL 
UL 
C 
n=ll 
3.64 
0.72 
6.56 
n=ll 
14.13 
4.2 
33.76 
C* 
n=9 
0.63 
0 
4.24 
n=9 
1. 75 
0 
36.27 
Macrophage Type 
Na 
n=l6 
18.24 
11.68 
36.07 
n=l6 
76.06 
52.08 
103.93 
Control macrophages 
Na* 
n=l5 
18.12 
10.16 
42.65 
n=15 
70.88 
38.35 
188.32 
Na** 
n=l4 
15.91 
10.28 
25.88 
n=l4 
66.09 
44.76 
101. 66 
Control macrophages+ 0.02% Ag in vitro 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages+ 0.02% Aq in vitro 
N.asteroides-activated macrophages + 0.002% Ag in vitro 
Total milliunits of urokinase (mu UK) 
Specific activity (mu UK/mg cell protein) 
number of samples 
TABLE 45 
Significance level (Mann-l'ihitney U-test, 2 tailed) achieved on com-
parison of difference experimental data groups : 7 day N.asteroides 
infection. 
Direct Assay Indirect Assay 
Data Groups 
Compared 
Tl 
2 hr 
T2 
4 hr 
T3 
6 hr 
Milli units 
of 
Urokinase 
Specific 
Activity 
1. 2 
1. 3 
1. 4 
1. 5 
2.3 
2.4 
2.5 
3.4 
3.5 
4.5 
KEY: 1 
2 
3 
4 
5 
1% 
0.1% 0.1% 0.1% 0.1% 0.1% 
0.1% 0.1% 0.1% 0.1% 1% 
0.1% 0.1% 0.1% 0.1% 0.1% 
0.1% 0.1% 0.1% 0.1% 0.1% 
0.1% 0.1% 0.1% 0.1% 0.1% 
0.1% 0.1% 0.1% 0.1% 0.1% 
Control macrophages 
Control macrophages+ 0.02% Ag in vitro 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages+ 0.02 Ag in vitro 
N.asteroides-activated macrophages+ 0.002 Ag in vitro 
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TABLE 46 
Fibrinolysis produced by macrophages from mice inoculated 7 days 
previously with N.brasiliensis or saline only: direct assay. % 
Fibrinolysis measured at 2 hourly intervals over 6 hours. 
A Tl 2 hr T2 4 hr T3 6 hr 
% Fibrinolysis % Fibrinolysis % Fibrinolysis 
C 0.42 0.47 2.19 1. 97 8.19 7.83 
3.57 2.09 11. 73 8.29 29.78 34.28 
0 0 0.72 0.69 3.53 5.2 
1. 24 1. 05 3.44 4.04 6.31 7.8 
1. 67 1. 99 7. 22 5.03 30.37 21. 00 
1. 91 1. 37 6.52 4.32 29.67 24.13 
2.09 1. 51 7.77 5.77 22.59 20.71 
1. 56 1. 65 9.22 5.79 23.13 26.78 
C* 0.44 0.59 2.58 2.57 9.54 9.16 
3.94 1. 98 18.43 9.43 45.85 31.54 
0 0.14 0 0. 72 1. 6 5.31 
1. 37 1. 24 3.64 3.17 7.43 6.69 
1. 66 2.84 8.09 11.18 28.77 32.5 
1. 9 2.01 9.87 11.51 35.1 32.04 
1. 89 1. 67 7.93 7.19 31.38 29.14 
0.76 1. 63 6.48 6.21 20.32 30.16 
----------------------------------------------------------------------
Nb 2.33 1. 89 9.11 9.06 24.22 26.06 
2.95 3.36 20.35 19.54 54.26 51. 5 
0.98 1.12 3.29 2.76 13.53 9.43 
4.43 4.39 17.19 11.68 33.91 25.93 
4.29 5.01 16.44 17.43 41.86 37.04 
3.06 2.61 12.15 10.99 37.87 50.89 
4.69 4.4 23.19 15.2 43.4 42.25 
1. 79 4.69 6.63 13.25 35.55 43.76 
Nb* 1. 88 1. 71 7.33 6.1 27.14 20.2 
3.45 3.52 10.94 10.95 29.74 31.04 
0.8 0.87 3.39 3.51 11. 63 12.5 
4.22 6.59 13. 37 20.97 24.23 35.16 
4.85 5.02 14.88 18.34 55.77 60.69 
2.53 5.6 14.47 25.42 47.27 56.48 
4.78 6.11 15.74 23.28 48.76 58.38 
4.54 5.34 22.27 24.91 56.02 52.45 
---- ------- - - - - -- -- - --- ---- - -- ------- --- - --- -----
Nb** 1. 4 1. 88 5.99 8.18 20. 96 21. 08 
2.68 3.04 15.94 18.28 34.38 42.58 
0.6 0.61 2.37 2.74 10. 78 10.16 
5.02 2.45 13.97 8.19 29.78 19.64 
2.4 2.91 22.97 23.02 53.5 53.59 
2.88 2.42 22.25 30.79 56.95 53.34 
7.67 3.05 24.81 25. 72 60.37 52.83 
5.9 2.91 30.47 26.99 62.29 54.9 
KEY: A 7 day N.brasiliensis direct assay 
Control macrophages C 
C* 
Nb 
Nb* 
Control macrophages+ 0.02% Antigen in vitro 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages+ 0.02% Antigen in 
vitro 
Nb** ~siliensis-activated macrophages + 0. 002% Antigen 
in vitro 
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TABLE 47 
7 day N.brasiliensis infection 
their 95% confidence limits. 
7d N.bras infect 
Direct 
Control 
Control 
+ 0.02% 
Ag 
Nb 
Nb+ 
0.02% 
Ag 
Nb+ 
0.002% 
Ag 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
uL 
M 
LL 
UL 
n=l6 
n=l6 
n=l6 
n=l6 
n=l6 
Tl 
1. 45 
0.92 
1. 83 
1. 5 
0.95 
1. 96 
3.27 
2.48 
4.04 
3.92 
2.83 
5.02 
2.73 
1. 91 
4.03 
median % fibrinolysis values and 
T2 
n=l6 
n=l6 
5.19 
3.5 
7.03 
6.53 
4.33 
9.35 
n=l6 13.14 
9.87 
16.4 
n=l6 14.64 
10.49 
19.08 
n=l6 17.59 
12.5 
23.92 
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T3 
n=l6 
n=l6 
n=l6 
n=l6 
n=l6 
18.77 
13.83 
25.69 
20.57 
15.88 
31.1 
36.88 
28.47 
43.4 
39.85 
29.7 
51.65 
38.99 
31. 5 
53.47 
TABLE 48 
Indirect assay data for macrophage PA from mice inoculated 7 days 
previously with N. brasiliensis or normal saline. Results expressed as 
milliunits of urokinase and as specific activity. 
Indirect 
Assay 
(a) 
(b) 
KEY: 
C 
C* 
Nb 
Nb* 
C C* Nb Nb* Nb** 
11.13 0.275 47.23 27.4 27.55 
0 0 38.74 15.38 27.15 
2. 72 3.37 56.75 70.41 64. 72 
20.21 2.05 46.22 83.56 38.92 
23.7 0.67 66.32 32.99 39.93 
17.0 1. 96 118. 92 30.5 38.49 
0 0 99.89 38.53 27.68 
0 0 106.82 24.23 42.29 
0 0 56.38 42.13 44.81 
0 0 38.75 51. 51 28.12 
39.12 24.51 
16.61 21.79 
36.78 
32.85 
34.4 
25. 96 
26.0 18.0 250.0 88.0 110.0 
0 0 189.62 138.28 218.42 
15.92 7.24 190.0 401. 88 341.3 
32.61 2.64 327.2 598.14 59.47 
60.86 2.37 408.0 85.4 47.88 
30.18 3.85 645.7 HD.68 83.22 
0 0 576.2 68.64 72.88 
0 0 887.21 102.46 176.92 
0 0 159.9 187.7 215.35 
0 0 81. 2 182.6 92.1 
53.6 71.66 
48.35 72.6 
131.1 
124.22 
118.63 
67.8 
Control macrophages 
Control macrophages+ 0.02% Antigen in vitro 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages+ 0.02% Antigen in 
vitro 
Nb** ~siliensis-activated macrophages + 0.002% Antigen 
(a) 
(b) 
in vitro 
Total rnilliunits of urokinase (rnU UK) 
Specific activity (mu UK/mg protein) 
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TABLE 49 
7 day N.brasiliensis infection : 
fidence l1m1ts for indirect assay. 
urokinase and as specific activity. 
median values and their 95% con-
Data expressed as milliunits of 
Indirect 
Assay 
n 
(a) 
(b) 
KEY: C 
C* 
Nb 
Nb* 
Nb** 
(a) 
(b) 
M 
LL 
UL 
M 
LL 
UL 
Macrophage Type 
C 
10 
6.93 
0 
15.67 
15.09 
0 
30.43 
C* 
10 
1. 03 
0 
5.14 
1. 93 
0 
9 
Control macrophages 
Nb 
16 
47.56 
36.6 
72.78 
219.91 
121. 43 
388.4 
Nb* 
10 
37.87 
26. 96 
58.28 
138.28 
88.0 
350.3 
Nb** 
12 
33.64 
27.42 
43.26 
124.51 
72.1 
200.39 
Control macrophages+ 0.02% Antigen in vitro 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages+ 0.02% Antigen in 
vitro 
~siliensis-activated macrophages + 0.002% Antigen 
in vitro 
Total milliunits of urokinase (mu UK) 
Specific activity (mu UK/mg protein) 
TABLE 50 
Significance level (Mann-Whitney U-test, 2 tailed) achieved on com-
7 day parison of different experimental data groups 
N.brasiliensis infection. 
Direct Assay Indirect Assay 
Data Groups 
Compared 
Tl 
2 hr 
T2 
4 hr 
T3 
6 hr 
Milliunits Specific 
of Activity 
1, 2 
1, 3 
1,4 
1, 5 
2,3 
2,4 
2,5 
3,4 
3,5 
4,5 
KEY: 1 
2 
3 
4 
5 
* 
Urokinase 
0.1% 0.1% 0.1% 0.1% 0.1% 
0.1% 0.1% 0.1% 0.1% 0.1% 
1% 0.1% 0.1% 0.1% 0.1% 
0.1% 0.1% 0.1% 0.1% 0.1% 
0.1% 0.1% 0.1% 0.1% 0.1% 
1% 0.1% 0.1% 0.1% 0.1% 
Control 
Control+ 0.02% Ag in vitro 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages+ 0.02% Ag in vitro 
N.bras1l1ensis-activated macrophages+ 0.002% Ag in vitro 
borderline significance 
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TABLE 51 
Fibrinolysis produced by macrophages from mice inoculated 13 days 
previously with N.asteroides or saline only direct assay. 
Fibrinolysis measured at 2 hourly intervals over 6 hours. 
A Tl 2 hr T2 4 hr T3 6 hr 
% fibrinolysis % fibrinolysis % fibrinolysis 
0.77 1.1 2.94 2.58 7.23 7.24 
1. 63 2.42 5.85 7.35 10.18 12.26 
1. 72 2.22 13.14 9.46 20.79 21. 42 
1. 36 1. 6 10.76 9.94 20.12 18.16 
C 6.92 5.54 20.17 21.25 40.51 43.04 
5.64 7.88 20.35 24.48 45.56 37.57 
7.85 8.09 22.97 19.68 47.34 37.31 
11. 61 5.19 24.22 13.52 53.54 26.67 
2.12 1. 61 6.63 4.82 18.58 14.47 
1. 38 1. 05 3.25 5.66 6.96 10.05 
0.91 0.85 6.91 5.65 15.06 10. 49 
0.75 6.05 6.83 18.83 12.24 44. 77 
c* 7.97 6.81 22.18 15.67 54.65 40.92 
9.33 7.53 24.95 19.01 59.88 53.59 
5.35 9.66 23.27 25.45 52.17 63.28 
6.97 22.21 
-----------------------------------------------------------------
2.76 1. 85 7.07 5.52 14.86 12.51 
27.12 18.62 36.33 36.12 46.02 43.94 
2.86 3.06 16.95 20.95 26.75 28.71 
Na 3.64 4.58 16.9 17.73 26.73 27.29 
15.7 9.57 33.73 26.85 52.76 41.59 
15.48 9.12 32.52 25.01 55.18 42.95 
12.04 14.37 29.45 32.08 47.65 49.28 
9.97 10.48 29.61 29.15 46.97 56.57 
2.28 2.81 6.06 8.77 12.86 18.55 
11. 9 21.87 31. 7 34.65 47.86 45.54 
Na* 0.69 1.18 8.83 9.38 15.89 18.21 
4.85 1. 64 21.81 19.35 36.86 31.00 
13.26 15.13 27.13 23.67 42.7 40.82 
16.73 24.28 30.87 30.75 49.04 52.0 
15.5 12.61 28.51 28.55 46.88 47.79 
14.74 14.91 27.78 24.57 43.11 45.16 
---------------------------- --- - ----- - -- -- --
Na** 
KEY: A 
E 
C 
C* 
Na 
Na* 
Na**= 
2.57 2.91 6.41 6.01 
21.45 15.82 33.68 35.4 
4.09 l. 37 20.03 10.27 
6.86 8.03 49.13 50.09 
9.86 13.58 21. 39 35.2 
8.44 15.05 18.92 32.68 
13.71 18.64 31.54 29.04 
13.07 12.79 32.8 25.63 
13d N.asteroides direct assay 
Experiment number 
Control macrophages 
16.56 13.93 
45.22 39.98 
32.04 16.85 
61.28 55.65 
39.29 58.79 
34.34 52.64 
57.19 46.22 
52.58 44.98 
Control macrophages+ 0.02% Antigen in vitro 
N.asteroides-activated macrophages 
N.astero1des-activated macrophages + 0.02% Antigen in 
vitro 
N.asteroides-acti va ted macrophage + 0. 002% Antigen in 
vitro 
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TABLE 52 
13 day N.asteroides infection : median% fibrinolysis and their 95% 
confidence limits. 
13 d Na Tl 
direct 
C 
M 
LL 
UL 
C +0.02% M 
antigen LL 
UL 
Na 
--------
Na 
+0.02% 
Ag 
--------
Na 
+0.002% 
Ag 
--------
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
n=l6 
n=l5 
n=l6 
n=l6 
n=l6 
4.38 
1. 97 
6.61 
4.43 
1. 61 
6.89 
9.55 
6.22 
14.1 
10.48 
7.22 
15.02 
10.61 
7.45 
14.06 
T2 T3 
------------------i---------------------
n=l6 
n=l5 
n=l6 
n=l6 
n=l6 
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14.49 
9.7 
18.87 
14. 22 
6. 77 
20.52 
25.3 
18.95 
30. 84 
23.8 
17.31 
28.53 
27.59 
19.85 
34. l 
n=l6 
n=l5 
n=l6 
n=l6 
n=l6 
28.29 
18.43 
37.31 
33.82 
15.41 
50.65 
38.64 
30.08 
47.65 
39.17 
30.33 
45.87 
42.93 
33.26 
51.09 
TABLE 53 
Indirect assay data for macrophage PA from mice inoculated 
previously with N.asteroides or normal saline. Results 
as milliunits of urokinase and as specific activity. 
13 days 
expressed 
Indirect 
Assay 
(a) 
( b) 
KEY: C 
C* 
Na 
Na* 
Na** 
(a) 
( b) 
Macrophage Type 
C C* Na Na* Na** 
1. 51 2.88 37.99 5.65 18.4 
16.13 11.04 62.47 67.3 51. 07 
0 10.65 79.49 80.01 63.65 
0 0 87.08 21. 3 67.97 
1. 95 1. 06 89.71 72.43 70.83 
55.25 1. 72 58.17 7.28 7.37 
0 2.21 12.66 
0.83 99.46 
5.04 
10.35 21.52 422.63 36.31 155.9 
113.95 68.08 647.35 906.95 457.16 
0 67.24 447.58 460.6 253.14 
0 0 534.23 66.12 135.59 
7.73 4.48 637.5 302.9 248.32 
175.26 7.33 187.74 22.19 20.47 
0 8.93 39.11 
2.44 287.29 
12.57 
Control macrophages 
Control macrophages+ 0.02% antigen in vitro 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages + 0.02% antigen in 
vitro 
~eroides-activated macrophages + 0.002% antigen in 
vitro 
Total millunits of urokinase (mu UK) 
Specific activity (mu UK/mg protein) 
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TABLE 54 
13 day N.asteroides infection median values and their 95% 
confidence limits for indirect assay. Data expressed as milliunits of 
urokinase and as specific activity. 
Indirect 
Assay 
n 
(a) 
(b) 
KEY: C 
C* 
Na 
Na* 
Na** 
(a) 
(b) 
C 
8 
M l. 45 
LL 0 
UL 28.38 
M 7.06 
LL 0 
UL 92.81 
C* 
9 
5.33 
l. 39 
50.84 
33.62 
5.91 
148. 11 
Macrophage Type 
Na 
6 
68.83 
58.51 
79.15 
478.43 
386.74 
570.12 
Control macrophages 
Na* 
7 
39.92 
6.46 
76.22 
212.92 
29.15 
683. 71 
Na** 
6 
43.19 
30.53 
55.85 
194.37 
107. 25 
289.49 
Control macrophages+ 0.02% antigen in vitro 
N.asteroides-activated macrophages 
N.astero1des-activated macrophages + 0.02% antigen in 
vitro 
~eroides-activated macrophages + 0.002% antigen in 
vitro 
Total milliunits of urokinase (mu UK) 
Specific activity (mu UK/mg cell protein) 
TABLE 55 
Significance level (Mann-Whitney U-test, 2 tailed) achieved on 
comparison of different experimental data groups 13 day 
N.asteroides infection. 
Direct Assay Indirect Assay 
Data groups 
compared 
Tl 
2 hr 
T2 
4 hr 
T3 
6 hr 
Milli units 
of 
Urokinase 
Specific 
Activity 
1, 2 
1, 3 
1,4 
1,5 
2,3 
2,4 
2,5 
3,4 
3,5 
4,5 
KEY: 1 
2 
3 
4 
5 
1% 1% 5% 
5% 1% 
1% 1% 5% 
1% 1% 
5% 1% 
1% 1% 
Control macrophages 
Control macrophages+ 0.02% antigen 
N.asteroides-activated macrophages 
1% 1% 
5% 5% 
1% 1% 
5% 0,1% 
5% 5% 
5% 5% 
5% 
N.asteroides-activated macrophages+ 0.02% antigen in vitro 
ii.asteroides-activated macrophages+ 0.002% antigen in vitro 
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TABLE 56 
Fibrinolysis produced by macrophages from mice inoculated 13 days 
previously with N.brasiliensis or saline only : direct assay. 
Fibrinolysis measured at 2 hourly intervals over 6 hours. 
13 d Nb 
Direct 
C 
C* 
Nb 
Nb* 
Tl 
3.337 
3.052 
3.787 
0.678 
3.38 
3.27 
3.32 
3. 72 
3.02 
3.24 
0.84 
3.09 
2.07 
3.6 
0.4 
10.42 
5.44 
15.73 
3.36 
5.98 
6.24 
3.27 
5.49 
8.75 
3.07 
15.38 
3.92 
2.09 
4.89 
5.63 
4.63 
7.19 
5.53 
18.65 
2 hr 
1. 583 
3.658 
3.28 
1.123 
3.28 
2.06 
3.13 
3.33 
2.87 
3.28 
1. 65 
2.87 
2.53 
4.58 
3.33 
10.23 
6.18 
14.12 
2.74 
4.52 
6.58 
8.42 
7.83 
6.01 
2.93 
18.49 
3.86 
6.32 
4.25 
4.72 
3.97 
11. 2 
5.6 
14.92 
T2 
21.114 
8.56 
32.43 
5.29 
10.65 
13.23 
8.9 
8.36 
16.84 
7.48 
6.51 
6.67 
5.08 
6.58 
1.46 
39.64 
23.34 
43.5 
14.94 
15.84 
16.18 
15.12 
13.48 
35.44 
13.59 
41.37 
13.73 
8.81 
10.01 
10.63 
10.87 
27.63 
18.05 
55.57 
4 hr 
15.94 
13. 75 
28.57 
5.25 
7.31 
5.96 
6.88 
7.79 
18. 72 
9.13 
6.69 
5.85 
7 .11 
10.86 
9.52 
38.65 
23.78 
40.67 
17.05 
14.3 
18.1 
22.27 
19.0 
21.17 
14.44 
46.57 
13.31 
13. 72 
13.41 
11. 52 
11. 39 
35.61 
22.25 
53.03 
T3 
36.19 
23.88 
57.07 
9.63 
19.34 
20.91 
17.92 
15.47 
33.5 
24.43 
9.99 
13.85 
10.6 
12.27 
2.36 
48.54 
48.41 
54.11 
25.64 
26.32 
29.57 
22.93 
18.66 
50.47 
37.49 
48.91 
27.93 
17.25 
16 .11 
18.19 
20.37 
46.22 
42.75 
54.53 
6 hr 
31.14 
26.63 
50.9 
10.04 
12.62 
9.89 
14.04 
13.19 
36.68 
24.03 
11.81 
9.69 
12.77 
20.26 
21.11 
51. 27 
51.12 
50.77 
24. 24 
20.54 
28.89 
39.56 
37.76 
28.64 
46.01 
52.48 
24.86 
24.25 
25.07 
21. 2 
19.82 
49.48 
46.22 
55.03 
- -- --- - --- --- - -- - - - - - --- -- -- ---- --
--- - - -- -- - -
Nb** 2.75 2.63 11. 66 10.50 20.95 20.91 
12.9 4.45 24.82 8.41 34.89 15.2 
6.58 2. 96 17.98 12.06 24.62 17.18 
9.5 4.77 16.77 16.31 28.42 24.74 
3.44 7.66 14.85 
----------------------------------------------
------------------------
KEY: 
C 
C* 
Nb 
Nb* 
Nb**= 
Control macrophages 
Control macrophages+ 0.02% Antigen in vitro 
N.brasiliensis-activated macrophages 
N.brasil1ens1s-activated macrophages + 0.02% Antigen in 
vitro 
~siliensis-activated macrophages + 0.002% Antigen 
in vitro 
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TABLE 57 
13 day N.brasiliensis infection : median% fibrinolysis and their 95% 
confidence limits. 
13 d Nb Tl T2 T3 
direct 
Control 
Control 
+ 0.02% 
antigen 
Nb 
Nb 
+0.02% 
Ag 
Nb 
+0.002% 
Ag 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
n=l6 
n=l4 
n=l6 
n=l6 
n=l5 
3.2 
2.23 
3.42 
2.81 
1. 93 
3.28 
6. 77 
5.01 
9.42 
4.94 
3.92 
9.16 
6.98 
4.45 
10.65 
n=l6 
n=l4 
n=l6 
n=l6 
n=l6 
TABLE 58 
10.71 
7.62 
17.725 
7.685 
6.18 
11. 755 
20.6775 
16.52 
29.32 
13.6575 
11. 8 
26.12 
19.5775 
13.635 
32.345 
n=l6 
n=l4 
n=l6 
n=l6 
n=l6 
20.45 
14.485 
37.31 
16.86 
11. 31 
23.335 
37.035 
29 .11 
44.265 
28.4625 
21.63 
36.97 
33.575 
22.785 
41.735 
Indirect assay data for macrophage PA from mice inoculated 13 days 
previously with N.brasiliensis or normal saline. Results expressed as 
milliunits of urokinase and as specific activity. 
Indirect 
Assay 
(a) 
(b) 
KEY: C 
C* 
Nb 
Nb* 
Nb** 
(a) 
(b) 
Macrophage Type 
C C* Nb Nb* Nb** 
15.04 10.36 47.6 26.22 32.17 
9.38 16. 26 44.75 41.52 9.46 
1.13 3.21 33.67 18.75 11.46 
2.6 4.24 43.2 13.67 
2.23 0.49 14. 72 
2.36 6.21 
100. 94 51.04 360.6 166.16 225.92 
112. 6 126.7 365.0 284.4 64.88 
2.51 9.01 47.15 132.3 44.24 
7.03 14.35 159.51 47.15 
4.58 1. 22 56.83 
4.87 14.78 
Control macrophages 
Control macrophages+ 0.02% antigen in vitro 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages+ 0.02% antigen in 
vitro 
~siliensis-activated macrophages + 0;002% antigen 
in vitro 
Total milliunits of urokinase (mU UK) 
Specific activity (mu UK/mg protein) 
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TABLE 59 
13 day N.brasiliensis infections 
confidence limits for indirect assay. 
urokinase and as specific activity. 
median values and their 95% 
Data expressed as milliunits of 
Indirect 
Assay 
n 
(a) 
(b) 
KEY: C 
C* 
Nb 
Nb* 
Nb** 
(a) 
(b) 
M 
LL 
UL 
C 
6 
2.6 
-0.18 
5.37 
C* 
6 
5.43 
2.28 
8.58 
Macrophage Type 
Nb 
5 
38.44 
30.l 
46.78 
Nb* 
3 
28.18 
13.33 
43.03 
Nb** 
4 
13.12 
4.98 
21.26 
M 7. 03 14.78 
-10. 05 
39.81 
203.88 
123.31 
284.45 
187.26 
88.09 
286.43 
60.45 
-4.68 
125.58 
LL -14.93 
UL 28.99 
Control macrophages 
Control macrophages+ 0.02% antigen in vitro 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages+ 0.02% antigen in 
vitro 
N.brasiliensis-activated macrophages + 0.002% antigen 
in vitro 
Total milliunits of urokinase (mU UK) 
Specific activity (mu UK/mg cell protein) 
TABLE 60 
Significance level (Mann-Whitney U-test, 
parison of different experimental 
N.brasiliensis infection. 
2 tailed) achieved on com-
data groups 13 day 
Data groups 
compared 
1, 2 
1, 3 
1,4 
1, 5 
2,3 
2,4 
2,5 
3,4 
3,5 
4,5 
KEY: l 
2 
3 
4 
5 
* 
Direct Assay 
Tl T2 T3 
2 hr 4 hr 6 hr 
0.1% 0.1% 1% 
0.1% 5% 
1% 5% 5% 
0.1% 0.1% 0.1% 
0.1% 0.1% 1% 
0.1% 0.1% 1% 
1% 
Control macrophages 
Indirect Assay 
Milliunits 
of 
Urokinase 
1% 
5% 
1% 
5% 
5% 
Specific 
Activity 
5% * 
5% 
5% 
5% 
Control + 0.02% antigen in vitro 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages+ ¢.¢2% antigen in-
vitro 
N.asteroides-activated macrophages+ ¢.¢¢2% antigen 
in vitro 
Borderline significance 
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TABLE 61 
Fibrinolysis produced by macrophages from mice inoculated 21 days 
previously with N.asteroides or saline only : direct assay. 
Fibrinolysis measured at 2 hourly intervals over 6 hours. 
21d Na 
Direct 
Tl 2 hr T2 4 hr T3 6 hr 
---------------------
---------------------
---------------------
---
5.86 7.54 22.57 16.55 30.0 32.16 
5.97 7.51 20. 57 15.97 33.92 28.19 
8.16 5.49 19.76 15.36 34 .11 34.87 
9.57 5.57 22. 7 18.67 35.04 35.9 
15.28 8.56 38.29 40.14 63.38 62.93 
14. 96 8.64 37.61 48.5 59.93 68. 25 
14.88 30.31 35.66 40.71 65.95 71.07 
14.97 38.56 42.37 35.22 60. 8 64.34 
C 10.94 12.24 29.21 31.16 39.82 49.99 
8.21 13. 46 25.22 34.75 42.26 45.72 
13.61 18.81 31.79 30.07 42.27 50.45 
12.54 20.94 27.36 27.88 45.27 47.76 
---------------------
---------------------
---------------------
---
6.81 6.57 19.33 21.45 26.94 33.83 
7.19 6.46 20.32 18.88 30.73 32.97 
c* 5.67 7.4 19.58 19.63 26.51 30.46 
7.5 8.6 14.39 20.79 28. 96 35.37 
22.84 31.21 40.65 47.55 55. 72 59.09 
21. 6 22.39 33.45 34.89 52. 72 50.07 
20.64 24.48 36.28 42.10 59.46 61. 37 
18.78 12.37 31.53 24.51 56.3 50.08 
21.57 17 .11 14.15 25.2 28.34 49.68 
10.95 26.24 23.79 31.16 37.29 40.4 
9.41 28.79 33.23 46.38 54.21 
10.25 
-------------------
-------------------
-------------------
---------
25.28 14.67 42.45 41.89 43.35 53.64 
23.97 17.65 47. 96 47.45 51. 52 58.65 
25.47 35.47 35.81 52.66 46.53 55.86 
13.04 32.78 40.08 53.67 50.92 54.46 
27.15 48.26 Si. 68 54.6 63.95 68.26 
Na 19.22 62.43 51. 09 59.44 62.02 67.87 
14.14 32.66 50.11 51.19 65.1 63.65 
28.97 21.02 51. 97 47.48 59.89 63.06 
11. 33 8.55 14.47 14.55 25.73 24.03 
9.84 16.96 16.44 17.43 27.89 26.07 
8.74 7.05 19.64 14.23 29.4 26.21 
6.47 6.02 17.94 13.09 27.74 24.85 
27.07 23.18 40.06 34.3 47.59 45.24 
13.55 20.5 41.99 40.07 52.86 45.92 
------ - - --
- ---- - -----
- --- - ----
- -- --- -
16.93 21.18 48.6 41. 52 55.61 46.9 
23.83 22.6 46.13 37.68 57. 72 45.47 
20.67 41.92 48.47 44.23 62.82 57.45 
12.13 45.56 40.63 52.18 63.41 60.49 
30.75 49. 72 50.04 53.31 63.28 61.22 
37.06 52.9 53.57 47.13 65.61 60.33 
Na * 5.85 12.92 12 .11 22.22 21.88 33.79 
8.47 10.21 12.03 22.46 21. 05 33.66 
7.48 9.24 10.33 21. 5 20.67 34.53 
9.89 12.59 22.04 
-------------------
-------------------
-------------------
---------
22.24 20.77 37. 3 30.89 50.11 44.67 
22.51 12.0 39.23 37.91 51.39 50.2 
20.16 19.29 37. 66 39.77 46.6 49.46 
21.12 19.98 39.39 38.86 45.4 51.22 
51. 77 47.14 48.77 52.09 57.56 64.68 
Na** 35.41 44.54 43.9 51. 08 57.02 60.57 
77.43 53.35 47.02 64.25 59.35 b2.3 
46.09 37.88 52.01 50.33 63.13 67.14 
29.74 26.25 47.22 41. 37 61.99 58.66 
9.28 10.53 20.17 20.1 31.34 31.42 
12.14 14.02 22.32 21.83 38.45 29.86 
12.74 9.74 20.84 20.33 33.25 30.95 
14.05 23.03 20.12 28.43 28.02 46.47 
-------------------
------------------·--------------
-------------------
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TABLE 61 (cont.) 
KEY: C Control macrophages 
C* = Control macrophages+ 0.02% antigen in vitro 
Na N.asteroides-activated macrophages 
Na* N.asteroides-activated macrophages+ 0.02% antigen in vitro 
Na**= N.asteroides-activated macrophages+ 0.002% antigen in vitro 
TABLE 62 
21 aay N.asteroides infection : median% fibrinolysis values and their 
95% confidence limits. 
21d N.ast infect. 
direct 
C 
M 
LL 
UL 
C + M 
0.02% LL 
antigen UL 
in vitro 
Na 
M 
LL 
UL 
Na M 
+0.02% LL 
antigen UL 
in vitro 
Na 
0.002% 
Ag 
M 
LL 
UL 
jn_yj. tJR ____ _ 
n=24 
n=22 
n=24 
n=23 
n=26 
Tl 
11.5875 
9.515 
14.75 
14.62 
9.78 
18.595 
19.945 
14.995 
26.215 
21. 5125 
15.33 
29.375 
24.73 
17.52 
32.75 
T2 
n=24 
n=22 
n=24 
n=23 
n=26 
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29.235 
25.29 
33.75 
26.885 
22.39 
31. 445 
35.805 
31. 6 
47.72 
37.3625 
29.62 
44.56 
37.3 
30.61 
44.08 
T3 
n=24 
n=22 
n=24 
n=23 
n=26 
47.845 
40.295 
53.485 
42.985 
37.36 
49.33 
46.51 
40.69 
57.2 
4 7. 435 
40.225 
55.155 
48.555 
43.34 
55.385 
TABLE 63 
Indirect assay data for macrophages PA from mice inoculated 21 days 
previously with N.asteroides or normal saline. Results expressed as 
milliunits of uork1nase and as specific activity. 
Indirect 
Assay 
(a) 
( b) 
KEY: C 
C* 
Na 
Na* 
Na** 
(a) 
( b) 
Macrophage Type 
C C* Na Na* Na** 
0 37.99 25.97 30.81 11.96 
0 25.44 48.0 39.85 36.12 
3 8.52 30.08 17.54 31.88 
0 16.96 29.18 26.02 21.19 
6.28 5.66 57.6 27.52 28.24 
7.14 16.68 21. 46 
7.12 20.59 
8.4 18.7 
0 69.14 56.85 80.92 24.55 
0 45.44 124.37 103.95 93.17 
35.76 19.65 73.81 41.44 71. 4 
0 37.61 70.85 56.52 45.81 
14.04 10.75 149.13 66.15 95.14 
15.49 42.31 60.95 
10.61 96.87 
21. 91 52.57 
Control macrophages 
Control macrophages+ 0.02% antigen in vitro 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages+ 0.02% ag in vitro 
N.astero1des-activated macrophage+ 0.002% ag in vitro 
Total m1lliunits of Urokinase (mU UK) 
Specific activity (mu UK/mg cell protein) 
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TABLE 64 
21 day N. asteroides infection 
fidence limits for indirect assay. 
urokinase and as specific activity. 
median values and their 95% con-
Da ta expressed as milliunits of 
Indirect 
Assay 
n 
(a) 
( b) 
KEY: C 
C* 
Na 
Na* 
Na** 
(a) 
( b) 
M 
LL 
UL 
C 
8 
3.57 
0 
7.34 
Macrophage Type 
C* 
5 
16.96 
8.76 
25.16 
Na 
8 
28.6 
18.7 
43.84 
Na* 
5 
27.52 
21.86 
33.18 
Na** 
6 
24. 72 
19.9 
29.54 
M 10.16 
LL 0 
32.55 
17.75 
33.18 
80.l 
52.57 
123.0 
66.15 
30.3 
81.99 
60.95 
19.9 
75.03 UL 24.9 
Control macrophages 
Control macrophages+ 0.02% antigen in vitro 
N.asteroides-activated macrophages 
N.astero1des-activated macrophages+ 0.02% ag in vitro 
N.asteroides-activated macrophage+ 0.002% ag in vitro 
Total milliunits of Urokinase (mU UK) 
Specific activity (mu UK/mg cell protein) 
TABLE 65 
Significance level (Mann-Whitney U-test, 
parison of different experimental 
N.asteroides infection. 
2 tailed) achieved 
data groups 
on com-
21 day 
Data groups 
compared 
1,2 
1,3 
1,4 
1,5 
2,3 
2,4 
2,5 
3,4 
3,5 
4,5 
KEY: l 
2 
3 
4 
5 
* 
Direct Assay Indirect Assay 
Tl T2 T3 
2 hr 4 hr 6 hr 
5% 
1% 5% 
0.1% 5% 
5% 
5% 
1% 1% 
Control macrophages 
Milli units 
of 
Urokinase 
5% 
0.1% 
0.1% 
0.1% 
Specific 
Activity 
1% 
1% 
1% 
5% 
Control+ 0.02% antigen in vitro 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages+ 0.02% antigen in 
vitro 
N.asteroides-activated macrophages+ 0.002% antigen in 
vitro 
Borderline significance 
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TABLE 66 
Fibrinolysis produced by macrophages from mice inoculated 21 days pre-
viously with N.brasiliensis or saline only direct assay. 
Fibrinolysis measured at 2 hourly intervals over 6 hours. 
21 d Nb 
Direct 
Tl 2 hr T2 4 hr T3 6 hr 
----------------------------------------------------
--------------
0.34 0.26 2.82 2.33 5.65 7.55 
1. 69 0.78 6.79 3.14 15.59 12.66 
1. 09 0.88 4.85 3.71 11.16 13.73 
4.27 5.49 20.76 20.7 33.74 35.12 
5.82 5.32 26.08 25.04 35.43 34.94 
5.78 5.52 19.33 17.76 34.4 34.96 
C 3.92 4.86 18. 96 24.63 35.12 39.92 
10.94 12.24 29.21 31.16 39.82 49.99 
8.21 13.46 25.22 34.75 42.26 45. 72 
13.61 18.81 31.79 30.07 42.27 50.45 
12.54 20.94 27.36 27.88 45.27 47.76 
----------------------------------------------------
--------------
0.16 0.89 2.91 3.31 6.07 6.39 
0.45 1. 25 2.76 7.4 6.89 17.63 
4.29 6.47 18.75 24.62 30.04 34.13 
C* 3.02 6.79 15.35 23.44 26.24 33.83 
6.16 6.28 17.28 24.49 27.53 35.12 
5.12 5.6 21. 02 22.1 35.41 36.55 
13.09 14.21 28.3 29.64 45.55 48.54 
13.16 21.15 25.88 32.13 42.05 45.85 
14.0 30.84 34.36 49.2 51. 98 
13.5 
4.86 2.1 21.15 8.69 31. 03 17.47 
1. 98 2.08 9.82 11. 53 13.42 33.73 
2.8 1. 99 10.66 12.39 23.88 22.66 
8.41 7.71 30.53 34.73 50.19 54.25 
8.99 9.32 29.99 33.5 49.19 51. 93 
Nb 7.18 7.67 26.21 28.58 42.7 45.43 
9.69 9.32 34.73 33.5 42.24 41. 73 
7.67 28.58 45.43 
19.57 15.84 34.99 29.16 51.97 42.59 
20.99 18.66 33.76 32.26 50.77 43.51 
16.69 18.85 32.45 31.79 44.72 49.36 
16.28 21.04 32.74 33.59 43.7 49.57 
------------------------------------------------
------------------
Nb* 
Nb** 
KEY: C 
C* 
Nb 
Nb* 
4.13 4.93 13.24 24.81 20.84 39.28 
1. 91 2.64 8.08 7.2 27.08 28.92 
1. 55 2.2 10.17 15.09 19.46 28.37 
8.98 7.36 30.74 35.58 46.81 49.7 
8.4 7.02 30.9 27.05 49.11 42.1 
6. 72 6.73 30.58 28.9 46.15 42.77 
5.89 7.38 22.97 24.77 40.78 41.17 
17.99 17.3 27.55 29.67 47.21 45.82 
15.77 17.49 26.91 30.87 43.77 42.67 
15.66 16.87 25.95 26.82 38.94 41.66 
18.81 13.57 29.87 24.48 47.08 38.35 
5.37 3.59 11. 92 9.13 19.36 15.26 
2.29 2. 71 10.13 9.69 30.35 29.81 
2.08 2.0 10.41 13.88 20.92 25.1 
7.42 10.0 28.02 27.86 40.31 37.09 
7.29 6.64 24.39 26.43 38.13 37.25 
5.67 5.1 24.33 25.75 34.13 38.32 
7.92 10.17 28.33 27.74 40.05 41.15 
18.92 20.08 31.94 25.88 46.51 45.28 
17.74 20.14 33.34 29.14 46.38 48.13 
19.65 31.11 32.3 47.54 
16.79 41. 05 
Control macrophages 
Control macrophages+ 0.02% antigen in vitro 
N.brasiliensis-activated macrophages 
N.brasil1ens1s-activated macrophages + 0.02% 
antigen in vitro 
Nb** N.brasil1ens1s-activated macrophage + 0.002% 
antigen in vitro 
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TABLE 67 
21 day N.brasiliensis infection : median% fibrinolysis and their 95% 
confidence limits. 
21 d Nb Tl T2 T3 
direct 
C 
M 
LL 
UL 
n=22 6.535 
3.505 
9.55 
C +0.02% M n=l8 
antigen LL 
6.99 
3.705 
10.145 in vitro UL 
Nb 
M 
LL 
UL 
Nb M 
+0.02% LL 
antigen UL 
in vitro 
Nb + M 
0.002% LL 
antigen UL 
in vitro 
n=23 
n=22 
10.36 
6.285 
13.185 
9.7 
6.155 
12.125 
n=20 9.645 
5.44 
12.78 
n=22 
n=l8 
n=23 
n=22 
n=20 
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19.86 
14.61 
25.93 
20.95 
14.395 
26.395 
26.8725 
21. 46 
31. 49 
25.91 
19.93 
28.41 
23.97 
18.9 
28.315 
n=22 
n=l8 
n=23 
n=22 
n=26 
34.67 
24.995 
40.42 
33.295 
24.47 
40.63 
43.125 
36.01 
47.28 
41.025 
34.975 
44.195 
37.395 
31.035 
41.735 
TABLE 68 
Indirect assay data for macrophage PA from mice inoculated 21 days 
previously with N.brasiliensis or normal saline. Results expressed 
as milliunits of urok1nase and as specific activity. 
Indirect 
Assay 
(a) 
( b) 
KEY: C 
C* 
Nb 
Nb* 
Nb** 
(a) 
(b) 
Macrophage Type 
C C* Nb Nb* Nb** 
7.58 2.08 16.95 9.16 13.25 
0.02 1. 42 12.56 30.73 43.22 
0 0 52.03 6.66 9.32 
0 3.98 7.58 19.02 22.1 
3 3.35 25.05 13.59 13.62 
10.7 8.01 31. 91 14.77 11.16 
9.37 7.25 34.58 39.75 31. 85 
0 32.15 33.69 45.02 
0 47.91 
9.11 
9.02 
9.24 
46.25 11. 2 254.62 56.0 235.55 
0.01 6.59 94.0 138.54 201.4 
0 0 211. 76 61. 95 76.89 
0 8.53 45.2 73.32 70.78 
35.76 9.61 70.95 48.66 57.88 
0 31. 33 100.46 53.24 40.21 
53.89 25.56 113.82 134.84 121.05 
41. 6 140.04 157.35 173.96 
0 113.82 
0 
16.93 
35.35 
Control macrophages 
Control macrophages+ 0.02% antigen in vitro 
N.brasiliensis-activated macrophages 
N.brasiliens1s-activated macrophages + 0.02% 
antigen in vitro 
N.brasiliensis-activated macrophages+ 0.002% 
antigen in vitro 
Total milliunits of Urokinase (mU UK) 
Specific activity (mu UK/mg cell protein) 
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TABLE 69 
21 day N.brasiliensis infection 
fidence -limits for indirect assay. 
urokinase and as specific activity. 
median values and their 95% con-
Da ta expressed as milliuni ts of 
Indirect 
Assay 
n 
(a) 
(b) 
KEY: C 
C* 
Nb 
Nb* 
Nb** 
(a) 
(b) 
M 
LL 
UL 
C 
13 
4.56 
0.01 
8.48 
C* 
7 
3.65 
0.71 
7.63 
Macrophage Type 
Nb 
9 
28.6 
16.32 
41. 97 
Nb* 
8 
20.8 
10.13 
33.69 
Nb** 
8 
22.64 
11.29 
38.4 
M 17.88 
LL 0.005 
UL 35.56 
10.8 
3.3 
28.45 
128.48 
79.51 
197.33 
94.73 
53.24 
138. 54 
121.71 
57.88 
201. 4 
Control macrophages 
Control macrophages+ 0.02% antigen in vitro 
N.brasiliensis-activated macrophages 
N.brasil1ensis-activated macrophages + 0.02% 
antigen in vitro 
N.brasiliensis-activated macrophages+ 0.002% 
antigen in vitro 
Total milliunits of Urokinase (mU UK) 
Specific activity (mU UK/mg cell protein) 
TABLE 70 
Significance level (Mann-Whitney U-test, 
parison of different experimental 
N.brasiliensis infection. 
2 tailed) achieved 
data groups 
on com-
21 day 
--------------------------------------- -------------------------
Direct Assay Indirect Assay 
--------------------------------------- -------------------------
Data groups 
compared 
1, 2 
1,3 
1,4 
1,5 
2,3 
2,4 
2,5 
3,4 
3,5 
4,5 
KEY: 1 
2 
3 
4 
5 
* 
Tl T2 T3 
2 hr 4 hr 6 hr 
5i 5% 
5% 5% 
5% 
Control macrophages 
Milli units 
of 
Urokinase 
0.1% 
1% 
0.1% 
0.1% 
1% 
0.1% 
Control+ 0.02% antigen in vitro 
N.brasiliensis-activated macrophages 
invitro 
N.bras1liensis-activated macrophages + 
in vitro 
Specific 
Activity 
0.1% 
0.1% 
0.1% 
0.1% 
0.1% 
0.1% 
¢. ¢2% an ti gen 
N.brasiliensis-activated macrophages + ¢.¢~2% antigen 
in vitro 
Borderline significance 
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TABLE 71 
Median % fibrinolysis values for N.asteroides and N.brasiliensis over 
the 21 day infection period. Data from direct assay. 
Control 
--------
Na 
Macrophage 
--------
Type 
Control 
--------
Nb 
----------------------
Time-
Point 
(hours) 
Period of Infection (days) 
2 7 13 21 
Tl 25.99 1. 29 4.38 11. 59 
2Hr 
T2 53.56 5.47 14.49 29. 24 
4Hr 
T3 71. 34 9.83 28. 29 47.85 
6Hr 
---------
-------- ------- ------ --------
Tl 30.09 6.11 9.55 19.95 
2Hr 
T2 64.15 20.29 25.3 35.81 
4Hr 
T3 78.2 32.81 38.64 46.51 
6 
---------
-------- ------- ------- -------
Tl 2.83 1. 45 3.2 6.54 
2Hr 
T2 6.58 5.19 10.71 19.86 
4Hr 
T3 16.21 18.77 20.45 34.67 
6Hr 
---------
-------- ------- ------- -------
Tl 11. 33 3.27 6.77 HJ. 36 
2Hr 
T2 27.85 13.14 20.68 26.87 
4Hr 
T3 44.92 36.88 37.03 43.13 
6Hr 
---------
-------- ------- ------- -------
TABLE 72 
Direct PA assay : median% fibrinolysis values for N.asteroides and 
N.brasiliensis expressed as percentage of their own controls (data 
calculated from Table 71) 
Na 
Macrophage 
Type -------
Nb 
Time-
Point 
(hours) 
Period of Infection 
2 7 13 
Tl 115% 473% 218% 
2Hr 
T2 119% 370% 174% 
4Hr 
T3 110% 333% 137% 
6Hr 
----------
-------- ------ -------
Tl 400% 226% 211% 
2Hr 
T2 423% 253% 193% 
4Hr 
T3 277% 196% 183% 
6Hr 
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(cays) 
21 
172% 
122% 
97% 
-------
159% 
135% 
124% 
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Chapter 4 
LYSOZYME RELEASE FROM MOUSE PERITONEAL MACROPHAGES: INFLUENCE OF 
IN VIVO INFECTION WITH NOCARDIA ASTEROIDES AND NOCARDIA 
BRASILIENSIS 
"Fleming believed in lysozyme. He believed it was bound to have 
a great future; 
work on it. 
he had discovered it and he had done marvellous 
Other scientists would follow the path he had 
opened. Others would purify it, advance it. With absolute 
confidence he used to say, "we sha 11 hear more about l ysozyme". 
Lady Amalia Fleming 
4.1 INTRODUCTION 
4. 1.1 EARLY HISTORY 
Elie Metchnikoff, a pioneer in the field of immunology, was the 
first to emphasize the importance of phagocytes in the host-
parasite relationship (Hirsch, 1965). He established that living 
micro-organisms were ingested by phagocytes and that most common 
microbes were rapidly killed and digested after being engulfed. 
He realised that some digestive ferment must be present in the 
phagocytic cells, but was not able to characterise it or even to 
determine whether enzymatic at tack was the process responsible 
for their death. 
In 1922, Alexander Fleming reported the discovery of a 
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"remarkable bacteriolytic element found in tissues and 
secretions". He believed that the substance was an enzyme and 
called it "lysozyme" (Fleming, 1922). The paper reports the 
widespread distribution of lysozyme and its high concentrations 
in hen's egg white, saliva, tears and nasal secretions; and this 
was the original work that established that leukocytes contained 
lysozyme. 
The early work on the chemistry, structure, antibacterial 
activity and distribution of lysozyme has been extensively 
reviewed by Glynn ( 1966), Imoto et al ( 1972) and Osserman and 
Law 1 or ( 1 9 6 6 ) • 
4.1. 2 CHEMICAL CHARACTERISTICS AND BACTERIOLYTIC MECHANISM 
Lysozyme (muramidase, N-acetyl muramide glycanohydrase, EC 
3.2.1.17) is a cationic enzyme mol wt 14,307 which catalyses the 
hydrolysis of N-acetyl muramic 
linkages in the bacterial cell 
specific substrate for lysozyme. 
beta-1,4 N-acetyl glucosamine 
wall. These linkages are the 
Bacterial cell walls consist, 
in general, of linear polysaccharide chains containing repeating 
units of N-acetyl glucosamine and N-acetyl muramic acid residues 
in beta-1,4 linkage (Strominger and Ghysen, 1967). A variable 
number of acetyl muramic acid residues have tetrapeptide chains 
attached in N-acetyl muramyl-L-alanine linkages. Cross 1 inks 
between tetrapeptide chains result in the formation of a three-
dimensional macromolecular net of peptidoglycan. This net 
envelopes the bacterium plasma membrane and protects the organism 
from osmotic lysis and gives the cell wall its rigidity. 
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Lysozyme breaks down this protective covering and the organism is 
then unprotected against osmotic stress (Gabig and Babier, 1981). 
The peptidoglycan substrate is present in the cell walls of both 
gram-positive and gram-negative bacteria and in fungi so lysozyme 
should be bactericidal to a wide range of organisms. Most 
bacteria, however, are resistant to lysozyme, either because 
access to the glucosidic linkages is impaired by other cell wall 
constituents or because the peptidoglycan itself has changed and 
is no longer a suitable substrate for the enzyme (Gabig and 
Babier, 1981). In the case of gram-negative bacteria, the 
surface layers containing lipopolysaccharides, lipids and 
proteins obscure the substrate and make it resistant to lysis 
(Miller, 1969). In gram-positive organisms the cell walls are 
more simple and the lipoprotein polysaccharide layers are absent, 
but other substances may be present which protect the organism 
against lysozymal action. Certain minimally virulent bacteria eg 
Mi crococcus l ysodei k ti cus, Ba c i 11 us mega ther i um, and fungi such 
as Cryptococcus neoformans are 
lysozyme action (Gabig and Babior, 
particularly susceptible to 
1981), and in these organisms 
the specific substrate is apparently located in a position 
directly accessible to the enzyme (Goldstein, 1983). 
Lysozyme is one of the 
Although not identical, 
( human s , rabbi ts , r a ts 
best characterised hydrolytic enzymes. 
lysozymes produced by different species 
and chickens) are similar in structure, 
molecular weight and biologic activity (Goldstein, 1983; Carroll 
and Martinez, 1979). Egg-white lysozyme from hens is the most 
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studied enzyme and is frequently used in place of mammalian 
enzymes in biologic studies. (Goldstein, 1983). 
4.1. 3 FUNCTION OF LYSOZYME 
The role of lysozyme as a bactericidal agent in mammalian sera 
and in resistance to infection has been the subject of 
controversy for years (Gordon et al, 1979; Selsted and Martinez, 
1978; Gordon, 1975; Martinez and Carroll, 1980, Imoto et al, 1972 
: 669). Reasons for this dispute include the fact that it is not 
universally present in vertebrate cells and secretions (Imoto et 
al, 1972 669); most pathogenic bacteria are insensitive to its 
lytic activity; the lack of uniform sensitivity of gram-positive 
bacteria to lysis by lysozyme, in addition investigation of the 
bactericidal potential of the enzyme has given rise to 
conflicting reports. It has been suggested that these 
con f 1 i ct i ng results a rose from the use of non-specific methods 
such as bentonite to remove lysozyme from serum and its 
replenishment with egg-white lysozyme which has a lower killing 
capacity than human serum lysozyme (Gordon et al, 1979; Imoto et 
al, 1972 669; 
Martinez, 1978). 
Martinez and Carroll, 1980; Selsted and 
Lysozyme has been described an an enzyme of 
proven bactericidal capacity (Kimura and Goldstein, 1981; 
Elsbach, 1973; Selsted ana Martinez, 1978; Biggar and Sturgess, 
1977); whereas others have stated that lysozyme appears to be 
incapable of killing most pathogenic organisms, except in cases 
where other agents sensitize naturally resistant micro- organisms 
to the action of the enzyme (Gabig and Babior, 1981; Goldstein, 
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1983; Mauel, 1983; Beaman and Beaman, 1984). It has been 
suggested that non-pathogenic bacteria may be avirulent because 
of their susceptibility to lysozyme (Fleming, 1922; Fleming, 
1974; Nathan, 1983; Klebanoff and Hamon, 1975 : 509). Lysozyme 
is of bactericidal importance primarily in the blood 
together with other non-specific components, kills 
where it, 
minimally 
virulent micro-organisms, and in this way reduces their invasive 
potential in establishing tissue infection (Selsted and 
Martinez, 1978; Goldstein, 1983). It has also been suggested 
that alveolar macrophage lysozyme, both intracellularly and 
released into the extracellular environment, may contribute to 
pulmonary defence (Biggar and Sturgess, 1977). 
'l'he main biological function of lysozyme is to hydrolyse the 
polysaccharide portion of bacterial cell walls (Goldstein, 1983; 
Lassar, 1983). This degradative ability is an important factor 
in the intracellular and extracellular dissolution of bacteria 
( Els ba ch , 19 7 3 ; 
the function of 
Goldstein, 1983) and some authors suggest that 
the enzyme is to digest dead micro-organisms 
rather than to kill them (Mauel, 
Klebanoff and Hamon, 1975 509; 
1983; Nathan et al, 
Beaman and Beaman, 
1980; 
1984). 
Results of the studies by Brumf it t and Glynn ( 1961) suggested 
that lysozyme 
of pathogenic 
may play a part in the intracellular destruction 
bacteria after phagocytosis; and Biggar and 
that bacterial Sturgess ( 1977) 
lysis by lysozyme 
showed 
occurs 
electronmicroscopically 
extracellularly. 
enzyme in extracellular digestion is clear 
Thus the role of the 
(Nathan, 1983) and it 
is certainly responsible for the intracellular breakdown of 
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sensitive microbes (Mauel, 1983; 
509). 
Klebanoff and Hamon, 1975 
A difference of opinion regarding a correlation between 
microbicidal activity of macrophages for lysozyme-resistant 
organisms and their lysozyme content is apparent from the 
literature. It 
lysozyme content 
has been stated that 
does not relate to 
mononuclear phagocyte 
their ability to kill 
phagocytosed micro- organisms (Nathan, 1983; Mauel, 1983; 
Klebanoff and Hamon, 1975 509) and that the lysozyme is 
probably not responsible for the enhanced antimicrobial activity 
of activated macrophages (Nathan et al, 1980). In contrast, 
Kimura and Goldstein (1981) 
in alveolar macrophages with 
demonstrated an absence of lysozyme 
impaired antimicrobial activity as 
a result of exposure to ozone; and Ridley et al, (1985) found 
that lower levels of lysozyme secretion were associated with the 
persistance of viable M.leprae segregated in macrophages. 
When lysozyme acts alone its most striking activity is against 
non-pathogenic organisms ( McClelland and van Furth, 1975). 
However, even in these situations lysozyme often only acts on 
organisms killed by complement (Nathan, 1983; Martinez and 
Carroll, 1980). Organisms can be rendered more susceptible to 
bacteriolysis by the action of other leukocytic factors or agents 
( Goldstein, 1983; Mc Cl el land and van Fur th, 197 5; Beaman and 
Beaman, 1984; Klebanoff and Hamon, 1975 509; Nathan, 1980) 
eg specific antibody and complement (Gordon 1978; Glynn and 
Milne, 1965), hydrogen peroxide and ascorbic acid (Miller, 1969), 
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the chelating agent versene (Repaske, 1956), leukocytic factors 
(Neeman, Lahav and Ginsburg, 1974) and lysozyme may function 
synergistically with these and other microbicidal mechanisms 
(Nathan, 1983). 'l'hus lysozyme is probably of little use against 
most pathogenic organisms, excf pt when other a gen ts sensitize 
lysozyme-resistant organisms to enzymatic action. 
Several studies have suggested a possible role of l ysozyrne in 
host defence mechanisms which extends beyond its microbicidal 
capabilities (Di Luzio, 1979 a and b : 447). Among the biologic 
properties suggested for l ysozyme a re a direct enhancement of 
phagocytosis by PMN (Klockars and Roberts, 1976) and by 
macrophages (Thacore and ~illett, 1966). These findings led to 
the proposal that lysozyme may function as a self-stimulatory 
secretory product of the macrophage ( Kokoshis et al, 1978). 
Other studies have suggested that lysozyme may be a mediator of 
the antitumour functions of macrophages (Osserman et al, 1973; 
1976). Di Luzio, 1979b: 448; Di Luzio, 1979a; Bordin ana Young, 
Thus the markedly elevated serum lysozyme levels in infected 
animals may play a role in phagocytosis and may 
tumour cell surface activities (Birrninghc.m and 
interfere with 
Jeska, 1981). 
The release of lysozyme from macrophages is constitutive 
(Gordon, Todd and Cohn, 1974) and the enzyme may therefore be an 
important mediator of macrophage functions (Osserman, 1975; 
Haneberg et al, 1984). 
In addition, results of a study by Gordon et al (1979) suggested 
that lysozyme may function in a negative feedback system to 
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modulate the inflammatory response. Human lysozyme was shown to 
be a potent inhibitor of chemotaxis and of the production of 
toxic oxygen radicals by stimulated PMN: and thus lysozyme may 
reduce tissue injury associated with the inf la mma tor y response 
without concomitant compromisation of the phagocytic capacity of 
PMN and host ~efence (Gordon et al, 1979). 
4 .1. 4 ASSAY METHODS 
Lysozyme activity is determined biochemically by measuring the 
rate of hydro! ys is of su3pens ions of Micrococcus lei sodei k tic us 
either spectrophotometrically (Litwack, 1955: 
Shahani, 1965: Gordon, Todd and Cohn, 
Parry, Chandon and 
1974: Selsted and 
Martinez, 1978: Morsky, 1983) or as zones of lysis in immuno-
diffusion plates {Osserman and Lawlor, 1966: Klockars, Petterson 
and Riska, 1976: Haneberg et al, 1984: Goldstein, 1983). The 
values for test samples are compared with those for standards by 
use of hen egg-white or other purified lysozyme preparations. 
Enzyme activity may be detected spectrophotometrically as low as 
5 ng/ml { Selsted and Martinez, 1978) and as low as 1 ng/ml by 
immunodiffusion methods {Osserman and Lawlor, 1966: Goldstein, 
1983). McClelland and Van Furth { 1975) used immunoelectro-
phoresis and autoradiography in their determination of sites of 
synthesis of lysozyme in tissues and by cells. Histochemical 
demonstration of lysozyme is achieved by the immunoperoxidase 
method {Mason and Taylor, 1975: Kimura and Goldstein, 1981: 
Steele, Eremin and Brown, 1983). At the cellular level lysozyme 
activity in mononuclear phagocytes can be demonstrated by lysis 
of M lysodeikticus over the individual cells (Syren and Raeste, 
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1971; van der Meer, 1980 : 751). 
4.1.5 DISTRIBUTION OF LYSOZYME AND CLINICAL SIGNIFICANCE 
The enzyme is widely distributed in mammalian tissues, as 
originally described by Fleming (1922; McClelland and van 
Furth, 1975; Gordon, 1975 463). Lysozyme is present in many 
body fluids, especially tears and breast milk. It is also found 
in sputum, nasal secretions, blood serum and plasma, peritoneal 
fluid and numerous other body fluids (Fleming, 1922; McClelland 
and van Furth, 1975). Mason and Taylor ( 1975) studied the 
distribution of lysozyme in normal and pathological human tissues 
and the reader is referred to this text for a full description. 
The major cell types involved in the synthesis and release of 
lysozyme are the monocyte and macrophage (Gordon, Todd and Cohn, 
1974; McClelland and van Furth, 1975: Osserman, 1975; Di 
Luzio, 1975 a and b 447: Lasser, 1983: Goldstein, 1983). 
Granulocytes contain lysozyme which is present in granules (Cohn 
and Hirsh, 1960; Klebanoff, 1975; Briggs, Perillie and Finch, 
1966; Syren and Raeste, 1971). In contrast to macrophages and 
monocytes, which continuously release lysozyme, neutrophils 
retain the enzyme within lysozomes and only release it in the 
course of degranulation (Osserman, 1975: 
death (McClelland and van Furth, 1975: 
Lasser, 1983) and cell 
Rea and Taylor, 1977). 
Mature neutrophils do not synthesize lysozyme but release 
preformed enzyme into the extracellular milieu; however these 
cells die after only a few hours in culture without further 
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production of enzyme (Gordon, Todd and Cohn, 1974). Several 
studies have revealed that 1 ymphocytes do not contain 1 ysozyme 
and do not synthesize it (Briggs, Perillie and Finch, 1966; 
Syren and Raeste, 1971; Gordon, Todd and Cohn, 1974; 
McClelland and van Furth, 1975). 
Lysozyme has been clearly demonstrated to be elevated in certain 
diseases these include diseases characterized by epi theloid 
cell granulomas, specifically sarcoidosis (Osserman and Lawlor, 
1966; 
1976; 
Di Luzio, 1979b; Rea and Taylor, 1978; Currie and Eccles, 
Goldstein, 1983), tuberculosis (Osserman and Lawlor 1966; 
Klockars, Petterson and Riska, 1976; Rea and Taylor, 1977), 
leprosy (Rea and Taylor, 1977), Crohn's disease (Falchuk, Perotta 
and Isselbacher, 1975; Goldstein, 1983), as well as in monocytic 
and myelomonocytic leukaemia (Osserman and Lawlor, 1966) and in 
myeloproliferative disorders (Gordon, Todd and Cohn, 1974; Di 
Luzio, 1979b). Serum lysozyme has been found to be elevated in 
pyogenic infections (Klockars, Petterson and Riska, 1976) and in 
r he u ma to i d a r t hr i t i s ( Pru z an ski , Sa i to a n d O g r y z lo , l 9 7 0 ; Re a 
and Taylor, 1977). 
4. l. 6 LYSOZYME PRODUCTION AND SECRETION BY MONONUCLEAR 
PHAGOCYTES 
Heise and Myrvik (1967) demonstrated that rabbit alveolar 
macrophages synthesize and secrete lysozyme into the medium when 
cultured in vitro, in the absence of phagocytosis. A major 
contribution to the field was made by Gordon, Todd and Cohn 
( 1974) when they showed that mouse peritoneal macrophages and 
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human monocytes synthesize and secrete lysozyme in culture. The 
production of lysozyme by mouse unstimulated, thioglycolate 
stimulated macrophages and by human blood monocytes was shown by 
assessing ce 11 1 ysa tes and conditioned medium (culture medium 
into which phagocytes had released enzyme) at daily intervals. 
The study showed that mononuclear phagocytes are active secretory 
cells with lysozyme as the major secretion product - 0.75-1 
microgram produced per lx10 6 cells per day. This represents as 
much as 2.5% of total cell protein (Gordon, 1980 : 1277; Gordon, 
Todd and Cohn, 1974) and approximately 25% of all extracellular 
protein (Gordon, 1978). Lysozyme production and secretion by 
mouse macrophages exceeds that of all other hydrolases, including 
Beta-galactosidase, Beta-glucuronidase and cathepsin D (Gordon, 
Todd and Cohn, 1974). Intracellular lysozyme levels remained 
relatively constant over the three day assay period, whereas 
extracellular lysozyme increased daily and represented 87-90% of 
total lysozyme after three days. The studies of lysozyme 
secretion are important in that they clearly established that 
this enzyme is intended mostly for secretion and not for 
intracellular digestion (Unanue, 1976). All three cell types 
showed a similar pattern of lysozyme accumulation in the 
extracellular medium, with stimulated cells producing 2-3 times 
as much lysozyme as the same number of unstimulated macrophages. 
Specific activity 
similar for the two 
of the 
types 
cells contain twice as much 
enzyme, based on cell protein, is 
of macrophage, since the stimulated 
protein per cell (Gordon, 1975 
464; Gordon, Todd and Cohn, 1974). Secretion of lysozyme by 
mononuclear phagocytes is characterized by substantial net 
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synthesis, a relatively constant intracellular concentration and 
continued accumulation in the medium over at least two weeks in 
culture (Gordon, 1980 : 1277). 
The rate of lysozyme secretion by peritoneal macrophages is 
independent of cell stimulation, ie chemical activation (Rea and 
Taylor, 1977), massive phagocytosis, or exposure to lymphokines, 
and the enzyme is considered a constitutive secretion product of 
the macrophage (Gordon, 1980 
197 8) • 
1275, 1277; Gordon and Cohn, 
Macrophages secrete the equivalent of their intra-cellular pool 
in 5-8 hours (Gordon, Todd and Cohn, 1974). Heise and Myrvik 
(1967) suggested that these cells synthesize lysozyme de novo, 
since the presence of inhibitors of protein and nucleic acid 
synthesis inhibits the production and secretion of lysozyme by 
macrophages. The bi osyn thesis and secretion of l yso zyme during 
in vitro culture was confirmed by incubation of macrophages in 
radio-active amino acids and the identification of 14 c-labelled 
lysozyme (Gordon, Todd and Cohn, 1974; McClelland and van 
Furth, 1975). Inhibitors such as colchicine and cycloheximide 
inhibited lysozyme production rather than its release and 
diminished secretion is generally associated with reduced 
intracellular levels (Gordon, Todd and Cohn, 1974). 
Schnyder and Baggiol ini ( 1978 a and b) used other non-specific 
stimuli such as proteose peptone to elicit mouse peritoneal 
macrophages and found that lysozyme secretion rate remains at the 
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level of non-elicited controls despite major changes in other 
parameters; thus confirming the findings of Gordon, Todd and 
Cohn (1974). 
The constitutive secretion of lysozyme is a cell-specific marker 
for the mononuclear phagocytes and PMN (Gordon, 1980 : 1278); and 
owing to its constancy, the rate of lysozyme secretion is a 
useful marker of macrophage viability (Baggiolini and Schnyder, 
1982). 
Gordon, Todd and Cohn (1974) demonstrated that, unlike PMN which 
have lysozyme in 
and Babior, 1981; 
both azurophilic 
Cohn and Hirsch, 
and specific granules 
1960; Gordon, 198 0 
(Gabig 
1278), 
lysozyme is secreted from a source other than lysozomes in 
nononuclear phagocytes. In contrast to peritoneal macrophages, 
alveolar macrophages may release stored enzyme after phagocytosis 
(Cohn and Wiener, 1963b; Gordon, 1980 1278). Haneberg et al, 
(1984) studied lysozyme release in vitro from human monocytes and 
granulocytes in suspension ie. that had not adhered to a 
nonphagocytosable surface. The workers found that the monocytes 
were capable of selective enzyme release on exposure to 
particulate stimuli similar to that of granulocytes. 
4.1.7. MODULATION OF LYSOZYME LEVELS 
Lysozyme physiology is affected in a variable way by stimuli 
which generally activate macrophages (Goldstein, 1983). Several 
studies have investigated lysozyme enzyme activity in macrophages 
from mycobacteria-treated animals, but the results are divergent. 
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Cohn and Wiener (1963a) compared intracellular lysozyme levels 
in normal and BCG-induced alveolar macrophages and found that 
BCG-i nduced eel 1 s contained a 3-fold higher 1 ysozyme activity. 
Similar results were described by Mizunoe and Dannenberg (1965) 
for both alveolar macrophages and peritoneal cells. Leake and 
Myrvik (1968) were first to show increased secretion of lysozyme 
by alveolar macrophages activated by BCG in vivo, they also 
found increased 1 ysozyme content of eel 1 extracts, indicating 
increased synthesis of enzyme; in agreement with Cohn and Wiener 
(1963a). In contrast, Ferencik, Stefanovic and Kotulova (1982) 
compared lysozyme levels in peritoneal macrophages elicited with 
parafin oil i.p. or activated by i.p. administration of BCG 
vaccine, and found decreased levels of 
macrophages compared to elicited ones. 
lysozyme in activated 
Serum 1 ysozyme, ref lee ting increased prod uc ti on of 1 ysoz yme by 
monocytes and alveolar macrophages is raised in tuberculosis 
(Klockars, Pettersen and Riska, 1976; Osserman and Lawlor, 1966; 
Goldstein, 1983) and in experimental BCG-induced animal granuloma 
(Carr et al, 1980). Similarly, serum lysozyme levels are raised 
in untreated leprosy ( Rea and Taylor, 1977). Rojas-Espinosa et 
al ( 1982) evaluated peritoneal macrophage lysozyme levels 
(intracellular) in a murine leprosy model and found that 
peritoneal cells harvested four months after infection had 
increased lysozyme levels when the enzyme was expressed in terms 
of cell number but not when expressed as specific activity, 
similar to the results of Gordon, Todd and Cohn (1974). 
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Lybe rg, 
vitro witl 
Closs and Prydz ( 1982) stimulated human monocytes in 
three different mycobacterial antigens purified 
protein derivative 
BCG - and foend 
presence of the 
(PPD) and sonicates of M.leprae and M.bovis 
that lysozyme release was enhanced in the 
sonicates but not in the presence of PPD. 
Ridley et al (1985) studied levels and distribution of lysozyme 
- positive cells and exudate in leprosy lesions. They fo,.md 
that lysozyme syn thesis ceases after macrophage ingestion of 
M.leprae and lower levels of lysozyme secretion were associated 
with the persistence of viable M.leprae segregated within 
macrophages. Lysozyme level, as a measure of the activating 
effects of mycobacteria or macrophages, was found to distinguish 
functionally competent from functionally incompetent cells in 
the leprosy lesion ( Ridley et al, 1985). 
Intracellular lysozyme levels were measured in ~ ndividual 
macrophages after in vitro infection with virulent or less 
virulent N.asteroides. Phagocytosis of N.asteroides in vitro did 
not modify intracellular l~sozyme levels (Beaman and Black, 
1985). 
Lysozyme levels were measured in murine experimental 
Corynebacterium ovis infection and 
intracellular lysozyme levels were found 
1970); and serum lysozyme was elevated 
peripheral macrophage 
to be increased (Hard, 
in experimental murine 
Brucella abortus infection (Birmingham and Jeska, 1981). 
The work on production and secretion of lysozyme by macrophages 
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after exposure to various a gen ts has rev ea led that some stimuli 
increase rates of lysozyme synthesis and these increases may or 
may not be accompanied by increased intracellular enzyme levels 
(Goldstein, 1983). However, from most of the studies cited it 
appears that although production of enzyme may be modulated, 
distribution, ie relative concentration of lysozyme between cell 
and medium, is rarely affected (Gee, Stevens and Hinman, 1980 a 
and b; Gordon, Todd and Cohn, 1974; Thyberg, Helgren and 
Blomgren, 1981; Maier and Ulevitch, 1981). 
The effects of different agents on macrophage lysozyme production 
and secretion has been studied by several workers. An exception 
to the above statement regarding relative concentration of 
lysozyme was found by Hinman et al (1980), who examined the 
effects 
alveolar 
of cigarette smoking on lysozyme activity in ~uman 
macrophages. Exposure to cigarette smoke caused a 5-
fold increase in lysozyme secretion without significantly 
altering intracellular lysozyme concentration. 
Mai er and Ulev itch ( 1981) investigated the response of rabbit 
hepatic macrophages to lipopolysaccharide (LPS) and their data 
confirmed the finding of others (Gordon, Todd and Cohn, 1974) 
that 85-90% of all lysozyme activity is found in the culture 
fluid by 72 hours incubation. Presence of LPS in vitro yielded a 
5-6-fold increase in the total amount of lysozyme activity in the 
LPS - stimulated macrophages as compared to controls. 
Blau et al (1983) exposed human milk macrophages to Concanavalin 
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A or endotoxin and found that these treatments resulted in a 
decreased lysozyme concentration in the extracellular medium. 
Macrophage lysozyme activity is not affected by exposure to many 
a gen ts sue h as chemi ca 1 a gen ts of ac ti va tion (Gordon, Todd and 
Cohn, 1974; Rea and Taylor, 1977). Exposure of alveolar 
macrophages to phorbol myristate acetate, an agent that 
stimulates many of the functional and metabolic changes that 
normally accompany phagocytosis, failed to increase lysozyme 
release (Biggar, 1978). Bray et al (1983) investigated the 
effect of parasitization by Leishmania mexicana mexicana on 
macrophage function in vitro and found that secretion of 
lysozyme in response known stimuli was not significantly altered 
by parasitization. 
The effect of inhibitory agents on macrophage lysozyme production 
and secretion has been studied. Gee, Stevens and Hinman (1980 a 
and b) showed that macrophages exposed in vitro to subtoxic 
concentrations of rifampin, a protein synthesis inhibitor, 
exhibited a concentration-dependent diminution in 
activity but did not affect its distribution between 
lysozyme 
cell and 
medium; i m pa i red syn t he s i s of 1 y so z y me n e c e s s a r i 1 y 1 i mi ts t he 
secretion of the enzyme, however rifampin does not appear to 
affect the secretory process per se. Similarly, in cultures 
treated with colchicine, an antimicrotubular drug, the total 
amount of lysozyme was reduced due to a decrease in both intra-
and extracellular enzyme levels (Thyberg, Helgren and Blomgren, 
1981). The fraction present in the medium did not differ from 
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that in the controls, in agreement with the findings of Gordon, 
Todd and Cohn (1974), and although there was a partial inhibition 
of lysozyme production in cells lacking cytoplasmic 
microtubules, the mechanism of secretion is not affected. 
4. l. 8 LYSOZYME PRODUCTION AS A MEASURE OF MACROPHAGE 
FUNCTIONAL STATUS 
Convincing evidence exists that lysozyme production by 
macrophages reflects their level of activation (Steele, Eremin 
and Brown, 1983). The first suggestion that elevated lysozyme 
levels may parallel the functional state of the reticuloendo-
thelial system was by Cappuccino, Winston and Perri (1964; Di 
Luzio, 1979 a and b 447). These workers administered BCG or 
E.coli bacterial endotoxin to mice and demonstrated that 
specific challenge to host defence v,ith these agents increased 
lysozyme levels in the kidneys and spleens of mice. A 
relationship between splenic hyperplasia and lysozyme activity 
was noted (Di Luzio, 1979b 448). Elevated levels of this 
enzyme are thus observed during periods of increased resistance 
to infection (Unanue, 1976; Glynn, 1968). 
A rise in the level of serum lysozyme with the growth of a 
syngeneic sarcoma in rats was shown by Currie and Eccles (1976). 
Serum lysozyme levels correlated with the immune status of the 
tumour and its macrophage content (the latter conclusion being 
based on the paper by Gordon, Todd and Cohn, 1974, ie that 
lysozyme release by macrophages is unaffected by their state of 
activation; a concept which has been invalidated - see 4.1.9). 
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The finding that the surgical removal of the tumour led to a 
rapid decrease in serum lysozyme levels prompted the suggestion 
that enzyme levels could be used as a measure of macrophage-
mediated host response to the tumour. 
In an elegant series of studies, Kokoshis and Di Luzio showed 
that serum lysozyme levels are an index of macrophage functional 
status (Kokoshis and Di Luzio, 1979: Kokoshis et al, 1978; 
reviewed by Di Luzio 1979 a and b). Macrophage activation induced 
by glucan (Di Luzio, 1979b) was characterised by a significant 
enhancement in serum lysozyme concentration, hyper-phagocytosis, 
macrophage hyperplasia, increased resistance to S.aureus 
infection and hepatosplenomegaly (Kokoshis et al, 1978), in 
contrast to unaltered activities of several lysozomal enzymes and 
SGOT. Glucan therefore appears to be capable of selectively 
influencing lysozyme production (Di Luzio, 1979a). In addition, 
the elevation of serum lysozyme levels by glucan was found to be 
dose dependent (Kokoshis and Di Luzio, 1979). In order to 
determine whether increased serum lysozyrne levels associated with 
glucan administration were due to an increased population of 
macrophages or to macrophage activation, methyl palmitate - an 
agent with potent suppressant effects on macrophages - was used 
to reverse the glucan stimulatory action on macrophages 
(Kokoshis and Di Luzio, 1979; Di Luzio, 1979b 456). Methyl 
palmitate administration resulted in a decreased serum lysozyme 
concentration and phagocytic function. The ability of this agent 
to reduce lysozyme levels in glucan-treated animals with 
persisting hepatosplenomegaly indicates that serum lysozyrne 
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level is an expression of macrophage functional activity rather 
than of macrophage pool size (Di Luzio, 1979 a and b; Kokoshis 
and Di Luzio, 1979). 
Tilkes and Beck (1983) used lysozyme production as test for 
macrophage function as did Lyberg, Closs and Prydz ( 1982), who 
used lysozyme as a measure of the activating effects of 
mycobacteria 
parameter was 
on macrophages 
used by Steele, 
(Ridley et al, 1985). The same 
Eremin and Brown ( 1983). These 
workers investigated lysozyme content of monocytes and 
macrophages associated with human breast cancer. Significantly 
more monocytes from patients with cancer contained lysozyme than 
monocytes from comparable 
activated circling blood 
controls, suggesting the presence of 
monocytes. However, tumour-
infiltrating macrophages were 
indicating that these cells are 
virtually devoid of the enzyme, 
at a low level of activation, 
possibly representing defective 
Eremin and Brown, 1983). 
antitumour activity (Steele, 
The idea 
consequent 
that diminished intracellular lysozyme levels and 
diminished secretion reflects a lack of macrophage 
activation was 
et al, (1985) 
also expressed by Rea and Taylor 
and Kimura and Goldstein ( 1981). 
(1977), Ridley 
Rea and Taylor 
(1977) suggested that the lack of macrophage activation may have 
been a consequence of specific cell-mediated immune 
unresponsiveness characteristic of lepromatous leprosy. Ridley 
et al ( 1985) used lysozyme as a determinant of macrophage 
a cti va tion in leprosy lesions through the leprosy spectrum and 
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found that 1 ysozyme distinguished func tiona 11 y competent from 
functionally incompetent epitheloid cells, and recently recruited 
macrophages from those that had ingested M.leprae bacilli - lower 
levels of lysozyme secretion were associated with the 
persistence of viable organisms segregated within macrophages. 
After chemotherapy and in immunological upgrading reactions 
lysozyme secretion was increased (Ridley et al, 1985), 
underlining the concept that 
macrophage functional status. 
lysozyme levels are a measure of 
4 .1. 9 THE CHOICE OF LYSOZYME AS A PARAMETER IN THIS STUDY 
Lysozyme was selected as a parameter in this study primarily 
because production of the enzyme is an index of macrophage 
fun c t i on a 1 s ta tu s ( Capp u cc i no , i'Ji n s ton a n d Perr i , 1 9 6 4 ; G 1 y n n , 
1968; Rea and Taylor, 1977; Di Luzio, 1979 a and b 460; 
Birmingham and Jeska, 1981; Lyberg, Closs and Prydz, 1982, 
Tilkes and Beck, 1983; Steele, Eremin and Brown, 1983; Ridley 
et al, 1985) and a 
increased lysozyme 
characteristic of activated macrophages is 
production (Unanue, 1976; Spicer et al, 
1979; Karnovsky et al, 1975; Hopper, Wood and Nelson, 1979; 
Lasser, 1983). 
It is well established that initial interactions between the 
facultative intracellular pathogen Nocardia and macrophages play 
a significant role in the pathogenesis of Nocardia infections 
(Beaman and Smathers, 1976; Beaman, 1977; Beaman, Goldstein, et 
al, 1978; Melendro, et al, 1978; Black et al, 1983; 1985). 
Nocardia infections result from unsuccessful eradication of 
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Nocardia organisms by phagocytes such as macrophages ( Black et 
al, 1985). This study attempts to find a further explanation for 
the "apparent paradox of a micro-organism that not only is not 
destroyed by the phagocytic cells, but uses them to secure its 
existence" (Rojas-Espinosa et al, 1982). The idea that macrophage 
function may be modified in association with nocardial disease 
has been expressed frequently in this thesis. Several recent 
studies have correlated impairments in bactericidal capacity 
with reductions in intracellular lysozomal enzyme concentrations 
(Black et al, 1983). Goldstein et al ( 1978) demonstrated an 
absence of acid-phosphatase and Beta-glucuronidase activity in 
r;iacrophages with impairments of microbicidal activity consequent 
to ozone exposure; and Kimura and Goldstein ( 1981) extended 
these studies by demonstrating reduced intracellular lysozyme 
concentrations in macrophages with defects in bactericidal 
activity as a result of exposure to ozone. Katoh (1981) 
demonstrated that macrophages infected with the intracellular 
parasite Mycobacterium leprae showed decreased intracellular 
levels of the lysozomal enzymes acid-phosphatase and Beta-
glucuronidase. He suggested that this modulation of lysozomal 
enzyme level may contribute to the intracellular survival of the 
pathogen. Others have investigated the influence of M.leprae 
infection on intracellular lysozyme levels and on secretion 
(Ridley et al, 1985; section 4.1.8). Lysozyme synthesis ceases 
after macrophage ingestion of M.leprae and lower levels of 
lysozyme secretion were associated with macrophages that had 
ingested organisms that remained viable. 
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Black et al, in very recent studies ( 1983, 1985), revealed that 
the intracellular level of activity of acid-phosphatase in 
macrophages is reduced by in vitro infection with live virulent 
N.asteroides organisms, and the greater the level of 
intracellular infection (in terms of number of organisms) the 
more the level of acid-phosphatase activity was reduced (see 
section 1.7.4.1). The study demonstrated a relation between the 
virulence of the strain of N.asteroides and the extent of the 
reduction in macrophage acid-phosphatase activity (Black et al, 
1983). In a related study, Black et al (1985) showed that 
lysozomal acid-phosphatase activity correlated with macrophage 
killing efficiency and is therefore an effective marker of 
macrophage ability to inhibit growth of or kill N.asteroides. 
Thus it appears that one of the mechanisms enabling virulent 
strains of N.asteroides to survive within macrophages is the 
ability of these organisms to alter lysozomal enzyme activity 
(Beaman et al, 1985). 
Despite the differences in opinion regarding the role of lysozyme 
in host defence, it is an enzyme of proven bactericidal 
capability (Kimura and Goldstein, 1981; Biggar and Sturgess, 
Elsbach, 1973) and it appears 1977; Selsted and Martinez, 1978; 
to be accepted that 1 ysozyme participates in the bactericidal 
process in cases where other agents such as antibody and 
complement (Martinez and Carroll, 1980) sensitize naturally 
resistant pathogenic organisms to the action of the enzyme (Gabig 
and Babior, 1981). In addition, a very recent study showed that 
neutrophils inhibit the growth of N.asteroides in vitro, in that 
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filament formation and amino acid uptake were inhibited for 
several hours. In an attempt to determine which antimicrobial 
components of neutrophils might contribute to this inhibition it 
was shown that lysozyme reduced both the amino acid uptake by, 
and the colony forming unit count of N.asteroides under some 
conditions, suggesting that lysozyme may play some part in the 
increased inhibitory process (Filice, 1985). Therefore lack of 
production and release of lysozyme in association with nocardial 
infection may contribute to the intracellular survival of this 
pathogen and lead to the development of progressive disease. 
We have examined the possibility that macrophage function in 
N.asteroides and N.brasiliensis infections may be 
be modulated over 
different. 
the 21 day Further, macrophage 
infection period. 
function may 
It 
macrophage function may 
activation or suppression 
differences using the 
release. 
is possible that any differences in 
r.ianifest as differences in degree of 
and it may be possible to demonstrate 
parameter of lysozyme production and 
The studies by Black et al ( 1983, 1985) investigated the effect 
of in vitro infection with N.asteroides on macrophage 
intracellular acid-phosphatase levels. This study examines the 
effect of in vivo infection with both N.asteroides and 
N.brasiliensis on macrophage intracellular lysozyme levels and on 
lysozyme release. 
Mononuclear phagocytes are indentified on the basis of certain 
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criteria and lysozyme qualifies as a cytochemical characteristic 
of these cells (van Furth et al, 1982) and of PMN (Gordon, Todd 
and Cohn 1974), however PMN do not survive overnight in culture 
so in the system described, lysozyme is a cell-specific marker 
for macrophages. 
Lysozyme release is also a useful marker of cell viability 
(Baggiolini and Schnyder, 1982). Determination of the parameter 
of lysozyme production could therefore serve as a control for 
other parameters studied in that the presence of viable 
macrophages in the cultures would be confirmed. 
On the basis of these considerations we have examined the 
parameter of lysozyme production and secretion from mouse 
peritoneal macrophages in N.asteroides and N.brasiliensis 
infections. 
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4.2 METHODS 
The method used is adapted from that described by Parry, Chandan 
and Shahani (1965) and Gordon, Todd and Cohn (1974). 
4. 2. 1 CELL CULTURES 
Mouse peritoneal macrophages were harvested using standard 
procedures, as detailed previously, from male ICR mice (25-309). 
Cells were obtained 2, 7, 13 or 21 days after intraperitoneal 
inoculation with live organisms of N.asteroides or 
N.brasiliensis, or from control, saline-inoculated mice. 
Cells were pooled, concentrated by centrifugation at 40c at a RCF 
of 576, differential counts were perforned using a Neubauer white 
cell counting chamber and viability was measured by tryµan blue 
exclusion (for oetails of culture, see Chapter 2). Cells were 
resuspended in Dulbecco's medium (DB) supplemented with 2~ FCS + 
h,P&S at a density of 2x10 6 macrophages per ml. Peritoneal cell 
suspensions were plated in numbered Falcon plasLic tissue culture 
dishes on sterile glass coverslips (22 x 22 mm) at a density of 
2xl0 6 macrophages per coverslip. Cells were glass adhered for 10 
minutes at 37°c in the presence of 5% carbon dioxide, coverslips 
were then flooded with 2 ml of DB supplemented with 2% FCS + 
M,P&S and incubated for 2-24 hours. The cells were washed twice 
vigorously with HBSS to remove non-adherent cells, and replated 
in 1 ml of DB + 5% HIFCS + M,P&S. In each experiment as many 
replicate cultures of control and Nocardia-activated macrophages 
as possible were prepared for study of lysozyme release, the 
minimum number of cultures prepared was one. T he n u rr, be r o f 
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cultures prepared depended on the number of macrophages harvested 
from the control and the Nocardia-inoculated mice, and the 
maximum number of cultures was prepared from the cells available. 
4.2.2 CUl'lULATIVE RELEASE OF LYSOZYME INTO CULTURE MEDIUM 
EXTRACELLULAR LYSOZYME. EXPERIMENTAL SERIES "A" 
"Conditioned medium" was col lee ted from mono layer cul tu res at 
intervals of approximately 24 hours over a four day period and 
centrifuged at RCF of 2654 for 5 minutes at 4°C to remove 
cellular debris. Harvested materials were stored at -20°c until 
assay. Monolayer cultures wer refed with 1 ml DB+ 5% HIFCS + 
M,P&S and reincubated. 
Conditioned r:,edium collected after 24 hours was termed samrle l 
(Sl) and labellea with the number and label of the culture from 
\.;hich it had been harvested. Similarly, conditioned medium (CM) 
collected after the second 24 hour incubation period \./as termed 
sample 2 (S2) and labelled with its culture number. S3 and S4 
etc refer to samples collected after the third 24 hour and fourth 
24 hour incubation periods. 
The cumulative amounts of lysozyme released into the medium by 
macrophages in each culture at each sampling interval over the 
incubation period were determined. Cumulative enzyme 
concentration in the medium over the first and second day of 
incubation is the sum of the amount of lysozyme present in the Sl 
and S2 conditioned medium collected from that specific culture. 
The cumulative release of enzyme from the culture over the three 
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day period would be the sum of the enzyme concentrations in the 
medium at Sl, S2 and S3. The cumulative release of lysozyme from 
macrophages in culture over a period of up to 10 days was 
calculated in this way. 
Cell morphology was studied by phase contrast microscopy 
immediately prior to harvest of conditioned meaium. Any cultures 
that appeared unhealthy were discarded (See section 2.12). 
Several replicate experiments were performed at: each time 
interval post-inoculation studied. Wherever possible, and in 
fact in most experiments, pooled macrophages were assessed for 
both plasr;1inogen activator (PA) and ly.sozyme release. 'I'his was 
done so that both parameters could be studied in the same batch 
of macrophages, because ly.sozyme is a cell-specific marker for 
sacrophages and release of the enzyme would establish that the 
cells in culture were macrophages. 
After the final sample had been collected in some experiments, 
the cell monolayers were washed twice with warm (37°C) 
phosphate-buffered saline (PBS) and the cells were lysed by 
addition of 1C00 microlitres of 0.5% Triton X-100. Tissue 
culture dishes were frozen and thawed once and scraped with a 
plastic policeman. The cell lysates were stored in Beckman 
microfuge tubes (Beckman Instruments, Inc., Palo Alto, 
California, 94304) at -20°c until Fluram assay (2.3). The 
specific activity of the cumulative lysozyme in the final sample 
was determined from these results. Experiments designated "a" in 
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the tables were done in this way. In some experiments 
determining cumulative release of lysozyme into culture medium, 
cell lysates were not prepared and hence specific activity was 
not calculated, e.g. in Table 77, specific activity was not 
determined for experiments 1 and 2, consequently they are not 
designated "a". Specific activity of cumulative lysozyme in the 
final sample was determined in experiments 3 and 4 and those 
results are shown in Table 78. 
The characteristic value for lysozyme secreted by resident mouse 
peritoneal macrophages is given as 20-60 micrograms/milligram of 
protein/24 hours (Morahan, 1980). 
4. 2. 3 EXPERIMENTAL AND CONTkOL CULTURES AND EFFECT OF IN 
VI T-RO ADD IT ION OF NOCARD I A ANTIGEN ON MACROPHAGE 
LYSOZYME RELEASE 
Control cultures of 2xl0 6 macropnages were always run in parallel 
with cultures of 2xl0 6 macrophages derived from mice previously 
inoculated with N.asteroides or N.brasiliensis organisms. 
The effect of in vitro addition of culture filtrate antigens of 
N.asteroides and N.brasiliensis respectively on lysozyme release 
by cultured macrophages harvested from N.asteroides- or 
N.brasiliensis-inoculated mice was determined. The antigen was 
added to the culture medium in the desired concentration after 
the cells had been glass-adhered for 10 minutes. The per i tone a 1 
cells were then incubated and cumulative lysozyme release from 
these cultures was determined as described previously. 
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The concentration of homologous antigen added to cultures was 
0.002% v/v. 
4.2.4 CELL LYSATES AND CONDITIONED MEDIUM CUMULATIVE 
RELEASE OF LYSOZYME AND SPECIFIC ACTIVITY. 
EXPERIMENTAL SERIES "B". 
In order to determine whether cell number in the different 
e xper imen ta l groups viz. control, Noc a rd ia-ac ti va ted macrophages 
and Nocardia-activated macrophages incubated in vitro with 
antigen was similar at each 24 hour sampling interval, the 
following modification to the method described under cell 
cultures was made. In the initial study of lysozyme release,all 
the cultures were incubated over a 4 day period and conditioned 
medium collected at 24 hour intervals and cumulative release of 
lysozyme determined (Experimental series "A"). 
This study was designed to determine the specific activity of the 
1 ysozyme released, and confirm that trends of 1 ysozyme rel ease 
shown in the individual experiments were not due to increased or 
decreased cell number, or increased cell protein content. 
Gordon, Toad and Cohn, ( 1974) and Rojas-Espinosa et al ( 1982) 
both found that lysozyme activity increased in the experimental 
macrophage group when expressed as a function of cell number, but 
was similar when expressed as specific activities. 
The e xper i r.1en ta l procedure was as described previously except 
that certain cell cultures were terminated immediately after 
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collection of the first sample of CM (Sl) ie. after 24 hours of 
incubation. The CM was collected from the remainder of the 
cultures, which were designated for longer incubation periods, 
and were refed with fresh medium and returned to the incubator. 
The macrophage monolayers from the cultures to be terminated were 
washed twice with PBS (37°) and 1000 microlitres of 0.5% v/v 
Tri ton X-100 added to 1 yse the eel 1 s. The cell monolayer and 
Triton were frozen and thawed once to facilitate cell lysis (Cohn 
and Hirsch, 1960; Biggar and Sturgess, 1977) and the monolayers 
scraped using a plastic policeman. The cell lysates were 
collected and stored in microfuge tubes and kept at -20°c until 
assay. 
After a further 24 hours incLlbation (S2) certain cultures were 
terminateo after collection of CM and cell lysates prepared. 
After collection of the CM from the remainder of the cultures 
they were refed and incubated for a further 24 hours when the S3 
samples and cell lysates were collected. The samples designated 
to incubate for the final 24 hours (S4) were refed and returned 
to the incubator. 
Equal numbers of cultures from each experimental group were 
terminated at each sampling interval whenever possible. This 
depended on the number of cultures in each group at the start of 
the experiment. In most experiments there were duplicate, 
triplicate or several replicate cultures for termination at each 
sampling interval, although in some cases there were not 
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sufficient cells for more than a single culture for termination. 
As a result of the daily termination of randomly selected 
cultures, there was a sequential decline in the number of dishes 
returned to the incubator each day, and on the fourth day the 
final cultures were terminated. 
done in this way. 
Experiments designated "b" were 
The results obtained in this way permitted calculation of the 
cumulative release of lysozyme and its specific activity at each 
interval over the four day incubation period. 
Release of enzyme after the initial 24 hour incubation period 
(Sl) was calculated for each culture and related to the amount of 
cell protein present in the lysate from that culture. The amount 
of protein present, oetermined spectrofluorimetrically as 
described previously (2.3), gives an indication of cell number 
and cell protein content. 
Cumulative release of enzyme after 48 hours incubation was 
calculated as the sum of the amount of enzyme present in the Sl 
and in the S2 sample for that culture. The specific activity of 
the lysozyme was determined by relating the total lysozyme so 
obtained to the amount of cell protein present in the lysate. 
Cumulative enzyme release and specific activity at S3 and S4 was 
calculated in the same way. 
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4.2.5 ASSAY OF LYSOZYME IN THE CONDITIONED MEDIUM RELEASED 
OR EXTRACELLULAR LYSOZYME 
Lysozyme present in conditioned medium was assayed by measuring 
the initial rate of lysis of a suspension of Micrococcus 
lysodeikticus (Sigma 0128, dried cells) with the aid of a Varian 
Cary 219 spectrophotometer (Varian Assoc Inc, Palo Alto, 
California 94303) fitted with a recorder. 
The lysozyme standard used was Sigma-L6876, from chicken egg-
white, 3 x crystallised, Grade 1, dialysed and lyophilised. The 
range used for the series of standards was 1 microgram/ml, 5 
micrograms/ml, 10 micrograms/ml, 20 micrograms/ml, 30 
ffiicrograms/ml prepared in DB+ 5% HIFCS + M,P&S. Other workers 
have found that samples cont.aining riigher than 30 micrograms/ml 
of lysozyme deviated from linearity after 30-60 seconds. They 
also demonstrated that it is necessary to use ini tia 1 reaction 
velocities as extensive end-product inhibition is apparent above 
15 micrograms of lysozyme (Parry, Chandan and Shahani, 1965). 
The Micrococcus lysodeikticus dried cells were suspended in 1/15 
M phosphate buffer pH 6.3 prepared as follows : 
Solution A: 
Solution B: Na 2 HP0 4 .2H 2o (Merck) 1.19 g/100 ml H2o 
Mix 81 ml solution A with 19 ml solution B = 1/15 M phosphate 
buffer. 
25 mg of Micrococcus lysodeikticus dried cells were suspended in 
100 ml of the phosphate buffer. 
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Reaction conditions were as follows: 
1ml of sample or standard was mixed at room temperature with 2ml 
Micrococcus lysodeikticus suspension, briefly stirred with an 
orange stick and the rate of decrease in turbidity was measured 
at 540 nm, using a full recording scale equal to l OD unit. The 
spectrophotometer was zeroed using distilled water and distilled 
water was used in the reference cuvette. The initial reaction 
rate was linear for at least 30 seconds and the logarithm of the 
reaction rate was directly proportional to the logarithm of the 
egg lysozyme concentration in the range 1-30 micrograms/ml. A 
log-log linear regression was drawn from the standards and sample 
concentration in microgram (/g) equivalents of chicken egg-white 
lysozyrr,e were calculated fror11 the linear regression (Fig 23). 
4.2.6 ASSAY OF INTRACELLULAR LYSOZYME 
Gordon (1978a) states that intracellular lysozyme levels are so 
low as to be barely detectable. Lysozyme present in the cell 
lysates was assayed spectrophotometrically by adapting the method 
used to assay lysozyme in conditioned medium. 
Lysozyme standards were prepared in 0. 5% v/v Tri ton X-100. The 
range used was 0.05 micrograms/ml, 0.1 micrograms/ml, 0.2 
micrograms/ml, 0.3 micrograms/ml, 0.4 micrograms/ml, 0.5 
micrograms/ml and 1 microgram/ml. 
prepared as described previously. 
Micrococcus lysodeikticus was 
The suspension was stirred 
hard using a magnetic stirrer for 30 minutes. The substrate 
suspension should be stable for one week at 4°c (Morsky, 1983). 
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The microfuge tubes of cell lysates were spun at 10 000 g for 1 
minute 50 seconds in a Beckman microfuge B (Beckman Instruments 
Inc., Palo Alto, California 94304) to remove cellular debris. 
Reaction conditions were as follows : 200 microlitres of standard 
or sample was mixed with 400 microlitres of cell suspension in a 
plastic counting tube (Greiner 115101, Germany), briefly mixed 
with an orange stick and poured into a 1 ml microcuvette 
(Spectrosil) at room temperature. 
Some samples contained very low concentrations of lysozyme. To 
increase the sensitivity of the assay so that enzyme 
concentrations in these samples could be determined, 3CG 
rnicrolitres of sample or standard were mixed with 150 microlitres 
of substrate. The range of lysozyme standards prepared for assay 
of these samples included concentrations of 0.0125 micrograms/ml 
and 0.025 micrograms/ml. 
The rate of decrease 1n turbidity was measured at 540 nm using a 
full recording scale equal to 0.05 OD units. The 
spectrophotometer was zeroed using distilled water and distilled 
water was used in the reference cuvette. The trace produced by 
low concentrations of standards and samples was often irregular 
for up to 3 minutes, but was linear after this period. Thereafter 
the reaction rate was linear for at least 2 minutes and was 
related to egg lysozyme concentrations by the following equation: 
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Y = M [1-exp(-ZX)] in the range 0.0125 - 1 microgram/ml, where 
Y = rate 
X = concentration 
and Mand Z are constants. 
Sample concentrations in microgram equivalents of chicken egg-
white lysozyme were calculated from the regression (Fig 24). 
4.2.7 STATISTICAL TREATMENT OF DATA 
To examine the significance of each experimental factor in this 
series of experiments, the Mann \Jhitney U Test (Siegel, 1956) was 
used to compare control and test groups. Medians and their 95% 
confidence limits were calculated by a method due to Tukey 
(Hollander and Wolfe, 1973). (For a more comprehensive 
discussion on statistical treatment of data, see Chapter 2.9). 
4.2.8 EXPERIMENTAL SERIES "A" AND "B" 
Experiments in which CM was collected at 24 hour intervals and 
fresh medium added to each of the cultures over 4-6 days of 
incubation were termed experimental series "A". In some of these 
experiments the specific-activity of the cumulative lysozyme in 
the final sample was determined, these are shown as experiment 
"a"; eg Table 77. 
In experimental series "B", specific activity of accumulated 
lysozyme in culture medium was determined at each sampling 
interval, as detailed in 4.2.4. In series "B", intracellular and 
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total lysozyme levels as well as their specific activities were 
also determined. 
The series of experiments in which the intracellular, 
extracellular and total lysozyme levels were determined were 
designated experimental series 11 b" and are shown as such in the 
tables. Ex per imen ts "a II and 11 b 11 
macrophages were obtained from the 
332 
were 
same 
run concurrently 
cell pool. 
and 
4.3 RESULTS 
4.3.l LYSOZYME RELEASE FROM MOUSE PERITONEAL MACROPHAGES 
In the initial series of experiments macrophage release of 
lysozyme into the culture medium was measured. In all figures 
and tables, data are expressed as microgram equivalents of hen's 
egg-white lysozyme. 
Gordon, Todd and Cohn ( 1974) showed that there is no endogenous 
1 ysozyme present in feta 1 ca 1 f serum; 1 ysozyme was stable after 
prolonged storage at -20°c and upon repeated freezing and 
thawing. 
Schnyder and Baggiolini (1978a), Gordon, Todd and Cohn (1974) and 
Maier and Ulev itch ( 1981) showed that 1 ysozyme remained fully 
active under culture conditions for at least 3 days. 
In this system, lysozyme measured is released from macrophages, 
since polymorphonuclear cells die within 6-12 hours in culture 
(Gordon, Unkeless and Cohn, 1974; Nathan, 1983) and non-adherent 
cells are removed by washing prior to incubating cells in 5% 
HIFCS. 
4.3.1.1 CALIBRATION OF THE EXPERIMENTAL SYSTEM 
4.3.1.1.l Optimum cell number 
When this investigation was started, 3xl0 6 peritoneal macrophages 
were plated in each tissue culture dish. It was found that a 
large proportion of macrophages had not adhered in the initial 2-
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24 hour incubation period, resulting in cultures which had widely 
distributed cells. This problem was overcome by reducing the 
cell number per dish to 2xl0 6 , by introducing sterile coverslips 
into the tissue culture dish, and by glass adhering 1 ml of cell 
suspension to the coverslip at 37°c, 5% co 2 for 10 minutes. 
Surface tension maintains the 1 ml cell suspension on the 
coverslip and after the initial adherence period the coverslip 
was flooded with 2 ml of DB + 2% FCS, M,P&S. Reduction of cell 
number reduced possible overcrowding on the coverslip and glass 
adhering for 10 minutes in a small volume minimized cell 
adherence to the plastic. This method achieved healthy cultures, 
as judged by morphology. It was possible to produce adequate 
amounts of lysozyme from lxl0 6 macrophages cultured on glass 
coverslips, however there appeared to be sufficient surface area 
on the coverslip to maintain 2xl0 6 macrophages, so the cell 
density chosen was 2xl0 6 macrophages per dish (Tables 73 and 74). 
4.3.1.1.2 Optimum incubation time 
Measurable amounts of lysozyme were released from cultures of 
control and N.brasiliensis-activated macrophages after 5-8 hours 
of incubation. It was found that lysozyme was secreted into the 
same culture medium by macrophages for up to 3 days without 
apparent ill-effect, (Table 75, Fig 25) as judged by morphology; 
however maintenance of cells in the. same culture medium for 4 
days or more resulted in macrophages which rounded up and did not 
appear healthy. 
Experiments were conducted in which conditioned medium was 
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collected at 24 hour intervals and the cultures refed with fresh 
medium for 8-10 days (Table 76). Lysozyme was released into the 
medium continuously over this period, and cultures appeared 
nor ma 1 as judged by morphology. This finding is in agreement 
with the findings of Gordon, Todd and Cohn (1974). 
It was decided that 24 hourly samples should be collected and 
that fresh medium should be added to the cultures at this point. 
Morphology was checked immediately prior to collection of the 
conditioned medium. 
4.3.2 INFLUENCE OF TIME-COURSE OF NOCARDIA INFECTION ON 
LYSOZYME RELEASE FROM MOUSE PERITONEAL MACROPHAGES 
Live organisms of N.asteroides or N.brasiliensis suspended in 
norma 1 sa 1 ine were inoculated in traper i tonea 11 y in to ICR male 
mice. Control mice were inoculated at the same time with normal 
saline only. Mice were sacrificed at various intervals post-
inoculation viz. 2, 7, 13 and 21 days, and the peritoneal 
macrophages harvested and cultured as detailed previously. 
Lysozyme release from control and Nocardia-activated macrophages 
was measured over a four to six day period for each time interval 
post-inoculation and the results compared. 
4.3.2.l TWO DAY N.ASTEROIDES INFECTION 
Control and N.asteroides inoculated mice were sacrificed 2 days 
post-inoculation and release of lysozyme into the culture medium 
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measured. 
4.3.2.1.l Accumulation of lysozyme in conditioned medium 
Over the four day incubation period lysozyme accumulated in the 
medium from both Nocardia-activated and control macrophages. 
There was an apparent 4.9-fold increase in the amount of lysozyme 
which accumulated in the culture medium of the control cells over 
4 days. There was a similar apparent increase (3.9-fold) in 
enzyme levels in the culture medium of the N.asteroides-activated 
macrophages over the same period. (The apparent increase in 
amount of lysozyme over the 4 days in culture was determined by 
dividing the median cumulative lysozyme value at S4 by the median 
lysozyme value at Sl for each of the 3 experimental groups). 
Four replicate experiments were performed. 
experiments are presented in Table 77. 
The data from these 
Table 78 represents the specific activity of the cumulative 
lysozyme released over the 4 days in culture for experiments 3a 
and 4a. 
Median cumulative lysozyme values and their 95% confidence limits 
are shown in Table 109 and Fig 26 for each sampling interval (Sl-
S4) over the 4 days in culture. There was no statistically 
significant difference between the amounts of lysozyme released 
from control macrophages and from macrophages activated with 
N.asteroides two days previously (Mann Whitney U Test). 
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4.3.2.1.2 Effect of in vitro addition of culture filtrate 
antigens of N.asteroides on accumulation of macrophage 
lysozyme in the medium 
Only one experiment was done (Experiment 4a and b) in which 
N.asteroides-activated macrophages were cultured in vitro with 
N.asteroides antigen for 24 hours. Apparently similar amounts of 
lysozyme were released by antigen-exposed activated macrophages 
when compared with amounts of lysozyme secreted by N.asteroides 
-activated cells, in experiment 4 (Table 77). 
4.3.2.1.3 Intracellular lysozyme and percentage of lysozyme 
secreted (Experimental Series "B") 
Two experiments (3b and 4b) were performed where the amounts of 
1 ysozyme present in tracel 1 ula r 1 y were determined. These data 
permitted calculation of the percentage of lysozyme secreted by 
the cells into the culture medium (Table 79). 
Percentage lysozyme = 
secreted 
Amount of lysozyme present 
extracellulary 
Intracellular+ extracellular 
lysozyme lysozyme 
X 100 
Gordon (1980 :1277) states that"lysozyme secretion in culture is 
characterized by a large net increase in total lysozyme - up to 
20-fold in 3 days, 75-95% of which is in the medium". In a study 
of lysozyme secretion from unstimulated and thioglycolate 
stimulated mouse macrophages and human monocytes, Gordon, Todd 
and Cohn (1974) demonstrated that 87-90% of total lysozyme 
337 
production was present in the medium after 3 days. In a separate 
study, Gordon, Unkeless and Cohn (1974) showed that the 
unstimulated mouse peritoneal macrophages secreted 95% of the 
total lysozyme after 48 hours in culture. Macrophages stimulated 
by phagocytosis or agents such as endotoxin or thioglycolate 
medium secreted 92-98% of the total lysozyme over the same time 
period. 
Table 79 shows that in experiments 3b and 4b control macrophages 
secreted 88-97% of total lysozyme after 48 hours, N.asteroides 
-activated macrophages secreted 78-99% and N.asteroides-activated 
macrophages exposed in vitro in antigen secreted 90-95% of total 
lysozyme over the same period of incubation. Therefore the 
percentage of lysozyme secreted by the macrophages did not appear 
to be modified by inoculation two days previously with 
N. as teroides, or by in vitro exposure to an ti gen. Simi la r 1 y, 
percentage secretion of lysozyme did not appear to be affected 
after 1 and 3 days of incubation. 
There was no statistically significant difference between the 
total lysozyme levels of control and N.asteroides-activated 
macrophage cultures at any of the sampling intervals (Sl, S2 and 
S3, Mann Whitney U Test). 
4.3.2.1.4 Lysozyme specific activity 
The specific activity of intracellular and extracellular lysozyme 
was determined spectrophotometrically in two experiments (3b and 
4b). The specific activity of the total amount of lysozyme was 
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calculated from these results. The data are presented in Table 
80. 
Comparison of the set of data in Table 79 with that in Table 80 
shows similar trends in results when they are expressed either as 
micrograms of lysozyme per 2xl0 6 macrophages or when expressed as 
micrograms per mg of cell protein. This trend was found in 
Experiments 3a and 4a, where specific activity of the cumulative 
lysozyme at S4 was determined. 
There was no statistically significant difference in the specific 
activities of the total lysozyme levels of control and 
N.asteroides-activated macrophages at any of the 3 sampling 
intervals (Sl, S2, S3) in Experiments 3b and 4b. 
4.3.2.2 TWO DAY N.BRASILIENSIS INFECTION 
Control and N.brasiliensis inoculated mice were sacrificed 2 days 
post-inoculation, macrophages cultured and release of lysozyme 
determined. 
4.3.2.2.1 Accumulation of lysozyme in conditioned medium 
Lysozyme was released by both control and N.brasiliensis 
-activated macrophages and accumulated in the medium over the 
four - six day incubation period. 
There was an apparent 4.1-fold increase in the amount of lysozyme 
which accumulated in the control macrophages culture medium and a 
similar apparent increase (3.6-fold) in the level in the 
N.brasiliensis-activated macrophage culture medium over the four 
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day incubation period. 
Seven replicate experiments were performed. The data from these 
experiments are presented in Table 81 and the median cumulative 
lysozyme values and their 95% confidence limits for each sampling 
interval (Sl-S4) in Table 110 and Fig 27. 
Data in Table 82 represent the specific activities of cumulative 
enzyme in the final sample for 4 experiments. (Experiments 5 and 
6 were terminated after 6 days incubation and Experiments 7a and 
Sa after 4 days incubation). Trends in results appear to be 
similar whether data are expressed in terms of cell number or in 
terms of specific activity. 
There was no statistically significant difference between the 
amounts of lysozyme released from control macrophages and from 
macrophages activated with N.brasiliensis two days previously. 
4.3.2.2.2 Effect of in vitro addition of culture filtrate 
antigens of N.brasiliensis on accumulation of 
macrophage lysozyme in the medium 
The influence of incubation with antigen on the amount of 
lysozyme present in the N.brasiliensis-activated macrophage 
culture medium was determined in 3 replicate experiments ( Table 
81). Fig 27 and Table 110 show the median cumulative lysozyme 
values and their 95% confidence limits. 
There was an apparent 2.5-fold increase in the amount of enzyme 
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which accumulated in the medium over 4 days. 
There was no statistically significant difference between the 
amount of enzyme released into the culture medium by these 
antigen-exposed macrophages and that released by control 
macrophages, as determined by comparing these data using the Mann 
Whitney U Test. 
Similarly, there was no significant difference between the amount 
of enzyme produced by N.brasiliensis-activated macrophages and 
N.brasiliensis-activated macrophages exposed in vitro to antigen. 
Specific activities of cumulative 1 ysozyme in the f ina 1 sample 
are shown in Table 82 and trends in results appear to be similar 
whether data are expressed as micrograms of lysozyme per 2xl0 6 
macrophages or as micrograms of lysozyme per mg of cell protein. 
4.3.2.2.3 Intracellular lysozyme and percentage of lysozyme 
secreted 
Two experiments ( 7b and Sb) were done in which the amounts of 
intra- and extracellular lysozyme, total lysozyme and percentage 
lysozyme secreted by the macrophages were determined (Table 83). 
There was no statistically significant difference in the total 
lysozyme levels in the 3 experimental groups over the 3 days in 
culture (Mann Whitney U Test). 
In experiments 7b and Sb 92-94% of the total lysozyme was 
secreted in to the medium by the control macrophages after 48 
hours of incubation. Over the same period 96-97% of the total 
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was secreted by the N.brasiliensis-activated macrophages and 93-
98% by the cells exposed in vitro to antigen. Similar 
percentages of enzyme were secreted by the different groups of 
cells after 1 and 3 days of incubation. Secretion was not 
affected by exposure to N.brasiliensis organisms or antigens, and 
all these groups of cells showed a 
accumulation. 
4.3.2.2.4 Lysozyme specific activity 
similar pattern of lysozyme 
Intracellular and extracellular lysozyme specific activities were 
determined in experiments 7b and 8b and the specific activity of 
the total lysozyme determined from these data (Table 84). 
Comparison of the data in Tables 83 and 84 shows similar trends 
in the results whether they are expressed as micrograms of 
lysozyme per 2xl0 6 macrophages or as micrograms of lysozyme per 
milligram of cell protein. 
There was no statistically significant difference in the total 
specific activites of lysozyme in the three experimental groups 
of cells over the 3 days in culture (Mann Whitney U Test). 
4.3.2.3 SEVEN DAY N.ASTEROIDES INFECTION 
Animals were sacrificed 7 days post-inoculation and release of 
lysozyme from cultured macrophages measured. 
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4.3.2.3.1 Accumulation of lysozyme in conditioned medium 
There was an apparent 3.8-fold increase in lysozyme levels in the 
culture medium of the control macrophages and 4. 3-fold increase 
in the level of enzyme in the medium of the N.asteroides 
-activated macrophages over the time of incubation. 
Six replicate experiments were completed and the data from these 
experiments are given in Table 85. Median cumulative lysozyme 
values and their 95% confidence limits are shown in Table 111 and 
Fig 28. 
Macrophages from mice inoculated 7 days previously with 
N.asteroides released less lysozyme into the culture medium than 
macrophages from mice inoculated with normal saline only. The 
difference was statistically significant at each 24 hour sampling 
interval over the four day incubation period. (Sl, p<0.01; S2, 
p<0.001; 
28). 
S3, p<0.001; S4, p<0.01; Mann Whitney U Test, See Fig 
Table 86 gives the specific activities of cumulative lysozyme in 
the final sample (S4) for three experiments. Trends of results 
appear similar whether data are expressed in terms of cell number 
or specific activity. 
4.3.2.3.2 Effect of in vitro addition of culture-filtrate 
antigens of N.asteroides on accumulation of macrophages 
lysozyme in the medium 
Macrophages from mice inoculated 7 days previously with 
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N.asteroides were incubated with antigen and accumulation of 
enzyme in the medium measured. 
experiments (Table 85). Median 
This was done in four replicate 
cumulative lysozyme values and 
their 95% confidence limits are shown in Fig 28 and Table 111. 
There was an apparent 5. 7-fold increase in the amount of 
extracellular lysozyme in the antigen-treated cultures over the 4 
day incubation period. The N.asteroides-activated macrophages 
incubated with antigen accumulated less lysozyme in the medium 
than control macrophages and this difference was statistically 
significant at each sampling interval. (Sl, p<0.05: S2 p<0.01: 
S3, p<0.0l: S4, p<0.01: Mann Whitney U Test). 
Specific activities of cumulative lysozyme in the final sample in 
two experiments are shown in Table 86. 
There was no statistically significant difference between the 
amount of l ysozyme present in the CM of N. as teroides-ac ti va ted 
macrophages and that in the CM of N.asteroides-activated 
macrophages incubated with antigen, as determined by the Mann 
Whitney U Test. 
4.3.2.3.3 Intracellular lysozyme and percentage of lysozyme 
secreted 
Table 87 shows the data from two experiments ( 9b and 10b) in 
which the amounts of intra- and extracellular lysozyme, total 
lysozyme and percentage released by the different experimental 
groups of cells were determined. In some ce 11 l ysa te samples 
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intracellular lysozyme levels were not measurable and these 
levels are given as zero in the table. 
80-86% of the total enzyme was secreted by the control 
macrophages over the 48 hour incubation period, 81-99% by the 
N.asteroides-activated, and 90-98% by the N.asteroides-activated 
cells cultured with antigen over the same period. 
There was a statistically significant difference in the total 
lysozyme levels in the control macrophages and in the 
N.asteroides-activated macrophages at each sampling interval over 
the 3 days in culture (Sl, p=0.016; S2, p=0.004; S3, p=0.004). 
Similarly, there was a statistically significant difference in 
the total lysozyme levels in control cultures and in cultures of 
N.asteroides-activated macrophages exposed in vitro to antigen at 
each sampling interval (Sl, p=0.048; S2, p=0.0024; S3, p=0.01); 
but no statistically significant difference between N.asteroides 
-activated macrophages and N.asteroides-activated macrophages 
exposed in vitro to antigen (Mann Whitney U Test). 
4.3.2.3.4 Lysozyme specific activity 
The specific activity of the intra- and extracellular lysozyme 
and hence total lysozyme was determined in experiments 9b and 10b 
( Table 88). 
Similar trends in results are obtained if the data are expressed 
in micrograms of lysozyme per 2x10 6 macrophages or micrograms of 
lysozyme per mg of cell protein, however statistical significance 
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was not achieved at each sampling interval, as it was when data 
were expressed in terms of cell number. There was a significant 
difference between total enzyme specific activity of control and 
N.asteroides-activated macrophages after 48 and 72 hours of 
incubation (S2, p=0.028; S3, p=0.006) and between control and 
N.asteroides-activated macrophages exposed to antigen after 72 
hours of incubation (S3, p<0.0l). 
4.3.2.4 SEVEN DAY N.BRASILIENSIS INFECTION 
Mice were sacrificed 7 days after inoculation with 
N.brasiliensis, the peritoneal cells harvested and cultured, and 
secretion and accumulation of lysozyme by the different groups of 
cells measured. 
4.3.2.4.1 Accumulation of lysozyme in conditioned medium 
Extracellular lysozyme appeared to increase 3.4-fold in the 
control cultures and 3.5-fold in the N.brasiliensis-activated 
cell cultures over the 4 days of incubation (Table 89). 
Ten replicate experiments were performed and the data from these 
a re given in Table 89. Median cumulative 1 yso zyme va 1 ues and 
their 95% confidence limits are given in Table 112 and Fig 29. 
Significantly less lysozyme accumulated in the CM of 
N.brasiliensis-activated macrophages than that of control 
macrophages (Mann Whitney U Test). The lysozyme levels were 
significantly lower in the N.brasiliensis-activated macrophage CM 
at each sampling interval (Sl, p<0.00l; S2, p<0.001; S3, 
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p<0.001; S4, p<0.01; Mann Whitney U Test, Fig 29). Table 90 
shows the specific activities of the cumulative lysozyme after 
the final day in culture ( experiments 5, 6 and 7 were incubated 
over 6 days and experiment 8a over 4 days). Apparently similar 
trends in results occurred whether the enzyme was expressed in 
terms of cell number or cell protein in all three experimental 
cell groups. 
4.3.2.4.2 Effect of in vitro addition of culture filtrate 
antigens of N.brasiliensis on accumulation of 
macrophage lysozyme in the medium 
Peritoneal macrophages harvested from mice inoculated 7 days 
previously with N.brasiliensis organisms were incubated in vitro 
with N.brasiliensis antigen and the accumulation of lysozyme in 
the medium measured in five replicate experiments (Table 89). 
Median cumulative lysozyme values and their 95% confidence limits 
are shown in Table 112 and Fig 29. There was an apparent 7.3-
fold increase in the amount of extracellular enzyme in the 
antigen-exposed cultures over the 4 days of incubation. 
The antigen-exposed macrophages accumulated less lysozyme in the 
CM than the control macrophages. This difference was 
statistically significant at each sampling interval. (Sl, p<0.01; 
S2, p<0.01: S3, p<0.01; S4 p<0.01; Mann Whitney U Test, Fig 
29). 
There was a significant difference between the amount of lysozyme 
produced by N.brasiliensis-activated macrophages and that 
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produced by those macrophages exposed in vitro to antigen after 
24, 48 and 72 hours in culture (Sl, p<0.001; S2, p<0.05; S3, 
p=0.05) but not after 96 hours in culture (Mann Whitney U Test). 
Less lysozyme was produced by the antigen-treated cultures. 
4.3.2.4.3 Intracellular lysozyme and percentage of lysozyme 
secreted 
Intra- and extracellular lysozyme levels and hence total lysozyme 
present was determined in one experiment (Sb). From these data 
the percentage of 1 ysozyme secreted by the different groups of 
macrophages was calculated (Table 91). Data in experiment Sb 
were tested for statistical difference using the Mann Whitney U 
Test (Siegel, 1956). In this test, statistical significance can 
be achieved on a minimum of nl = 3 replicate samples and n2 = 4 
replicate samples; and if there is no overlapping of the data 
when they are ranked, p= 0.056 for a two-tailed test. 
There was a significant difference, within the limitations of the 
data, between the amount of extracellular, intracellular and 
total lysozyme in control cultures and those amounts in 
N.brasiliensis-activated macrophages after 1 day of incubation 
(Sl, p=0.056 in each case). Significant differences were found 
between control intra- and extracellular and total lysozyme 
levels and those levels in cultures with antigen, after 1 day of 
incubation (Sl, p=0.056 in each case). 
72-86% of total enzyme was secreted by control cells, 77-94% by 
N.brasiliensis-activated cells and 85-89% by antigen-treated 
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cells after 1 day of incubation. 
At the end ofthe second day of incubation, controls had secreted 
76-81% of total enzyme, and N.brasiliensis-activated and antigen-
treated 80-97% and 94-95% respectively. 
After 3 days in culture, control macrophages had secreted 94-96%, 
N.brasiliensis-activated 92-97% and antigen-treated 74-86% of 
tota 1 1 yso zyme. 
Although total lysozyme levels in the N.brasiliensis-activated 
macrophages and antigen-treated macrophages appeared to be lower 
than total lysozyme in controls, 
appear to be affected. 
4.3.2.4.4 Lysozyme specific activity 
secretion of enzyme did not 
Intracellular and extracellular specific activities of lysozyme 
and total enzyme specific activity are given in Table 92. 
Similar trends in results are seen whether results are expressed 
in micrograms of lysozyme per 2xl0 6 macrophages or as micrograms 
of lysozyme per milligram of cell protein. 
Within the limitations of the data, there is a statistically 
significant difference between the amount of extracellular, 
intracellular and total lysozyme in control cultures and the 
extracellular, intracellular and total lysozyme in 
N.brasiliensis-activated cultures (p = 0.056 in each case)and 
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between these levels in control cultures and antigen-exposed 
cultures (p = 0.056 in each case) after 24 hours of incubation 
(Mann Whitney U Test). 
After 2 days of incubation there was a statistically significant 
difference between the amounts of extracellular enzyme in 
cultures of N.brasiliensis-activated macrophages and antigen-
treated cul tu res ( p = 0. 056). This 
expressed as micrograms of lysozyme 
was 
per 
found when results were 
2xl0 6 macrophages or as 
micrograms of lysozyme per milligram of protein. 
4.3.2.5 THIRTEEN DAY N.ASTEROIDES INFECTION 
Thirteen days after inoculation with N.asteroides mice were 
sacrificed, the peritoneal cells harvested and cultured, and 
secretion and accumulation of lysozyme in the culture medium 
measured. 
4.3.2.5.1 Accumulation of lysozyme in conditioned medium 
There appeared to be a 5.4-fold increase in the amount of 
extracellular lysozyme in control cultures and a 4.8-fold 
increase in levels of enzyme in the CM of N.asteroides-activated 
macrophages over 4 days of incubation (Table 93). 
Table 93 gives the data from four replicate experiments and Table 
113 and Fig 30 show the median cumulative 1 ysozyme va 1 ues and 
their 95% confidence limits at each sampling interval. 
There was no statistically significant difference between the 
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amount of extracellular enzyme in control cultures and that in 
N.asteroides-activated macrophage cultures (Mann Whitney U Test). 
Table 94 shows the cumulative lysozyme specific activities of the 
final samples in two experiments (experiment 2 was incubated over 
6 days and experiment 4a over 4 days). Trends in results are 
apparently similar whether expressed in terms of cell number or 
total protein content). 
4.3.2.5.2 Effect of in vitro addition of culture filtrate 
antigens of N.asteroides on accumulation of macrophage 
lysozyme in the medium 
Two experiments (3a and 4a) were performed in which the effect of 
in vitro exposure to N.asteroides antigens on lysozyme 
accumulation into the medium was determined (Table 93). 
Apparently similar amounts of enzyme were released by antigen-
exposed cells and N.asteroides-activated cells. 
4.3.2.5.3 Intracellular lysozyme and percentage of lysozyme 
secreted 
Intra- and extracellular lysozyme levels were determined in one 
experiment(4b) (Table 95). 
control macrophage over 3 
The percentage of enzyme secreted by 
days in culture was similar to that 
secreted by N.asteroides-activated macrophages, and by 
N .asteroides-acti va ted macrophages exposed in vitro to antigen. 
The percentage of lysozyme secreted by these macrophages was 
similar to the percentages determined in other experiments 
performed at different times after inoculation of the mice, and 
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concurs with the data in the literature. 
4.3.2.5.4 Lysozyme specific activity 
Table 96 shows the intracellular, extracellular and total 
lysozyme specific activities. 
Similar trends in results are found whether data are expressed as 
micrograms of lysozyme per 2xl0 6 macrophages or as micrograms of 
lysozyme per milligram of cell protein. 
4.3.2.6 THIRTEEN DAY N.BRASILIENSIS INFECTION 
Secretion and accumulation of lysozyme into the medium was 
measured in control macrophage cultures and in cultures of 
macrophages harvested from mice inoculated 13 days previously 
with N.brasiliensis. 
4.3.2.6.l Accumulation of lysozyme into the culture medium 
Lysozyme was released into the medium by control and 
N.brasiliensis-activated macrophages and accumulated over 4-10 
days in culture. 
There was an apparent 5-fold increase in the amount of 
extracellular enzyme in control cultures and a 4.6-fold increase 
in levels of enzyme in the medium of N.brasiliensis-activated 
macrophages over 4 days of incubation (Table 97). 
Table 97 gives the data from eight replicate experiments. The 
median cumulative lysozyme values and their 95% confidence limits 
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are presented in Table 114 and Fig 31. 
There was a statistically significant difference in the amount of 
lysozyme present in the extracellular medium of the control and 
N.brasiliensis-activated macrophages after the second, third and 
fourth day of incubation, but not after the first day in culture 
(S2, p<0.05; S3, p<0.05; S4 p<0.05; Mann Whitney U Test, Fig 31). 
Less enzyme was produced by N.brasiliensis-activated macrophages. 
Table 98 gives the specific activites of the cumulative lysozyme 
in the f ina 1 sample ( ex per imen t 3 was incubated over 10 days, 
experiment 7 over 6 days and experiment Ba over 4 days). Trends 
in results are similar whether data were expressed in terms of 
cell number or total cell protein. 
4.3.2.6.2 Effect of in vitro addition of culture filtrate antigen 
of N.brasiliensis on accumulation of macrophage 
lysozyme in the medium 
Two experiments (7 and Ba) were performed in which extracellular 
lysozyme levels were measured in cultures of N.brasiliensis 
-activated macrophages after exposure to antigen (Table 97). Fig 
31 and Table 114 show the median cumulative lysozyme values and 
their 95% confidence limits. 
There was an apparent 3.2-fold increase in the amount of 
extracellular lysozyme over the 4 day incubation period. The 
pattern of accumulation of enzyme in the extracellular medium of 
the antigen-treated cultures appeared to be similar to that of 
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the N.brasiliensis-activated macrophages and there was no 
significant difference in the amounts of enzyme produced by these 
groups of cells. There was, however, a statistically significant 
difference between the amounts of enzyme produced by control 
macrophages and N. bras i liens is-activated macrophages exposed to 
antigen in vitro after 2, 3 and 4 days in culture(S2, p<0.05; 
S3, p<0.05; S4, p<0.05) (Mann Whitney U Test, Fig 31). 
4.3.2.6.3 Intracellular lysozyme and percentage of lysozyme 
secreted 
Intra- and extracellular lysozyme levels were measured in one 
experiment (Sb) and total enzyme present calculated from this 
data (Table 99). 
72-87% of total enzyme was secreted by control macrophages after 
1 day of culture, 71-87% of total by N.brasiliensis-activated 
cells and 70-90% by antigen-treated cells over the same time 
period. 
After 2 days in culture, controls had secreted 95% of total 
enzyme, N.brasiliensis-activated 93-98% and antigen-treated cells 
92-98% of total enzyme. Controls secreted 95-97% of total, 
N.brasiliensis-activated 83-98% and antigen-treated cells 98% by 
the end of the third day in culture. 
After 2 days of incubation, total enzyme levels in control and 
N.brasiliensis-activated macrophage cultures were compared, as 
were lysozyme levels in control and antigen-treated cultures. In 
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both cases total lysozyme levels were significantly different 
within the limitations of the data at a p value of 0.056 (Mann 
Whitney U Test). 
4.3.2.6.4 Lysozyme specific activity 
Intracellular, extracellular and total lysozyme specific 
activities were determined in experiment Sb (Table 100). 
Total lysozyme specific activities in control and N.brasiliensis 
-activated cultures were significantly different after l day of 
incubation, p = 0.056. 
4.3.2.7 TWENTY ONE DAY N.ASTEROIDES INFECTION 
4.3.2.7.l Accumulation of lysozyme in conditioned medium 
There was an apparent 3. 7-fold increase in lysozyme levels in 
control cultures and a 5.6-fold increase in N.asteroides 
-activated cells over the 4 days in culture. 
Four replicate ex per imen ts were performed ( Table 101). Median 
cumulative l ysozyme values and their 95% confidence limits a re 
shown in Table 115 and Fig 32. 
Extracellular enzyme levels in N.asteroides-activated macrophage 
cultures were significantly less than those in control macrophage 
cultures at each sampling interval over the 4 days of incubation 
(Sl, p=0.05; S2, p<0.01; S3, p<0.01; S4, p<0.01; Mann Whitney 
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U Test, Fig 32). 
Table 102 shows the specific activities of the cumulative 
lysozyme in the final sample for two experiments. Macrophages 
were incubated over 4 days and trends in results appear similar 
whether data are expressed in terms of cell number or total cell 
protein. 
4.3.2.7.2 Effect of in vitro adaition of culture-filtrate 
antigens of N.asteroides on accumulation of macrophage 
lysozyme in the medium 
Two experiments (3b and 4b) were done in which N.asteroides 
-activated macrophages were exposed in vitro to antigen and 
extracellular lysozyme levels measured (Table 101). 
cumulative levels are shown in Table 115 and Fig 32. 
Median 
There was an apparent 5.6-fold increase in the amount of 
extracellular lysozyme in these cultures over the 4 day 
incubation period. There was a statistically significant 
difference be tween the amounts of 1 ysozyme produced by control 
macropnages and by N.asteroides-activated macrophages exposed in 
vitro to antigen at each sampling interval over the 4 days in 
culture (Sl, p<0.01; S2, p<0.01; S3, p<0.01; S4, p<0.01; Mann 
Whitney U Test, Fig 32). 
The pattern of accumulation of lysozyme in the extracellular 
medium appeared to be similar to that of the N.asteroides 
-activated macrophages. 
356 
4.3.2.7.3 Intracellular lysozyme and percentage of lysozyme 
secreted 
In experiments 3b and 4b intra- and extracellular enzyme levels 
were measured and total lysozyme calculated from these data 
( Table 103). 
v;here in tracel 1 ula r levels could not be measured, a va 1 ue of 0 
has been entered on the table. 
Similar percentages of enzyme were released by the different 
groups of cultures at the different sampling intervals. These 
percentages were similar to the percentages of enzyme released by 
cultures of cells harvested at different times after inoculation 
of the animals with Nocardia. 
Total lysozyme levels in control and N.asteroides-activated 
macrophage cultures were significantly different after 1, 2 and 
3 days in culture with less lysozyme in N .asteroides-acti vated 
macrophage cultures ( S 1, p = 0.002; S 2, p = 0.004; S3, p = 
0.01). Similarly, significantly less total lysozyme was present 
in N.asteroides-activated macrophages exposed in vitro to antigen 
compared to control macrophages at each sampling interval (Sl, p 
= 0.008; S2, p = 0.036; S3, p = 0.01; Mann Whitney U Test). 
4.3.2.7.4 Lysozyme specific activity 
Specific activity of intracellular, extracellular and total 
lysozyme was determined in experiments 3b and 4b (Table 104). 
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Where intracellular lysozyme levels and hence specific activities 
could not be measured, a value of zero has been entered on the 
table. 
Specific activities of total lysozyme in N.asteroides-activated 
macrophages were significantly less than those in control 
macrophages at each sampling interval (Sl, p = 0.002; S2, p = 
0.004; S3, p = 0.01). Similarly, total lysozyme specific 
activities were significantly less in antigen-treated cultures 
com pa red with controls 
0.008; S2, p = 0.036; 
over the 3 days of incubation (Sl, p = 
S3, p = 0.032; Mann Whitney U Test). 
Results were similar whether expressed in terms of cell number or 
in terms of total protein content. 
4.3.2.8 TWENTY ONE DAY N.BRASILIENSIS INFECTION 
4.3.2.8.l Accumulation of lysozyme in conditioned medium 
Lysozyme was released by both control and N.brasiliensis 
-activated macrophages and accumulated in the medium over the 4-6 
days in culture. 
There was an apparent 5-fold increase in the levels of 
extracellular lysozyme in control cultures and a 6.4-fold 
increase in enzyme levels in N.brasiliensis-activated macrophage 
cultures over 4 days. 
Eight replicate experiments were performed (Table 105). Median 
cumulative lysozyme values and their 95% confidence limits are 
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shown in Table 116 and Fig 33. 
There was no statistically significant difference between the 
extracellular lysozyme levels in control cul tu res and those in 
cultures of macrophages harvested 21 days post-inoculation with 
N.brasiliensis. Table 106 shows the cumulative lysozyme specific 
activities of the final sample. (Experiments 2, 4, 6 and 7 were 
incubated over 6 days ana experiment Ba over 4 days.) Trends in 
results were similar whether data were expressed in terms of cell 
number or total cell protein. 
4.3.2.8.2 Effect of in vitro addition of culture-filtrate 
antigens of N.brasiliensis on accumulation of 
macrophage lysozyme in the medium 
In one experiment (Ba) N.brasiliensis-activated macrophages were 
exposed to antigen for 24 hours and extracellular lysozyme levels 
measured (Table 105). 
The pattern of accumulation of enzyme in the extracellular medium 
appeared to be similar to that of the N.brasiliensis-activated 
cells. 
4.3.2.8.3 Intracellular lysozyme and percentage of lysozyme 
secreted 
Table 107 gives data from experiment 8b in which intra- and 
extracellular lysozyme levels were measured. 
After 48 hours in culture, controls had secreted 82-85% of total, 
N. brasi 1 iensis-acti va ted macrophages 76-86% and an ti gen-treated 
359 
cells 88%. The controls had released 87-98% of total by the end 
of the third day in culture, the N.brasiliensis-activated 83-90% 
and antigen-treated 80-86%. 
Similar percentages of total enzyme were secreted by control and 
N.brasiliensis-activated cells after the first day of incubation. 
4.3.2.8.4 Lysozyme specific activity 
Table 108 gives the lysozyme specific activities for experiment 
Sb. 
Trends in results appear to be similar whether the data are 
expressed as micrograms of lysozyme per 2xl0 6 macrophages or as 
micrograms of lysozyme per milligram of cell protein. 
4.3.3 RATE OF LYSOZYME ACCUMULATION IN CONDITIONED MEDIUM 
Gordon, Todd and Cohn ( 1974) found that the rate of lysozyme 
production and secretion is remarkably constant for severdl 
different types of macrophages under a variety of culture 
conditions (section 4.1.6). He states that "the rate of lysozyme 
production and secretion by peritoneal macrophages is independent 
of cell stimulation" (Gordon, 1980 1277; Gordon, Todd and 
Cohn, 1974). 
The rate of accumulation of 1 ysozyme in conditioned medi urn was 
determined in control macrophage cultures; in cultures of 
macrophages derived from mice inoculated with N. as teroides and 
N.brasiliensis respectively; and in cultures of N.asteroides or 
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N.brasiliensis-activated macrophages exposed in vitro to 
homologous culture filtrate antigens. These rates of 
accumulation were determined 2, 
inoculation. 
7 I 13 and 21 days post-
Rate of accumulation of enzyme over 4 days in culture was 
determined by drawing linear regressions of the median cumulative 
lysozyme values vs time of incubation. The slopes of the linear 
regressions are an indication of rate of accumulation of enzyme 
in the medium (Figs 34-41 incl). 
The general impression gained from these figures is that rate of 
release of enzyme from control macrophages is greater than that 
from Nocardia-activated macrophages. The suggestion that rate of 
lysozyme release from mouse peritoneal macrophages is not 
perturbed by stimuli was not confirmed 
finding was not surprising since it is 
in this study. This 
known that lysozyme 
physiology is affected in a variable way by stimuli prone to 
activate macrophages (Goldstein, 1983): in addition, decreased 
synthesis of enzyme (which appears to occur in Nocardia 
infections) necessarily is associated with diminished secretion 
(Gordon, Todd and Cohn, 1974). 
4.3.4 DIFFERENCES IN MACROPHAGE FUNCTION IN N.ASTEROIDES AND 
N.BRASILIENSIS INFECTIONS 
The possibility that macrophage function may be different in 
N.asteroides and N.brasiliensis infections was investigated by 
comparing lysozyme release in the two infections at 2, 7, 13 and 
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21 days post-inoculation. It was thought that any differences in 
macrophage function may manifest as differences in degree of 
activation or suppression. Median values for Nocardia-activated 
macrophage secreted lysozyme were calculated as percentage of 
control a t each s amp 1 in g interval and res u 1 ts compared by 
inspection. From Tables 109 and 110 it appears that macrophages 
from mice inoculated two days previously with N.asteroides 
secrete less lysozyme after two days in culture than macrophages 
from mice inoculated two days previously with N.brasiliensis 
(N.asteroides-activated cells secreted 63,8% of control enzyme 
values at S4, whereas N.brasiliensis-activated cells secreted 
104.17% of control enzyme values after the same time in culture). 
Amounts of lysozyme secreted by N.asteroides-activated 
macrophages were, however, not significantly different from that 
secreted by controls (Mann Whitney U Test, Fig 26). 
Macrophage response with 
post-inoculation appear, 
respect to lysozyme release at 
by inspection, to be similar 
7 days 
in both 
N.asteroides and N.brasiliensis infection (Tables 111, 112). 
It appears from the data ( % control) shown in Tables 113, 114 
that there may be a difference in macrophage function in the two 
infe~tions as determined by lysozyme release by macrophages 
harvested 13 days post-inoculation. In addition, there was no 
significant difference between the amount of enzyme released by 
control cells and N.asteroides-activated cells, but the 
difference between control and N.brasiliensis-activated 
macrophage enzyme release was statistically significant after 2, 
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3 and 4 days of incubation. 
Inspection of the data in Tables 115 and 116 reveals an apparent 
difference in 21 day N.asteroides and N.brasiliensis infections 
in relation to secretion of lysozyme (N.asteroides-activated 
macrophages secreted 41% of control lysozyme values after 4 days 
in culture, whereas N.brasiliensis-activated cells secreted 79% 
of the control enzyme value). Further, there was a significant 
difference between control and N.asteroides-activated cells at 21 
days post-inoculation. 
4.3.5 MODULATION OF LYSOZYME RELEASE OVER THE 21 DAY 
INFECTION PERIOD 
In an attempt to determine whether lysozyme release is modulated 
over the 21 day period of infection in N.asteroides and 
N.brasiliensis infections, percentage control lysozyme values at 
T4 were plotted against duration of infection (Fig 42). Lysozyme 
release by N.asteroides-activated macrophages was similar at 2 
and 13 days and at 7 and 21 days, with high levels at 2 and 13 
days (apparent maximum at 13 days)and low at 7 and 21 days. In 
contrast, lysozyme release by N.brasiliensis-activated 
macrophages was maximal at 2 days, minimal at 7 days and 
thereafter sequentially increased at 13 and 21 days. Thus enzyme 
secretion appeares to be modulated in both N.asteroides and 
N.brasiliensis infections over the 21 day period of infection. 
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4.4 DISCUSSION 
These studies demonstrate reduced intracellular levels and 
diminished secretion of lysozyme in vitro by Nocardia-activated 
macrophages at certain time intervals post-inoculation. In 
addition, the results confirm that mouse peritoneal macrophages 
cultured in vitro con tin uousl y secrete considerable amounts of 
lysozyme into the culture medium. 
Previous workers have investigated the influence of in vitro 
infection with N.asteroides on intracellular lysozomal enzyme 
concentrations (sections 1.4.4.1; 4.1.9). The present study 
at tempted to el uc ida te further the mechanisms or intracellular 
even ts enabling Nocardia organisms to 
macrophages. 
persist and grow within 
Mononuclear phagocytes harvested from mice inoculated 2 days 
previously with N.asteroides and cultured in vitro produce 
amounts of enzyme that are not significantly different from that 
produced by control macrophages over the 4 day period in 
culture. Similarly, lysozyme production by macrophages in vitro 
is not modulated by in vivo inoculation with N.brasiliensis 2 
days previously. 
Macrophages harvested from mice inoculated 7 days previously with 
N.asteroides and N.brasiliensis respectively, produce 
significantly less lysozyme than cultures of control macrophages. 
This statistically significant difference was shown at each 24 
hour sampling interval over the 4 days in culture. Therefore the 
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functional status of macrophages harvested from mice inoculated 
7 days previously with either of these opportunitic pathogens is 
lowered with respect to this parameter of macrophage function. 
Examination of these animals prior to sacrifice revealed that the 
mice were ill with apparent loss of weight and harsh coat; post-
mortem revealed hepatosplenomegaly and numerous abscesses in the 
tissues. From appearance of animals and post-mortem examination 
it would appear that the acute phase of infection over the 
period of 2-21 days post-inoculation was 2-7 days (Section 
2 • 5 • 4 • 3 • 9 ) • 
There was no significant effect of inoculation 13 days previously 
with N.asteroides on lysozyme production by macrophages. 
Production of lysozyme by macrophages from mice inoculated 13 
days previously with N.brasiliensis was not significantly 
different from that produced by control cells after 1 day in 
culture. However, N.brasilienis-activated macrophages produced 
significantly less enzyme than controls after 2, 3 and 4 days in 
culture. Slight modulation of production of enzyme may only 
manifest itself after a day in culture a sma 11 decrease in 
amounts of enzyme produced per day may only become apparent when 
the cumulative enzyme is calculated. This decrease in amount of 
lysozyrne produced after 2, 3 and 4 days in culture and not after 
1 day may indicate that these macrophages are returning to 
normal functional status with respect to this parameter, as the 
acute phase of the infection (2 - 7 days) is passed. Prior to 
sacrifice animals were apparently well, only distinguishable 
from controls by apparent loss of weight. Post-mortem 
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examination again rev ea led marked hepa tosplenomega l y and wel 1 
developed, often encapsulated abscesses in the peritoneal 
cavity. 
Similar amounts of lysozyme were produced by control macrophages 
and by macrophages from. mice inoculated 21 days previously with 
N.brasiliensis, indicating a return to normal functional status 
with respect to this determinant of macrophage function. Post-
mortem examination of these animals generally revealed markedly 
reduced hepa tosplenomegaly and abscesses which were smaller and 
apparently healing or occasionally absent. These observations at 
post-mortem were also made for mice inoculated 21 days previously 
with N.asteroides. However, less lysozyme was produced by 
N.asteroides-activated macrophages over each 24 hour period of 
incubation than was produced by control eel ls. This difference 
was statistically significant after 1, 2, 3 and 4 days in 
culture. This finding was unexpected when related to the post-
mortem examinations. It may, however, reflect the recrudescent 
nature of the Noc a rdia infection, and al though the post-mortems 
did not reveal gross increases in nocardial activity, the 
apparently healing lesions may have been undergoing a repeated 
inflammatory process. Gonzalez-Ochoa (1973) reported on a study 
in which strains of Nocardia were inoculated into the foot pads 
of mice. 
animals had 
One week after inoculation with N.asteroides, 90% of 
trauma tic tumora tion and after 2 weeks 50% of the 
mice showed no sign of infection. After 3 weeks the apparently 
healed lesions once again showed signs of inflammation which 
progressed to form mycetomas after 2 months. In the same study, 
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using N.brasiliensis, Gonzalez-Ochoa showed an inflammation 
which healed and then regressed to form mycetomas over 2 months. 
In addition, activated macrophages may be found only at certain 
stages of infection (Mackaness, 1970b). It is not inconceivable 
that macrophages may be inhibited at various stages of infection. 
Macrophages from mice previously inoculated with N.asteroides and 
N.brasiliensis respectively were incubated in vitro with 
homologous culture fitrate antigens and the influence of these 
antigens on lysozyme production determined. 
Macrophages harvested from mice 2 days post-inoculation with 
N.brasiliensis and incubated with antigen produced amounts of 
lysozyme that were not significantly different to that produced 
by control cells; lysozyme production by these cells appeared to 
be similar to enzyme production by control cells. 
Macrophages from mice harvested 7 days after inoculation with 
N.asteroides and exposed in vitro to antigen produced 
significantly less enzyme than control cell's at each sampling 
interval over the 4 day incubation period; however, production 
of lysozyme by N.asteroides-activated macrophages was not 
modified by antigen exposure. Similarly, macrophages from mice 
inoculated 7 days previously with N.brasiliensis produced 
significantly less lysozyme than control macrophages after 1, 2, 
3 and 4 days of incubation. An unexpected finding was that 
exposure to antigen in vitro significantly decreased lysozyme 
production by N.brasiliensis-activated macrophages (harvested 
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from mice 7 days post-inoculation) after 1, 2 and 3 days in 
culture. Cumulative lysozyme levels were not significantly 
different after 4 days of incubation. Exposure of N.asteroides-
activated or N.brasiliensis-activated macrophages to antigen in 
vitro did not significantly modify lysozyme production at the 
other intervals post-inoculation studied. 
Previous workers have at tempted to el uc ida te the mechanisms of 
nocardial-induced alteration 
Black, 1985). Black et al 
of macrophage function ( Beaman and 
(1983) correlated relative virulence 
and resistance to killing with reduction in intracellular acid-
phosphatase levels. In addition, lysozomal acid-phosphatase 
activity correlated with macrophage killing efficiency and is 
therefore an effective marker of macrophage ability to inhibit 
growth of, or kill N.asteroides (Black et al, 1985). The same 
workers used the same experimental system (in vitro infection of 
unstimulated peritoneal macrophages with virulent and less 
virulent N.asteroides [Black et al, 1983]) to measure macrophage 
intracellular levels of lysozyme. However, intracellular 
lysozyme levels were not modified following phagocytosis of 
increasing numbers of virulent N. as teroides (Beaman and Black, 
1985). The results of 
intracellular lysozyme 
the present study show that 
levels are decreased following 
macrophage 
infection 
with N.asteroides at certain time intervals post-inoculation. 
These conflicting results may perhaps be explained in terms of 
difference in exper imen ta 1 design - in the present study, mice 
were inoculated intraperitoneally with N.asteroides and the 
infection allowed to develop for up to 21 days, whereas in the 
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study by Beaman and Black ( 1985), washed monolayers of normal 
mouse macrophages were infected in vitro for 1 hour and then 
washed to remove extracellular nocardiae (Black et al, 1983). 
Nocardia-induced decrease in macrophage intracellular lysozyme 
levels may not occur in the absence of a full complement of 
immunological events: in addition, in the in vivo system 
described, statistically significant decreases in lysozyme levels 
were shown only after the infection had progressed for 7 days. 
Percentage secretion of lysozyme appeared to be similar in the 
three types of macrophages studied. This is in agreement with 
the literature - production of lysozyme may be modulated by 
various a gen ts whereas dis tri bu tion be tween eel 1 and medium is 
generally not affected (Section 4.1.7). Diminished secretion is 
generally associated with reduced intracellular levels since 
impaired synthesis necessarily limits secretion; and this 
phenomenon was demonstrated 
which lysozyme secretion was 
in the series of experiments in 
measured. The mechanism of the 
decrease in intracellular enzyme level associated with Nocardia 
infection was not investigated in this study, but it appears 
that de novo synthesis of the enzyme is inhibited in macrophages 
from mice inoculated 7 days previously with N.asteroides and 
N.brasiliensis and in mice inoculated 13 days previously with 
N.brasiliensis and 21 days previously with N.asteroides. If 
lysozyme was lost from within the cells it presumably would have 
accumulated in the medium and distribution between cell and 
medium wou:d have been affected. Similarly, lysozomal 
degranulation is not the mechanism involved in the nocardial-
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induced decrease in acid-phosphatase activity (Beaman and Black, 
1985). 
It is possible that inactivation of enzyme occurred, however 
others have shown that protein synthesis inhibitors prevent the 
synthesis of new 1 ysozyme (Gordon, Todd and Cohn, 197 4: Gee, 
Stevens and Hinman, 
synthesis is reduced 
1980 a and b) 
on ingestion 
and that macrophage protein 
of M. leprae with conseguen t 
cessation of lysozyme synthesis (Ridley et al, 1985). The 
Noca rdiae and Mycobac ter iae are homogenous and closely related 
taxa (Lamb, Delville and Cocito, 1978): in addition Nocardia, 
M.tuberculosis and M.leprae are intracellular parasites (Beaman, 
1976 : 19: 389: Cruickshank et al, 1973: Rojas-Espinosa et al, 
1982). In macrophage cultures from infected mice the total 
amount of lysozyme was reduced due to a decrease in both intra-
and extra eel 1 ula r enzyme levels, therefore the fraction present 
in the medium 
that lysozyme 
did not differ from the controls. This suggests 
production is partially inhibited, whereas the 
mechanism of secretion does not appear to be affected. De novo 
synthesis of lysozyme therefore appears to be inhibited in 
macrophages from mice inoculated 
N.asteroides and N.brasiliensis and 
7 days previously with 
in mice inoculated 13 days 
previously with N.brasilienis and 21 days previously with 
N.asteroides. 
The histopa tho log ica 1 studies by Folb, Jaffe and Altmann (1976) 
suggested that aspects of macrophage function may be different in 
N.asteroides and N.brasiliensis infections and it was postulated 
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that macrophage responses may be impaired in N.brasiliensis 
infection. Lysozyme release was sign if ican tl y reduced com pa red 
with controls at 7 and 13 days post-inoculation with 
N.brasiliensis. However, lysozyme release was significantly 
reduced compared with controls at 7 and 21 days post-inoculation 
in N.asteroides infection as well. Therefore comparison of 
macrophage lysozyme release in the two infections did not reveal 
any major differences in macrophage function although some 
differences were shown. Macrophage responses to these two 
Nocardia infections with respect to this parameter of macrophage 
function appear to 
inoculation. This 
be different at 
apparent difference 
13 
is 
and 21 days post-
manifested by the 
significant 
days in 
differences in amounts of enzyme secreted over four 
culture by N.asteroides-activated and control 
macrophages at 21 days post-inoculation; and by N.brasiliensis 
-ac ti va ted and 
in addition to 
expressed as 
control macrophages at 13 days post-inoculation, 
the trends noted on inspection of the data when 
percentage control enzyme value. There is also a 
possible difference between N.asteroides-activated cells and 
N.brasiliensis-activated macrophages at 2 days post-inoculation. 
Macrophage function with respect to release of lysozyme appears 
to be modulated over the 21 day period of infection in both 
N.asteroides and N.brasiliensis infections. It is known that 
highly activated macrophages exist for only a limited period 
during the course of most infectious diseases (Mackaness, 1970a : 
66), changing more or less gradually to reach a peak of activity 
and then returning to normal (Mackaness, 1970a : 67). This 
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finding was therefore not unexpected. 
Specific activities of lysozyme within the cells and in the 
culture medium were determined in several representative 
experiments at each time interval post-inoculation studied. In 
the system described equal numbers of mononuclear phagocytes 
were distributed in tissue culture dishes at the start of the 
experiments. Lysozyme specific activities were measured to ensure 
that experimental trends were similar whether the enzyme was 
expressed in terms of number of macrophages cultured or in terms 
of total 
activity 
cell protein. The 
may be related to 
experiments show that lysozyme 
the amount of cellular protein 
without changes in trends of results as a consequence. 
Decreased lysozyme intracellular levels and consequent decreased 
secretion of the enzyme macrophages by does not appear to be a 
result of 
morphological 
toxicity since the cultures were healthy by 
criteria ( 2.12), significant decreases in enzyme 
level did not occur at 2 days post-inoculation with either 
N.asteroides or N.brasiliensis, or at 13 days post-inoculation 
with N.asteroides or at 21 days post-inoculation with 
N.brasiliensis. In addition, macrophages from the same cell pool 
showed significant increases in plasminogen activator release 
(Chapter 3). 
The nocardial cell walls are resistant to the action of lysozyme 
(Bourgeois and Beaman, 1976; Law and Marks, 1982). However, 
glycine potentiates the effects of lysozyme on the cell wall of 
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N.asteroides and N.caviae the enzyme converted these 
organisms to spheroplasts which then grew as L-phase variants 
(Bourgeois and Beaman, 1976; see 1.7.5.3). It has been 
suggested that wall-deficient forms are produced by 
interaction with activated macrophages and that these forms 
are refractory to the degradative enzymes and persist in the 
tissues (Beaman and Scates, 1981). Whether reduction in 
macrophage lysozyme production and secretion is related to 
the development of L-forms remains to be elucidated. 
The implications of decreased lysozyme production and 
Several studies secretion by macroi:,hages are 
have correlated impairments 
reductions in intracellular 
(Kimura and Goldstein, 1981; 
in the intracellular levels 
interesting. 
in bactericidal capacity with 
lysozomal enzyme concentrations 
Black et al, 1985). Reductions 
of both the acid hydrolases 
(Goldstein et 
1985) and in 
al, 1978; Katoh, 1981; Black et al, 1983, 
intracellular levels of lysozyme (Kimura and 
Goldstein, 1981; Ridley et al, 1985) have been associated 
with defects in bactericidal function and tumoricidal 
function (Steele, Eremin and Brown, 1983). Black et al 
(1983) suggested that reductions in acid-phosphatase activity 
imply organism-induced macrophage dysfunction and that these 
reductions suggest a general decrease in lysozomal activity 
in macrophages. The present study extends these observations 
by demonstrating reduced concentrations of lysozyme in both 
N.asteroides and N.brasiliensis infections at 7 days 
373 
post-inoculation; in N.brasiliensis infection at 13 days and 
in N.asteroides infection at 21 days post-inoculation. There 
is convincing evidence that lysozyroe production by 
macrophages reflects their level of activation (Kokoshis et 
al, 1978; Di Luzio, 1979 a and b). The finding that 
production and hence secretion of lysozyroe by mouse 
peritoneal macrophages is inhibited at certain stages of 
Nocardia infection suggests that at these stages the 
macrophages are at a low level of activity. Filice (1985) 
has indicated that lysozyroe may play some part in host 
defence against N.asteroides. Reduction of intracellular 
levels of lysozyroe may contribute to and facilitate the 
intracellular survival and growth of the Nocardia parasite. 
In addition, lysozyroe may function as a self-stimulatory 
secretion product of the macrophage (Kokoshis et al, 1978) , 
therefore decreased secretion of the enzyme may impair host 
defence mechanisms and contribute to the pathogenesjs of 
Nocardia infections. 
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4.6 TABLES 
TABLE 73 
Lysozyme production by 1 X 106 macrophages (fg of lysozyme) 
13d Sl S2 S3 S4 S5 S6 
Nb day 1 day 2 day 3 day 4 day 5 day 6 
C 2 4.5 9.25 10.25 11.75 13 
Nb 0.5 1. 5 3.25 4.5 5.75 7 
KEY: C 
Nb 
1 x 106 Control macrophages 
1 x 106 N.brasiliensis-activated macrophages 
13d Nb mice inoculated 13 days previously with N.brasiliensis 
TABLE 74 
Lysozyme production by 3 X 106 macrophages (?g of lysozyme) 
13d Nb Sl S2 S3 S4 S5 S6 S7 
C 0.018 0.395 0. 771 1. 52 2.26 3.44 4.39 
0.376 1. 281 2.186 2.93 4.12 5.8 6.53 
Nb 0.376 0.694 0.896 1. 28 2.99 4.68 5.4 
0.083 0.168 1.004 1. 39 1. 77 3.45 4.18 
0.083 0.104 0.544 2.26 2.39 4.07 5.25 
0.083 0.46 0.714 1. 9 2.65 4.33 5.51 
0.083 0.46 2.15 2.53 2.92 5.66 6.38 
0.083 0.99 1. 72 2.1 3.29 4.97 
KEY: C = 3 X 106 Control macrophages 
Nb = 3 X 106 N.brasiliensis-activated macrophages 
13d Nb mice inoculated 13 days previously with N.brasiliensis 
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TABLE 75 
Optimum time of incubation. 
7d Nb 5 hrs 8hrs 25 hrs 48hrs 56 hrs 72 hrs 
Cl 1 1. 738 3.878 8.658 
C2 8.25 8.988 9. 726 
C3 10.7 
Nb 1 0.33 2.97 
Nb 2 1 3.64 
Nb 3 1. 65 2.388 
Nb 4 2.64 4.29 
Nb 5 2.14 
Nb 6 5.12 
KEY: C = Control macrophages 
Nb= N.brasiliensis-activated macrophages 
Macrophages were harvested from control and N.brasiliensis inoculated 
mice 7 days after inoculation. 3 replicate cultures of control 
macrophages and 6 replicate cultures of activated macrophages were 
prepared as described previously. Conditioned medium was collected 
from the replicate cultures at different times (as shown in the 
tables) over the 72 hour incubation period and assayed for lysozyme 
activity. After collection of the CM, cultures were re fed and 
returned to the incubator. The experiment was terminated after 72 
hours and the cumulative lysozyme release determined. 
Lysozyme accumulated in the medium over the 72 hour incubation period 
irrespective of time of incubation between sampling and it was decided 
that a 24 hourly sampling interval would be employed. 
TABLE 76 
Lysozyme release from 2 x 106 macrophages over an 8 day incubation 
period. Mice were inoculated with N.brasiliensis organisms or normal 
saline 13 days prior to sacrifice. (Micrograms of lysozyme) 
2d Sl S2 S3 S4 S5 S6 S7 S8 
Nb 
C 2.0 4.75 9.75 14.0 18.75 20.75 23.0 26.0 
n=l 
Nb 2.0 6.0 10.75 14.5 19.5 21. 5 24. 5 27.5 
n=3 3.0 7.75 14.25 19.75 25.25 28.0 30.5 33.0 
2.25 5.0 9.0 14. 25 20.0 23.0 25.5 28. 0 
X 2.417 6.25 11. 33 16.17 21.58 24.17 26.83 29.5 
sd 0.52 1. 39 2.67 3.10 3.18 3.4 3.21 3.04 
KEY: C 2 X 106 Control macrophages 
Nb 2 X 106 N.brasiliensis-activated macrophages 
X Mean 
sd Standard deviation 
n no. of replicates 
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TABLE 77 
2 day N.asteroides infection accumulation of lysozyme in 
conditioned medium over 4 days in culture. Experimental series "A". 
Data from 4 replicate experiments for lysozyme released by control and 
N.asteroides-activated macrophages and 1 experiment for enzyme 
released by antigen-exposed macrophages. CM assayed at daily 
intervals. 6 (Data expressed as micrograms of lysozyme/2xl0 macrophages) 
S.int 
Inc. time 
C 
Na 
Na+ 
0.002% 
Antigen 
in vitro 
E 
1 
2 
3a 
4a 
1 
2 
3a 
4a 
4a 
KEY: s.int 
Inc.time 
E 
C 
Na 
Sl 
1 day 
1. 28 
1. 28 
0.99 
1. 88 
1. 91 
1. 91 
3.2 
3.2 
1. 43 
1. 28 
1. 28 
0.85 
2.19 
1. 43 
2.82 
1. 73 
0.85 
2.96 
1. 76 
1. 91 
0.81 
0.81 
0.65 
0.81 
S2 
2 days 
2.54 
2.88 
1. 61 
3.24 
2.95 
7.24 
9.47 
2.52 
2. 71 
2. 71 
3.28 
2.52 
4.6 
3.51 
3.86 
3.82 
3.82 
1.46 
1. 62 
1. 46 
1. 79 
Sampling interval 
Incubation time 
Experiment number 
S3 
3 days 
4.31 
2.08 
5.75 
4.28 
10.46 
13.41 
3.29 
4.88 
5.05 
6.03 
5.85 
5.62 
4.86 
5.0 
2.69 
3 
3.64 
2. 72 
S4 
4 days 
2.53 
9.02 
5.9 
12.64 
15.97 
4.14 
5.99 
6.33 
7.91 
6.70 
6.39 
5.76 
6.04 
3.89 
4.09 
4.49 
4.41 
Control macrophages 
N.asteroides-activated macrophages 
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TABLE 78 
2 day N.asteroides infection 
lysozyme released. 
M0 
type 
C 
Na 
Na+ 
0. 002% 
An ti gen 
in vitro 
KEY: E 
F 
E F Cumulative 
lysozyme 
released 
(fg) 
3a '54 9.02 
5.9 
4a S4 12.64 
15.97 
3a S4 6.39 
5.76 
6.04 
4a S4 3.89 
4.09 
4a S4 4.49 
4.41 
Experiment number 
Final sample 
specific activity of cumulative 
Specific 
activity 
( pg per mg of 
cell protein) 
58.3 
28.12 
49.51 
58.23 
17.26 
12.63 
21.61 
6.24 
6.89 
20.58 
8.3 
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TABLE 79 
2 day N.asteroides infection : Lysozyme production over 3 days in culture 
as rg lysozyme per 2 x 106 macrophages). Experimental series "B". 
% secretion (Lysozyme expressed 
E a 
C 3b 1. 33 
4b 3.2 
4.64 
Na 3b 1. 91 
1. 62 
4b 0.51 
0.65 
Na** 4b 0.27 
0.65 
KEY: a 
Na** 
Sl S2 
b C d a b C d a b 
0.16 1.49 89.32 3.24 0.10 3.34 96.9 4.71 0.15 
3.25 0.48 3.73 87.1 5.01 0.06 
0.23 3.43 93.2 6.14 0.40 6.54 93.88 14.06 0.61 
0.51 5.15 90.07 6.67 0.89 7.56 88.21 9.67 0.54 
0.17 2.08 91. 98 2.95 0.04 2.99 98.75 4.71 0.17 
0.13 1. 75 92.85 2.66 0.75 3.41 77. 98 4.86 0.09 
3.24 0.16 3.40 95.3 3.69 0.19 
0.06 0.57 88.89 1. 66 0.14 1. 80 92. 29 4.41 0.24 
0.24 0.89 73.1 1. 32 0.15 1. 47 89.9 3.64 0.26 
0.23 0.50 54. 23 1.96 0.09 2.05 95.5 3.33 0.31 
0.24 0.89 73.35 1. 72 0.18 1. 90 90.46 3.47 0.03 
extracellular lysozyme: b = intracellular lysozyme: c = total lysozyme 
N.asteroides-activated macrophages+ 0.002% antigen in vitro 
S3 
C d 
4.86 96.99 
5.07 98.83 
14.67 95.83 
10.21 94.67 
4.88 96.5 
4.95 98.2 
3.88 95.0 
4.65 94.9 
3.90 93.2 
3.64 91. 6 
3.50 99.l 
d % secreted 
TABLE 80 
Specific activity of lysozyme produced by macrophages over 3 days in 
culture (Lysozyme expressed as fg of lysozyme per mg of cell protein). 
E a 
3b 6.16 
C 
4b 9.63 
10.04 
3b 6.90 
5.23 
Na 
4b 2.07 
3.05 
Na** 
4b 0.92 
3.26 
KEY: E 
a 
b 
C 
C 
Na 
Na** 
Sl S2 S3 
b C a b C a b C 
0.74 6.90 10.32 0.33 10.65 17.5 0.54 18.04 
18.09 2.68 20.77 26.49 0.32 26.81 
0.70 10.33 17.28 1.13 18.41 50.16 2.18 52.35 
1.11 11.15 19.90 2.66 22.56 29.73 1. 67 31. 40 
0.60 7.50 12.38 0.16 12.54 17 .11 0.61 17. 72 
0.40 5.63 10.93 3.09 24.01 22.7 0.43 23.13 
12.73 0.63 13.36 16.57 0.86 17.43 
0.26 2.33 5.99 0.05 6.49 16.58 0.89 17.47 
1.12 4.17 3.48 0.64 4.11 18.37 0.16 38.52 
0.78 1.70 9.93 0.47 10.40 12.71 1.18 13.89 
1.19 4.45 5.44 0. 57 6.01 13.14 0.12 13.26 
Experiment number 
Extracellular lysozyme 
Intracellular lysozyme 
Total lysozyme 
Control macrophages 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages+ 0.002% antigen 
in vitro 
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-.1.ftDUC. 0.1. 
2 day N.brasiliensis infection Accumulation of lysozyme in 
conditioned medium over 4 days in culture. Experimental series "A". 
Data from 8 replicate experiments in 3 of \.'hich N.brasiliensis 
-activated macrophages \.'ere exposed to antigen in vitro. Lysozyme 
expressed as ?g of lysozyme per 2 x 106 macrophages. 
S.int 
Inc.time 
Sl 
1 day 
S2 
2 days 
S3 S4 
3 days 4 days 
C 
Nb 
Nb** 
KEY 
E 
2 
3 
4 
5 
6 
7a 
2.0 
2.47 
1. 74 
1. 53 
1. 66 
1. BB 
1. 56 
2.48 
1. 56 
5.6 
4.75 
4.48 
4. 27 
3.08 
3.79 
3.76 
2.43 
2.95 
1.89 
9.75 
6.49 
6.53 
4.07 
5.35 
5.31 
2.88 
3.15 
3.17 
14.0 
7.84 
7.46 
4.52 
6.77 
6.16 
4.04 
3.71 
3.58 
10.9 
14.06 
17.87 
22.13 
25.2 
25.53 
28.6 
Ba 
1 
2 
3 
4 
5 
6 
7a 
Ba 
5 
7a 
Ba 
S.int 
Inc.time 
E 
Nb 
Nb** 
2.56 
3.33 
3.85 
0.90 
0.83 
2.0 
3.0 
2.25 
2.59 
2.47 
2.47 
2.47 
2.47 
0.82 
1. 04 
1. 38 
1. 26 
1. 94 
1. B 
2.07 
1. B 
3.04 
2.34 
6.97 
6.27 
5.08 
4.32 
5.47 
4.32 
2.07 
1. 94 
2.49 
6.27 
3.4 
4.32 
3.22 
4.91 
5.02 
5.54 
2.16 
1. 44 
6.0 
7.75 
5.0 
3.94 
4.25 
3.82 
2.32 
3.0 
2.64 
2.97 
3.42 
3.73 
3.35 
3.76 
2.92 
13.24 
11.87 
7.09 
6.5 
7.48 
5.85 
4.47 
4.92 
3.84 
11.87 
5.12 
6.18 
5.84 
Sampling interval 
Incubation time 
Experiment number 
6.56 
6.93 
7.32 
3.85 
1. 82 
10.75 
14.25 
9.0 
6.18 
5.81 
4.76 
3.58 
4.04 
3.46 
4. 72 
4.0 
4.38 
4.38 
5.04 
3.64 
19.17 
18.14 
B.74 
8.28 
B.64 
7.89 
5.57 
6.23 
4.37 
17.47 
6.65 
8.22 
7.75 
10.5 
9.88 
11. 01 
14.5 
19.75 
14.25 
7.42 
7.26 
6.21 
4.01 
4.66 
4.08 
5.18 
4.45 
5.1 
4.71 
6.33 
4.59 
22.03 
20.32 
11. 91 
10.74 
11. 47 
11. 71 
5.9 
6.68 
5.09 
19.82 
9.23 
10.44 
10.45 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages+ 0.002% 
antigen in vitro 
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TABLE 82 
2 day N.brasiliensis infection : specific activity of cumulative 
lysozyme released. 
M0 E F Cumulative Specific 
Type lysozyme activity 
released (pg per mg of 
(pg) cell protein) 
5 S6 10.13 52.59 
9.88 61. 48 
10.48 79.l 
6 S6 6.39 48.7 
5.17 31. 75 
C 5.42 42.27 
7a S4 25.53 82.81 
28.6 98.87 
Ba S4 10.5 68.09 
9.88 47.35 
11. 01 61. 43 
5 S6 9.76 72.3 
9.41 86.l 
8.23 65.4 
7.28 64.4 
6 S6 12.81 73.15 
9.34 44.7 
Nb 
7a S4 22.03 83.99 
20.32 70.49 
Ba S4 11. 91 61. 72 
10.74 82.62 
11.47 53.0 
11. 71 64.09 
Nb + 5 S6 7.98 60.18 
0.002% 9.53 95.35 
Ag in vitro 11.15 85.7 
7a S4 19.82 58.43 
8a S4 9.23 49.13 
10.44 68.87 
10.45 53.88 
KEY: E Experiment number 
F Final sample 
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w 
I.O 
.i:,,. 
TABLE 83 
2 day N.brasiliensis infegtion : Lysozyme production over 3 days in culture 
as fg lysozyme per 2 x 10 macrophages). Experimental series "B". 
% secretion (Lysozyme expressed 
E 
C 7b 
8b 
Nb 7b 
8b 
Nb** 7b 
8b 
KEY: a 
Nb** 
Sl S2 
a b C d a b C d a b 
6.97 0.87 7.84 88.9 12.9 0.95 13. 85 93.15 21. 01 0.67 
15.4 1.15 16.55 93.05 28.87 0.69 
4.25 0.40 4.65 91. 3 6.19 0.36 6.55 94.6 6.57 0. 20 
3.96 0.56 4.32 86.97 8.07 0.46 8.53 94.6 6.0 0.19 
3.94 0.81 4.75 82.88 5.38 0.46 5.84 92.0 7.85 0.20 
5.27 0.68 5.95 88.58 14.66 0.45 15 .11 97.02 19.94 0.39 
3.58 0.57 4.15 86.19 5.92 0.22 6.14 96.4 8.71 0.30 
4.7 0.16 4.86 96.6 5.41 0.23 5.64 95.9 8.43 0.32 
3.04 0.22 3.26 93.3 6.52 0.16 6.68 97.7 7.93 0.19 
7.93 0.21 
5.6 0.98 6.58 85.07 9.68 0.44 10.12 95.66 12.85 0.15 
3.58 0.50 4.08 87.7 5.05 0.34 5.39 93.7 8.21 0.24 
4.13 0.10 4.23 97.65 5.66 0.28 5.94 95.4 8.8 0.21 
3.04 0.81 3.85 78.9 5.89 0.13 6.02 97.8 8.58 0.23 
extracellular lysozyme; b = intracellular lysozyme; c = total lysozyme 
N.brasiliensis-activated macrophages+ 0.002% antigen in vitro 
S3 
C d 
21.68 96.9 
29.56 97.67 
6. 77 97.09 
6.19 96.95 
8.05 97.5 
20.33 98.l 
9.01 96.67 
8.75 96. 36 
8.12 97.66 
8. 15 97.3 
13.0 98.85 
8.45 97.19 
9.01 97.64 
8.81 97.42 
d % secreted 
TABLE 84 
2 day N.brasiliensis infection specific activity of lysozyme 
produced by macrophages over 3 days in culture. ( Lysozyme expressed 
as ?g of lysozyme/mg of cell protein) 
E a 
7b 11. 33 
C 
Sb 13.64 
13.37 
11. 47 
7b 12.14 
Nb 
Sb 17.02 
36.4 
13.83 
7b 14.30 
Nb** 
Sb 14.68 
25.23 
9.27 
KEY: E 
a 
b 
C 
C 
Nb 
Nb** 
Sl S2 S3 
b C a b C a b C 
1. 41 12.74 25.95 1. 91 27.86 46.67 1. 49 48.61 
27 .11 2.03 29.14 71. 78 1. 71 73.49 
1. 49 17.13 30.42 1. 75 32.18 40.14 1. 20 41.34 
2.00 15.37 31. 48 1. 80 33.28 38.27 1. 20 39.47 
2.37 13.84 25.47 2.18 30.65 47.45 1. 22 48.67 
1. 57 13.70 39.7 1. 22 40.92 74.88 1. 45 76.33 
2.73 19.75 27.69 1. 03 28. 72 45.32 1. 57 46.89 
1. 27 37.67 27.89 1.18 29.09 29.52 1.12 30.64 
1. 0 14.83 35.35 0.84 36.19 44.89 1. 07 45.97 
13.20 1.19 44.39 
2.51 16.81 28.45 1. 29 29.74 41.82 0.49 42.31 
2.05 17.72 20.33 1. 37 21.70 45.58 1. 32 46.90 
0.61 25.85 28.06 1. 37 29.43 48.17 1.16 49.33 
2.48 11.75 26.47 0.59 27.06 47.46 1. 26 48.71 
Experiment number 
Extracellular lysozyme 
Intracellular lysozyme 
Total lysozyme 
Control macrophages 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophages+ 0.002% antigen 
1n vitro 
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TABLE 85 
7 day N.asteroides infection Accumulation of lysozyme in 
conditioned medium over 4 days in culture. Experimental series "A". 
Data from 10 replicate experiments, in 4 of which N.asteroides 
-activated macrophages were exposed io antigen in vitro. Lysozyme 
expressed as rg of lysozyme per 2 X 10 macrophages. 
S.int 
Inc.time 
C 
Na 
E 
l 
2 
3 
4 
5 
6 
9a 
10a 
2 
4 
Sl 
l day 
4.6 
4.34 
0.91 
l. 28 
1.15 
0.03 
0.22 
0.84 
0.88 
2.36 
3.74 
l. 53 
l. 01 
0.69 
2.93 
2.93 
2.62 
0.67 
0.004 
0.67 
0.44 
l. 28 
0.004 
0.34 
l. 39 
0.12 
0.99 
0.51 
0.22 
0.91 
0.84 
0.51 
0.99 
0.22 
S2 
2 days 
5.88 
8.18 
2.75 
2.28 
2.42 
l. 01 
2.06 
2.2 
7.49 
2.48 
l. 52 
l. 84 
5.78 
7.99 
5.89 
0.92 
0.23 
0.78 
0.62 
1.42 
0.44 
l. 2 
2.59 
0.66 
l. 53 
l. 59 
0.87 
l. 55 
1.49 
1.16 
l. 85 
0.87 
396 
S3 
3 days 
4.07 
3.55 
4 
2.1 
2.62 
3.34 
3.36 
2.88 
11.14 
12.7 
10.47 
1.06 
l. 58 
1. 87 
2.88 
l. 37 
2.07 
1. 92 
l. 32 
l. 62 
l. 62 
l. 32 
2.25 
l. 57 
S4 
4 days 
4.66 
3.98 
4.52 
2.5 
3.71 
9.23 
4.39 
3.91 
16.11 
17.15 
15.7 
l. 49 
1.6 
2.52 
3.52 
2.01 
3.76 
3.48 
2.10 
2.17 
2.16 
l. 87 
3.22 
2.54 
TABLE 85 continued 
5 1. 86 
6 1. 21 2.41 3.38 5.74 
0. 71 4.16 4.91 5.86 
0. 29 0. 77 2.33 3.28 
1. 21 1. 63 2.7 3.65 
7 1. 28 1. 73 3.31 4.31 
2.19 3.47 4.75 5.74 
1.88 3.16 
8 0.58 0.9 2.33 2.78 
0.45 2.3 4.18 5.03 
0. 72 
0.72 
9a 0.38 0.73 0.88 0.99 
0.38 0.65 1. 0 1.11 
0.18 0.62 0.96 1.19 
0.28 0.55 0.70 0.91 
10a 1.17 1. 77 2.85 4.71 
0.44 0.94 2.13 3.54 
0.67 1. 07 2.03 3.33 
0.79 1. 39 2.91 3.88 
5 1.16 3.05 
2.36 
1. 38 
6 0.53 0.78 1. 86 3.24 
0.15 1. 32 2.07 3.45 
0.29 
Na** 
9a 0.38 0.65 0.8 0.91 
0.18 0.32 0.67 0.71 
10a 0.67 1.16 2.35 3.87 
0.67 1. 07 2.03 3.67 
0.55 1. 60 2.79 3.54 
0.44 1.15 2.23 3.64 
KEY S.int Sampling interval 
Inc.time Incubation time 
E Experiment number 
Na N.asteroides-activated macrophages 
Na** N.astero1des-activated macrophage cultures 
+ 0.002% antigen in vitro 
397 
TABLE 86 
7 day N.asteroides infection specific activity of cumulative 
lysozyme released. 
M0 E F Cumulative Specific 
Type lysozyme activity 
released (pg per mg of 
(ygl cell protein) 
4 S4 3.73 27.58 
C 9a S4 4.39 9.83 
3.91 9.44 
10a S4 16.11 67.89 
17.15 66.76 
15.7 53.02 
4 S4 2.52 21. 69 
3.52 27.59 
2.01 13.38 
3.76 16.53 
3.48 20.36 
2.1 13.64 
Na 2.16 18.3 
1. 87 15.46 
3.22 20.56 
2.54 16.24 
9a S4 0.99 6.42 
1.11 5.03 
1.19 7.38 
0.91 3.92 
10a S4 4.71 21.62 
3.54 10.54 
3.33 8. 77 
3.88 15.00 
Na + 9a S4 0.91 4.29 
0.002% 0. 71 2. 77 
Ag in vitro 
10a S4 3.87 20.46 
3.67 19.78 
3.54 18.09 
3.64 19.06 
KEY: E Experiment number 
F Final sample 
398 
w 
I..D 
I..D 
TABLE 87 
7 day N.asteroides infiction : Lysozyme production over 3 days in culture 
pg lysozyme per 2 x 10 macrophages). Experimental series "B". 
% secretion (Lysozyme expressed as 
E 
9b 
C 
10b 
9b 
Na 
10b 
Na** 9b 
10b 
KEY: a 
Na** 
a 
1. 01 
0.69 
2.46 
1. 81 
1. 46 
0.58 
0.38 
0.48 
0.66 
0.66 
0.43 
0.66 
0.28 
0.28 
0.38 
0.79 
1.17 
1.17 
0.79 
Sl S2 
b C d a b C d a b 
0.14 1.15 88 1. 89 0.29 2.18 86.68 3.85 0.91 
0.34 1. 03 67.3 2.43 0.60 3.03 80.14 3.57 0.25 
1. 22 3.69 66.67 6.78 1. 45 8.23 82.4 11. 96 0.92 
0.52 2.37 78.55 6. 77 1. 03 7.80 86.75 10.72 0.70 
0.34 1. 80 81.1 0.71 0.006 0.71 99.l 1. 05 0.03 
0.03 0.61 95.4 0.48 0.12 0.60 83.5 0.80 0.06 
0.11 0.50 77. 8 1. 21 0.14 1. 35 89.5 0.97 0 
0.14 0.62 76.9 0.65 0.07 0.72 90.07 0. 77 0.36 
0.07 0.73 91. 6 1. 61 0.23 1. 84 87.34 2.76 0.24 
0.07 0.73 91. 4 1. 50 0.06 1. 56 96.5 3.19 0.20 
0.04 0.51 86.4 1. 26 0.14 1. 40 89.95 2.58 0.09 
0.07 0.73 91. 6 1.15 0.29 1. 43 79.99 2.35 0.20 
0.11 0.38 71.8 0.65 1. 52 0.81 81.1 1.11 0 
0.02 0.30 92.8 0.73 0.16 0.89 81. 7 1. 00 0.07 
0.03 0.41 87.5 0.73 0.02 0.75 97.66 0.72 0.04 
0.01 0.80 98.21 2.08 0.12 2. 20 89.95 2.34 0.03 
0.03 1. 20 97.33 1. 92 0.38 2.32 83.4 3.52 0.01 
0.08 1. 24 93.98 1. 65 0.30 1. 94 84.6 2.33 0.12 
0.01 0.80 98.21 1. 96 0.18 2.14 91. 4 3.48 0.07 
extracellular lysozyme; b = intracellular lysozyme; c = total lysozyme 
N.asteroides-activated macrophages+ 0.002% antigen in vitro 
S3 
C d 
4. 77 80.8 
3.83 93.3 
12.88 92.9 
11. 42 94.2 
1. 08 97.7 
0.87 92.8 
0.80 95.5 
3.00 92.1 
3.39 94.2 
2.67 96.7 
2.55 92.3 
1. 07 93.2 
0.74 95.6 
2.37 98.9 
3.54 99.6 
2.46 95 
3.56 98.05 
d % secreted 
TABLE 88 
7 day N.asteroides infection : specific activity of lysozyme produced 
by macrophages over 3 days in culture. (Lysozyme expressed as µg of 
lysozyme/mg of cell protein) I 
E a 
9b 3.77 
2.88 
C 
10b 5.01 
3.40 
9b 9.99 
3.15 
2.44 
1. 5 
Na 
10b 4.22 
4.57 
2.85 
4.20 
9b 1. 47 
1. 04 
2.42 
Na** 
10b 5.50 
8.39 
4. 6!:i 
4.88 
KEY: E 
a 
b 
C 
C 
Na 
Na** 
Sl S2 S3 
b C a b C a b C 
0.52 4.29 7.23 1.11 8.35 16.41 3.88 20.29 
1.4 4.28 10.05 2.49 12.54 47.28 3.37 50.65 
2.50 7.51 19.59 4.18 23.77 53.15 4.09 57.24 
0.93 4.33 21.15 3.23 24.38 41.99 2.58 44.57 
2.33 12.32 3.99 0.04 4.03 7.81 0.19 8.00 
0.15 3.3 2.70 0.64 3.34 3.73 0.29 4.02 
0.69 3.13 2.01 0.83 7.85 4.29 0 0 
0.45 1. 95 3.71 0.41 4.12 5.89 0.28 6.17 
0.39 4.60 9.6 1. 39 10.99 10.13 0.87 11.00 
0.43 5.00 8.3 0.3 8.6 17.14 1.1 18.24 
0.45 3.30 7.6 0.85 8.45 16.54 0.58 17 .11 
0.38 4.58 6.36 1. 59 7.95 16.53 1. 4 17.93 
0.57 2.04 3.71 0.86 4.57 4.86 0 0 
0.08 1.12 3.97 0.89 4.86 4.27 0.31 4.58 
0.35 2.77 3.17 0.08 3.25 3.33 0.17 3.50 
0.1 5.60 10.77 0.62 11. 39 13.38 0.15 13.53 
0.23 8.62 14.05 2.79 16.84 17.71 0.06 17.78 
0.30 4.94 9.94 1.8 11. 74 12.26 0.64 12.90 
0.09 4.97 12.49 1.17 13.66 16.19 0.32 16.51 
Experiment number 
Extracellular lysozyme 
Intracellular lysozyme 
Total lysozyme 
Control macrophages 
N.asteroides-activated macrophages 
N.astero1des-activated macrophages+ 0.002% antigen 
in vitro 
400 
TABLE 89 
7 day N.brasiliensis infection Accumulation of lysozyme in 
conditioned medium over 4 days in culture. Experimental series "A". 
Data from 8 replicate experiments, in 5 of which N.brasiliensis 
-activated macrophages were exposed to antigen in vitro. Lysozyme 
expressed as fg of lysozyme per 2 x 10 6 macrophages. 
S.int 
Inc.time 
C 
Nb 
E 
l 
2 
3 
4 
Sl 
l day 
7.5 
3.75 
3.0 
3.0 
3.97 
3.63 
2.84 
3.76 
2.34 
5 1. 99 
2.59 
1. 99 
7 
Ba 
l 
2 
3 
2.89 
4.15 
3.34 
0.83 
1.18 
2.5 
2.25 
3.75 
3.0 
2.5 
3.0 
2.75 
2.0 
2.25 
2.5 
2.0 
1. 24 
0.94 
1. 24 
S2 
2 days 
11. 25 
7.25 
7.0 
6.56 
9.4 
8.61 
7.39 
8.41 
3.27 
5.93 
5.01 
1. 89 
3.05 
4.0 
3.5 
4.75 
3.0 
4.75 
3.5 
4.25 
5.75 
4.25 
4.5 
2.18 
1. 98 
1. 99 
401 
S3 
3 days 
16.75 
9.5 
9.25 
7.7 
12.11 
10.84 
10.34 
10.04 
5.76 
8.7 
7.36 
4.58 
4.61 
6.0 
4.5 
6.0 
5.0 
7.5 
6.5 
6.5 
8.75 
7.75 
7.0 
2.75 
3.12 
2.56 
S4 
4 days 
20.75 
11.16 
12.95 
12.14 
11. 87 
11. 47 
6.93 
9.35 
8.91 
5.76 
5.36 
6.0 
4.5 
7.0 
6.0 
9.0 
7.5 
11. 75 
10.0 
10.0 
TABLE 89 continued 
4 1. 21 2.96 1. 37 2.67 
0.04 0.75 2.65 3. 72 
1.1 1. 81 5.61 6.72 
3.76 4.47 3.56 4.4 
0.71 3.05 2.76 3.94 
0. 71 1. 92 
5 1. 99 
1. 76 
2.23 
2.23 
6 1. 28 2.86 5.75 7.44 
0.85 1. 99 4.61 6.68 
1. 43 2.86 5.75 8.5 
0.85 2.43 5.88 7.32 
7 1. 48 2.52 3.92 4.32 
0.95 1. 89 3.29 3.97 
Ba 0.62 1.19 1. 54 1. 57 
0.62 1. 38 1. 98 2.02 
0.62 1. 08 1. 42 1.46 
0.35 1. 03 1. 39 1. 86 
4 0.29 2.63 4.04 4.88 
0.29 2.63 3.58 4.5 
0.71 1. 42 2.26 3.18 
1. 75 4.1 5.16 7.31 
5 1. 99 
Nb** 
6 0.72 1. 89 4.25 5.69 
0.45 2.95 5.81 8.18 
0.99 1. 99 4.35 6.56 
7 0.79 1. 94 3.88 4.16 
8a 0.44 0.78 1. 27 1.49 
0.35 1.15 1. 26 1. 48 
0.28 0.62 1.11 1. 33 
0.35 1.15 1. 26 1. 36 
KEY S.int Sampling interval 
Inc.time Incubation time 
E Experiment number 
Nb N.brasiliensis-activated macrophages 
Nb** N.bras1l1ens1s-activated macrophages + 0.002% 
antigen in vitro 
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TABLE 90 
7 day N.brasiliensis infection : specific 
lysozyme released. 
M0 
Type 
C 
Nb 
Nb + 
0.002% 
Ag in vitro 
KEY: E 
F 
E F 
4 S6 
7 S6 
Ba S4 
4 S6 
6 S6 
7 S6 
Ba S4 
6 S6 
Ba S4 
Experiment number 
Final sample 
Cumulative 
lysozyme 
released 
V1gl 
15.09 
15.28 
14.78 
13.57 
11. 38 
12.60 
11. 77 
5.76 
5.36 
3.92 
4.88 
8.64 
5.92 
10.15 
8.28 
11. 43 
9.77 
6.20 
4.65 
5.09 
1. 57 
2.02 
1.46 
1. 86 
9.07 
11. 57 
1.49 
1. 48 
1. 33 
1. 36 
403 
activity of cumulative 
Specific 
activity 
leg per mg of 
11 protein) 
105.17 
124.29 
85.2 
71. 83 
69.57 
77. 33 
74.5 
21. 94 
25.07 
19.52 
14.08 
35.52 
21.12 
96.26 
52.9 
57.0 
59.2 
44.22 
33.47 
25.62 
8.22 
13. 2 
8.36 
10.0 
66.9 
84.4 
8.76 
6.71 
7.07 
9.67 
,t,. 
0 
,t,. 
TABLE 91 
7 day N.brasiliensis infection : Lysozyme production over 3 days in culture 
as fg lysozyme per 2 x 106 macrophages). Experimental series "B". 
% secretion (Lysozyme expressed 
E 
C 8b 
Nb 8b 
Nb** 8b 
KEY: a 
Nb** 
a 
1.87 
1. 31 
1. 31 
0.44 
0.62 
0.44 
0.44 
0.53 
0.44 
0.44 
0.44 
Sl S2 
b C d a b C d a b 
0.51 2.38 78.7 2.24 0.72 2.95 75. 77 4.35 0.28 
0.21 1. 52 86.4 
0.51 1. 82 72.16 2.63 0.61 3.24 81. 3 4.88 0.20 
0.09 0.53 83.1 0.9 0.03 0.93 96.8 1. 85 0.13 
0.04 0.66 94.5 0.80 0.20 1. 06 80.41 2.09 0.07 
0.13 0.57 77. 6 0.80 0.02 0.82 97.25 0.93 0.04 
0.11 0.55 79.3 0.92 0.08 
0.06 0.58 89.5 0.92 0.05 0.97 94.98 1. 26 0.33 
0.05 0.49 88.97 1. 42 0.08 1. 50 94.9 1. 08 0.38 
0.07 0.51 85.7 1.15 0.08 1. 23 93.78 1. 66 0.28 
0.06 0.49 88.8 1. 51 0.09 1. 61 93.95 
extracellular lysozyme; b = intracellular lysozyme; c = total lysozyme 
N.brasiliensis-activated macrophages+ 0.002% antigen in vitro 
S3 
C d 
4.63 93.9 
5.08 96.15 
1.98 93.6 
2.16 96.9 
0.97 96.4 
1. 01 92.2 
1. 59 79.4 
1.46 73.9 
1. 94 85.6 
d % secreted 
.i,. 
0 
lJ1 
TABLE 92 
7 day N.brasiliensis infection 
of cell protein) 
lysozyme production by macrophages over 3 days in culture ~g lysozyme per mg 
E 
C 8b 
Nb Bb 
Nb** Bb 
KEY: a 
E 
Na** 
Sl S2 S3 
a b C a b C a b 
7.91 2.14 10.05 8.10 2.59 10.68 15.11 0.98 
6.33 0.99 7.32 9.33 1.15 10.48 20.55 0.82 
5.58 2.15 7.73 
2.60 0.53 3.14 3.13 0.10 3.23 11. 91 0.81 
3.27 0.19 3.46 3.95 0.78 4.73 8.12 0.26 
2.45 0. 71 3.16 3.57 0.1 3.67 3.86 0.15 
2.32 0.60 2.92 4.96 0.42 
2.67 0.31 2.98 5.38 0.28 5.66 6.18 1. 61 
2.36 0. 29 2.66 6.14 0.33 6.46 5.14 1. 81 
2.54 0.42 2.96 5.75 0.38 6.13 10.33 1. 74 
2.08 0.26 2.34 6.46 0.42 6.87 
extracellular lysozyme; b = intracellular lysozyme; c = total lysozyme 
Experiment no. 
N.asteroides-activated macrophages+ 0.002% antigen in vitro 
C 
16.09 
21.36 
12.72 
8.37 
4.01 
5.38 
7.79 
6.95 
12.07 
TABLE 93 
13 day N • asteroid es infection a cc um u la ti on of l y so z y me in 
conditioned medium over 4 days in culture. Experimental series "A". 
Data from 4 replicate experiments in 2 of which N.asteroides 
-activated maclophages were exposed in vitro to antigen. (µg of 
lysozyme/2 x 10 macrophages) / 
s.int Sl S2 S3 S4 
Inc. time l day 2 days 3 days 4 days 
E 
l 0.67 3.61 7.04 10.11 
1. 94 4.88 7.3 10.37 
0.67 3.09 6.03 9.1 
2 1. 87 2.5 2.04 4.0 
0.45 1. 39 
C 
3a 1. 28 1. 86 2.15 2.44 
2.19 
4a 1. 21 2.5 4.25 5.01 
1. 05 3.23 4.27 5.36 
l 1. 5 4.93 5.95 7.61 
1. 5 4.19 4.63 6.29 
0.67 3.61 5.21 6.87 
1. 5 4.19 5.21 
2 0.71 2.19 3.16 6.61 
3.63 5.99 7.31 8.26 
Na 
3a 0.72 2.3 2.78 3.96 
0. 72 1. 3 1. 68 3.07 
"'· 72 1. 71 2.39 3.37 
4a 
"'· 59 0. 77 1. 81 2.45 0.59 1. 5 2.02 2.5 
Na+ 3a 0.85 3.04 3.75 5.83 
0.002% 
Antigen 4a 0.29 0.94 1.84 2.07 
in vitro 
KEY: s.int Sampling interval 
Inc.time Incubation time 
E Experiment no. 
TABLE 94 
13 day 
lysozyme 
M0 
Type 
C 
Na 
Na + 
Antigen 
in vitro 
KEY: E 
F 
N.asteroides 
released. 
E F 
2 S6 
4a S4 
2 S6 
4a S4 
4a S6 
infection 
Cumulative 
lysozyme 
released 
(pg) 
6.60 
5.01 
5.36 
9.50 
2.45 
2.5 
2.07 
Experiment number 
Final sample 
406 
specific activity of 
Specific 
activity 
(fg per mg of 
cell protein) 
32.9 
26.98 
23.84 
52.1 
28.8 
13.01 
17.57 
cumulative 
,i::,. 
0 
-...J 
TABLE 95 
13 day N.asteroides infection : Lysozyme production over 3 days in culture 
as ?g lysozyme per 2 x 106 macrophages). Experimental series "B" 
% secretion (Lysozyme expressed 
E 
C 4b 
Na 4b 
Na** 4b 
KEY: a 
E 
Na** 
Sl S2 S3 
a b C d a b C d a b 
1. 21 0.28 1. 49 81. 39 2.66 0.12 2.78 95.9 3.81 0.15 
0.59 0.56 1.15 51. 5 3.25 0.13 3.38 96.1 3.83 0.20 
1. 05 0.23 1. 28 81. 8 1.12 0.06 1.18 94.9 2.58 0.12 
0.59 0.19 0.78 75.7 1. 22 0.05 1. 27 95.7 1. 56 0.11 
0.44 0.16 0.60 73.5 1. 09 0.43 1. 52 71. 6 2.14 0.07 
0.29 0.18 0.47 61.4 1. 04 0.14 1.18 87.8 1. 38 0.08 
extracellular lysozyme: b = intracellular lysozyme: c = total lysozyme: d 
Experiment no. 
N.asteroides-activated macrophages+ 0.002% antigen in vitro 
TABLE 96 
C d 
3.96 96.2 
4.03 95.1 
2.7 95.5 
1. 67 93.5 
2.21 97 
1. 46 94.5 
% secreted 
13 day N.asteroides infection 
of cell protein) 
lysozyme production by macrophages over 3 days in culture (rg lysozyme per mg 
E 
C 4b 
Na 4b 
Na** 4b 
KEY: a 
E 
Na** 
a 
6.46 
3.91 
7. 71 
3.42 
3.16 
1. 34 
Sl S2 S3 
b C a b C a b 
1.48 7.93 10. 82 0.47 11. 28 23.61 0.93 
5.6 9.51 17.73 0. 72 18.45 18.02 0.94 
1. 7 9.41 6.71 0.36 7.07 12. 71 0.6 
1. 09 4.51 8.28 0.37 8.65 7.08 0.48 
1.14 4.3 5.52 2.19 7. 71 11.94 0.37 
1. 37 2.71 4.78 0.66 5.44 10.55 0.61 
extracellular lysozyme: b = intracellular lysozyme: c = total lysozyme 
Experiment no. 
N.asteroides-activated macrophages + 0.002% antigen in vitro 
C 
24.54 
18.95 
13.31 
7.49 
12.31 
11.16 
TABLE 97 
13 day N.brasiliensis infection accumulation of lysozyme in 
conditioned medium over 4 days in culture. Experimental series "A". 
Data from 8 replicate experiments in 2 of which N.brasiliensis 
-activated macrophages were exposed in vitro to antigen. (fg of 
lysozyme/2 x 106 macrophages) 
S.int 
Inc. time 
C 
Nb 
Nb** 
E 
1 
2 
3 
4 
6 
7 
Ba 
1 
3 
4 
5 
7 
Ba 
7 
Ba 
KEY: S. int 
Inc.time 
Nb** 
Sl 
1 day 
0.67 
1.94 
0.6 
4.34 
3.35 
4.51 
2.51 
0.82 
1. 86 
1.86 
1.99 
1. 83 
1. 83 
2.3 
2.4 
1. 5 
1. 72 
1. 5 
0.75 
1. 25 
3.5 
3.5 
0.62 
0.82 
0.95 
0.95 
1. 2 
1. 52 
1. 52 
1. 52 
1. 38 
1. 29 
0.94 
1. 83 
1. 52 
2.15 
S2 
2 days 
3.61 
4.88 
3.09 
8.68 
7.19 
8.75 
5.5 
1. 75 
4.07 
4.9 
4.76 
3.87 
3.85 
5.23 
5.09 
3.64 
4.66 
3.0 
1. 5 
3.75 
6.0 
7.0 
1. 44 
1.44 
2.27 
2.76 
3.27 
2.97 
2.97 
2.42 
3.07 
2.85 
1. 83 
2.97 
3.46 
Sampling interval 
Incubation time 
S3 
3 days 
7.04 
7.3 
6.03 
13.02 
12.04 
15.75 
9.75 
3.13 
5.5 
5.99 
6.16 
4.96 
5.09 
6.32 
6.11 
4.66 
5.38 
6.5 
5.0 
6.5 
10.0 
9.5 
1. 78 
1. 78 
3.04 
3.53 
3.74 
3. 72 
3.61 
2.92 
3.68 
3.78 
2.92 
3.46 
4.24 
S4 
4 days 
10.11 
10.37 
9.1 
15.89 
14.91 
16.25 
13.0 
3.95 
7.08 
8.55 
7.35 
6.98 
8.88 
7.77 
6.15 
8.0 
7.75 
8.5 
14.75 
10.75 
4.32 
5.13 
5.02 
5.28 
5.01 
4.01 
4.01 
4.97 
4.70 
5.64 
N.brasiliensis-activated macrophage cultures 
+ 0.002% antigen in vitro 
408 
TABLE 
13 day N.braailiensis infection : 
lyaozyme 
M0 
Type 
C 
Nb 
Nb + 
0.002% 
antigen 
in vitro 
KEY: E 
F 
released. 
E 
3 
7 
Sa 
3 
7 
Sa 
Sa 
F Cumulative 
lyaozyme 
released 
(fg) 
S10 33.25 
S6 9.41 
S4 8.55 
7.35 
6,98 
8.88 
S10 17.75 
20.75 
17.25 
S6 7.34 
8.85 
9.57 
S4 5.28 
5.01 
4.01 
S4 4.97 
4.70 
5.64 
Experiment number 
Final sample 
98 
specific activity of 
Specific 
activity 
(pg per mg of 
cell protein) 
232.8 
52.8 
43.69 
40.42 
23.51 
40.22 
166.2 
103.75 
171.47 
41. 88 
30.33 
44.8 
24.2 
23.89 
23.14 
17.19 
27.27 
21. 5 
409 
cumulative 
.i:,. 
f-.J 
0 
TABLE 99 
13 day N.brasiliensis infection : Lysozyme production over 3 days in culture 
as fg lysozyme per 2 x 106 macrophages). Experimental series "B". 
% secretion (Lysozyme expressed 
E 
C 8b 
Nb 8b 
Nb** 8b 
KEY: a 
E 
Nb** 
Sl S2 S3 
a b C d a b C d a b 
l. 99 0.29 2.28 87.5 4.32 0.22 4.54 95.18 6.03 0.20 
2.15 0.32 2.47 87.l 3.88 0.19 4.07 95.29 5.39 0.27 
l. 52 0.59 2.11 71. 9 4.15 0.18 4.33 95.14 6.63 0.34 
2.15 0.78 2.93 73.5 4.01 0.21 4.22 95.11 
l. 83 0.27 2.09 87.5 2.69 0.04 2.73 98.58 3.49 0.70 
l. 68 0.25 l. 93 87.07 3.25 0.10 3.35 97.06 3. 77 0.08 
l. 52 0.59 2.11 71. 9 2. 72 0.19 2.91 93.36 4.06 0.08 
l. 52 0.40 2.17 69.99 3.3 0.17 3.47 95.14 3.33 0.08 
l. 52 0.16 l. 68 90.3 2.38 0.19 2.57 92.55 4.60 0.07 
l. 00 0.02 l. 02 97.6 
extracellular lysozyme; b = intracellular lysozyme; c = total lysozyme; d 
Experiment no. 
N.brasiliensis-activated macrophages +0.002% antigen in vitro 
C d 
6.23 96.8 
5.66 95.3 
6.97 95.18 
4.19 83.3 
3.85 97.8 
4.14 98.l 
3.41 97.7 
4.68 98.44 
% secreted 
,i:::,. 
I-' 
I-' 
TABLE 100 
13 day N.brasiliensis infection 
mg of cell protein) 
lysozyme production by macrophages over 3 days in culture 'rg lysozyme per 
E 
C Sb 
Nb 
Nb** 
KEY: a 
E 
Na** 
a 
4.78 
5.80 
2.59 
5.58 
7.62 
7.64 
7.68 
5.46 
5.93 
Sl S2 S3 
b C a b C a b 
0.69 5.47 16.13 0.81 16.95 20.14 0.66 
0.86 6.66 11. 33 0.55 11. 89 18.87 0.93 
1. 01 3.6 12.81 0.54 13. 35 21.64 1.10 
2.01 7.59 12.91 0.66 13.57 
1. 09 8. 71 12.56 0.18 12.74 17.43 3.5 
1.13 8. 77 13.81 0.42 14.23 19.25 0.43 
3.0 10.68 10.06 0.72 10.78 25.1 0.48 
1.44 6.90 11.14 0.57 11. 71 15.25 0.37 
0.64 6.56 11.95 0.96 12.91 21. 72 0.39 
7.38 0.18 7.55 
extracellular lysozyme; b = intracellular lysozyme; c = total lysozyme 
Experiment no. 
N.brasiliensis-activated macrophages+ 0.002% antigen in vitro 
C 
20.80 
19.80 
22.74 
20.93 
19.68 
25.59 
15.62 
22 .11 
TABLE 101 
21 day N.asteroides infection Accumulation of lysozyme in 
conditioned medium over 4 days in culture. Experimental series "A". 
Data from 4 replicate experiments in 2 of which N.asteroides 
-activated mac6ophages were exposed in vitro to antigen. (µg of lysozyme/2 x 10 macrophages) / 
S.int 
Inc. time 
C 
Na 
E 
1 
2 
3a 
4a 
l 
2 
3a 
4a 
Na+ 3a 
0.002% 
Antigen 4a 
in vitro 
KEY: S. int 
Inc.time 
E 
Sl 
l day 
3.35 
0.67 
2.13 
2.46 
2.11 
1.19 
2.87 
0.67 
1. 08 
0.44 
0.16 
0.25 
0.1 
0.65 
0.44 
0.35 
0.1 
0.4 
0.62 
S2 
2 days 
9.24 
5.52 
4.41 
4.37 
4.02 
2.95 
4.37 
3.54 
1. 87 
1. 79 
0.88 
0.47 
0.72 
1. 59 
0.75 
0.65 
0.22 
0.71 
l. 03 
Sampling interval 
Incubation time 
Experiment no. 
S3 
3 days 
12.11 
7.46 
5.06 
5.92 
5.49 
4.07 
5.24 
5.48 
2.66 
2.52 
1. 48 
1.11 
1.14 
2.38 
l. 25 
1.15 
0.71 
l. 06 
l. 31 
S4 
4 days 
10.l 
5.55 
8.67 
8.63 
6.63 
4.83 
3.81 
2.66 
2.66 
3.05 
3.56 
2.05 
l. 64 
2 
2.7 
2.35 
TABLE 102 
21 day N.asteroides infection 
lysozyme released. 
M0 
Type 
E F 
3a S4 
C 4a S4 
3a S4 
Na 4a 
Na + 3a 
0.002% 
Antigen 4a 
in vitro 
S4 
S4 
S4 
Cumulative 
lysozyme 
released 
(fg) 
5.55 
8.67 
8.63 
6.63 
4.83 
3.81 
2.66 
2.66 
3.05 
3.56 
2.05 
1. 64 
2.0 
2.7 
2.35 
KEY: E 
F 
Experiment number 
Final sample 
specific activity of cumulative 
Specific 
activity 
(pg per mg of 
cell protein) 
39.32 
37.06 
35.57 
31.62 
63.61 
21. 83 
20.31 
16.83 
19.15 
25.64 
16.5 
13.38 
18.76 
20.44 
19.64 
412 
~ 
f-' 
w 
TABLE 103 
21 day N.asteroides infection : Lysozyme production over 3 days in culture 
macrophages). Experimental series "B". 
Sl S2 
E a b C d a b C d 
C 3b l. 72 0.28 2.00 86. 22 4.54 0.14 4.86 96.6 
2.9 0.39 3.29 88.26 4.42 0.02 4.44 99.6 
4b l. 75 0.48 2.23 78.36 6.15 0.59 6.74 91. 25 
l. 75 0.23 l. 98 88.3 5.8 0.56 6.36 91. 26 
l. 3 0.44 l. 73 74.8 3.37 0.26 3.63 92.96 
Na 3b 0.65 0.12 0.76 85.58 1. 87 0.52 2.39 78.2 
0.37 0.13 0.51 73.94 l. 88 0.03 1. 91 98.7 
0.37 0.08 0.45 82.85 l. 59 0.0011 l. 59 99.9 
4b 0.16 0.02 0.18 87.36 1. 08 0.11 1.19 90.7 
0.44 0.09 0.53 83.5 0.48 0 
0.07 0.04 0.12 63.0 0.65 0.07 0.73 90.0 
0.15 0.02 0.18 90.0 I 0.22 0.06 0.28 78.4 
Na** 3b 0.51 0.03 0.54 94.8 1.17 0.40 1. 57 74.4 
4b 0.4 0.09 0.49 82.15 0.6 0 
0.4 0.08 0.48 84.1 0.30 0.07 0.38 80.6 
0.44 0.04 0.44 91.1 0.50 0 
0.29 0.0081 0.3 97.3 l. 01 0.06 l. 07 94.48 
% secretion (?g lysozyme/2 x 106 
S3 
a b C d 
4.79 0.28 5.07 94.6 
6.7 0.22 6.92 96.88 
6.59 1.19 7.78 84.73 
6.66 0.52 7.18 92.78 
l. 97 0.13 2.09 93.6 
1.96 0.03 l. 99 98.4 
l. 78 0.08 1. 86 95.48 
0.96 0.09 1.04 91.6 
1.48 0.05 1. 53 94.8 
0.82 0.07 0.89 92.4 
l. 82 0.04 1. 85 98.l 
l. 47 0.04 l. 52 96.9 
2.27 0.10 2.37 95.0 
l. 02 0.27 l. 30 78.9 
l. 79 0. 20 l. 98 90.0 
KEY: a extracellular lysozyme; b = intracellular lysozyme; c 
Experiment no. 
total lysozyme; d % secreted 
E 
Na** N.asteroides-activated macrophages+ 0.002% in vitro 
TABLE 104 
21 day N.asteroides infection : specific activity of lysozyme produced 
by macrophages over 3 days in culture. ( Lysozyme expressed as /g of 
lysozyme/rng of cell protein) 
E a 
C 3b 6.65 
4.14 
4b 5.51 
5.11 
4.25 
Na 3b 2.26 
1.17 
1. 31 
4b 0.72 
1. 64 
0.26 
0.58 
Na** 
3b 2.34 
4b 1. 57 
1. 72 
1. 81 
1. 29 
KEY: E 
a 
b 
C 
C 
Na 
Na** 
Sl S2 S3 
b C a b C a b C 
0.89 7.54 11. 38 0.36 11.74 22.87 1. 32 24.19 
0.66 4.80 18.63 0.07 18.67 
1. 52 6.84 18.87 2.60 21. 47 30.06 0.97 31.05 
0.68 5.79 14.5 1. 39 15.89 13.31 2.40 15.71 
1.4 5.65 12.72 0.96 13.68 20.62 1. 61 22.22 
0.38 2.64 7.28 2.03 9.31 8.66 0.56 9.22 
0.41 1. 58 6.46 0.08 6.55 8.44 0.14 8.58 
0.27 1. 58 6.07 0.0043 6.07 
0.08 0.81 5.46 0.56 6.02 7.70 0.37 8.07 
0.32 1. 96 2.37 0 2.65 0.24 2.89 
0.15 0.41 2.70 0.3 3.00 10.17 0.35 10.54 
0.06 0.64 1.05 0.29 1. 34 4.84 0.4 5.24 
0.12 2.46 3.63 1. 25 4.88 10. 53 0.2 10.73 
0.34 1. 94 2.93 0 18. 32 0.26 8.58 
0.32 2.04 1. 38 0.33 1. 71 20.34 0.88 21. 22 
0.18 1. 99 2.67 0 6.03 1. 61 7.64 
0.04 1. 32 5:01 0.29 5.31 12.75 1.4 14.15 
Experiment number 
Extracellular lysozyme 
Intracellular lysozyme 
Total lysozyme 
Control macrophages 
N.asteroides-activated macrophages 
N.asteroides-activated macrophages+ 0.002% antigen 
in vitro 
414 
TABLE 105 
21 day N.brasiliensis infection Accumulation of lysozyme in 
conditioned medium over 4 days in culture. Experimental series "A". 
Data from 8 replicate experiments, in 1 of which N.brasiliensis 
-activated macrophages were exposed to antigen in vitro. Lysozyme 
expressed as fg of lysozyme per 2 x 10 macrophages. 
S.int 
Inc.time 
C 
Nb 
Nb** 
KEY 
E 
1 
2 
3 
4 
5 
6 
7 
Ba 
1 
2 
3 
4 
5 
6 
7 
Ba 
Ba 
s.int 
Inc.time 
E 
C 
Nb 
Nb** 
Sl 
1 day 
0.75 
4.5 
2.0 
2.0 
2.0 
4.75 
4.0 
0.57 
0.57 
1.14 
4.21 
3.97 
3.14 
3.18 
2.01 
3.18 
2.9 
4.38 
1. 28 
1.16 
1.16 
1. 0 
4.75 
1. 0 
2.0 
2.0 
2.0 
1. 24 
0.75 
1. 89 
2.21 
2.1 
1. 21 
1. 21 
2.1 
0.62 
S2 
2 days 
1. 0 
10.0 
10.0 
5.75 
4.0 
9.25 
7.5 
1. 71 
1.13 
9.22 
10.45 
8.31 
6.05 
5.15 
5.51 
7.45 
7.03 
3.36 
3.65 
4.07 
3.0 
10.75 
4.75 
3.5 
5.75 
5.25 
3.59 
1. 59 
7.38 
4.97 
4.46 
2.87 
3.1 
3.76 
2.05 
Sampling interval 
Incubation time 
Experiment number 
Control macrophages 
S3 
3 days 
3.0 
17.0 
18.0 
10.75 
9.75 
14.0 
10. 5 
2.65 
2.08 
10.91 
12.79 
9.63 
8.95 
8.19 
8.98 
10.2 
11.1 
5.73 
5.47 
5.89 
4.25 
16.75 
7.75 
10.0 
9.0 
9.45 
9.35 
5.9 
3.71 
4.23 
4.75 
3.49 
S4 
4 days 
5.25 
3.75 
24.5 
15.25 
13.75 
16.0 
12.5 
3.59 
13.35 
14.35 
10. 78 
11.16 
10.26 
10.79 
12.54 
12.66 
24.03 
12.5 
9.93 
5.75 
23.75 
13.25 
14.0 
11. 34 
12.1 
8.66 
6.47 
6.47 
8.75 
5.57 
N.brasiliensis-activated macrophages 
N.brasiliensis-activated macrophage cultures 
+ 0.002% antigen in vitro 
415 
TABLE 106 
21 day N.brasiliensis infection : specific activity of cumulative 
lysozyme-released. 
E F Cumulative Specific 
lysozyme activity 
released ~g per mg of 
erg) 11 protein) 
2 S6 34.25 185.69 
32.25 146.7 
4 S6 20.25 89.2 
16.0 48.0 
6 S6 17.49 107.96 
C 18.91 120.0 
13.86 125.2 
7 S6 16. 72 128.22 
16.9 88.08 
18.04 153.59 
18.37 123.16 
22.38 200.21 
Ba S4 24.03 113.91 
12.5 59.96 
9.93 38.l 
2 S6 30.5 227.1 
4 S6 19.25 66.6 
19.5 61. 7 
Nb 
6 S6 15.52 104.5 
7 S6 20.02 119. 56 
Ba S4 8.66 18.08 
6.47 14.45 
6.47 19.62 
Nb + Ba S4 8.75 18.33 
0. 002% 5.57 16.21 
Ag in vitro 
KEY: E Experiment number F Final sample 
416 
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TABLE 107 
21 day N.brasiliensis infiction : Lysozyme production over 3 days in culture 
as pg lysozyme per 2 x 10 macrophages). Experimental series "B" 
% secretion (Lysozyme expressed 
E 
C 8b 
Nb 8b 
Nb** 8b 
KEY: a 
E 
Nb** 
Sl S2 
a b C d a b C d a b 
1. 65 0.30 1. 95 84.55 3.51 0.62 4.13 85.1 5.37 0.09 
1. 28 0.31 1. 59 80.3 4.5 0.97 5.47 82.2 6.11 0.87 
5.99 0.32 
0.8 0.16 0.96 83.1 2.66 0.84 3.50 76 4.86 0.64 
0.61 0.09 0.69 87.6 3.36 0.53 3.89 86.3 3.8 0.44 
2.24 0.60 2.84 78.8 3.68 0.76 
1. 64 0.50 2.14 76.5 2.87 0.38 3.25 88.2 3.51 0.59 
2.5 0.34 2.84 87.98 2.75 0.70 
extracellular lysozyme; b = intracellular lysozyme; c = total lysozyme; d 
Experiment no. 
N.brasiliensis-activated macrophages+ 0.002% antigen in vitro 
S3 
C d 
5.46 98.4 
6.98 87.5 
6.31 94.9 
5.50 88.4 
4.24 89.7 
4.45 82.8 
4.10 85.6 
3.45 79.7 
%. secreted 
J:,. 
I-' 
a: 
TABLE 108 
21 day N.brasiliensis infection 
mg of cell protein) 
lysozyme production by macrophages over 3 days in culture erg lysozyme per 
E 
C 8b 
Nb 8b 
Nb** 8b 
KEY: a 
E 
Nb** 
Sl S2 
a b C a b C a 
5.56 1. 02 6.58 13.76 2.42 15.91 31. 60 
4.81 1.12 5.99 16.08 3.48 19.55 24.13 
27.82 
2.18 0.44 2.62 6.77 2.14 8.10 9.66 
1. 40 0.19 1. 59 9.7 1. 54 11. 24 10.04 
6. 71 1. 81 8.52 11. 33 
6.66 0.89 7.55 9.36 
3.66 1.13 4.79 7.3 1. 00 8.30 6.77 
extracellular lysozyme; b = intracellular lysozyme; c = total lysozyme 
Experiment no. 
N.brasiliensis-activated macrophages+ 0.002% antigen in vitro 
S3 
b C 
0.52 32.12 
3.44 27.57 
1. 50 29.32 
1. 27 10.93 
1.15 11.19 
2.35 13.68 
1. 58 10.94 
1. 72 8.49 
TABLE 109 
2 day N.asteroides infection. Median lysozyme and their 95% 
confidence limits for N.asteroides-activated macrophages at each 
sampling interval. Median lysozyme values expressed as percentages 
of their own controls. 
Sampling 
Interval Sl S2 S3 S4 
Median l. 90 3.17 6.27 9.25 
C LL l. 28 2.08 4.01 5.84 
UL 2.56 8.36 8.53 12.66 
Na Median l. 52 3.11 4.86 5.9 
LL 1.12 2.49 3.88 4.93 
UL 2.05 3.67 5.52 6.7 
%C 80 98.l 77.5 63.8 
TABLE 110 
2 day N.brasiliensis infection : Median lysozyme values expressed as 
percentage controls. 
Sampling 
Interval Sl S2 S3 S4 
C Median 2.47 4.34 6.45 8.64 
LL 1. 78 3.4 4. 72 5.71 
UL 3.85 9.17 14.04 16.15 
Nb Median 2.47 4.59 6.32 9.00 
LL l. 93 3.41 4.64 5.94 
UL 3.4 5.79 8.86 12.49 
% C 100 105.7 97.98 104.17 
Nb+ Median 3.45 5.35 6.94 8.56 
0.002% LL 2.22 4.15 4.97 5.5 
Ag UL 5.3 9.03 12.85 15.15 
%C 139.68 123.27 107.6 99.07 
TABLE 111 
Seven day N.asteroides infection 
as percentage controls 
Sampling 
Interval 
Control 
macrophage 
cultures 
N .asteroides-
activa ted 
macrophages 
N .asteroides -
activated 
macrophages 
+ 0.002% Ag 
M 
LL 
UL 
M 
LL 
UL 
%C 
M 
LL 
UL 
%C 
Sl 
l. 82 
0.98 
2.65 
0.695 
0.48 
0.95 
38.2 
0.6 
0.36 
l. 26 
32.97 
median lysozyme values expressed 
S2 
4.04 
2.16 
5.3 
1.26 
0.97 
l. 69 
31. 2 
1.13 
0. 72 
2.06 
27.97 
419 
S3 
3.91 
2.99 
8.02 
2.1 
l. 67 
2.59 
53.7 
1. 998 
1. 27 
2.43 
51. l 
S4 
6.84 
3.91 
10.84 
2.97 
2.36 
3.62 
43.4 
3.42 
1. 98 
3.71 
50.0 
TABLE 112 
Seven day N.brasiliensis infection 
expressed as percentage controls 
median lysozyme values 
Sampling 
Interval 
Control 
macrophage 
cultures 
M 
LL 
UL 
N.brasiliensis- M 
activated LL 
macrophages UL 
%C 
N. brasiliensis - M 
activated LL 
macrophages UL 
+ 0.002% Ag %C 
Sl 
3.05 
2.44 
4.06 
1. 62 
1.19 
2.12 
53.1 
0.58 
0.37 
1.14 
19.01 
S2 
6.66 
4.81 
8.33 
2.89 
2. 27 
3.43 
43.4 
1. 89 
1. 28 
2.63 
28.38 
TABLE 113 
S3 
8.94 
7.04 
10.81 
4.46 
3.58 
5.44 
49.88 
3.18 
1. 77 
4.35 
35.57 
S4 
10.32 
7.92 
13.06 
5.70 
4.36 
7.06 
55.23 
4.24 
2.34 
5.91 
41. 09 
13 day N.asteroiqes infection 
percentage controls. 
median lysozyme values expressed as 
Sampling 
Interval 
Control 
Macrophage 
Cultures 
N .asteroides -
Ac t1 va ted 
Macrophages 
M 
UL 
UL 
M 
LL 
UL 
%C 
Sl 
1. 27 
0.67 
1. 87 
1. 05 
0.66 
2.11 
82.68 
S2 
2.83 
1. 95 
3.99 
2.93 
1. 61 
4.19 
103.53 
TABLE 114 
Thirteen day N.brasiliensis infection 
expressed as percentage controls. 
Sampling 
Interval 
Control 
macrophage 
cultures 
M 
LL 
UL 
N.brasiliensis - M 
activated LL 
macrophages UL 
%C 
N.brasiliensis - M 
activated LL 
macrophages UL 
+ 0.002% Ag %C 
Sl 
2.02 
1. 34 
3.09 
1. 42 
1.1 
2.13 
70. '29 
1. 52 
1. 28 
1. 76 
75.25 
420 
S2 
4.79 
3.85 
6.3 
3.23 
2.42 
4.22 
67.43 
2.96 
2.55 
3.37 
61. 8 
S3 
4.63 
2.1 
3.17 
3.80 
2.30 
5.21 
82.07 
S4 
6.80 
3.28 
10. 24 
5.06 
3.07 
7 .11 
74.41 
median lysozyme values 
S3 
6.81 
5.56 
9.75 
4.62 
3.39 
6.31 
67.84 
3.62 
3.29 
3.95 
53.16 
S4 
9.99 
7.82 
12.57 
6.53 
5.08 
9.26 
65.37 
4.83 
4.25 
5.41 
48.35 
TABLE 115 
Twenty-one day N.asteroides infection 
expressed as percentage controls. 
Sampling 
Interval 
Control 
macrophage 
cultures 
N .asteroides-
activa ted 
macrophages 
N .asteroides -
activated 
macrophages 
+ 0.002% Ag 
M 
UL 
UL 
M 
LL 
UL 
%C 
M 
LL 
UL 
%C 
Sl 
2.11 
1. 58 
2.65 
0.57 
0.13 
1. 98 
27.01 
0.42 
0.31 
0.53 
19.91 
S2 
4.41 
3.34 
5.48 
1. 85 
0.395 
3.96 
41. 95 
0.75 
0.48 
1. 02 
17.0 
TABLE 116 
Twenty-one day N.brasiliensis infection 
expressed as percentage controls. 
Sampling 
Interval 
Control 
macrophage 
cultures 
M 
LL 
UL 
N.brasiliensis- M 
activated LL 
macrophages UL 
%C 
Sl 
2.59 
1. 95 
3.38 
1. 61 
1. 21 
2.11 
62.16 
421 
S2 
6.02 
4.58 
7.58 
4.38 
3. 25 
6.17 
72. 76 
median lysozyme values 
S3 
5.92 
4.32 
7.52 
2.63 
1.13 
5.36 
44.43 
1. 2 
0.87 
1. 53 
20.27 
S4 
7.83 
6.68 
8.98 
3.24 
2.69 
3.79 
41.38 
2.35 
2.69 
2.73 
30.01 
median lysozyme values 
S3 
9.51 
6.96 
11. 21 
7.63 
5.07 
10.5 
80.23 
S4 
12.94 
11.16 
17.01 
10.24 
6.47 
16.21 
79.13 
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Chapter 5 
PART 1 : MORPHOLOGICAL CHARACTERISTICS OF MACROPHAGES FROM MICE 
PREVIOUSLY INFECTED WITH N.ASTEROIDES OR N.BRASILIENSIS: A 
STUDY USING THE PHASE-CONTRAST INVERTED MICROSCOPE. 
5.1 INTRODUCTION 
In addition to the numerous biochemical and functional 
manifestations of a state of activation, macrophages harvested 
from animals recently infected with any of a variety of 
facultative intracellular parasites show a number of 
characteristic morphological changes when compared to normal 
cells ( Blanden, 1968; Mackaness, 1970 62; Lazdins et al, 
1978; Johnston, 1982). 
5. l. l MORPHOLOGICAL FEATURES OF ACTIVATED MACROPHAGES 
PHASE-CONTRAST MICROSCOPY 
The morphology of the macrophage varies depending on its state of 
activity (Elhelu, 1983). The mononuclear phagocytes in the 
normal mouse peritoneal cavity are young monocyte-like cells 
( Cohn and Benson, 1965a); the shape of the nucleus is reniform 
but may vary from horse-shoe shaped to fusiform ( Fedorko and 
Hirsch, 1970; Lessin and Bessis, 1972 736); they attach 
firmly and 
culture and 
subsequently spread on plastic or glass surfaces in 
become highly polarised and oriented as time in 
culture progresses. On phase contrast microscopy, secondary 
lysozomes (phase dense granules, Polliack and Gordon, 1975) and 
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endocytic vesicles are 
cell spreads, pseudopods 
seen in the perinuclear area. As the 
start to form, there is a ruffling of 
the membrane borders and mitochondria appear as phase-dense rods 
scattered through the cytoplasm. \'Ji th more prolonged time in 
culture there is a progressive increase in the size of the cell 
and the number of phase-dense granules ( Cohn and Benson, 1965; 
Cohn, 1968; Cohn, 1975). 
Macrophage activation is manifested by a variety of morphological 
changes. The most characteristic features are their content of 
mitochondria (filamentous phase-dense bodies), lysozomes 
( spherica 1 phase-dense granules) and pinocytic ac ti vi ty ( number 
of phase- lucent vesicles). Increased numbers of lysozomes and 
levels of lysozomal enzymes has been accepted as one of the most 
conspicuous features during in vivo activation (Blanden, 1968; 
Mackaness, 1970 : 62; Reikvam, Grammeltdveldt and Hoiby, 1975). 
Typically, lysozomes 
perinuclear area in 
and pinocytic vesicles are seen in the 
activated macrophages (Nogueira and Cohn, 
1978; Reikvam, Grammeltveldt and Hoiby, 1975). 
Another morphological change which is very apparent in activated 
macrophages is its larger size, which is reflected in its 
increased protein content (Cohn, 1978). Activation is 
manifested by a lower nucleo-cytoplasmic ratio (McLaughlin, 
Ruddle and Waksman, 1972) ie cells from infected animals seem to 
have a much more extensive cytoplasm (Blanden, 1968) with large 
numbers of mitochondria. Nog uiera and Cohn ( 197 8) noted that 
activated macrophages spread symmetrically and had intensely 
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ruffled plasma membranes. Macrophages from ECG-infected animals 
spread more rapidly than control macrophages and 
whereas the normal cells became 
assumed a 
elongated rounded shape 
(Mackaness, 1970; 62). Increased ruffling of the membrane and 
prominence of 
that have been 
1980). Lipid 
pseudopodia are also characterisic of macrophages 
exposed to irritants (Ogmundsdottir and Weir, 
droplets are prominent in some stimulated 
macrophages (Hirsch and Fedorko, 1970 16) and increased 
adhesiveness is a well known 
(Hopper, Wood and Nelson, 1979; 
property of activated macrophages 
Lasser 1983). 
5.1. 2 CHARACTERISTICS OF ACTIVATED MACROPHAGES MORPHOLOGY 
AS A PARAMETER 
changes are characteristic of activated Morphological 
macrophages. Changes which are most commonly documented as 
being characteristic are increased adhesiveness, rate and extent 
of spreading, increased ruffling of the membrane and prominence 
of pseudopodia, increased number of cytoplasmic granules and 
vacuoles (Ogmundsdottir and Weir, 1980; Hopper, Wood and Nelson, 
1979; Lasser, 1983). In addition, it has been suggested that 
the morphology of macrophages and their in vitro behaviour 
reliably portray their antimicrobial activity in vivo (Blanden, 
Lefford and Mackaness, 19 69) • Macrophage morphology was 
therefore selected as a parameter of macrophage activation. 
5.2 METHOD 
Macrophage cul tu res were monitored by phase contrast microscopy 
throughout the culture period. Monolayer cultures of macrophages 
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from mice previously inoculated with live Nocardia organisms were 
compared with cultures from saline-inoculated mice incubated 
under identical conditions and always run in parallel. 
Macrophage morphology was monitored in living monolayer cultures 
by phase-contrast microscopy using a Leitz Diavert Inverted 
Microscope (Wild Heerbrug, Switzer land) fitted with 10, 20 and 
32x phase-contrast objectives and 16x eyepieces. The Leitz 
Diavert inverted microscope was fitted with a Wild MPS 61 camera 
with a 10x eyepiece and a Wild MPS 55 Photoautomat box and 
photographs were taken on Ilford PAN F black and white film. 
5.3 RESULTS 
Culture conditions, such as presence or absence of serum, were 
found to influence the morphology of macrophages (Cohn and 
Benson, 1965b), whether from Nocardia-inoculated or control mice. 
Therefore cultures were always run in parallel. Generally, 
normal macrophages show two basic types of morphology in culture: 
either they are extended or stella te or they are rounded with 
abundant cytoplasm. With increasing time in culture the 
proportion of stellate cells increases, in agreement with the 
findings of Stuart, Habeshaw and Davidson(l978 : 31.6). 
Phase-contrast micrographs of macrophage cultures destined for 
assay of lysozyme and plasminogen activator release ( direct and 
indirect method) and for scanning electron microscopy were taken. 
For details of culture conditions see 3.2.3, 3.2.4, 4.2.1 and 
2.8. The morphology of Nocardia-activated macrophages was 
distinctly different from that of control macrophages 
446 
irrespective of culture conditions. Appearance of control cells 
was dependent on the culture medium and macrophages in general 
assumed a characteristic morphology in the same media in 
replicate experiments. This is also true for Nocardia-activated 
macrophages, but to a lesser extent. 
5.3.1 TWO DAY N.ASTEROIDES INFECTION 
Typical phase-contrast micrographs of living macrophages from 
mice inoculated 2 days previously with N. asteroides or normal 
saline only are shown in Figs 43, 44. Control cells are present 
predominantly in the rounded form (cells have been in culture for 
13.5 hours). The N.asteroides-activated macrophages are larger 
and are more well-spread, contain more lysozomes and phase-lucent 
vesicles. Cells are rounded with abundant cytoplasm or are 
stellate or dendritic in shape. 
5.3.2 TWO DAY N.BRASILIENSIS INFECTION 
Two day N. brasi liensis-acti va ted macrophages in general appear 
larger than controls, have longer pseudopodia, contain more 
phase dense granules and are more irregularly shaped than control 
cells, irrespective of culture conditions. Phase contrast 
micrographs are shown in Figs 44, 45 (13.5 hour incubation). 
Macrophages harvested from mice inoculated 2 days previously with 
N.asteroides or N.brasiliensis and cultured for 13.5 hours 
exhibit increased size, increased and more rapid spreading, 
increased pinocytic activity, ruffled membrane activity, 
increased numbers of perinuclear lysozomes, irregular shapes with 
long pseudopodia and frequently spread symmetrically, as shown in 
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Figs 43, 45. 
Noca rd ia-ac ti va ted macrophages showed more rapid spreading than 
control cells after 30 minutes of incubation, and the difference 
in rate of spreading was even more marked after 2. 5 hours of 
incubation. 
5.3.3 SEVEN DAY N.ASTEROIDES INFECTION 
Macrophages from mice inoculated 7 days previously with 
N.asteroides appear to contain more phase dense granules and 
phase translucent vesicles than control cells. They also seem to 
be more well spread and to assume more irregular shapes and to 
have longer pseudopodia than controls. In some cul tu res ( eg 
indirect PA) macrophages are large and predominantly rounded with 
extensive cytoplasm and numerous perinuclear lysozomes and 
vesicles, whereas controls are generally stella te, have fewer 
granules and are not as large. Cells in culture for direct assay 
for PA are shown in Fig 46. In this culture medium, the 
Nocardia-activated macrophages have assumed a stellate 
conformation and pseudopodia are prominent, as are perinuclear 
phase dense granules. Control cells (not shown) were similar in 
appearance to those shown in Fig 47. 
Macrophages from mice inoculated 7 days previously with 
N.asteroides show more rapid spreading than controls after 2 
hours of incubation. 
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5.3.4 SEVEN DAY N.BRASILIENSIS INFECTION 
In the phase-contrast mi crographs shown in Figs 4 7, 48 ( 3 day 
cultures) N.brasiliensis-activated macrophages are larger than 
control cells, they have assumed a rounded morphology with a 
more extensive cytoplasm and vast numbers of lysozomes in the 
perinuclear cytoplasm. Some of the N.brasiliensis-activated 
cells have assumed a stellate conformation with long pseudopodia. 
Other cultures of N.brasiliensis-activated macrophage were 
predominently stellate or dendritic in shape with very extensive 
pseudopodia, numerous perinuclear lysozomes and were larger than 
controls. Increased rate of spreading of N.brasilinsis-activated 
cells compared to control cells was noted after 2 hours in 
culture. 
5.3.5 THIRTEEN DAY N.ASTEROIDES INFECTION 
The morphology of thirteen day N.asteroides-activated macrophages 
was dis tine tl y different from control macrophages, irrespective 
of culture conditions. Control macrophages in culture for 
indirect PA assay (serum-free medium) were very elongated or 
stellate in shape whereas the Nocardia-activated macrophages were 
more symmetrically spread, appeared larger than controls and 
contained numerous perinuclear lysozomes and pinocytic vesicles. 
These cells were either rounded with extensive cytoplasm or were 
stellate with numerous long pseudopodia. In Figs 49, 50 (40 hour 
incubation), 
shown. In 
macrophages in culture for direct PA assay are 
this culture, control cells contain numerous 
pinocytic vesicles whereas N.asteroides-activated macrophages 
449 
contain very few. 
pseudopodia and are 
The latter 
stellate in 
cells 
shape 
have numerous long 
or are rounded with 
extensive cytoplasm and prominent perinuclear lysozomes. In 
addition, these cells exhibited more rapid spreading after 2.5 
hours in culture than control cells. 
5.3.6 THIRTEEN DAY N.BRASILIENSIS INFECTION 
Thirteen day N.brasiliensis-activated macrophages were distinctly 
different from control cells, as was found in the cell cultures 
described above. General characteristics of N.brasiliensis-
activated macrophages are increased numbers of perinuclear 
lysozomes, increased pinocytic activity (increased numbers of 
phase-dense vesicles), cells appear to be larger and to have 
assumed a more extreme stellate conformation than controls. 
These cells also tended to have many long thin pseudopodia. As 
in the cultures described above, N.brasiliensis-activated 
macrophages were present as large rounded cells with extensive 
cytoplasm and numerous perinuclear lysozomes. 
In Figs 51, 52 the cells have been cultured for 2.5 hours. 
N.brasiliensis cells appear to spread more rapidly and 
extensively than control cells, to assume more stellate or 
dendritic conformations, to have increased lysozomal activity and 
to have increased ruffled membrane activity, compared to control 
cells. 
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5.3.7 TWENTY-ONE DAY N.ASTEROIDES INFECTION 
Characteristics of cultured macrophages from mice inoculated 
twenty-one days previously with N .as teroides and compared with 
controls were increased number of phase-dense granules 
(lysozomes) in the perinuclear area, increased pinocytic 
activity and cells were generally rounded and symmetrically 
spread with extensive cytoplasm or were stellate with numerous 
irregular pseudopodia. 
for 24 hours. It is 
Macrophages in Figs 53, 54 were cultured 
difficult to determine from these 
photomicrographs whether increased spreading has occured in the 
Nocardia-activated cultures, however, symmetrically spread cells 
with extensive cytoplasm are a feature of the N.asteroides 
-activated cell culture. More rapid spreading of Nocardia 
-activated macrophages than control cells was noted after 2.5 
hours in culture: 
5.3.8 TWENTY-ONE DAY N.BRASILIENSIS INFECTION 
Morphology of twenty-one day N.brasiliensis-activated macrophages 
is similar to the morphology of macrophages harvested from mice 
at the various times post-inoculation described above, therefore 
photomicro-graphs are not shown. Characteristics are increased 
numbers of phase dense granules and tendency of cells to become 
markedly stellate with long pseudopodia or rounded with 
extensive cy top la sm, compared to the controls. In creased 
spreading was noted in N.brasiliensis-activated macrophage 
cultures compared to control cells after 2.5 hours in culture. 
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5.3.9 PROTEIN CONTENT AS AN EXPRESSION OF CELL SIZE 
Activated macrophages exhibit increased size, which is reflected 
in their increased protein content (Cohn, 1978). However, the 
protein content per 106 cells from BCG-vaccinated mice dropped in 
comparison to control cells (Kondo and Kanai, 1977) and 
macrophages from BCG-trea ted mice had a lower protein content 
than those injected with thioglycola te medium (Nathan and Root, 
1977). To evalula te whether the apparent increase in size of 
macrophages harvested from mice previously inoculated with 
Nocardia was associated with an increase in protein content, 
macrophages were harvested from mice 2 days pos t-inoc ula tion, 
glass adhered and washed after 2 hours in culture, incubated for 
a further 10 hours and protein content determined spectrofluori-
metrically as described previously (2.3). A typical experiment is 
shown in Table 117, and it appears from these data that protein 
content is similar in control, N.asteroides-activated and 
N.brasiliensis-activated macrophages. 
5.4 DISCUSSION 
Macrophages harvested from mice recently infected with 
N. as teroi des and N. brasi liensis are ac ti va ted according to the 
parameter of morphological 
characteristic of activated 
change. Differences in morphology 
macrophages were observed in both 
N.asteroides and N.brasiliensis-activated macrophages over the 
two to twenty-one day period post-inoculation under study. 
Differences in macrophage appearance between control and Nocardia 
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macrophage cultures were found in all experiments. The most 
characteristic changes were increased numbers of perinuclear 
lysozomes and changes in 
cultures of cells from 
the shape of the macrophages in the 
animals infected with Nocardia. In 
general Nocardia- activated macrophages appear to be larger than 
controls, although sometimes this difference was marginal. 
Difficulties in determining whether Nocardia-activated 
macrophages are larger than control cells was generally 
experienced only in older cultures. Unstimulated cells have been 
described as remaining rounded for several hours but after 24 
hours in culture are well spread with active membrane ruffling. 
Thioglycolate or endotoxin stimulated cells spread rapidly within 
30 minutes, and remained wel 1 spread during further cultivation 
but resembled unstimulated cells more closely after 2 days 
(Polliack and Gordon, 1975). 
Macrophages from mice recently infected with intracellular 
parasites such as mycobacteria exhibit an increase in size and 
spreading (Johnston et al, 1982), and enhanced spreading of 
macrophages on glass has been defined as a property of activated 
macrophages (Johnston, Chadwick and Cohn, 1981). Macrophages from 
mice previously inoculated with Nocardia spread more rapidly and 
more extensively and certainly appeared larger than control cells 
early in culture (Figs 43, 44, 45, 51, 52). Morphology of 
macrophages from Noca rdia-inocula ted mice does not appear to be 
related to period of infection or to be different in N.asteroides 
and N.brasiliensis infections. 
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This study was performed on living cells in tissue culture. The 
failure to note distinct mitochondria and consistently enhanced 
pinocytic activity may perhaps be accounted for by the 
difficulties encountered in photography of cells in tissue 
culture. It would therefore be useful to perform a study of 
Wright-Giemsa stained macrophages after varying periods in 
culture. 
Morland and Kaplan ( 1977) point out that al though morphological 
data have been widely used as criteria for macrophage activation, 
their study showed that such criteria are ambiguous and difficult 
to evaluate. They consider that not only spreading and granular 
content should be taken into account, but also the extent of 
ruffling and details of cell surface morphology should be 
considered. These aspects are detailed in part 2 of this 
chapter. However, 
a useful method of 
and many of the 
these conditions. 
phase contrast morphology of living cells is 
examining eel ls free of fixation ar ti facts, 
larger organelles may readily be seen under 
From this study it is apparent that the 
morphological appearance of macrophages from mice recently 
infected with Nocardia differs from that of unstimulated cells 
and that several morphological criteria of macrophage activation 
are fulfilled by these cells. 
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PART II : A SCANNING ELECTRON MICROSCOPY STUDY OF THE SURFACE 
CHARACTERISTICS OF MACROPHAGES FROM MICE PREVIOUSLY INOCULATED 
WITH N.ASTEROIDES AND N.BRASILIENSIS. 
5.6 INTRODUCTION 
The development of the scanning electron 
radically altered the visualization of cell 
microscope ( SEM) has 
surface morphology 
and has provided a new ultrastructural parameter which greatly 
adds to the information accumulated by more conventional 
approaches (Walters, Papadimi triou and Robertson, 1976) such as 
light microscopy and transmission electron microscopy. The 
great depth of field of the SEM allows visualisation of the 
overall three- dimensional surface morphology of individual 
cells, and of the fine structures present on the cell surface 
(Papadimitriou, Finlay-Jones and Walters, 1973). 
also reveals de ta i 1 s of the spatial relationships 
culture and of cell-to-cell interactions. 
The technique 
of cells in 
5.6.l NOMENCLATURE OF SURFACE MORPHOLOGICAL FEATURES 
Many terms are used to describe the surface projections of 
macrophages. Newell ( 1980 231) has sta tea that definition of 
surface features of leukocytes is extremely difficult since 
surface projections are transient in nature and their shape and 
size are greatly affected by changes in their environment and by 
preparation procedures. 
There appears to be a variety of descriptions of the features of 
the macrophage cell surface in the literature (Finch et al, 1982; 
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Carr 1980 : 260; Newell, 1980 : 231; Oliver and Berlin, 1982; 
Saint-Guillain et al, 1981; Papadimitriou, Finlay-Jones and 
Walters, 1973). It was felt that it would be helpful to define 
the terms used to describe surface features in this study at 
this point. Criteria for the identification of surface features 
are given in Table 118. Varying combinations of these surface 
features distinguish the surface ultrastructure of the macrophage 
(Carr, 1980 : 260). 
5.6.2 SURFACE STRUCTURE OF NORMAL MOUSE PERITONEAL 
MACROPHAGES 
The first SEM description of macrophage surfaces by Carr, Clarke 
and Salisbury ( 1969) gave a new perspective of the function and 
morphology of macrophages and lead to a number of studies of 
macrophage surfaces, workers concentrating on improved specimen 
preparations and hence preservation of membrane processes 
( Warfel and El berg, 
Gordon, 1975). 
1970; Albrecht et al, 1972; Polliack and 
Numerous cell shapes, ranging from compact and spherical to 
completely spread, elongated (polarized), irregularly shaped or 
stellate have been observed in macrophages (Finch et al 1982; 
Warfel and El berg, 1970; Johnson and Davies, 1981). Typical 
morphology of spherical and spreading macrophages adherent on 
glass coversl ips is described by Poll iack and Gordon ( 197 5), 
Albrecht, Jordan and Hong, (1978) and Johnson and Davies (1981). 
Spreading cells typically exhibit pseudopodia and together with 
spherical cells have ruffles and ridges which traverse the 
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surf ace in irregular pat terns, microv i 11 i and lamell ipodia and 
sometimes blebs. Spreading cells attach to the glass by an 
extension of the membrane which appears as transparent veils of 
cytoplasm which spread centrifugally over the substrate and are 
smooth compared to the main cell body. 
flatter and smoother as spreading 
The cell thus becomes 
progresses, ruffling or 
rolling of the veil edges or generation of long thin thread-like 
processes (filopodia) follows (Warfel and Elberg, 1970; Newell, 
1980 : 264, 265; Walters, Papadimitriou and Robertson, 1976). An 
increased flattening with time in culture was observed with great 
variation in shape and degree of spreading (Polliack and Gordon, 
1975). 
having a 
Macrophages settled on glass have been described as 
"fried egg" appearance (Carr, 1980 : 261) - the smooth 
flat surface of the peripheral cytoplasmic veils becomes raised 
over the main body of the cell - the nucleus is centrally 
orientated - and this area has an extensive series of membranes 
of various shapes and sizes on its surface (Polliack and Gordon, 
1975; Warfel and Elberg, 1970; Newell 1980 265). Elongated 
and stellate cell surfaces were also associated with microvilli 
frequently than 
1981). The range 
or ridges but these features occurred far less 
with the spherical forms (Johnson and Davies, 
of different cell shapes seen in macrophage cultures suggests 
that retraction and spreading of cells occurs 
(Newell, 1980 : 265). 
continuously 
The surface morphology of adherent cells does not reflect their 
morphology in situ (Newell, 1980 264); and the macrophage 
surface structure is influenced by the characteristics of the 
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substrate to which it is attatched (Daems 1980 : 62). 
5.6.3 EFFECTS OF VARIOUS AGENTS ON MACROPHAGE MORPHOLOGY 
SEM STUDIES 
In their original study, Carr, Clarke and Salsbury (1969} found 
that cells stimulated with glycerol trioleate (i.p. injection) 
were more irregular in shape, had rougher surfaces and showed 
more prominent ridge-like and flange-like processes than 
controls. A number of studies followed this and the effect of a 
wide variety of agents on macrophage surface morphology has been 
documented. i. p. Injection of minera 1 oi 1 gave rise to cells 
that were markedly polar with many ridges and villi and some 
ruffling at the ends of long pseudopods (Morland and Kaplan, 
1977); paraffin-induced macrophages were larger and flatter than 
controls with a closely packed pattern of ridges or flaps and 
more numerous spherules (Papadimitriou, Finlay-Jones and 
Walters, 1973). Thioglycolate and endotoxin-elicited 
macrophages showed greatly enhanced membrane activity -
extensive spreading, ie flatter cells, larger surface area with 
prominent ruffles, ridge-like profiles and more frequent 
filopodia, also multiple perforations and cytoplasmic pits 
compared to control cells (Polliack and Gordon, 1975). Morland 
and Kaplan ( 1977) found similar results with endotoxin. Daems 
(1980 96) makes the comment that the exudate macrophage 
population is much more pleomorphic than that in the unstimulated 
peritoneal cavity, since differentiation of monocytes into 
macrophages occurs during the development of the inflammatory 
process. 
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Guttner et al (1975) attempted to correlate macrophage functional 
status with morphology by using chemotherapeutic agents which 
reduce phagocytosis. These agents made cell surface projections 
thicker, shorter and fewer in number, whereas antimetaboli tes 
which did not reduce phagocytosis did not produce any cell 
surface changes. Rat peritoneal macrophages rounded up in the 
presence of zinc - treated cells were mostly spherical with only 
a few showing radical protrusions and extensive pseudopodia were 
rare ( Chvapil et al, 1977). Guinea pig macrophages exposed in 
vitro to a benzoguinone ( shown to provide complete nons pee if ic 
immunity against lethal pathogens in mice) were larger with more 
extensive ruffles and lamellipodia formation was more extensive 
I 
and occurred more frequently - this data confirmed others 
findings that activated phagocytes are associated with extensive 
p 1 a s m a m e m b r a n e r u f f 1 i n g , f i l o p o a. i a a n a 1 a m e 1 1 i p o a i a 
(Biemesderfer et al, 1978; Polliack and Gordon, 1975). 
5.6.3.1 MODIFICATION OF MACROPHAGE SURFACE STRUCTURES IN IN 
VIVO AND IN VITRO INFECTION SEM AS A PARAMETER IN 
THIS STUDY 
Morphological changes are known to accompany the transformation 
of a macrophage from a resting to an activated state, such as 
occurs in chronic intracellular infection (Morland and Kaplan, 
1977). Other observers have found changes in plasma membrane 
surface architecture in resting and activated macrophages using 
SEM. Peritoneal macrophages from mice previously immunized with 
'I'rypanosoma Cruzi had the appearance of stimulated or activated 
macrophages with extensive spreading and numerous fine filopodia, 
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which were often branched (Reed, Douglas and Speer, 1982; 
Polliack and Gordon, 1975: Morland and Kaplan, 1977). 
Virulent and less virulent strains of N.asteroides were added to 
cul tu res of rabbit a 1 veolar macrophages and their in te rac tion 
studied by SEM. Macrophage response appeared to depend on the 
strain of the Nocardia infecting them. The virulent strain 
induced a high degree of macrophage aggregation leading to the 
formation of giant ce 11 s and destruction of the intracellular 
Nocardia, whereas few giant cells were noted in cultures infected 
with the less virulent strain. In the presence of Nocardia, 
macrophages became rounded and the organisms were phagocytosed. 
Macrophages that had phagocytosed Nocardia no longer spread on 
the glass surface, but remained rounded. Macrophages containing 
large numbers of organisms became smooth surfaced spheres with 
the Nocardia filaments projecting through the cell cytoplasm 
(Beaman, 1977). 
Exposure of macrophages to mycoplasmas 
of antimycoplasma antibody gave rise 
in vitro in the presence 
to cells with a diffusely 
granular appearance. Increased occurrence of ruffled membranes, 
large and small lacunae and folding over of the mycoplasmas was 
noted (Jones, Minick and Young, 1977). 
This SEM study was done as an extension of the phase contrast 
microscopy studies described in part 1, since it is important to 
consider the fine details of surface morphology of cells when 
evaluating morphology as a parameter of macrophage activation 
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(Morland and Kaplan, 
cell iden ti f ica tion, 
the macrophage can 
1977). In addition, SEM can be 
since there are certain features 
be recognized (Polliack et al, 
used for 
by which 
1974). 
However, some functional marker is required for confirmation 
(Carr, 1980 : 260). The combination of cell morphology with 
lysozyme release 
identification. 
would therefore provide conclusive 
5.7 METHODS 
Specimen preparative techniques are extremely important in the 
preservation of delicate eel l surface structures, and there are 
several reviews of the procedures for cell preparation (Boyde, 
1980; Bell and Revel, 1980). 
The method used was a modification of the method of Polliack and 
Gordon (1975). 
(Section 2.8). 
Macrophages were cultured as described previously 
After 40 hours in culture, glass coverslips 
layered with peritoneal cells were examined by phase contrast 
microscopy and were washed twice with HBSS at 37°c and then 
fixed for 5 minutes with 2% glutaraldehyde (8% aqueous solution, 
TAAB 
were 
Laboratories 
then rinsed 
Equipment, 
twice in 
Reading, 
HBSS at 
Berks 
37°c. 
UK) • Coverslips 
Physiological 
temperature was used in order to minimise dis tor ti on. Fresh 
fixative was 
minutes at 
then 
37°c. 
layered over the 
Samples were 
coverslips for a 
then placed at 
further 10 
4°c in 2% 
glutaraldehyde for at least 24 hours. Coverslips were then 
rinsed twice in sodium cacodylate buffer (0.lM, pH 7.2 with 
sodium hydroxide 0.2M) to remove any unreacted fixative and then 
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post-fixed in 2% Osmium tetroxide for l hour (o5 o4 , Merck) ins-
collidine (Polysciences Inc, Warrington, Penna 18976; pH 7. 2, 
prepared according to manufacturer's instructions). Cells are 
washed prior to fixation to remove serum proteins and cell-
secreted substances which would otherwise be fixed on to cell 
surfaces ( Bell and Revel, 1980 : 4). 2% Glutaraldehyde appears 
to give acceptable results with most cells and is the usual 
concentration used (Bell and Revel, 1980 5). Post-fixation 
with o5 o4 is not an absolute requirement for SEM but it aids in 
prevention of the elution of membrane lipids during dehydration, 
which appear as small cell surface pi ts (Newell, 1980 : 225). 
The ma in consideration in SEM is to stabilise the cell surface 
characteristics sufficiently so that they are not altered by the 
harshness of subsequent processing (Bell and Revel; 198 0 7). 
o5 o4 fixation is recommended prior to critical point drying (CPD) 
in order to preserve fine details of membrane s true ture (Boyde, 
Bailey and Vesely, 1974). 
Coverslips were washed three times with distilled water and 
dehydrated in a graded series of alcohol (5%, 10%, 20%, 40%, 60%, 
70%, 80%, 90%, 100%) for 5 minutes each, with great care to avoid 
premature drying while 
solution to another 
alterations in surface 
transferring attatched cells from one 
surface tension changes can induce 
morphology ( Biemesderfer et al, 1978). 
Specimen shrinkage occurs during ethanol dehydration, the most 
rapid shrinkage occuring in 80% ethanol (Boyde, 1980). After 
dehydration, specimens were transferred to fresh absolute 
alcohol. The specimen was then transferred into the precooled 
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high pressure chamber of a Polaron Critic a 1 Point Dryer (CPD) 
apparatus and critical point drying was done using liquid co2 as 
the transition fluid. The CPD permits drying of a sample 
without exposure to surface tension and the distorting effects 
that accompany it (Bell and Revel, 1980 : 16). 
Samples were then cut to fit Cambridge Series 100 stubs and 
mounted using conductive silver paint on the stub and coverslip 
edge. Stubs were mounted and sputter-coated under partial vacuum 
with Argon bleed. Samples were sputter coated with gold-
palladium to a thickness of 25 nm in a modified Hummer 4. The 
sputter coater was used in pulsed mode to reduce heating 
effects. 
Samples were then viewed in a Cambridge Stereoscan Sl80 scanning 
electron microscope at an accelerating voltage of 15 - 20 KV at 
a tilt angle of 35°. Micrographs were recorded on Ilford FP4 
film at instrument magnifications 
of macrophages was estimated by 
et al, 1982) and median diameter 
limits calculated. 
5.8 RESULTS 
from x 300 - x 11 000. Size 
measuring cell diameters (Finch 
values and their 95% confidence 
As in the study of cell morphology using phase contrast 
microscopy, control and Nocardia-acti va ted macrophage cul tu res 
were always run in parallel. Low power scanning electron 
micrographs (about x 300) invariably revealed different 
morphological characteristics for control and Nocardia-activated 
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cells when micrographs were compared. Representative 
micrographs were shown in Figs 55-57 inclusive. In each group, 
eel 1 shape ranges from compact and spher i ca 1 to markedly 
flattened, with intermediate shapes including elongated, 
triangular, stellate or irregularly shaped. 
of control macrophages are still spherical 
A higher proportion 
after 48 hours in 
culture than in either of the other two groups, whereas 
N.asteroides and N.brasiliensis-activated macrophages 
become elongated or very irregular in shape. Well-spread 
have 
cells 
in both the Nocardia-activated macrophage cultures appear to be 
more markedly flattened than those in control cultures - in the 
latter the dome-shaped central nuclear region is very prominent. 
5.8.l SEM OF CONTROL MACROPHAGES 
Shape and surface morphology of control macrophages was, in 
general, similar to that described in the literature and 
summarized in section 5.6.2. Representative examples of control 
macrophage shape and surface characteristics are shown in the 
micrographs Figs 58-63 inclusive. 
Inspection of Figs 58, 59 reveals that control macrophages have 
spread to a certain extent, have assumed spherical or irregular 
shapes, have a ruffled surface and numerous peripheral radiating 
filopodia. Breaking off of filopodia is an artefact due to cell 
shrinkage on dehydration. Membrane structure varies from 
ruffled and ridged, eg Fig 62, to highly microvillous (Fig 61), 
to smooth with raised ruffled nuclear area (Fig 63). This 
micrograph shows an elongated macrophage with long pseudopodia 
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flanked by two well-spread cells. Extensive filopodia are a 
commonly noted characteristic of control macrophages. The 
micrograph (Fig 60) shows a spherical cell which has started to 
spread on the glass substrate by extending a veil of cytoplasm 
beneath the dome-shaped nuclear area. The cell has extensive 
filopodia and microvilli. 
Macrophage size was estimated by measuring the diameter of 
spherical cells or the length of the long axes of triangular or 
elongated cells. Median values and their 95% confidence limits 
were determined and these data and are shown in Table 119. 
5.8.2 SEM OF N.ASTEROIDES-ACTIVATED MACROPHAGES 
Although, as stated previously,' there was a clear distinction 
between morphology of N.asteroides-activated and control 
macrophages using low and high power SE.M, no clear distinction 
was apparent between cells harvested 2, 7, 13 or 21 days post-
inoculation, ie time post-inoculation did not appear to influence 
surface morphology. N. as teroides-acti va ted macrophages exhibited 
characteristic surface ruffles and ridges, eg the spherical cell 
in Fig 64; and this was the most commonly noted surface 
structure for spherical cells, al though some spreading spheres 
were covered with microvilli and occasionally blebs (Fig 65). 
This cell also has extensive radiating peripheral filopodia. 
Comparison of spherical cells in control and N.asteroides 
-activated macrophages revealed that consistent characteristics 
of activated cells were more prominent and larger undulating 
membrane ruffles, deeper folds, prominent flaplike-protrusions 
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(Figs 75, 80, 81) and in general a greater variety of membrane 
processes over the surface were noted. 
N.asteroides-activated macrophages assumed a wide range of 
shapes. Extensive spreading was a feature of these cultures with 
cells becoming highly polarized or elongated with long 
pseudopodia terminating in broad ruffled cytoplasmic veils ( Fig 
66) or in numerous radiating slender filopodia ( Fig 67). Cells 
assumed stella te or triangular forms with pseudopodia or broad 
veil-like larnellipodia and long filopodia ( Figs 67, 68). As in 
control cul tu res, spread macrophages had fewer surface ruffles 
than the spherical cells, however, N.asteroides-activa ted well-
spread cells appeared to be smoother than controls which were 
similar, but less extreme conformations. Flattened well-spread 
macrophages (part shown in Fig 67) had smooth peripheral veils 
of cytoplasm, subplasmalemmal sphericles and ruffled perinuclear 
area. N.asteroides-activated macrophages were generally 
associated with filopodia, eg the spreading cell in Fig 71. 
Macrophage size was estimated in exactly the same way as for 
control cells and median values and their 95% confidence limits 
calculated, and shown in Table 119. N.asteroides-activated cells 
were thus similar in size to controls when spherical but spread 
cells appeared to be larger than controls, from the median values 
(Table 119). This difference was, however, not statistically 
significant (Mann Whitney U Test). 
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5.8.3 SEM OF N.BRASILIENSIS-ACTIVATED MACROPHAGES 
Examination of SEM micrographs of macrophages harvested from mice 
2, 7, 13 and 21 days post-inoculation with N.brasiliensis did not 
reveal any dis tine ti ve differences in surface morphology which 
could be related to duration of infection. The most marked 
effect of prior inoculation with N.brasiliensis on macrophage 
morphology was the extremes of shape of cells. The contrast in 
shape is easily seen by comparing the low power micrographs of 
control and N.brasiliensis-activated cells (Fig 58, 72). 
Cell shape varied from spherical (Fig 73) to markedly flattened 
(Figs 77, 78, 75) to stellate or highly irregular in shape (Figs 
88, 89, 86). Characteristic complex surface ruffles and ridges 
and in some cases microvilli were present on cells, with surface 
ruffling being far more prominent in compact spherical cells 
than in well-spread cells (Johnson and Davies, 1981). 
Surface projection of spherical N.brasiliensis-activated 
macrophages were larger and more prominent and present in a 
greater variety than those of control cells. Characteristic 
protrusions were undulating extensive thick ruffles and ridges 
with deeper folds between them than controls: some cells had 
large flanges of membrane perpendicular to the cell surf ace and 
others showed larger indented bulbous projections (Fig 70, 
compared to Fig 73). 
In spread cells surface ruffling was associa tea with the raised 
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central nuclear area. Subplasmalemmal sphericles were evident 
in markedly flattened macrophages (Fig 76) as well as craters in 
the smooth peripheral cytoplasm of some flattened cells. 
N.brasiliensis-activated macrophages showed greatly enhanced 
membrane activity evidenced by extensive flattening of cells with 
ruffled veil edges (Figs 74, 57) and frequent filopodia. 
Extensive lamellipodia and pseudopodia were cha rac te r is tic, 
these features terminating in ruffled veil edges or numerous 
radiating filopodia (Figs 78, 75, 77). Highly polarized long 
thin cells were 
ruffled central 
commonly seen, with the characteristic raised 
area and pseudopodia terminating in veils of 
cytoplasm or 
irregularly 
radiating filopodia. Comparison of micrographs of 
spread control and N.brasiliensis-activated 
macrophages revealed that in genera 1 fewer surface projections 
were associated with activated cells than control cells. 
Macrophage size was estimated and median values and their 95% 
confidence limits calculated, and shown in Table 119. The median 
diameter of spherical cells was similar to that of controls and 
N.asteroides-activated macrophages. N.brasiliensis-activated 
cells when spread were similar in size to N.asteroides-activated 
macrophages but appeared to be larger than control cells, from 
the median values. This difference was however, not statistically 
significant (Mann Whitney U Test), except for control cells 
compared to N.brasiliensis-activated cells in the elongated from 
(significant at the 0.03 level). 
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5.8.4 GENERAL COMMENTS ON SEM CHARACTERISTICS 
The most marked morphological difference between control and 
Noca rdia-ac ti va ted macrophage 
was the variety and extremes 
cul tu res when examined using SEM 
of shape assumed by the Nocardia-
activated macrophages. Although both control and Nocardia-
activated macrophages spread extensively, Nocardia-activated 
macrophages appeared to be more flattened than controls. 
Nocardia-activated macrophages appeared to spread more 
extensively than did control cells, gauged from cell size, 
however this difference was not significant, except for control 
and N.brasiliensis-activated cells in the elongated form. These 
results concur with those of the phase-contrast microscopy study. 
A further characteristic, which was more difficult to asse~s, was 
that fewer f ilopodia appeared to be associated with Nocardia-
acti va ted macrophages than with control cells. It is obvious from 
the micrographs presented that Nocardia-acti va ted macrophages 
were often associated with extensive filopodia formation but 
assessment of over 200 micrographs revealed that irregularly 
shaped cells ( eg Fig 78), markedly elongated and triangular or 
stellate cells had fewer filopodia than controls in similar but 
less extreme conformations. The long pseudopodia of highly 
polarized Nocardia-acti va tea macrophages appeared to terminate 
more frequently in broad undulating ruffled cytoplasmic veils 
(eg Fig 66) than in filopodia (eg the control macrophages shown 
in Fig 79). 
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There did not appear to be any difference in the morphology of 
N.asteroides and N.brasiliensis-activated macrophages. In both 
groups extremes of shape were evident and no characteristic 
surface features could be associated with either group. In 
addition, duration of infection did not appear to influence cell 
surface morphology. 
5.9 DISCUSSION 
Control, unstimulated macrophages show morphologic evidence of a 
high degree of activity with numerous ruffles, ridges and 
microvilli traversing the cell surface in a random fashion; and 
the presence of long cytoplasmic extensions. This finding in in 
agreement with that of Polliack and Gordon (1975). Numerous fine 
radiating f i lo pod ia associated with control eel ls were present. 
The presence of numerous filopodia has been associated with 
stimulated or activated macrophages (Polliack and Gordon, 1975; 
Reed, Douglas and Speer, 1982). Macrophage stimulation occurs as 
a result of the presence of serum in the culture medium and cell 
surface s true tures are consequently modified ( Albrecht, Jordan 
and Hong, 1978; Cohn and Benson, 1965b). Morland and Kaplan 
(1977) also found that formation of filopodia occured when cells 
were cultured in serum- containing medium. 
Macrophage surface structure has been shown to be dependent on 
the degree of macrophage stimulation (Daems, 1980: 83; Albrecht, 
Jordan and Hong, 1978). Stimulated cells are described as being 
larger and flatter than unstimulated cells with greater 
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variation in cell shape and surface projections, as well as 
being associated with pseudopodia, broad lamellipodia with 
rolled edges and filopodia ( Polliack and Gordon, 1975; Carr, 
1980 : 266). 
Nocardia-activated macrophages differed from controls in several 
respects when their morphology was compared using SEM. Activated 
macrophages appeared to be larger than control cells when 
spread, they showed greatly increased membrane activity 
manifested by more extensive spreading, the presence of larger 
and more varied ruffles and membranous micro-projections 
(spherical cells) and the more frequent appearance of 
lamellipodia with prominent rolled edges and pseudopodia. In the 
literature, stimulated macrophages are associated with more 
extensive and more prominent ruffles and other membranous 
processes giving the stimulated cell a rougher appearance (Carr 
et al, 1969; Albrecht et al, 1972; Polliack and Gordon, 1975). 
Lamellipodia formation was more extensive and occurred more 
frequently in stimulated or ac ti va ted phagocytes ( Poll iack and 
Gordon, 1975; Biemesderfer, 1978). 
Nocardia-activated macrophages were very much more pleomorphic in 
nature than control cells, adopting extremes of shapes. Greater 
variation in shape is a characteristic of stimulated macrophages 
(Poll iack and Gordon, 197 5; Carr, Clarke and Salsbury, 1969; 
Carr, 1980 : 266). 
A variety of shapes were adopted by macrophages in both control 
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and Nocardia-ac ti va ted macrophage cul tu res but the incidence of 
the different shapes differed markedly in the different cultures, 
with Nocardia-activated macrophages characterized by markedly 
flattened, stellate or elongated macrophages whereas control 
cultures showed large numbers of spherical cells and spread cells 
were not as flattened as Nocardia-activated macrophages. 
Stimulated cells are described as being larger and flatter than 
unstimulated cells (Papadimitriou, Finlay-Jones and Walters, 
1973) and it has been suggested that flattening of rounded cells 
is a result of cell activation (Adler et al, 1979). Sphericles 
(lysozomes) were noted in the smooth cytoplasmic extensions of 
flattened Noca rdia- activated macrophages and increased numbers 
of lysozomes are associated with activated cells ( section 
5.1.1). 
Irregularly-shaped, well-spread Nocardia-activated macrophages 
had numerous peripheral processes but lacked extensively ruffled 
membranes. This same appearance was described for Brucella-
acti va ted macrophages ( Albrecht et al, 1978a). This phenomenon 
may perhaps be explained by the concept that well-spread 
macrophages use the extensive membrane folds of spherical cells 
to supply extra membrane required in spreading (Newell, 1980 : 
256). Since Nocardia- activated cells spread more extensively 
than control cells it follows that they would have fewer surface 
ruffles than control macrophages. 
Beaman (1977) found that macrophage response to Nocardia depended 
on the strain of Nocardia being studied. In this study 
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morphological characteristics could not be strictly associated 
with either N.asteroides or N.brasiliensis. Seaman's 
experimental system differs from that used here in that 
macrophages were exposed to virulent and less virulent Nocardia 
asteroides in vitro and this could explain the lack of 
correlation of the data. 
In conclusion, morphology of control and Nocardia-activated 
macrophages when compared using SEM is different. Nocardia-
activated macrophages display many of the characteristics of 
activated macrophages as detailed in the literature and on the 
basis of the morphology studies using phase contrast and SEM, may 
be considered to be activated. 
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FIG. 43. Phase-contrast pho~omicrograph of living macrophages 
from mice inoculated 2 days previously with 
N.asteroides. Cells were incubated for 13.5 hours (magnification x 320). 
Cultures shown in figs 43-45 inclusive were incubated 
under the same conditions and run concurrently. 
FIG. 44. Phase-contrast photomicrograph of living macrophages 
from mice inoculated 2 days previously with saline 
only. Cells were incubated for 13.5 hours (magnification x 320). 
, 4 7 4 
FIG. 45. Phase-contrast photomicrograph of living macrophages from mice inoculated 2 days previously with N.brasiliensis. Cells were incubated for 13.5 hours 
· (magnification x 32 0 ). 
FIG. 46. Phase-contrast photomicrograph of living macrophages from mice inoculated 7 
N.asteroides. Cells were (magnification x 200). 
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days previously 
incubated for 46 
with 
hours 
FIG. 47. Phase-contrast photomicrograph of living macrophages 
from mice inoculated 7 days previously with saline 
only. Cells were incubated for 72 hours (magnification 
X 200). 
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Cultures shown in figs 47 and 48 were incubated under 
the same conditions and run concurrently. 
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FIG. 48. Phase-contrast photomicrograph of living macrophages 
from mice inoculated 7 days previously with 
N.brasiliensis. Cells were incubated for 72 hours 
(magnification x 200). 
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FIG. 49. Phase-contrast photomicrograph 
from mice inoculated 13 days 
only. Cells were incubated for 
X 200). 
of living macrophages 
previously with saline 
42 hours (magnification 
Cultures shown in figs 49 and 50 were incubated under 
the same conditions and run concurrently. 
FIG. 50. Phase-contrast photomicrograph of living macrophages 
from mice inoculated 13 days previously with 
N.asteroides. Cells were incubated for 42 hours 
(magnification x 200). 
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FIG. 51. 
FIG. 52. 
Phase-contrast photomicrograph of living from mice inoculated 13 days previously 
only. Cells were incubated for (magnification x 200). 
macrophages 
with saline 
2.5 hours 
Cultures shown in figs 51 and 52 were incubated under the same conditions and run concurrently. 
Phase-contrast photomicrograph of living macrophages from mice inoculated 13 days previously with N. brasil iensis. Cells were incubated for 2. 5 hours (magnification x 200). 
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FIG. 53. 
FIG. 54. 
Phase-contrast photomicrograph 
from mice inoculated 21 days 
only. Cells were incubated for 
X 200 ). 
of living macrophages 
previously with saline 
24 hours (magnification 
Cultures shown in figs 53 and 54 were incubated under 
the same conditions and run concurrently. 
Phase-contrast photomicrograph of living macrophages from mice inoculated 21 days previously with N.asteroides. Cells were incubated for 24 hours (magnification x 200). 
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ALL CULTURES WERE INCUBATED FOR 40 HOURS 
FIG. 55 
Scanning electron micro-
graph of macrophages from 
mice inoculated 21 days 
previously with saline 
only (magnification x 
310). 
FIG. 57 
Scanning electron micro-
graph of macrophages from 
mice inoculated 7 days 
p r e v i o u s l y w i t h 
N.brasiliensis (magnifi-
cation x 305). 
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FIG. 56 
Scanning electron micro-
graph of macrophages from 
mice inoculated 13 days 
previously with 
N.asteroides (magnifi-
cation x 350). 
FIG. 58 
Scanning electron micro-
graph of macrophages from 
mice inoculated 21 days 
previously with saline 
only (magnification x 
1150). 
FIG. 59 
Scanning electron micro-
graph of macrophages from 
mice inoculated 21 days 
previously with saline 
only (magnification x 
1540). 
FIG. 61 
Scanning electron micro-
graph of a highly micro-
villous triangular-shaped 
macrophage harvested from 
mice inoculated 13 days 
previously with saline 
only (magnification x 
3500). 
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FIG. 60 
Scanning electron micro-
graph of a spherical cell 
with extensive filopodia 
and microvilli. Mice 
were inoculated 21 days 
previously with saline 
only (magnification x 
7700). 
FIG. 62 
Scanning electron micro-
graph of a triangular-
shaped macrophage with 
ruffled and ridged 
membranes. Mice were 
inoculated 7 days 
previously with saline 
only (magnification x 
1710). 
FIG. 63 
Scanning electron micro-
graph of an elongated 
macrophage with long 
pseudopodia and raised 
ruffled nuclear area; be-
tween two flattened, 
well-spread cells. Mice 
were inoculated 13 days 
previously with saline 
only (magnification x 
3070). 
FIG. 65 
Scanning electron micro-
graph of a spreading 
spherical macrophage 
showing microvilli and 
blebs as well as radia t-
ing peripheral filopodia. 
Mice were inoculated 13 
days previously with 
N • a s t e r o i d e s 
(magnification x 5100). 
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FIG. 64 
Scanning electron micro-
graph of a spherical 
macrophage with surface 
ruffles and ridges. Mice 
were inoculated 7 days 
p r e v i o u s l y w i t h 
N • a s t e r o i d e s 
(magnification x 6600). 
FIG. 66 
Scanning electron micro-
graph of an elongated 
macrophage with long 
pseudopodia terminating 
i n b r o a d r u f f l e d 
cytoplasmic veils. Mice 
were inoculated 2 days 
p r e v i o u s l y w i t h 
N • a s t e r o i d e s 
(magnification x 2410). 
FIG. 67 
Scanning electron micro-
graph . of a triangular-
shaped macrophage with 
pseudopodia terminating 
in numerous radiating 
slender filopodia (13 day 
N.asteroides infection; 
magnification x 200 0 ). 
FIG. 69 
Scanning electron micro-
graph of a spherical 
macrophage showing 
prominent membrane 
ruffles and flap-like 
protrusions (7 day 
N.asteroides infection; 
magnification x 6800). 
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FIG. 68 
Scanning electron micro-
graph of a triangular-
shaped macrophage with 
fairly smooth membranes 
and broad lamellipodia (2 
day N.asteroides 
infection; magnification 
X 3140). 
FIG. 70 
Scanning electron 
micrograph of a spherical 
macrophage showing 
ruffled membranes. Mice 
were inoculated 2 days 
previously with saline 
only (magnification x 
7 500). 
FIG. 71 
Scanning electron micro-
graph of a spreading cell 
showing filopodia and 
membrane ruffles (7 day 
N.asteroides infection; 
magnification x 4100). 
FIG. 73 
Scanning electron micro-
graph of a spherical mac-
rophage showing prominent 
surface ruffles ( 2 day 
N.brasiliensis infection; 
magnification x 7500). 
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FIG. 72 
Scanning electron 
micrograph of macrophages 
harvested from mice incu-
bated 7 days previously 
with N.brasiliensis. 
Micrograph shows varia-
tion in shape of cells 
(magnification x 910). 
FIG. 74 
Scanning electron micro-
graph of a flattened 
macrophage showing raised 
ruffled nuclear pole and 
smooth cytoplasmic veils 
(enhanced membrane ac-
tivity shown by increased 
spreading and frequent 
filopodia). Mice were 
inoculated 7 days 
p r e v i o u s 1 y w i t h 
N • b r a s i 1 i e n s i s 
(magnification x 3500 ). 
FIG. 75 
Scanning electron 
micrograph of a well-
spread, irregularly 
shaped macrophage which 
is markedly flattened 
with smooth cytoplasmic 
veils, some ruffling over 
the nuclear pole, broad 
veils and numerous 
filopodia (21 day 
N.brasiliensis infection· 
magnification x 1960). ' 
FIG. 77 
Scanning electron micro-
graph of a triangular-
shaped macrophage showing 
extensive pseudopodia and 
filopodia (2 day 
N.brasiliensis infection; 
magnification x 4100). 
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FIG. 76 
Scanning electron 
micrograph of a markedly 
flattened macrophage 
showing smooth cytoplas-
mic veils with subplas-
malemmal sphericals and 
ruffled area over the 
nuclear pole ( 7 day 
N.brasiliensis infection; 
magnification x 2820). 
FIG. 78 
Scanning electron 
m i c r o g r a p h o f a n 
elongated, irregularly 
shaped macrophage with 
extensive lamellipodia 
and pseudopodia ( 7 day 
N.brasiliensis infection; 
magnification x 7500). 
FIG. 79 
Scanning electron 
micrograph of 3 control 
macrophages showing 
ruffled membranes and 
extensive filopodia. Mice 
were inoculated 2 days 
previously with saline 
only (magnification x 
1740). 
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5.11 TABLES 
TABLE 117 
Protein content as an expression of cell size. Macrophages harvested 
from mice 2 days post-inoculation. Cells \.ashed after 2 hours in 
culture to remove non-adherent cells then inoculated for a further 
10 hours before assay (1 x 106 macrophages plated initially). 
Control 
N.asteroides-
Activated 
1;. brasil iensis-
Activa ted 
/9 cell protein 
in 50 fl sample 
2.46 
3.22 
4.57 
5.26 
5.76 
4.21 
2.93 
3.52 
3.24 
3.07 
7.06 
5.84 
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in l x 106 macrophages 
49.2 
64.4 
91. 4 
105.2 
115.2 
84.2 
56.6 
70.4 
64.8 
61. 4 
141.2 
116.8 
TABLE 118 
Nomenclature of macrophage surface projections observed by SEM 
Lamellipodium Extended flap-like process, veil or large undulating 
membrane, generally smooth but may be interrupted by 
intracytoplasmic spherules or ruffles. 
Pseudopodium 
Filopodium 
Ruffle 
Ridge 
Microvilli 
Bleb 
cobblestone 
era ter 
Lacuna 
Broad, footlike process extended out1.1ard along a 
substrate from the central nuclear cell area. 
Long, thin, thread-like process projected from the cell 
along the substrate, often appearing as an attachment 
extension and generally beginning at a cell substrate 
junction. 
Membrane extension appearing as a wavy, undulating fold 
roughly perpendicular and found anywhere on a cell 
surface. 
Broad-based narrow surface fold. 
Short, cylindrical or finger-like 
roughly perpendicular to the cell 
diameter and variable length. 
membrane 
surface 
extensions 
of uni form 
Hemispherical or bulbous projections extended out1.'ard 
from the cell surface. 
A membrane patch 1.1hich is round and platelike and 
1.·hich is layered against the cell surface, 1,,,i th the 
appearance of a collapsed ruffle. Cells 1.1ith 
cobblestones have a layered appearance. 
A rounded indentation 
smooth peripheral area. 
Small opening. 
or small depression in 
----------------------------------------------------------------------
Spherule Intracellular or intracytoplasmic spherical body, may 
represent a subplasmalemmal cytoplasmic organelle, 
probably a lysozome or lipid body. 
----------------------------------------------------------------------
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Macrophage 
diameter 
triangular 
confidence 
Control 
Na 
Nb 
TABLE 119 
size from SEM micrographs, estimated by measuring 
of spherical cells or the length of the long axes 
or elongated cells median values and their 
limits (data expressed in 1m). 
M 
LL 
UL 
M 
LL 
UL 
M 
LL 
UL 
Sphere 
n=l6 
9.245 
8.245 
10.3 
n=9 
8.49 
7.53 
9.99 
n=ll 
7.74 
6.77 
8.805 
Macrophage Shape 
Flattened 
n=2 
30.15 
8.2 
52.10 
n=O 
n=6 
29.4 
26.83 
31. 97 
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Triangle 
n=9 
18.79 
16.06 
30.5 
n=6 
25.1 
21.99 
28.21 
n=9 
27.01 
20.61 
35.6 
Elongated 
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44.27 
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n=lO 
58.9 
51. 1 
66.8 
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56.55 
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61. 5 
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Chapter 6 
DEVELOPMENTS IN UNDERSTANDING THE PATHOGENESIS OF NOCARDIA 
ASTEROIDES AND NOCARDIA BRASILIENSIS INFECTIONS 
6.1 DISCUSSION 
There are several reasons why our efforts in this study have been 
focused on the macrophage: 
1. The histological features of experimental Nocardia infection 
suggested an important role of the macrophage in normal host 
defence against the organisms; 
2. The macrophage plays a pivotal role in defence against 
related infections such as tuberculosis, 
leishmaniasis and listeriosis; 
leprosy, 
3. In the literature on experimental Nocardia infections and on 
in vitro studies it has been shown that activated 
macrophages are important in host defence against Nocardia. 
When this study was begun, the role of the macrophage in host 
resistance to Nocardia was unclear. The investigation was 
prompted by an interest in determing whether differences noted in 
experimental murine Nocardia infections might be explained in 
part or in whole by differences in macrophage function. Also, 
few investigations have directly examined the effects of Nocardia 
infection on macrophage function. Black et al ( 1983, 1985) 
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studied the effect of N.asteroides infection on macrophage 
intracellular levels of the acid hydrolase acid-phosphatase; 
apart from this work, biochemical aspects of macrophage function 
in Nocardia infections do not appear to have been reported in any 
detail. Other aspects of macrophage function in Nocardia 
infection that have been studied are phagocytosis (Beaman, 1979; 
Davis-Scibienski and Beaman, 1980 a and c; Black et al, 1983, 
1985), macrophage migration inhibition (Sundararaj and Agarwal, 
1977a) and macrophage aggregation (Sundararaj and Agarwal, 
1977a). 
In looking at macrophage function in experimental Nocardia 
infections, we clearly had to examine biochemical, functional, as 
well as morphological aspects and for this reason the various 
parameters reported were selected. 
It is known that facultative intracellular parasites are able to 
survive and multiply within macrophages. Their capacity to 
resist the microbicidal mechanisms of these cells is a major 
factor in their pathogenicity (Mauel, 1982). The parasites 
appear to survive by one or both of two mechanisms: (i) they have 
acquired the ability to avoid or counteract the effects of 
lysozomal enzymes and (ii) they may gain access to host cells 
without stimulating the respiratory burst. There are at least 
three mechanisms whereby intracellular parasites are able to 
avoid the destructive effects of lysozomal constituents: 
inhibition of phagosome-lysozome fusion, resistance to lysozomal 
constituents and escape from phagolysozomes. Resistance to 
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lysozomal constituents may possibly be achieved by presence of a 
protective coating of non-digestible material around the 
organism, or the in tracel 1 ula r pathogens may release substances 
capable of blocking the lysozomal enzymatic machinery (Mauel, 
1982). It was hoped that a study of biochemical aspects of 
macrophage function would clarify mechanisms of resistance of the 
Nocardia organism to host defence and contribute to the knowledge 
of mechanisms of pathogenesis of the nocardiae. 
Macrophage activation is an essential part of the cellular immune 
response and evidence has already been presented that plasminogen 
activator, lysozyme release and morphological and ultrastructural 
changes truly reflect the state of macrophage activation. This 
study provides evidence of marked alterations in several 
macrophage functions during the first 21 days in the course of 
infection with N.asteroides and N.brasiliensis. The data show 
that macrophages are activated with respect to some parameters of 
macrophage activation in experimental murine N.asteroides and 
N.brasiliensis infections. In contrast, macrophage function was 
shown to be impaired by measurement of the index of macrophage 
function, lysozyme release. Inoculation of live organisms in the 
absence of adjuvants and assessment of macrophage activation in 
terms of microbicidal activity (Filice, Beaman and Remington, 
1980) or in terms of cell cytoxicity (Krick and Remington, 1975) 
also gave rise to conflicting results. Morland and Kaplan (1977) 
state that activation is not a uniform and stereotyped response. 
Wing et al (1977) found that antimicrobial and antitumour 
effects of different populations of ac ti va ted macrophages were 
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not necessarily mutually consistent (Hopper, Wood and Nelson, 
1979). In this work it has been shown that macrophages from mice 
recently inoculated with pa tho gen ic Noc a rdia a re ac ti va ted in 
terms of release of the enzyme plasminogen activator, morphology, 
ultrastructure and in vitro spreading activity, and that 
macrophage activation occurs early during experimental infection 
with N.asteroides and N.brasiliensis. 
In addition, this investigation attempted to determine whether 
certain biochemical alterations in macrophage function occur in 
association with nocardial infections. This study demonstrates 
reduced intracellular levels and diminished secretion of lysozyme 
in vitro by Nocardia-activated macrophages at various time 
intervals post-inoculation. Davis-Scibienski and Beaman (1980a) 
suggested 
might be 
that maintenance of nocardial intracellular viability 
due to resistance to rather than avoidance of the 
hydrolytic environment and that organisms might be able to 
i nae ti va te the con ten ts of the 1 ysozomes. Intracellular acid-
phosphatase levels are shown to be reduced in N.asteroides 
infection ( Black et al, 1983, 1985): and macrophage protein 
synthesis is reduced on ingestion of M.leprae, with consequent 
cessation of lysozyme synthesis (Ridley et al, 1985). From the 
results of the present study it appears that de novo synthesis of 
lysozyme is inhibited by Nocardia at certain times during infec-
tion. Black et al (1983) suggested that reduced acid-phosphatase 
activity suggests bacteria-induced macrophage dysfunction and 
that reduction of lysozomal enzyme levels correlates with the 
pathogenesis of intracellular parasites. Reduction in 
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intracellular lysozyme levels may facilitate intracellular 
survival of the Nocardia parasite and contribute to the 
pathogenesis of the disease. 
This study examines the possibility that macrophage responses in 
N.asteroides and N.brasiliensis infections may be different by 
comparing biochemical, morphological and ultrastructural aspects 
of macrophage function in these infections. In terms of the 
aspects of macrophage function studied, major differences in 
macrophage responses to inoculation with N.asteroides and 
N.brasiliensis were not found, although minor differences in 
enzyme release were shown at certain times post-inoculation in 
the two types of infection. Production and release of lysozyme by 
peritoneal macrophages appears to be different at 13 and 21 days 
post-inoculation. Simi la rl y, the degree of macrophage response 
in terms of plasminogen activator release appears to be different 
in N.asteroides and N.brasiliensis infections, although 
plasminogen activator release by macrophages is significantly 
enhanced over the 21 day period post-inoculation. Strain of 
micro-organism did not appear to influence morphology of 
macrophages, as judged by phase-contrast and SEM. 
The implications of the findings in this study of macrophage 
function and its relationship to the his topa tho log i ca 1 features 
of the nocardial lesion are interesting, al though reduction in 
macrophage intracellular levels of lysozyme has not entirely 
explained the differences in the pathogenesis and pathology of 
the two infections studied lysozyme level is reduced in both 
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N.asteroides and N.brasiliensis infections at 7 days post-
inoculation. This calls into question whether the original 
suggestion that the local pathogenic response to experimental 
murine infection with N.asteroides and N.brasiliensis might be 
quite different ( Folb, Jaffe and Altmann, 1976). However, the 
evidence seems to be sound that the original observation was a 
valid one (Uesaka et al, 1971; Melendro et al, 1978; Ximenez et 
al, 1980; Rico et al, 1981; Conde et al, 1982). Another 
explanation might be that although a fairly broad series of 
probes has been used, that aspect of macrophage function that 
determines the difference in pathological response has not been 
identified. The third poss ibi 1 i ty is that the differences in 
pathological responses are explained by non-macrophage factors, 
eg lymphocytes, humeral factors, etc. This is difficult to 
accept because structurally and ultrastructurally it appeared 
that the difference between the two lesions resided in the 
macrophage. Therefore a study of the interelationships between 
reductions in macrophage intracellular lysozomal enzyme levels 
and the histopathological features of the lesion should clarify 
these findings. 
What has been shown in the work reported here, and by others, is 
that the macrophage is definitely involved in murine responses to 
acute nocardial infections and that there appears to be a time 
sequence of biochemical events. 
The his topa tho logical studies by Folb, Jaffe and Altmann ( 1976) 
suggested that parameters of macrophage function may be depressed 
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in N.brasiliensis infection. This was shown to be so with 
respect to lysozyme release at 7 and 13 days post-inoculation. 
However, lysozyme release was also inhibited at 7 and 21 days 
post-inoculation with N.asteroides, indicating depression of 
macrophage function in infections due to this strain as well. 
The alternative idea that degree of activation or inhibition of 
macrophage function may be different in N.asteroides and 
N.brasiliensis infections appeared to be correct with regard to 
release of plasminogen activator and lysozyme. 
We originally concerned ourselves with the study of Nocardia 
infections because we saw them as opportunistic in certain cases. 
It appears that all opportunistic infections are characterised by 
an extensive macrophage response in the body. In addition, there 
are striking parallels between the related organisms Nocardia and 
M.leprae, e.g. they are both facultative intracellular parasites, 
both are identifiable in macrophages, both produce different 
forms of pathological response and both reduce intracellular 
lysozyme levels. The consensus of opinion is that cell-mediated 
immunity is diminished in lepromatous leprosy (Rojas-Espinosa et 
al, 1982). It is likely that one mechanism of immunosuppression 
associated with opportunistic infections operates through 
suppression of macrophage function. This study, as in others, 
has shown that an aspect of macrophage function is impaired in 
experimental murine Nocardia infections. However, pathogenicity 
of Nocardia organisms and host defence consist of a complex and 
multiple series of factors (section 1.8). Reduction in 
intracellular lysozyme level and diminished secretion is one of 
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the factors which may contribute to the pathogenicity of the 
disease. 
There are several limitations in the work presented in this 
dissertation: 
(1) The study is necessarily selective because it has not been 
possible to encompass the full spectrum of macrophage 
responses. 
(2) It has not been possible to use in vitro systems that 
examine more acutely the reactions between various 
components of cell-mediated immunity - for instance, systems 
to separate lymphocyte - macrophage interactions were not 
employed. 
(3) The findings of this study in the mouse model can not 
necessarily be extrapolated to the human system. There is 
no proof that these two nocardial infections produce 
pathology in humans comparable to that produced in the mouse 
model. 
However, the macrophage clearly has a significant place in host 
response to Nocardia infections. 
If the hypothesis that modulation of biochemical function of 
macrophages by Nocardia infections is related to the differences 
in his topa tho logy of the two lesions is correct, perhaps more 
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vigorous investigation of lymphocyte function and interactions 
with macrophages needs to be undertaken to elucidate the 
differences in the pathogenesis of the two infections studied. 
6.2 SUMMARY OF FINDINGS OF THIS STUDY 
1. Release of macrophage plasminogen activator: 
1.1 Murine peritoneal macrophages exhibit significantly 
increased in vitro secretion of pla sminogen ac ti va tor in 
both N.asteroides and N.brasiliensis infections. Secretion 
of plasminogen activator was significantly elevated at 2, 7, 
13 and 21 days post-inoculation compared with controls. It 
follows that macrophages from mice recently infected with 
the pathogens N.asteroides and N.brasiliensis are activated 
in terms of this parameter of macrophage activation. 
1.2 Macrophage responses to both N.asteroides and N.brasiliensis 
appear to be modified over the 21 day period of infection 
with respect to plasminogen activator release. Macrophage 
function in N. as teroides and N. bras i 1 iens is infections is 
similar in that release of plasminogen activator is elevated 
in both infections. 
1. 3 However, the pat tern of secretion of pla sminogen ac ti va tor 
in N.asteroides infection appears to be different to that in 
N.brasiliensis infection. Therefore the alternative idea 
that the degree of macrophage activator may be different in 
N.asteroides and N.brasiliensis infections appears to be 
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correct with regard to the release of plasrninogen activator. 
1.4 Macrophage activation in terms of release of plasminogen 
activator occurs early in infection, that is at 2 days post-
inoculation. 
2. Intracellular lysozyme levels and release of the enzyme. 
2.1 Secretion of lysozyme was significantly reduced in both 
N.asteroides and N.brasiliensis infections at 7 days post-
inoculation, in N.brasiliensis infection at 13 days post-
inoculation and in N.asteroides infection at 21 days post-
inoculation. The functional status of macrophages is 
impaired at certain intervals post-inoculation. 
2.2 This study demonstrates reduced intracellular levels as well 
as diminished secretion of lysozyme in vitro by Nocardia-
acti va ted macrophages at various time intervals post-
inoculation. 
2.3 It appears that de novo synthesis of lysozyrne is inhibited 
by Nocardia at certain times during infection. 
2.4 Production and release of lysozyrne by peritoneal macrophages 
appears to be different in experimental N.asteroides and 
N.brasiliensis infections at 13 and 21 days post-inoculation 
and possibly at 2 days post-inoculation. 
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2.5 Macrophage responses to infections with N.asteroides and 
N.brasiliensis are modified over the 21 day infection period 
with respect to release of lysozyme. 
2.6 Impairment of macrophage function in terms of reduced 
intracellular levels and diminished secretion of lysozyme 
may be one of the mechanisms of pathogenesis of the 
nocardiae. 
3. Morphological and ultrastructural aspects of macrophage 
function. 
3.1 Morphological and ultrastructural characteristics of 
activated macrophages were exhibited by macrophage from 
Nocardia-infected mice at each time interval post-
inoculation studied. Features of activated macrophage were 
shown using both phase-contrast and scanning electron 
microscopy. 
3.2 There did not appear to be any differences in the morphology 
or ultrastructure of N.asteroides- and N. brasiliensis 
-ac ti va ted macrophages whether viewed using phase-contrast 
or SEM. 
3.3 Duration of infection did not appear to influence cell 
morphology. 
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3.4 Enhanced in vitro spreading activity was observed in 
cultures of macrophages from Nocardia-infected mice 
throughout the period of study. 
3.5 Macrophage activation in terms of morphological 
characteristics and spreading ability occurs early in 
infection, that is at 2 days post-inoculation. 
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